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ABSTRACT 
Antigenotoxicity and Anticarcinogenicity Studies of Tea PoIyphenolics in 
Mammalian Systems 
A large number of substances such as drugs, cosmetics, pesticides and 
petroleum products have been established as mutagens. Ames Test confirmed that several 
components of the human diet contains a great variety of natural mutagens or `nature's 
pesticides'. The main danger of'  such- AvRt 'spread --:and inadvertant exposure lies in the 
danger of their potential of enhancing genetic- load.. The environmental mutagens are 
attributed to several humanilis.Jike-cgncer, atheroscerlosis and ageing. The increasingly 
wide use of these mutagens in almosf`eveiy••sphere of human life, requires an urgent need 
for studies on the possibility of intervention through antimutagenic action. A large 
number of natural substances are capable of inactivating environmental mutagens. The 
characterization of these substances is also important for the possibility of intervention 
and using them as chemotherapeutic or prophylactic agents against human ill-healths, 
attributable to mutations. These substances are termed as 'antimutagens'. 
Plants are the essential source of medicines. Through the advances in 
pharmacology and synthetic organic chemistry, the dependence on natural products, 
remain unchanged. In India, the majority of populations use traditional natural prepartion 
derived from the plant material for the treatment of various diseases. There is an 
increasing evidence that specific substances found in certain foods can enhance general 
healthy eating recommendations e.g. phenolic compounds found in plants. Tea is rich in 
specific phenolic compounds including flavonoids, the effective antioxidants found 
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throughout the plant kingdom. Tea is processed differently in different parts of the world 
to give green (20%), black (78%) or oolong tea (2%). Black tea represents approximately 
78% of total consumed tea in the world, whereas green tea accounts for approximately 
20% of tea consumed. The fresh Green tea leaves contain four major catechins as 
colourless water soluble compounds, epicatechin (EC), epicatechin gallate (ECG), 
epigallocatechin (EGC) and epigallocatechin gallate (EGCG). BIack tea, obtained by tea 
Ieaves fermentation contains oxidized compounds that combine with other polyphenols to 
form orange-red compounds called theaflavins. There are four individual theaflavins in 
black and oolong tea which are theaflavin (TF1), theaflavin-3-gallate (TF2A), theaflavin-
3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3). The theaflavins react with more 
units to form the thearubigins. 
People have been consuming brewed tea from the leaves of the Camellia 
sinensis plant for almost 50 centuries. Although health benefits have been attributed to 
tea, especially green tea, since the beginning of its history, scientific investigations of this 
beverage and its constituents have been underway for less than three decades. Currently, 
tea, in the form of green or black tea, next to water, is the most widely consumed 
beverage in the world. Tea polyphenols comprise about one-third of the weight of the 
dried leaf, and - they exhibit biochemical and pharmacological activities including 
antioxidant activities, inhibition of cell proliferation, induction of apoptosis, cell cycle 
arrest and modulation of carcinogen metabolism. Several plant-based nutrients and non-
nutrients that can inhibit mutagenesis and proliferation have been identified. Some of the 
most promising nutrients identified as chemopreventive agents in colon cancer prevention 
include isoflavones, curcumin, calcium, vitamin D and more recently Green tea 
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polyphenols (GTP). In addition to inhibiting mutagenesis and proliferation, these 
compounds are relatively non-toxic, are of low cost and can be taken orally or as a part of 
the daily diet. Epidemiological and laboratory studies have identified Epigallocatechin 
gallate (EGCG) in green tea polyphenols, as the most potent chemopreventive agent that 
can induce apoptosis, suppress the formation and growth of human cancers including 
colorectal cancers (CRC). There is growing interest in the possible health benefits of tea, 
specially of Green tea 
Present study, therefore, is directed towards investigation of the 
antigenotoxic and anticarcinogenic action of tea polyphenolics, mainly Green tea 
polyphenols. Gas Chromatography and Mass Spectrometry of Green tea extract was 
performed for detection of polyphenolic contents in the Green tea extract. 
The study was conducted in three phases, where the first phase deals with 
in vivo assessment of possible toxicity risks of Green tea extract (GTE) in mice. 
Experiments, were conducted to determine the oral lethal dose (LD5O). The GTE dose 
ranges of 100 to 5000 mg/kg body weight was administered orally to the mice and the 
treated groups were observed continuously for 10 days (acute toxicity). The effects on the 
weight changes and some biochemical parameters were evaluated. Increase in the body 
weight of the GTE treated groups was normal. The plasma concentrations of urea, 
creatinine and SGOT (serum glutamic oxaloacetic transaminase) were not much changed 
as compared to controls. The Ievels of GSH (Reduced Glutathione), SOD (Superoxide 
Dismutase) and CAT (Catalase) were found slightly increased in the animals that 
received the GTE tested doses, but the increase was not significant. The acute toxicity 
value (LDSQ) of the GTE was determined to be more than 5000 mg/kg body weight, 
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indicating that it poses no risk to general health of treated animals. But still not more than 
four cups a day of highly concentrated (up to 3% of green tea extract) may be consumed. 
The second phase of the study deals with in vitro assessment of 
antigenotoxic potentials of tea polyphenols. The study included the damage induced by 
Trenbolone, Methyltestosterone, Docetaxel and Tamoxifen, in human lymphocytes in 
vitro, and then treatment of these cultures with Tea polyphenols. Each of the above four 
mentioned drugs were studied at different concentrations and were found to be genotoxic 
in the presence as well as absence of S9 mix. The reactive species liberated by genotoxic 
steroids and anticancer drugs, before or after metabolic activation, may be responsible for 
their genotoxic action. In this study, we have seen the antigenotoxic effect of Green tea 
extract (GTE), Epigallocatechin gallate (EGCG), Epi Catechin Gallate (CG) and Black 
tea extract (BTE), both in presence and absence of metabolic activation. Metaphase plates 
so obtained were used for Sister chromatid exchange (SCEs) analysis, Chromosomal 
aberration (CAs) analysis and calculation of Replication index (RI). 
Trenbolone is a synthetic steroid used frequently by veterinarians on livestock as a 
promoter of growth in animal husbandry. It is not used in an unrefined form, but is rather 
administered as Trenbo[one acetate. Trenbolone compounds have not yet been approved 
by the Food and Drug Administration, USA for use by humans due to their considerable 
negative side effects, although bodybuilders use the drug illegally to increase their body 
mass and strength. About 10 - 60 µM of Trenbolone was studied in human lymphocytes 
in vitro using parameters as CAs, SCEs and RI, both in the presence and in the absence of 
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metabolic activation. Trenbolone at different concentrations (10, 20, 30, 40 and 60 .tM) 
was found to be genotoxic in the presence as well as absence of S9 mix. 
Green Tea Extract (GTE) tested doses, 1.075X 10-4, 2.127 X 10-4 and 3.15 
X 10-4 g/ml, CG (tested doses were 10, 20 and 30 µM) and EGCG ( tested doses were 
20 and 30 p.M) were administered with 40 and 60 M of Trenbolone, in different sets of 
experiments. The treatment leads to a significant reduction of CAs and SCEs, and an 
increase in RI, suggesting a protective role of tea polyphenols against Trenbolone-
induced genotoxic damage. 
Methyltestosterone is a 17-alpha-alkylated anabolic steroid used to treat men with a 
testosterone deficiency. It is also used in women to treat breast cancer, breast pain, 
swelling due to pregnancy. People who abuse Methyltestosterone could suffer from acute 
poisoning and may also be at risk of death from premature heart disease or cancer. 
10 - 60 uM of Methyltestosterone was studied in human lymphocytes in vitro using SCEs 
and RI, both in the presence and in the absence of metabolic activation. 
Methyltestosterone at different concentrations (10, 20, 30, 40 and 60 µM) was found to 
be genotoxic in the presence as well as absence of S9 mix. The effect of GTE was 
studied against Methyltestosterone-induced genotoxic damage using SCEs and RI. 
Green Tea Extract (GTE) tested doses, 1.075X 10', 2.127 X 10-4 and 3.15 X 
10-4 g/ml, was administered with 40 and 60 }iM of Methyltestosterone. This treatment 
results in substantial reduction of SCEs and increase in cell cycle kinetics suggesting a 
protective role of GTE. 
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Docetaxel is a clinically well established anti-mitotic chemotherapy medication used 
mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel has 
an approved claim for treatment of patients who have locally advanced, or metastatic 
breast or non small-cell lung cancer. It is also useful in the patients, who have undergone 
anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. 
About 3 and 6 gM of Docetaxel was studied in human lymphocytes using CAs, SCEs and 
RI, both in the presence and in the absence of metabolic activation. Docetaxel, at both 
these concentrations, was found to be genotoxic in the presence as well as absence of 59 
mix. 
Green Tea Extract (GTE) tested doses, 1.075X 10-4, 2.127 X 10-0 and 3.15 
X l0-4 gfml, CG (tested doses were 10, 20 and 30 µM), EGCG (tested doses were 20 
and 30 µM) and 1.075 X 10-4, 2.127 X 104 and 3.15 X 10-4 glml of Black tea extract 
(BTE), were administered with 3 and 6 pM of Docetaxel, in the different sets of 
experiments, both in the presence as well as absence of S9 mix. The results so obtained 
indicated a significant reduction of CAs and SCEs, and an increase in RI, suggesting a 
protective role of tea polyphenols against Docetaxel induced genotoxic damage. 
Tamoxifen (TAM) is an anti-oestrogen used to treat patients with early-stage breast 
cancer, as well as those with metastatic breast cancer. It has been proposed that this non-
steroid and its reactive intermediates increase the risk of endometrial and uterine cancer in 
breast cancer patient receiving TAM therapy. Human TAM metabolites have 
carcinogenic potential. About 3 and 6µM of Tamoxifen citrate salt was studied in 
cultured human lymphocytes using CAs, SCEs and RI, both in the presence and in the 
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absence of metabolic activation. Tarnoxifen, at both these concentrations was found to be 
genotoxic in the presence as well as absence of S9 mix. 
Green Tea Extract (GTE) dosesl.075X 10-4, 2.127 X 104 and 3.15 X 
10-4 g/ml and Black tea extract (BTE) doses 1.075X 10', 2.127 X 10-4 and 3.15 X 104  
g/ml, were administered with 3 and 6 µM of Tamoxifen, in different sets of experiments, 
both in the presence as well as absence of S9 mix. We found a significant reduction in 
CAs and SCEs, and an increase in the cell cycle kinetics, implying an antigenotoxic 
action of tea extract used. 
The genotoxic endpoints used here are well known markers of 
genotoxicity and any reduction in the frequency of these genotoxic endpoints gives us 
indication of the antigenotoxicity of a particular compound that leads in reduction of the 
frequency of these genotoxic endpoints. In this part of the study we have found that Tea 
polyphenols can modulte the genotoxic effects of the drugs, indicating their protective 
role 
The third phase of study deals with in vitro assessment of 
anticarcinogenic potentials of Green tea extract. Cytotoxicity of the Methanolic 
extract of Green tea was evaluated by the assessment of its in vitro impact on the Human 
Breast cancer cell line (MCF-7) and Human Embryonic Kidney cell line (HEK 293). 
Cytotoxicity assays like Cellular metabolic MTT assay and Neutral Red uptake assay 
were performed along with observation of the morphological and nuclear changes in the 
cell lines by using inverted microscope. The results revealed that the methanolic extract 
of Green tea had a significant cytotoxic impact on MCF-7 cells and HEK 293 cells with 
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the minimum inhibitory concentration (1050 mean value) of 592.6 gglml and 1041.35 
µgfml, respectively, on both the cell Iines. 
The antigenotoxic and anticarcinogenic potential of the plant extracts have 
been attributed to their total phenolic content. The anticarcinogenic potential of tea 
polyphenols have been correlated with their cytotoxic effects with the induction of 
apoptosis, activation of caspases, inhibition of protein kinase, modulation of cell cycle 
regulation and inhibition of cell proliferation, making it a protective beverage. 
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CHAPTER ONE 
INTRODUCTION 
In India, the majority of populations use traditional natural preparations derived 
from the plant material for the treatment of various diseases and for that reason it has 
become necessary to assess their antimutagenic potential or even mutagenic potential. 
The plant extracts have molecules that may either enhance or reduce the genotoxic 
effect of a particular compound. The knowledge of the particular plant extract will 
contribute in developing the basis of herbal medicine (Roncada et al., 2004). The 
antigeotoxic potential of the plant extracts have been attributed to their total phenolic 
content (Maurich et al., 2004). Medicinal herbs contain complex mixtures of 
thousands of compounds that can exert their antioxidant and free radical scavenging 
effect either seperately or in synergistic ways (Romero- Jimenez et al., 2005). 
A large number of substances such as drugs, - cosmetics, pesticides and 
petroleum products have been established as mutagens (Marshall et al., 1976; Hahn et 
al., 1991). Ames Test can confirm that several components of the human diet contain 
a great variety of natural mutagens or nature's pesticides'(Kawai et al., 2006). The 
main danger of such widespread and inadvertant exposure lies in the danger of their 
potential for enhancing genetic load. The environmental mutagens are linked with 
several human ills like cancer, atheroscerlosis and ageing (Jensen et al., 1990). Thus, 
the increasingly wide use of these mutagens in almost every sphere of human life, 
requires an urgent need for studies on the possibility of intervention through 
antimutagenic action. A large number of natural substances are capable of inactivating 
environmental mutagens. The characterization of these substances is also important 
for the possibility of intervention and using them as chemotherapeutic or prophylactic 
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agents against human ill healths attributable to mutations. These substances are 
termed as `antimutagens' (Yamamoto and (3aynor., 2006). They are found in various 
food items in variable quantities. The chemicals present in plants are called 
phytochemicals and include flavanoids, vitamin A, C, E, beta- carotenes etc. 
Polyphenolic phytochemicals are common substances throughout the plant kingdom. 
They provide an important role in plant metabolism, provide some defense against 
predators (by their astringency), form the brilliant colors in many fruits and 
vegetables, and prevent premature seed germination. Being so ubiquitous, 
polyphenols naturally form an integral part in human and animal diets. Until recently, 
their role had been classified by animal nutritionists as "antinutrients" due to the 
adverse affect on protein and carbohydrate digestibility of tannin, which is itself a 
compound polyphenol. But in last few decades these polyphenolic compounds have 
gained special attention as they showed high antioxidant and anticarcinogenic 
properties. 
PHENOLIC PHYTOCHEMICALS 
Non•Flavonold Polyphenols 
e.g. hydrolysable tannins 
(ellagic acid) 
Fiavonoids 
largest group of plant phenols 
common C8-C3-C6 skeleton 
• may be termed polyphenols 
Phenolic Acids 
not polyphenols 
OH benzoates 	OH•cinnamates 
raspberry 	coffee 
strawberry 
Flavonofs Flavones 	Flavanois 
tea celery 	tea 
apples parsley 	apples 
onions wine 
Isoflavones 	Flavanones 	Anthocyanidines 
soy 	 citrus fruits 	red ovine 
blueberries 
cherries 
Catochins 
green tea 
	
Theaflavins 	ThearubigIns 
black tea 	black tea 
Tea is second only to water as the most consumed beverage in the world. Tea has 
been consumed worldwide since ancient times to maintain and improve health. The 
health benefits associated with tea consumption have resulted in the wide inclusion of 
green tea extracts in botanical dietary supplements, which are widely consumed as 
adjuvants for complementary and alternative medicines. The tea shrub (genus 
Cainellia, family Theaceae) [chromosome number (2n=30)] is a perennial evergreen 
plant with its natural habitat in the tropical and sub tropical forests of the world. 
Cultivated varieties are grown widely in its home countries of South and South East 
Asia, as well as in parts of Africa and the Middle East. Tea is a rich source of 
polyphenols called flavonoids, the effective antioxidants found throughout the plant 
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kingdom. The slight astringent, bitter taste of green tea is attributed to these 
polyphenols, specially flavanoids. The flavonoids are members of a class of natural 
compounds that recently has been the subject of considerable scientific and 
therapeutic interest. The flavonoids appear to have played a major role in successful 
medical treatments of ancient times, and their use has persisted up to now .A group of 
flavonoids in green tea are known as catechins, which are quickly absorbed into the 
body and are thought to contribute to some of the potential health benefits of tea. The 
health benefits of tea ranging from a lower risk of certain cancers to weight loss, and 
protection against Alzheimer's, have been linked to these polyphenolic content of the 
tea. These polyphenols are also believed to have a wide range of pharmaceutical 
benefits, including antihypertensive (Henry et al., 1984; Hara et al., 1987), 
antioxidative (Zhang et al 1997; Halder and Bhaduri, 1998) and hypolipidemic (Chan 
et al., 1999; Kono et al., 1992) activities. Historical references of tea date back to 
5,000 years. Tea was consumed even earlier by the indigenous peoples of China. Tea 
has been recorded as having medicinal value in a Chinese medical book (Maciocia, 
2005). In Chinese and Indian traditional medicine, tea has been used for: treatment of 
insomnia, calming effects, mental and visual clarity, thirst quenching, detoxification 
of poisons, improving digestion, prevention of indigestion, breaking down oils, fats, 
body temperature regulation, improving urination, speeding bowel evacuation, 
treatment of dysentery, loosening of phlegm, strengthening of teeth, treatment of epi-
gastric pain, treatment of skin fungus, reducing hunger and adding to longevity. 
The fresh tea leaves contain four major catechins, [Figure A] as colourless 
water soluble compounds: epicatechin (EC, 6.4% approximately of the total 
catechins), epicatechin gallate (ECG, 13.6% approximately of the total catechins), 
epigallocatechin (EGC, 19% approximately of the total catechins) and 
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epigallocatechin gallate (EGCG, 59% of the total catechins) (Zhu et al., 2000). EGCG 
makes up about 10-50% of the total catechin content and appears to be the most 
powerful of the catechins. 
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Figure A. Structures of green tea flavonoids (reproduced from Zuo etal., 2002) 
Epicatechin Molecular weight: 290 
Epigallocatechin Molecular weight: 306 
Epicatechin'-3-gallate Molecular weight: 442 
Epigallocatechin-3-gallate Molecular weight: 458 
r. 
Leaves of Camellia sinensis soon begin to wilt and oxidize if not dried quickly 
after picking. The leaves turn progressively darker because chlorophyll breaks down 
and tannins are released. This process, an enzymatic oxidation, is called fermentation. 
Tannins, a group of simple and complex phenol, polyphenols and flavonoid 
compounds produced by plants. Tannins are relatively resistant to digestion or 
fermentation (Abe et al., 2008). The next step in processing is to stop the oxidation 
process at a predetermined stage by heating, which deactivates the enzymes 
responsible. Processing of tea involves following steps (Werkhoven, 1978): 
• Withering (the process of letting leaves lose moisture content after plucking, 
often the first step in the processing of tea). 
• Rolling (ruptures cell walls allowing the polyphenols to become oxidized). 
• Fermenting (the process of the polyphenols becoming oxidized). 
• Firing (halts the fermentation process and begins desiccation). 
• Drying (reduces moisture content to make the final product more stable). 
The various types of tea are made by different combinations of these 
processes. The young shoots or flushes are plucked and processed into green 
(unfermented), black (fermented), oolong (red, partially fermented) or yellow 
(partially fermented) teas. In fermented teas, the action of leaf oxidizing enzymes help 
in converting the tannins and catechins of the tea leaves into brown/red colored 
products. Compared with green and oolong tea, black tea is the most consumed 
beverage. Black tea represents approximately 78% of total consumed tea in the world, 
whereas green tea accounts for approximately 20% of tea consumed and oolong tea 
for approximately 2%. 
Most of the green tea catechins, during the manufacture of black tea, 
are oxidized and converted into orange or brown products known as theaflavins (TF) 
7 
and thearubigins (TR). These compounds retain the basic C6-C3-C6 structure and are 
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thus still classified as flavonoids. Theaflavins consist of two catechin molecules 
joined together, and account for about 10% of the converted catechins, whereas the 
thearubigins are more complex flavonoid molecules, whose structural chemistry are 
still unknown, and may account for up to 70% of flavonoids in black tea. The major 
TF in black and oolong tea are theaflavin (TF1), thea#lavin-3-gallate (TF2A), 
theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3)[Figure B]. 
Figure B. Main polyphenols found in Black and Oolong Tea 
n 
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Theaflavin Molecular weight: 564.5 
Theaflavin-3-gallate Molecular weight: 716.6 
Theaflavin- 3'-gallate Molecular weight: 716.6 
Theaflavin-3,3'-digallate Molecular weight:868.8 
Black tea polyphenols have numerous health benefits, including the 
prevention of chronic diseases such as cancer and cardiovascular diseases. Evidences 
support the protective ability of black tea polyphenols to reduce the risk of coronary 
heart disease (CHD), with an intake of about 3 cups per day (Lin et al., 1999; Lin et 
al., 2006). Apart from antioxidative activity, abundant epidemiological studies, with 
both in vitro and in vivo studies, showed that black tea polyphenols particularly 
theaflavins, have ability to act as anti-carcinogen. Theaflavins and Thearubigins are 
responsible for the characteristic color and flavor of black tea. 
Dried green tea leaves contain about 3 0-40% Catechins, 3-6% Caffeine, -310 
mg polyphenols per 6 ounces, while black tea (Crushed tea leaves -* Polyphenol 
oxidase— Oxidations Polymerization) contains 3-10% Catechins, 2-6% 
Theaflavins, > 20% Thearubigins, 3-6% Caffeine, -340 mg polyphenols per 6 ounces 
(According to Nutritional Science Research Group, Division of Cancer Prevention). 
Both catechins and theaflavins have recently received much attention as protective 
agents against cardiovascular disease and cancer. (Imai and Nakachi,1985; 
Buschman., 1998; Yang, 1999). They are also believed to have a wide range of other 
pharmaceutical benefits, including antihypertensive (Henry et al., 1984; Hara et al., 
1987) , antioxidative (Zhang et al 1997; Haider and Bhaduri, 1998) and hypolipidemic 
(Chan et al., 1999; Kono et al., 1992) activities. 
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1.1 DESCRIPTION OF THE TEST CHEMICALS USED 
Here is a brief description of the drugs used in this study for their known potential 
genotoxic effects. 
(i) Trenbolone 
Trenbolone is a synthetic steroid used frequently by veterinarians on livestock as a 
promoter of growth in animal husbandry (Richold, 1988). It is not used in refined 
form , but is rather administered as trenbolone acetate. Trenbolone compounds have 
not yet been approved by the Food and Drug Administration, USA for use by humans 
due to their considerable negative side effects. Although bodybuilders use the drug 
illegally to increase their body mass and strength. A normal bodybuilding dosage can 
range from 200 mg/week up to 1400 mg/week. Due to the relatively short metabolic 
half-life of trenbolone acetate, dosages should commonly be split into injections at 
least once every two days. Trenbolone enanthate can be injected once a week. Cases 
of prostate and hepatic cancers have been associated with long term anabolic steroid 
abuse (Roberts and Essenhigh, 1986; Overly et al., 1984). 
Trenbolone* 
CISH2202 Molecular weight 270.366 
1713-Hydroxyestra-4,9, 1 1-trien-3-one 
Trenbolone compounds increase nitrogen uptake by muscles after 
metabolization, Ieading to increased rate of protein synthesis. Prostate and hepatic 
cancers associated with anabolic steroid abuse has led to the study of Trenbolone, at 
different doses, for genotoxicity induction in cultured human lymphocytes using 
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chromosomal aberrations and sister chromatid exchanges as parameters, in the 
presence as well as absence of metabolic activation system. 
(ii) Methyltestosterone 
Methyltestosterone is a 17-alpha-alkylated anabolic steroid used to treat men with a 
testosterone deficiency. It is also used in women to treat breast cancer, breast pain, 
swelling due to pregnancy. Only strict doses of 1-2 tabs of 50 mg Methyltestosterone 
are used. The general rule of thumb is to use 0.5 or 0.6 mg per pound of bodyweight, 
because of the negative effects on the liver, its often not used for more than a two or 
three weeks. People who abuse Methyltestosterone could suffer from acute poisoning 
and may also be at risk of death from premature heart disease or cancer. A case of 
night blindness was reported after continuous use of Methyltestosterone (Nisbett et 
al., 1985). For women, long term effects include voice changes and fusion of the 
epiphyses in children. Androgen ingestion by a pregnant mother can cause virilization 
of a female fetus (Dewhurst and Gordon,1984). Orally active (17-alpha substituted) 
anabolic steroids can cause abnormalities of hepatic function, manifested as 
abnormally elevated hepatic enzyme activity in biochemical tests of liver function and 
sometimes as overt jaundice. The histological abnormality of peliosis hepatitis has 
been associated with anabolic steroid use (Soo et al., 1992). Angiosarcoma (Falk et al, 
1979) and a case of hepatocellular carcinoma in an anabolic steroid user has been 
reported by Overly et al., 1984. 
Methyltestosterone* 
C2OH30O2 Molecular Weight. 302.46 
17-13-hydroxy-17-methylandrost-4-en-3-one 
OH GHQ ... O 
CH H 
~{ 	H 
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(iii) Docetaxel 
Docetaxel (brand name Taxotere) is a clinically well established anti-mitotic 
chemotherapy medication used mainly for the treatment of breast, ovarian, and non-
small cell lung cancer (Lyseng-Williamson and Fenton, 2005). Docetaxel has an 
approved claim for treatment of patients who have locally advanced, or metastatic 
breast or non small-cell lung cancer and those who have undergone anthracycline-
based chemotherapy and failed to stop cancer progression or relapsed. Docetaxel is 
marketed worldwide under the jname Taxotere by Sanofi-Aventis. Evaluation of 
docetaxel pharmacokinetics in phase II and III clinical studies were with 100 mg/m2 
1 
dosages given over one-hour f infusions every three weeks. Docetaxel is a 
i 
chemotherapeutic agent and is a cytotoxic compound and so is effectively a 
biologically damaging drug (Rang et aI., 2003). Because docetaxel is a cell cycle 
specific agent, it is cytotoxic to all dividing cells in the body. 
Docetaxel* CA3H53NO14 Molecular weight :807.879 g/mol 
(2R,3S) N-carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5, 20-epoxy-1, 2, 4, 7, 10, 13- 
hexahydroxytax-11-en-9-one 4-acetate 2-benzoate, trihydrate 
(iv) Tamoxifen (TAM) 
Tamoxifen (TAM) (Sold under brand name: Nolvadex, Istubal, and Valodex) is an 
anti-oestrogen used to treat patients with early-stage breast cancer, as well as those 
with metastatic breast cancer. As adjuvant therapy, tamoxifen helps prevent the 
original breast cancer from returning and also helps prevent the development of new 
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cancers in the other breast.(The BIG 1- 98 Collaborative Group, 2009) It has been 
proposed that this non-steroid and its reactive intermediates increase the risk of 
endometrial and uterine cancer in breast cancer patients receiving TAM therapy 
(International Agency for Research on Cancer, 1996). Human TAM metabolites has 
carcinogenic potential. 4- hydroxyl-N-desmethyltamoxifen (metabolites Bx) reacts 
with DNA in vitro in absence of any other activating factors. During long term 
treatment with TAM, even rare DNA modifications could accumulate to levels which 
may affect genome stability( Blumberg et al., 1998). 
Tamoxifen* 
C32H37NOg Molecular Weight 563.6 
(Z)-2-[4-(1,2-Diphenylbut-l-enyl)phenoxy]-N,N-dimethylethylamine citrate 
(iv) Methyl methanesulfonate (MMS) 
Methyl methanesulfonate (MMS) is a monofunctional DNA alkylating agent and a 
carcinogen (Beranek, 1990 and Lawley, 1989). Exposure to MMS appears to be 
limited to laboratory research persons (Hazardous Substance Data Bank, 2000). It is 
used in cancer treatment. MMS primarily methylates DNA on N7-deoxyguanine and 
1V3-deoxyadenine (Pegg, 1984). Several studies have found that cells are most 
sensitive to MMS during progression through S phase (Tercero and Diffley, 2001; 
Schwartz, 1989; Fung et a1.,2002). Exposure to MMS causes a checkpoint-
independent reduction in the rate of replication fork progression, likely due to a 
physical impediment of fork progression caused by alkylated DNA or some 
13 
intermediate in lesion processing (Tercero and Diffley, 2001). Methyl 
methanesulfonate induce DNA single-strand breaks and alkali-labile sites in human 
lymphocytes in vitro (Boerrigter et al., 1991) 
Methyl methanesulfonate* 
C2H603S Molecular Weight 110.1 
00 
0 	GF~a 
(* All structural formula of chemicals are reproduced from National Centre for 
Complementary and Alternative Medicine) 
1.2 DESCRIPTION OF THE NATURAL PLANT PRODUCTS USED 
(1) Green tea extract (GTE) 
Several catechins are present in significant quantities in green tea extract as; 
epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG) and 
epigallocatechin gallate (EGCG). EGCG makes up about 10-50% of the total catechin 
content and appears to be the most powerful of the catechins with antioxidant activity 
about 25-100 times more potent than vitamin C and vitamin E. 
(ii) Black tea extract (GTE) 
Four individual theaflavins found in black tea are theaflavin (TF1), theaflavin-3-
gallate (TF2A), theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3). The 
theaflavins react with more units to form the thearubigins. Theaflavins consist of two 
catechin molecules joined together, and account for about 10% of the converted 
cateehins, whereas the thearubigins are more complex flavonoid molecules, whose 
structural chemistry are still unknown, and may account for up to 70% of flavonoids 
in black tea extract. Thearubigins are responsible for the characteristic color and 
flavor of black tea. 
(iii) Epigallocatechin-3-gallate (EGCG) 
Epigallocatechin Gallate is the most abundant and potent polyphenol found in green 
tea. It breaks up into hydrogen peroxide and superoxide anion radical under quasi-
physiological conditions (at pH 7.4 and 37°C with oxygen). The effective 
concentration of EGCG in the blood or tissues of tea drinkers is in the range 0.1 to 1.0 
pmollL (Yang, 1997), an important factor in deciding whether an in vitro modulation 
of biological activity by EGCG is likely to be relevant in vivo. 
Epigallocatechin-3-gallate 
(iv) Catechin Galltae (CG) 
Epicatechin gallate (ECG) is the third major catechin component in green tea, but it 
shows strong biological activity in some aspects, including apoptosis, cell growth 
inhibition, and membrane transport system in various cells. It acts as an antioxidant 
and a free radical scavenger (Balentine et al., 1998). Reduction in atherosclerotic 
plaques (Chyu et al., 2004) and in carcinogenesis was seen in vitro (Mittal et al., 
2004) and also in vivo. 
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1.3 TONICITY OF A TEST COMPOUND 
There is a general belief that herbs are safer than pharmaceuticals because they are 
natural. But the fact is, in low amounts, they may be ineffective while in the right 
amounts, they may prove beneficial. Their use in high quantities and over a prolonged 
period maybe injurious to health. 
Scientific research has demonstrated that many traditionally used 
herbal medicines are potentially toxic and some are even mutagenic and carcinogenic 
(De SaFerrira and Vargas, 1999). The toxicity benchmarks for herbal drugs therefore 
depend on. purity, herbs containing toxic substances, bioavailability, and reported 
adverse effects (Ahmad et al., 2006). Acute toxicity is the toxicity that manifests 
itself immediately or within 14 days following exposure of animals or humans to 
single doses of chemicals (xenobiotics) by ingestion, inhalation or through the skin. 
Acute toxicity tests are generally carried out in rodents and occasionally in rabbits. 
Their current purpose is to identify a clearly toxic but sub-lethal dose, and to provide 
a rough guide for dose selection in subsequent repeated dose toxicity tests. 
1.4 GENOTOXICITY OF A TEST COMPOUND 
Genotoxicity evaluation is an important part of the toxicological assessment of test 
compounds in preclinical drug development. As genotoxic compounds may pose a 
potential risk of carcinogenicity and heritable mutations, positive results in 
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genotoxicity tests, such as clastogenicity or aneugenicity, are of key relevance in drug 
development. Internationally acceptable guidelines (International Conference on 
Harmonisation of Technical Requirements for Registration of Pharmaceuticals for 
Human Use (ICH) S2B, 1997) recommend the conduct of in vitro and in vivo 
genotoxicity assays to detect the potential of the test compounds to induce small 
mutations andlor chromosomal damage. On a chromosomal level, routine test 
procedures are the chromosomal aberration test (CAT) in vitro in human lymphocytes 
(or in vitro mouse lymphoma assay). This is supplemented by an in vivo test for 
chromosomal damage using rodent hematopoietic cells (chromosomal aberrations in 
bone marrow cells or an analysis of micronuclei in bone marrow; ICH S2B, 1997; 
Muller et al.,1999). 
A number of "indirect" mechanisms have been described that may result in 
positive genotoxicity results, including inhibition of enzymes of DNA synthesis, DNA 
repair, or DNA-topoisomerases, and generation of reactive oxygen species (ROS) 
(Scott et al., 1991). Cytotoxicity may also contribute to indirect genotoxicity 
(Kirkland et al., 2011). Additionally, processes that involve DNA degradation, like 
apoptosis, may lead to positive genotoxicity test results in clastogenicity assays 
(Meintieres et al., 2001; Meintieres and Marzin, 2004). 
Approximately 30% of all marketed pharmaceuticals exhibit positive 
genotoxicity results when tested in the standard ICH genetic toxicology battery. But 
most of these molecules have not been shown epidemiologically to pose an inherent 
risk of cancer to patient populations at the doses and frequencies of medication 
(Snyder, 2007). 
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1.5 ANTICARCINOGENICITY OF PLANT PRODUCTS 
Cancer is a class of diseases in which a group of cells display uncontrolled growth 
(division beyond the normal limits), invasion (intrusion on and destruction of adjacent 
tissues), and sometimes metastasis (spread to other locations in the body via lymph or 
blood). These three malignant properties of cancers differentiate them from benign 
tumors, which are self-limited, and do not invade or metastasize. Most cancers form a 
tumor but some, like leukemia, do not. 
Cancer may affect people at all ages, even fetuses, but the risk for most 
varieties increases with age. Cancer causes about 13% of all human deaths. (Jang et 
al.,1997). Nearly all cancers are caused by abnormalities in the genetic material of 
the transformed cells. These abnormalities may be due to the effects of carcinogens, 
such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-
promoting genetic abnormalities may be randomly acquired through errors in DNA 
replication, or are inherited, and thus present in all cells from birth. The heritability of 
cancers is usually affected by complex interactions between carcinogens and the 
host's genome. 
Medicinal plants have played important roles in the last half century in the 
treatment of cancer and most new clinical applications of plant secondary metabolites and 
their derivatives have been applied towards combating cancer. The National Cancer 
Institute collected about 35,000 plant samples from 20 countries and has screened around 
114,000 extracts for anticancer activity (Shoeb, 2006). Of all available anticancer drugs 
between 1940 and 2002, 40% were natural products or natural product-derived with 
another 8% considered natural product mimics (Newman et al., 2003). 
W 
A diet which is rich in plant foods contains a variety of secondary metabolites 
and contributes to protecting the body against cancer. Secondary metabolites carried 
out a number of protective functions in the human body. They can boost the immune 
system, protect the body from free radicals and relevantly exhibit anti-carcinogenic 
activity by serving properties as protective agents against various pathogens and as 
growth regulatory molecules. Due to these physiological functions, secondary 
metabolites are potential anticancer drugs, since either direct cytotoxicity is affected 
on cancer cells or affected on tumor development. 
A variety of phytochemicals, such as sulfides, isothiocyanates, 
glucosinolates, flavonoids, carotenoids, phenols, and diarylhepanoids, are known to 
mediate chemopreventive responses (Jang et al., 1997). One of the most fascinating 
molecules is EGCG. It exhibits antioxidant and antimutagen properties along with the 
anticarcinogenic property. 
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1.6 CELL CYCLE AND CHECKPOINTS 
The cell cycle is the sequence of events between mitotic cell divisions of eukaryotic 
cells. The cycle is divided into four phases (Fig 1.): GI (G standing for gap), S (DNA 
synthesis), G2 and M (mitosis). The interval between the completion of mitosis and 
the beginning of DNA synthesis is called GI-phase. During GI- phase, cells grow and 
monitor their environment to take a decisive step for DNA replication. During S-
phase DNA is replicated and at the end of S-phase each chromosome consists of two 
identical chromatids joined together at a region called centromere. 
The interval between the end of DNA synthesis and the onset of mitosis is 
called G2-phase. The G2-phase provides a safety gap, to ensure that DNA replication 
is complete and to monitor the cell growth and the environment before cell division. 
During mitosis, chromosomes become shorter and condensed and the spindle 
microtubules attach to the centromere to ensure that the sisterchromatids are equally 
divided between the daughter cells. Finally, two daughter cells are formed, which will 
enter a new cell cycle. 
I
M-phase: 
cell division 
GP/M  
checkpoint ~'~~ • 0 
G2-phase:  
preparation  
for mitosis  
Go-phase: 
quiescent state 
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S-phase: 
DNA synthesis 
intra-S-phase 
checkpoint 
I 	G,-phase: 
4 	preparation for DNA synthesis 
G,1S 
checkpoint 
Fig 1: Standard eucaryotic cell cycle stages and checkpoints adapted from Alberts et 
al.(1994) and Sancar et al. (2004). The cell cycle is divided into four successive phases, 
G1, S (DNA synthesis), G2 and M (mitosis). Certain cell types leave the cell cycle and 
enter a resting state called GO. The cell cycle is controlled by three main checkpoints: 
Gl/S, infra-S-phase and G2%I checkpoint. 
When cells progress from one cell cycle stage to another, the integrity of the DNA is 
examined at specific points, called checkpoints (Sancar et al., 2004). 'There are three main 
checkpoints, i.e. GIIS checkpoint, intra-S-phase checkpoint and G2/M checkpoint. The 
checkpoints employ sensor proteins to detect DNA damages as well as complex signal 
transduction pathways to inhibit the cell cycle progression. The arrest is thought to 
provide additional time for the repair of lesion and the extant of this effect depends on the 
genetic background of the cells (Fournier and Taucher-Scholz, 2004). 
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1.7 CELL DAMAGE 
Cell damage is induced by reactive oxygen species (ROS). ROS are either free 
radicals, reactive anions containing oxygen atoms, or molecules containing oxygen 
atoms that can either produce free radicals or are chemically activated by them. 
Examples are hydroxyl radical, superoxide, hydrogen peroxide, and peroxynitrite. 
The main source of ROS in vivo is aerobic respiration, although ROS are also 
produced by peroxisomal 13-oxidation of fatty acids, microsomal cytochrome P450 
metabolism of xenobiotic compounds, stimulation of phagocytosis by pathogens or 
lipopolysaccharides, arginine metabolism, and tissue specific enzymes (Nicholls and 
Budd, 2002). 
Under normal conditions, ROS are cleared from the cell by the action of 
superoxide dismutase (SOD), catalase, or glutathione (GSH) peroxidase. The main 
damage to cells results from the ROS-induced alteration of macromolecules such as 
polyunsaturated fatty acids in membrane lipids, essential proteins, and DNA. 
Additionally, oxidative stress and ROS have been implicated in disease states, such 
as Alzheimer's disease, Parkinson's disease, cancer, and aging. 
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1.8 ASSAY SYSTEMS/ GENOTOXIC ENDPOINTS USED 
1.8.1 In vivo assessment of possible toxicity risks of tea extract in mice 
In vitro methods such as cell and tissue cultures are increasingly being used, but their 
predictive capacity is still severely limited. Hence, in vivo method to assess the possible 
toxicity risks of any compound are very necessary as we can determine the lethal dose 
(LD50) of the compound. The LD50 value (lethal dose 50%) using animals (usually based 
on rats or mice) gives a value for the death of half the animals tested. An LD50 of 2 g/kg 
refers to the total weight of material testedibody mass of test animal that caused death in 
half the number tested. Thus, if a human weighed 70 kg then it might be expected that 
140 g could be consumed before it was fatal. 
1.8.2 In vitro assessment of possible antigenotoxic potentials of tea polyphenols 
Chromosomal Aberrations: 
Normal human cell contains 46 chromosomes consisting of 22 pairs of autosomes and 
one pair of sex chromosomes: XX in the female and XY in the male. After exposure 
to physical agents including ionizing radiation, chemicals etc. DNA damage is 
induced. These damages can be either repaired, mis-repaired to form an exchange-
type aberration or remain unrepaired. Generally, aberrations are investigated in 
mitotic cells by an optical microscope. When aberrations are induced in GO/G1-phase 
cells that consist of a single chromatid, they are also replicated during S-phase giving 
rise to "chromosome-type" aberrations involving both chromatids at identical 
positions. In contrast, when damages are induced in S- or G2-phase cells containing 
replicated DNA, each chromatid acts independently. In this case, aberrations seen at 
metaphase affect only one of the two chromatids of a chromosome and are referred to 
as "chromatid-type" aberrations. Most commonly, observations are made at 
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metaphase, using "solid-staining" with dyes which give high contrast chromatin 
staining and negligible cytoplasmic coloration. For more critical work, the 
chromosomes are banded in various ways, which allows chromosome identification, 
detection of some forms invisible with solid-staining, and offers more precise 
positioning of the lesion interaction points (Savage, 1977). 
Chromosome aberrations are an important biomarker of cancer risk and are 
used since the mid 1960s for biological dosimetry. Chromosomal aberration 
assessment serves as a good indicator of the clastogenic effects of chemical agents 
(Gebhart, 1970; Buckton and Evans, 1982; Hsu, 1982; Afzal, 2010). The chromatid 
type aberrations include chromatid gaps, breaks and deletions. The chromosome type 
aberrations include, isochromatic gaps and breaks, inter-chromosomal exchanges 
resulting in ring chromosome and acentric fragments, and interstitial deletions 
resulting in acentric fragments (Hsu, 1982). A gap cytogenetically is distinguished 
form a break, depending on the length of the non-staining region in the chromosome. 
If the attenuated region is shorter than the width of the chromatid, it is classified as 
gap and if longer than the width, it is a break. But the problem in this classification is 
that chromosome at prometaphase are elongated with a small width of chromatid, 
while at late metaphase they are condensed with larger width. This results in 
classification of more breaks in early metaphase and more gaps in late metaphase. 
Gaps were not evaluated as CA according to Mace et al., 1978. Therefore gaps were 
not included in scoring CAs in the present study. Criteria to classify the different 
types of aberrations were in accordance with the recommendation of EHC 46 for 
Environmental Monitoring of Human Population (IPCS, 1985). 
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Any damage altering the normal morphology of a chromosome (be it due to 
damage to DNA and chromatin or the packing proteins of chromosomes) could 
interfere with normal functioning of the chromosome, causing genotoxicity. A 
methodology for assaying the genotoxicity has been given by Afzal et al., 2008. 
Sister Chromatid Exchanges: 
Sister chromatid exchange (SCE) represents, the interchange of DNA strands between 
sister chromatid at apparently homologous loci. SCEs were first demonstrated by 
Taylor (1958) through autoradiographic technique using tritium labeled thymidine. 
The detection of SCEs become simple and more precise with the incorporation of 
Bromodeoxyuridine (BrdU) into the DNA by culturing cells for two cell cycles to 
give one unifilary substituted and one bifilary substituted chromatid in a chromosome 
(Latt, 1973). Subsequent differential staining of these chromatid were obtained by 
fluorescent dyes (Latt, 1981) or fluorescent plus Giemsa stain (Perry and Wolf, 1974). 
The SCE test is usually performed on human peripheral blood lymphocytes. As 
peripheral lymphocytes are in the resting G stage of the cell cycle, they have to be 
stimulated to divide by an aspecific antigen, like phytohaemagglutinin. To collect a 
sufficient number of mitotic cells, a spindle inhibitor like colcemid may be added 
shortly before fixation (at 72 hours) to block cells in (pro)metaphase of the second 
mitosis. To allow for a differential staining that enables the researcher to distinguish 
both chromatids, BrdU (bromo-deoxy-uridine) is added to the culture medium for the 
duration of two complete cell cycles. Chromatids in which only one strand of DNA 
incorporated BrdU show a normal dark Giemsa staining, whereas those with two 
substituted strands, stain less darkly. If an exchange occurred, this can be seen as the 
dark part changes to the other arm, termed as "harlequin chromosomes". The 
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technique can also be used to estimate the division rate, as first metaphases stain 
uniformly dark than subsequent metaphases. 
The frequency of SCEs has been found to be greatly increased on exposure 
to mutagenic agents. Therefore, SCEs are considered to be sensitive indicators of 
DNA damage (Latt, 1974; Perry and Evans, 1975; Carrano et al, 1978). A positive 
correlation between the frequencies of chromosome aberrations and SCEs has been 
found with most of the known mutagenic chemicals (Latt, 1974).The mechanism of 
these end points is probably different. One system cannot replace the other. Therefore 
both the endpoint should be scored to assess the genetic damage and their 
amelioration caused by test chemicals. 
Cell Growth Kinetics: 
Cell cycle kinetics analysis is based on the differential staining technique of sister 
chromatids. Scoring cell preparation at M1, M2, and M3 (metaphase 1st, 2nd and 3rd 
replication cycle) is a sensitive method for detecting delay or stimulation in human 
lymphocyte cultures (Tice et al, 1976; Crossen and Morgan, 1977). 
The rate at which mitosis occurs is measured by the mitotic index. The index gives an 
idea about the stimulation of lymphocytes for division and hence the mitotic activity 
in the culture (Mellarango and Smith, 1984; Sinha et al, 1984). Any change in the 
mitotic index following drug exposure when compared to concurrent control, provides 
information on mitotic stimulative or mitotic depressive activity of the drugs and 
chemicals. 
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Each test chemical was tested on the cultured human lymphocytes 
utilizing Chromosomal aberrations, Sister chromatid exchange (SCE) and Cell growth 
kinetics assays in the absence as well as in the presence of metabolic activation. 
1.8.3 In vitro assessment of possible anticarcinoienic potentials of tea 
nomphenols 
Cellular metabolic MTT Assay: 
MTT assay is a cyototoxicity testing method based on the cleavage of tetrazolium salt 
to purple formazan crystals by mitochondrial enzymes of metabolically active cells. 
Tetrazolium dye reduction, which is dependent on NADPH-dependent oxidoreductase 
enzymes largely in the cytosolic compartment of the cell (Berridge et al., 1993; 2005). 
Therefore, reduction of MTT and other tetrazolium dyes increases with cellular 
metabolic activity due to elevated NAD(P)H flux. Resting cells such as thymocytes 
and splenocytes that are viable but metabolically quiet reduce very little MTT. In 
contrast, rapidly dividing cells exhibit high rates of MTT reduction. 
Neutral Red uptake Assay. 
The Neutral Red uptake assay developed by Borenfreund and Puerner (1985) is used 
for cytotoxicity testing in monolayer cell cultures. It is based on the ability of viable 
cells to incorporate the weak cationic supravital dye Neutral Red via non-ionic 
diffusion and accumulate it in the lysosomes. Accumulation of NR in the lysosomes is 
presumed to be due to trapping of the protonated form of the dye within the acid 
milieu of lysosomes on one hand. Binding to fixed acidic charges in the lysosomal 
matrix (e.g. acidic polysaccharides) is also thought to play a role (Bulychev et al., 
1978). Alterations of the cell surface or the sensitive lysosomal membrane lead to 
lysosomal fragility and other changes that gradually become irreversible (Bitensky, 
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1963). Cellular damage induced by xenobiotics results in a decreased retention and 
accumulation of NR in lysosomes (Filman et al., 1975). The amount of accumulated 
NR in the lysosomes can be detected photometrically after elution and colour intensity 
is indicative of the cell viability (Borenfreund and Puerner, 1985). 
CHAPTER 2 
REVIEW OF LITERATURE 
2.1 Bioavailability of Tea Polyphenols 
Pharmacokinetic studies of single doses of EGCG or green tea polyphenols have 
demonstrated low bioavailability thought to be due to pre-systemic elimination. This 
elimination is saturated at repeated high doses; 800 mg as a one off dose led to a peak 
plasma level of 234.9 ng/ml +1-140.9, whereas repeated daily dosing of 800 mg for 
four weeks led to a higher peak concentration of 390.3 ng/ml +I- 231.4 (Chow et al., 
2001, 2003). This increase in peak plasma level following repeated dosing did not 
result from accumulation, but rather may have been due to inhibited pre-systemic 
elimination. 
Green tea polyphenols have been demonstrated to be available in human 
prostate tissue following oral consumption. Consumption of green tea containing 4.1 
mg EGCG per kg body weight led to a mean prostate EGCG concentration of 40 
pmollg (Henning et al., 2006).Oral doses of 600 mg EGCG orally led to a maximum 
plasma EGCG concentration of 321 ng/ml (Henning et al., 2005). The bioavailability 
of theaflavins appears to be even lower, in healthy volunteers consuming 700 mg 
theaflavins, the peak plasma concentration detected was ing/ml at two hours (Mulder 
et all., 2001). 
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2.2 Cytotoxicity of Tea Polyphenols 
A review of the available information on EGCG and GTE mutagenicity, reported in 
the available literature, has been shown here in tabular form. 
Tea Test Dose; study Result References 
Preparation system/strain or details 
tested cell line (activation, 
solvent, schedule) 
Endpoint: mutation 
EGCG S typhimurium Ames test w S-9, High dose — Weisburger, 
TA100 dose not reported positive; low dose 1996 
— negative 
Green tea S typhimurium Ames test w/wo S-9, Negative Yamane et 
extract  TA98, TA100 0-5000  mglplate al., 1996 
Green and S. typhimurium Ames test wtwo S-9, Positive only with Tewes et al., 
black tea TA98, TA100 0— 1.0 mllplate cell-free extract of 1990 
infusions infusion of 4 g/150 cecal bacteria 
ml water w/wo S-9 
Black tea 	S. typhimurium 	Ames test w/wo S-9, Negative 	Nagabhusha 
TA98, TA100, 0— 550 mg/plate 	 n et al., 
TA1535. TA1538 	 1991 
Black tea 	D. melanogaster Somatic mutation Positive Graf et al., 
wing and recombination 1994 
test (SMART), 0 — 
40% (w/v) 
Endpoint: sister chromatid exchange (SCE) 
EGCG 	Chinese hamster 20 mg/ml Potentiated Imanishi et 
cells mitomycin C- al., 1991 
induced SCE 
Endpoint: chromosomal aberrations (CA) 
Chinese hamster 20 mg/ml Potentiated Imanishi et 
EGCG cells mitomycin C- al., 1991 
induced CA 
Black tea Swiss mouse bone 1.756 mg10.16 ml Mildly clastogenic Mukherjee 
infusion marrow cells distilled water, by etal., 1997 
gavage, 2X/d, 7 d 
Endpoint: DNA damage  
EGCG pBR322plasmid 0-0.!  mM Potentiated DNA Ohshima et 
single strand al., 1998 
breaks by 
diethanolamine 
NONOate 
Endpoint: microsomal degranulation 
	
Green tea infusion Isol. Wistar rat 40 mg/nil in vitro 	Positive 	 Minocha et 
liver 	 al., 1986 
microsomes 
Green tea infusion Wistar rats (in 	160 mg/kg bw 1X 	Positive 	 Minocha et 
vivo study) 	sc, rats sacrificed al., 1986 
after 10 hr and 
microsomes 
prepared 
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2.3 Metabolism of Tea Polyphenols 
Many metabolism processes including intestinal metabolism, microbial metabolism, 
hepatic metabolism and chemical degradation are involved in the fate of tea, and are 
responsible for its low availability in animals and in humans. Tea flavonoids are 
found to be absorbed from the upper intestine. A small percent of tea flavanols are 
directly absorbed in the small intestine and excreted in the urine, and many of them 
are found to conjugate (Van et al., 2006). Bacterial flora in the colon metabolizes 
flavonoids, that are not absorbed in the small intestine and then microbial 
metabolized flavonoid are absorbed from colon (Kohn et al., 2003; Meng et al., 2002; 
Wang et al.,2001). Although the plasma antioxidant activity potential of both green 
tea and black tea are not significantly different, the uptake of theaflavin found in the 
black tea is comparatively low as compared with that of catechin and very small 
amount of theaflavin were reported in in plasma and urine (Mulder et al., 2001; 
Rietveld et al., 2003). 
flippuric acid has been identified as the major urinary metabolite of black 
tea consumption (Clifford et al., 2000). Catechins are mainly excreted in urine as 
giucuronide and sulphate conjugates (Yang et al. 1998). Recently, Van et at 
confirmed that hippuric acid and 1,3-dihydroxyphenyl-2-O-sulfate are major 
metabolites of both green tea and black tea and both compounds found were the end 
products of flavonoid degradation by colonic bacteria (Van et al., 2006). 
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2.4 Anti-oxidant properties of Tea Polyphenols 
Many non-nutrient flavanoids are thought to exhibit anti-oxidant properties. This anti-
oxidation may be demonstrated by direct scavenging and reduction of oxygen free 
radicals; by terminating propagatory chains of lipid peroxidation, scavenging reactive 
nitrogen species thereby inhibiting tyrosine nitration and DNA deamination and by , . 
chelating transition metal ions thus inhibiting the generation of iron-induced free 
radicals (Rice-Evans, 1999). It is the arrangement of phenolic hydroxyl groups on the 
B ring of catechins that produces the low reduction potential capable of reduction 
reactions, this is enhanced by the addition of a gallate group to the C ring. This 
explains the hierarchy of antioxidant potential demonstrated by green tea catechins: 
EGCG = ECG > EGC > EC ((Rice-Evans, 1999). In reducing highly oxidizing free 
radicals, aroxyl radicals are formed by hydrogendonation, which then react with 
further radicals to produce stable quinones: 
HO-Fl-OH + R• —* HO-F1-O• + RH 
H0-F1-0• + R• —* O=F1=O + RH 
(R- = superoxide, peroxyl, alkoxyl or hydroxyl radicals) 
The hierarchy of catechins in lipid peroxyl radical scavenging potency is EGG = 
EGCG = EC > EGC which reflects the reduced ability of EGC to access lipids 
because of its high aqueous solubility (Salah et al., 1995). 
Peroxynitrite (ONOO) is an oxidizing and nitrating radical generated 
following rapid nitric oxide production such as in inflammation (Huie and Padmaja, 
1993). Tea catechins can inhibit this nitration with the following hierarchy of 
potencies ECG = EGCG > EC = EGC, this suggests that the gallate group is an 
important area of activity in these reactions (Pannala et al., 1997). 
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Green tea polyphenols can chelate metal ions Like iron and copper to prevent 
their participation in Fenton and Haber-Weiss reactions (Mckay and Blumberg, 2002; 
Kim et al., 2003). They may also function indirectly as antioxidants through the 
inhibition of the redox sensitive transcription factors; inhibition of prooxidant' 
enzymes such as lipoxygenoases, xanthine oxidase; and induction of antioxidant 
enzymes such as glutathione-S-tranferases and superoxide dismutases (Cabrera et al., 
2006), Similarly, the repeated consumption of green tea and encapsulated green tea 
extracts for one to four weeks has been reported to decrease the biomarkers of 
oxidative status (McKay and Blumberg, 2002). Furthermore, oxidative DNA damage, 
lipid peroxidation and free radical generation were reduced after •consuming -6 
cups/day of green tea for seven days in a study with 40 male smokers in China and 27 
men and women (smokers and non-smokers) in the United States (Klaunig et al., 
1999; Cabrera et al.,2006). Leung et al (2001) showed that theaflavins of black tea 
equally possessed antioxidant potency as catechins of green tea by inhibition of LDL 
oxidation in vitro (Leung et al., 2001). 
2.5 Effect of milk protein on antioxidant activities Tea Pdlyphenols 
There are some evidences showing that tea polyphenols possess high binding affinity 
for proline rich proteins such as casein (Luck et al., 1994). Firstly, Brown and Wright 
(1963) using electrophoretic methods investigating the interaction between milk 
proteins and tea polyphenols showed that tea polyphenols mainly interact with the a-
casein complex and the f -casein of the milk. dobstl et al. (2006) indicated that there is 
the non-covalent cross-linking of EGCG by casein, emphasizing the interaction of tea 
polyphenols with proteins. A recent study, Huang et al., 2007 uses Quartz Crystal 
Microbalance with Dissipation Monitoring to investigate the interaction between 
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EGCG and globular protein, BSA (bovine serum albumin). This study has shown that 
there is aggregation of BSA through EGCG bridges and mainly from the galloyl 
group. Black tea is commonly consumed in Western countries, while consumption of 
green tea is confined mainly to Asia and Middle East, where it is generally taken 
without the addition of milk. Adding milk to tea especially black tea is a tea drinking 
habits in Asia and UK. Milk is generally added to tea to reduce the astringency caused 
by flavonoid-like tannin substance, which then appear to precipitate in the tea cup. 
While some studies have demonstrated that milk protein have effect on antioxidant 
potential of tea polyphenols, others have shown that milk protein does not reduce the 
antioxidant activities of tea polyphenols. It has been reported that the interaction 
between tea polyphenols and protein such as milk protein affects tea polyphenols 
antioxidant potential in vitro (Art et al., 2002, Langley-Evans., 2000). The effect of 
black tea consumption with or without milk on the antioxidative status in vivo remains 
to be established unequivocally and has been the issue of much debate. 
2.6 Tea Polyphenols and Cancer 
Cell signal pathway referred to signal transduction is responsible for regulating 
cellular proliferation or apoptosis. This process includes stimulating a cellular 
response by which information from an extracellular signal is transmitted from the 
plasma membrane into the cell following signal transmission through the intracellular 
molecule. Then a cell responds by stimulating the gene transcription through proteins 
known as transcription factors. AP-1 and NF-1cB are two transcription factors which 
are extremely crucial in tumor promoter-induced transformation, and both of them get 
influenced differentially by the MAP kinase pathway response towards extracellular 
mitogens and various other cellular activities, such as cell division and apoptosis. 
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Green tea extracts contain a unique set of catechins that possess biologic 
activity in antioxidant, antiangiogenesis, and antiproliferative assays that are 
potentially relevant to the prevention and treatment of various forms of cancer 
(Cooper at al., 2005). Green tea and (-)-epigallocatechin gallate (EGCG) are now 
acknowledged cancer preventives in Japan and this use has made it possible for us to 
establish the concept of a cancer preventive beverage (Fujiki et al., 2002). Green tea 
polyphenols inhibit angiogenesis and metastasis, (Isemura et al., 2000; Ju et al., 2007) 
and induce growth arrest and apoptosis through regulation of multiple signaling 
pathways. Catechins are involved in thiol-dependent activation of mitogenic-
activated protein kinases (Opare Kenndy et al., 2001) .EGCG revealed a wide range 
of target organs for cancer prevention (Fujiki H, 2005). Epigallocatechin gallate, 
EGCG regulates expression of VEGF, matrix metalloproteinases, uPA, IGF-1, EGFR, 
cell cycle regulatory proteins and inhibits NF1C B, PI3-KIAkt, Ras/RaffMAPK and 
AP-1 signaling pathways, thereby causing strong cancer chemopreventive effects 
(Shankar at al., 2007). Epigallocatechin gallate has a possible role in chemoprevention 
and chemotherapy of various types of cancers mainly prostate cancer (Siddqui et al., 
2007; Siddiqui et aI., 2006) and colon cancer (Xiao et al., 2007; Yuan et al., 2007) . 
EGCG inhibits the growth of gastric cancer by reducing VEGF production and 
angiogenesis, and is a promising candidate for anti-angiogenic treatment of gastric 
cancer (Zhu et al., 2007). Green tea polyphenols and EGCG treatment were also 
found to induce apoptosis and inhibit the proliferation when the tumor tissue sections 
were examined by immunohistochemistry (Thangapazham at al., 2007). It has been 
confirmed by various techniques that EGCG inhibits telomerase and induces 
apoptosis in drug-resistant lung cancer cells (Sadava et al., 2007). EGCG may be 
useful in the chemoprevention of breast carcinoma in which fatty acid synthase (FAS) 
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overexpression results from human epidermal growth factor receptor (HER2 or/and 
HERS signaling) (Pan et al., 2007). EGCG inhibits the growth of gastric cancer by 
reducing VEGF production and angiogenesis, and is a promising candidate for anti-
angiogenic treatment of gastric cancer (Zhu et al., 2007). EGCG inhibited the in vitro 
growth of invasive bladder carcinoma cells and decreases the migratory potential of 
bladder carcinoma cells (Rieger-Christ et al.,2007). EGCG has a preventive effect on 
the growth of liver and pulmonary metastases of orthotopic colon cancer in nude 
mice, and this anticancer effect could be partly caused by activating the Nrf2-UGT1A 
signal pathway (Yuan et al., 2007). The inhibitory effect of (-)-EGCG on activation of 
the epidermal growth factor receptor is associated with altered lipid order in HT29 
colon cancer cells (Adachi et al., 2007). Activation of Forkhead box 0 transcription 
factor (FOXO3a) by the green tea polyphenol epigallocatechin-3-gallate induces 
estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells 
(Belguise et al., 2007). (-)-EGCG inhibits Her-2/neu signaling, proliferation, and 
transformed phenotype of breast cancer cells (Pianetti et al., 2002). 
A number of recent researches have presented the data on black tea 
polyphenol induced cellular signal transduction pathway associated with AP-1, NF-
KB, and MAP kinase. Black tea polyphenols, the theaflavins, may have a major 
impact on the chemoprevention of oral cancer, than the green tea polyphenols 
(Chandra et al., 2006). In the JB6 mouse epidermal cells, theaflavin inhibited AP-1 
transactivation and AP-1 DNA binding activity through JNKs/SAPKs inactivation 
(Dong et al., 1997). Lin et al found that theaflavin-3,3'-digallate blocked the 
activation of NF-iB, phosphoralation of IicB, and reduced lipopolysacchride-induced 
nuclear accumulation of transcription factor NF-KB (Lin et al., 1999). Pan et al also 
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indicated that theaflavin-3,3 '-digallate was shown to inhibit IKKI, and IKK2, two 
putative IiBa kinases involved in NF-xB activation, and its effect was stronger than 
other tea polyphenol like EGCG (Pan et al., 2000). 
Both Epigallocatechin-3-gallate and theaflavin-3,3'-digallate (major 
green and black tea polyphenols, respectively) inhibit the phosphorylation of c-jun 
and p44/42 (ERK 1/2). The galloyl structure on the B ring and the gallate moiety are 
important for the inhibition (Yang et al., 2000). Most of the relevant mechanisms of 
cancer prevention by tea polyphenols are not related to their redox properties, but are 
due to the direct binding of the polyphenol to target molecules, including the 
inhibition of selected protein kinases, matrix metalloproteinases, and DNA 
methyltransferases. There has been consistent findings in animal models of skin, lung, 
colon, liver and pancreatic cancer that tea and tea polyphenol administration inhibit 
carcinogen-induced increase in thelevel of oxidized DNA base (Frei, 2003). 
2.7 Tea Polyphenols and Skin 
The outcome of the several experimental studies suggests that green tea possess anti- 
inflammatory and anticarcinogenic potential, which can very well be exploited against 
a variety of skin disorders (Katiyar et al., 2000 a, b). Green tea polyphenols act as 
chemopreventive, naturally healing, and anti-aging agents for human skin (Hsu S, 
2005). (-)- EGCG is the major and most photoprotective polyphenolic component of 
the green tea (Katiyar et al., 2006). The inhibition UV light-induced DNA damage in 
the form of cyclobutane pyrimidine dimers (CPDs) in the skin by green tea 
polyphenols treatment may, at least in part, be responsible for the inhibition of 
photocarcinogenesis (Katiyar et al., 2000a). Green tea polyphenol induces caspase-I4 
in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in 
the flaky skin mouse model (Hsu et al., 2007). Signal transducers and activators of 
37 
transcription (STATs) play a critical role in signal transduction pathways. 
Phosphorylation of STAT1 (Ser727) occurs through PI-3K, ERKs, p38 kinase, JNKs, 
PDK1 and p90RSK2 in the cellular response to UVB. Theaflavins and EGCG show 
an inhibitory effect on UVB-induced STATI (Ser727), ERKs, 3NKs, PDK1 and 
p90RSK2 phosphorylation (Zykova et al., 2005). EGCG inhibits the 12-0- 
tetradecanoylphorbol-13-acetate (TPA) induced DNA binding of NF-kappaB and 
CREB by blocking activation of p38 MAPK, which may provide a molecular basis of 
COX-2 inhibition by EGCG in mouse skin in vivo (Kundu and Surh, 2007). ECG, 
dose-dependently attenuates UVB-induced keratinocyte death. Moreover, ECG 
markedly inhibited UVB-induced cell membrane lipid peroxidation and H202 
generation in keratinocytes, suggesting that ECG can act as a free radical scavenger 
when keratinocytes were photodarnaged (Huang et al., 2007). EGCG prevents UVB-
induced skin tumor development in mice, and this prevention is mediated through: (a) 
the induction of immunoregulatory cytokine interleukin (IL) 12; (b) IL-12-dependent 
DNA repair following nucleotide excision repair mechanism; (c) the inhibition of 
UV-induced immunosuppression through IL-12-dependent DNA repair; (d) the 
inhibition of angiogenic factors; and (e) the stimulation of cytotoxic T cells in a tumor 
micro environment (Katiyar et al., 2006). 
2.8 Tea Polyphenols and Apoptosis 
EGCG induces growth arrest and apoptosis through multiple mechanisms, and can be 
used for cancer prevention, mainly pancreatic (Shankar et al., 2007). EGCG could 
induce apoptosis in vivo in Sarcoma 180 cells through alteration in G2/M phase of 
the cell cycle by up-regulation of p53, bax and down-regulation of c-myc, bcl-2 and 
UI B, U4-U6 UsnRNAs (Manna et al., 2006). EGC inhibits DNA replication and 
consequently induces leukemia cell apoptosis (Smith et al., 2000). EGCG can induce 
is 
apoptosis of the human gastric cancer cell line MRN45, and the effect is in a time-
and dose-dependent manner. The apoptotic pathway triggered by EGCG in MKN45 is 
mitochondrial-dependent (Ran et al., 2007). The 0-acetylated EGCG analogs 
possessing a p-NH(2) or p-NHBoc (Boc; tert-butoxycarbonyl) D-ring (5 and 7) act as 
novel tumor cellular proteasome inhibitors and apoptosis inducers with potency 
similar to natural EGCG and similar to EGCG peracetate (Osanai et al., 2007). EGCG 
might prevent alveolar bone resorption by inhibiting osteoclast survival through the 
caspase-mediated apoptosis (Yun et al., 2007). EGCG treatment has a dose-
dependent effect on ROS generation and intracellular ATP levels in MCF-7 cells, 
leading to either apoptosis or necrosis, and that the apoptotic cascade involves INK 
activation, Bax expression, mitochondrial membrane potential changes, and activation 
of caspase-9 and caspase-3 (Hsuuw and Chan, 2007). Interesting results has been 
obtained in a study that EGCG inhibits cardiac myocyte apoptosis and oxidative stress 
in the pressure overload induced cardiac hypertrophy. Also, EGCG prevents 
cardiomyocyte apoptosis from oxidative stress in vitro. The mechanism may be 
related to the inhibitory effects of EGCG on p53 induction and bcl-2 decrease (Sheng 
et al., 2007). EGCG induces apoptosis in human prostate carcinoma cells by shifting 
the balance between pro- and antiapoptotic proteins in favor of apoptosis (Hastak et 
al., 2003). Tea catechins have ability to produce H(2)O(2) and that the resulting 
increase in H(2)O(2) levels triggers Fe(Il)-dependent formation of highly toxic 
hydroxyl radical, which in turn induces apoptotic cell death (Nakagawa et al., 2000). 
2.9 Tea consumption and Weight loss 
Molecular mechanisms of fatty acid synthase gene suppression by tea polyphenols 
(EGCG, theaflavins) may bring down-regulation of EGFR/PX3KIAktJSp-1 signal 
transduction pathways, suggesting hypolipidemic and anti-obesity effects of tea and 
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tea polyphenols (Lin et al., 2006). Green tea extract intake is associated with 
increased weight loss due to diet-induced thermogenesis, which is generally attributed 
to the catechin epigallocatechin gallate (Shixian et al., 2006). 
2.10 Neuroprotective effects of Tea Polyphenols 
Green tea polyphenols have demonstrated neuroprotectant activity in cell cultures and 
animal models, such as the prevention of neurotoxin-induced cell injury (Pan et al., 
2003). Recent findings from in vivo and in vitro studies concerning the transitional 
metal (iron and copper) chelating property of green tea, and its major polyphenol, (-)- 
epigallocatechin-3-galIate, suggests 	its 	potential role in the treatment of 
neurodegenerative diseases (Mandel et al., 2006). EGCG may exhibit protective 
effects against advanced glycation endproducts (AGEs) induced injury in neuronal 
cells, through its antioxidative properties, as well as by interfering with AGEs- AGE 
receptor (RAGE) interaction mediated pathways, suggesting a beneficial role for this 
tea catechin against ueurodegenerative diseases (Lee et al., 2007). Catechin gallates 
(through the galloyl moiety) contribute to the neuroprotective effects of both green 
and black teas.Not only green but also black teas may reduce age-related 
neurodegenerative diseases, such as Alzheimer's disease (Bastianetto et al., 2006). 
2.11 Description of test chemicals used 
Trenbolone 
Literature reports the in utero exposure to Trenbolone masculinizes female Sprague-
Dawley rats (Hotchkiss et al., 2007).A study shows that trenbolone acetate is 
teratogenic and immunotoxic in Japanese quail (Quinn et al., 2007b). Trenbolone 
delayed onset of puberty in Japanese quail males, inhibited cloacal gland 
development, and reduced male reproductive behaviors (Quinn et al., 2007a). 
Trenbolone showed genotoxic activity in the case of in vitro micronucleus test in 
Syrian Hamster embryo(SHE) cells and was also positively reported in the Ames test 
without metabolic activation (Marzin, 1991). Trenbolone can transform SHE cells in 
culture, independent of its hormonal action and without grossly damaging DNA 
(Schiffmann et al., 1985). Cases of prostate and liver cancers have been associated 
with the long term anabolic steroid abuse (Roberts and Essenhigh, 1986; Overly et al., 
1984). 
Methyltestosterone 
The only legitimate therapeutic indications for this anabolic steroids are (a) 
replacement of male sex steroids in men who have androgen deficiency, for example 
as a result of loss of both testes (b) the treatment of certain rare forms of aplastic 
anaemia which are or may be responsive to this anabolic androgens. (ABPI Data 
Sheet Compendium, 1993). 
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Docetaxel 
It is a taxane, which is relatively new class of anticancer drug which have shown 
promise against breast, ovarian, non-small cell lung, and head and neck cancers 
(Rowinsky, 1997; von Hoff, 1997). They are known to cause genetic damage by 
interaction with other cellular targets such as enzymes and microtubules and play a 
critical role in DNA replication or in the segregation of chromosomes during cell 
division. As they affect microtubules, it might be expected that they would induce 
numerical chromosome aberrations (aneuploidy). The major cellular target for taxanes 
is the aj3-tubulin dimer. They block the cell cycle during mitosis in the transition 
from prometaphase to metaphase, as has been observed with numerous spindle poison 
agents (Jordan and Wilson, 1998). Tinwell and Ashby have addressed their genetic 
toxicity (Tinwell and Ashby, 1994). The genotoxicity of docetaxel is due to its 
aneugenic effect, a behaviour expected for a compound that has microtubule 
stabilization activity and is a potent inhibitor of mitotic cellular division (Jordan and 
Wilson, 1998) 
Tamoxifen (TAM) 
It is the world's most widely used chemotherapeutic agent, which has undergone 
many trials in several countries to determine whether its administration to healthy 
women at high risk of breast cancer can reduce the risk of malignancy. The results are 
mixed. Tamoxifen forms adduct with DNA (after undergoing metabolic pathway) as a 
metabolite a- hydroxytamoxifen, as tested in rats (Philips, 2001). This mechanism can 
be well defined as genotoxic. On the other hand human liver appears protected against 
activation of Tamoxifen to DNA binding species in short term tests, however it has 
been proved genotoxic in vivo. 
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OBJECTIVES OF THE PRESENT STUDY 
Toxic chemicals affect basic functions of cells which are common to all cells and their 
toxicity can be measured by assessing cellular damage. The development of in vitro 
and in vivo cytotoxicity assays has been driven by the need to rapidly evaluate the 
potential toxicity of large numbers of compounds. In vitro assays are more preferable 
ones as they limit animal experimentation whenever possible, and are useful in 
carrying out the tests with small quantities of compound. Tea polyphenols mainly the 
Green tea polyphenols act as potential antioxidant, chemopreventive, and 
anticarcinogenic agent, hence we have focused our investigations on mainly Green tea 
polyphenols or extract. 
Our main objectives were: 
a To isolate tea polyphenols from Green tea, procured from Kangra (H.P.) by 
Gas Chromatography and note the formulations. The polyphenolic fractions 
will be identified by Mass Spectroscopy (GC-MS) before use. Alternatively, 
known Green tea polyphenoIs can be procured for antigenotoxicity trial. 
• To assess possible toxicity risks of Green tea extract in vivo and to determine 
its LD50 in mice. 
• To. induce genotoxic damage (in vitro) by known mutagens viz. MMS in 
human lymphocytes; 
• To assess the genotoxic damage (in vitro) by anabolic steroids and anticancer 
drugs in human lymphocytes, by standard systems viz. Chromosomal 
aberrations, sister chromatid exchange, cell cycle kinetics; 
• To conduct the antigenotoxicity assays using tea polyphenols against the 
genotoxic damage induced by above mentioned drugs, using standard systems 
viz. Chromosomal aberrations, sister chromatid exchange, cell cycle kinetics 
in human lymphocytes in vitro and to suggest some mechanism for the action 
of antigenotoxic principles. 
+ To conduct the cytotoxicity assays using tea compounds on human cancer cell 
lines in vitro to assess the possible anticarcinogenic potentials of green tea 
polyphenols. 
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CHAPTER THREE 
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3.1 Gas Chromatography and Mass Spectrometry (GC-MS) for 
Detection of Polyphenolic Contents in Green Tea Extract. 
3.1.1 Principle 
The principle behind GC-MS is as follows: 
(1) Identification and quantization of volatile and semi volatile organic compounds in 
complex mixtures, (2) Determination of molecular weights and (sometimes) elemental 
compositions of unknown organic compounds in complex mixtures, and (3) Structural 
determination of unknown organic compounds in complex mixtures both by matching 
their spectra with reference spectra and by a priori spectral interpretation. 
3.1.2 Procedure followed 
GC-MS analyses were performed with a Perkin Elmer Auto XL gas 
chromatograph and Turbo mass spectrophotometer. Chromatographic resolution was 
achieved with 30 x 250µ DB-5 capillary columns which had 0.25µm film thickness 
and helium as the carrier gas. The column temperature was kept at 50°C for 1 min and 
then programmed to 280°C at a rate of 10°C/min. The mass spectrometer was 
operated at 70 eV (electron volt) of electron ionization energy. Injector and analyzer 
temperatures were set at 290 and 315°C, respectively. 
Identification of compounds in the Green tea extract was achieved by 
comparing the gas chromatographic retention times and mass spectra with the 
authentic standards. Quantification of these compounds was conducted by relating the 
peak areas of identified compounds to that of the internal standard. 
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3.2 In vivo Assessment of Possible Toxicity Risks of Green Tea 
Extract in Mice 
3.2.1 Chemicals 
0.1 M Tris-HCL buffer (Sigma-Aldrich); 
Glycine-NaOH (50 mmollL, pH 10) (Gibco, Invitrogen); 
Adrenaline (1 mmolfL) (Gibco,Invitrogen); 
ASAT kit- Crest Biosystems Pvt Ltd.; 
Picric acid (Sigma-Aldrich); 
Sodium hydroxide (Sigma-Aldrich); 
Creatinine (Sigma-Aldrich); 
Urea reagent, (Gibco, invitrogen); 
Diacetyl monoxime reagent (Gibco, Invitrogen); 
Standard urea (Gibco,Invitrogen); 
TCA - 25% Solution (Sigma-Aldrich); 
TCA - 5% Solution (Sigma-Aldrich); 
Phosphate buffer Solution (pH.8) - 0.2M (Sigma-Aldrich); 
Dithiobis (2- nitrobenzoic acid) DTNB - 0.6 mM (Sigma-Aldrich); 
Reduced glutathion (GSH) (Sigma-Aldrich); 
Sodium pyrophosphate buffer (0.025M, pH 8.3) (Sigma-Aldrich); 
Phenazine methosulphate (PMS) (186µM) (Sigma-Aldrich); 
Nitroblue tetrazolium (NBT) (300M) (Sigma-Aldrich); 
NADH (780µM) (Sigma-Aldrich); 
Glacial acetic acid(Sigma-Aldrich); 
n-butanol(Sigma-Aldrich); 
Potassium phosphate buffer (50mM, pH 6.4) (Sigma-Aldrich); 
Phosphate buffer: 0.067 M (pH 7.0) (Sigma-Aldrich); 
Hydrogen peroxide (2mM) in phosphate buffer(Sigma-Aldrich). 
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3.2.2 Determination of LD50 of tea extract in mice: 
Acute toxicity of the plant was determined by the calculation of LD50 which 
represents the dose that can be fetal to 50% of any rats group (Hruskova, et al., 1961). 
Determination of LD50 in rats was conducted to determine the proper treatment dose 
that should be used in this experiment. The LD50 is one way to measure the short — 
term poisoning potential (acute toxicity). 
3.2.3 Green tea extract preparation 
Green tea was collected from the farms of Kangra (Himachal Pradesh, India). Green 
tea extract (GTE) was prepared according to Khan et al., (2009) by adding 30g green 
tea leaves to 500m1 of boiling water, which is steeped for 15-20 min. The resulting 
infusion was cooled to room temperature and then filtered. The tea leaves were 
steeped a second time with 500m1 of boiling water and filtered again, and the two 
filtrates were combined to obtain 3% green tea extract (3 g tea leaves/100 ml water). 
This dietary treatment reflected a daily consumption of 3 cups of green tea by an adult 
human weighing 70 kg. The resulting clear solution is similar to tea brews consumed 
by humans. The extract was poured into the animals feeding bottles. The mice were 
supplied with freshly prepared tea extract every morning. 
3.2.4 Animals and experimental design 
Animals Swiss albino mice (Mus musculus L.) 35 - 50 g, 10-12 weeks old were 
procured from Lucknow (U.P.), India and were grouped in five different 
polypropylene cages (four animals/group, total 20 mice). The animals were fed ad 
libitum and allowed to adjust to the new environment for one week before starting the 
experiment, at a mean temperature of 25°C. Permission was granted for 
experimentation by the departmental ethical committee. During the experiments, 
maximum care was taken to minimize animal suffering and, in addition, the number 
of rats used was kept at minimum. 
Animals were randomly divided into five experimental groups each of four animals 
as follows: 
1) Group I (control): Animals were given standard diet and tap water. 
2) Group II: Animals were given standard diet and green tea extract (GTE). This 
Group was given 100 mg/kg body weight GTE instead of drinking water 
within a repeated dose for 10 days to determine the dose dependent effect. 
3) Group III: Animals were given standard diet and 1000 mg/kg body weight 
GTE instead of drinking water within a repeated dose for 10 days to determine 
the dose dependent effect. 
4) Group IV: Animals were given standard diet and 2500 mg/kg body weight 
GTE instead of drinking water within a repeated dose for 10 days to determine 
the dose dependent effect. 
5) Group V: Animals were given standard diet and 5000 mg/kg body weight 
GTE instead of drinking water within a repeated dose for 10 days to determine 
the dose dependent effect. 
3.2.5 Measurement of body weight and daily fluid intake 
Fluid intake was recorded daily within the 10 day period. Animals drank from 
graduated water bottles and at the same time each day, the decrement in the amount of 
fluid consumed over 24 hours was measured by subtracting the day reading from that 
of the previous day. End-of-treatment weights were used for weight analysis. 
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3.2.6 Acute toxicity study 
The mice were observed throughout the ten days treatment, and all signs of toxicity, 
their latencies and deaths were recorded. Behavior and other physiological activities 
of all the above five groups of mice were noted. 
3.2.7 Preparation of Specimens 
The animals were starved overnight for 12 hours before the blood was collected. After 
the experimental period of 10 days, blood was collected from the orbital sinus of mice 
under ether anesthesia. This blood was centrifuged at 3000 rpm at 4°C for five 
minutes to obtain the blood serum. Serum was placed into a -20°C freezer until the 
time of the assay. 
All animals were sacrificed by cervical decapitation under light ether 
anesthesia on the eleventh day. Immediately after sacrifice, the liver was dissected 
out, washed in the ice-cold saline, and the homogenate was prepared in 0.1 M Tris-
HCL buffer (pH 7.4). The homogenate was centrifuged and the supernatant was used 
for the assay of marker enzymes. The supernatant was placed into a -20°C freezer 
until the time of the assay. 
3.2.8 Biochemical Parameters investigated 
Plasma was used for the determination of the concentration of urea, creatinine and 
serum glutamic oxaloacetic transaminase (SGOT). Liver homogenate was used for the 
determination of the levels of Glutathione (GSH), Superoxide Dismutase (SOD) and 
Catalase (CAT) using appropriate reagents and kits supplied by manufacturers. 
Optical density measurement was done using Spectrophotometer (Beckman Coulter, 
U.S.A.). 
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3.2.8.1 Estimation of Serum Creatinine 
Alkaline picrate method by Brad and Scrota, 1948 was used to measure serum 
creatinine. 
Principle: 
Creatinine in a protein free solution reacts with alkaline picrate with the development 
of a red color complex. The intensity of the developed color is measured at 520 nm. 
Reagents: 
Saturated picric acid solution: Take 13gm picric acid in litre water. Allow the excess 
picric acid to remain in contact with the water, shaking it occasionally. Filter and store 
it in a polyethene bottle. 
Sodium hydroxide- 0.75N, 
Stock creatinine standard- 150mg%, dissolve 150mg creatinine in 100ml water 
(100mmol/L). To prepare working standard solution, stock standard solution was 
diluted 10 times before use. 
Procedure: 
Deproteinization of sample: 
0.5 ml of serum was added to 3 ml picric acid and 0.5 ml distilled water was added to 
make up the volume to 4m1. Mixed well and kept in a boiling water bath exactly for 1 
minute. It was cooled immediately under tap water and centrifuged at 2000rpm/min. 
2m1 of the supernatant was added to 0.5 ml 0.75N NaOH, mixed well and allowed to 
stand at room temperature exactly for 20 minutes and optical density was measured 
immediately at 520nm. 0.5m1 of standard and blank solution was added to 1.5 ml 
picric acid and 0.5ml NaOH. 
Calculations: 
Test O.D. — Blank O.D. 
Serum creatinine, mg 1100ml = 
Standard O.D. — Blank O.D. 
3.2.8.2 Estimation of Serum Urea 
The method described by Marsh et al., 1965 was used for the assay. 
Principle: 
Urea reacts with hot acidic diacetyl monoxime in presence of thiosemicarbazide and 
produces a rose purple colored complex which is measured colorimetrically. 
Reagents: 
Urea reagent, diacetyl monoxime reagent 
Standard urea. 
Procedure: 
To 2.5m1 of diluted urea reagent, O.Olml serum was added and mixed well. 0.25m1 
diacetyl monoxime reagent was added to the above mixture and was mixed well 
again. The samples were kept in boiling water bath exactly for 10 minutes and cooled 
then immediately under running water for 5min, mixed again well and optical density 
was read at 525 nm. Calculation was done using urea standard 30 mg%. 
Calculations: 
Test O.D. 
Serum urea, mg / dl = --------------------- 
Standard O.D. 
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3.2.8.3 Estimation of Serum Glutamate-Oxaloacetate-Transaminase 
(SGOT) (EC 2.6.1.1) 
Levels of serum glutamic oxaloacetic transaminase (SGOT) were determined usimg 
Rietman and Frankel's method adopting ASAT kit by colorimetric method. Values 
were expressed as N/L One international unit (IU/L) is defined as the amount of 
enzyme that catalyzes the transformation of one micromole of substrate per minute 
under specified conditions. 
Principle: 
Samples of serum were incubated with either DL-aspartate and a ketoglutarate for 
SGOT determination. The oxaloacetic acid so formed was then reacted with 
2,4dinitrophenylhydrazine to form an adduct which absorbs Iight at 505 nm. 
3.2.8.4 Estimation of Reduced Glutathione (GSH) 
The method described by Moron et al. (1979). 
Principle: 
GSH is measured by its reaction with Dithiobis 2- nitrobenzoic acid (DTNB) to give a 
yellow colored complex with absorption maximum at 4 l2nm. 
Reagents: 
TCA - 25% Solution 
TCA - 5% Solution 
Phosphate buffer Solution (pH.8) - 0.2M 
Dithiobis (2- nitrobenzoic acid) DTNB - 0.b Mm 
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Procedure: 
To 0.5 ml of liver homogenate, 125pl of 25% TCA was added to precipitate protein. 
The tubes were then cooled on ice for 5 minutes and the mixture was further diluted 
with 0.6 mI of TCA. The resulting solution was centrifuged for 10 minutes at 1500 
rpm and 0.3ml of resulting supernatant was taken for GSH estimation. The volume of 
the aliquot was made up to 1 ml with 0.2M phosphate buffer. 2m1 of freshly prepared 
0.6mM DTNB was added to the tubes and intensity of yellow color formed was read 
at 412nm. Standard curve of GSH was prepared using concentrations varying from 5-
1 OOnm in 5% TCA for assay. Values were expressed as jig /mg protein. 
3.2.8.5 Estimation of Superoxide Dismutase (SOD) (EC 1.15.1.1) 
SOD was assayed according to the method of Kakkar et al. (1984). 
Principle: 
The assay of SOD is based on the inhibition of the formation of NADH-phenazine 
methosulphate-nitroblue tetrazolium formazon. The colour formed at the end of the 
reaction can be extracted into butanol and measured at 560nm. 
Reagents: 
1. Sodium pyrophosphate buffer (0.025M, pH 8.3) 
2. Phenazine methosulphate (PMS) (186µM) 
3. Nitroblue tetrazolium (NBT) (300µM) 
4. NADH (780µM) 
5. Glacial acetic acid 
6. n-butanol 
7. Potassium phosphate buffer (50mM, pH 6.4) 
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Procedure: 
The assay mixture contained 1.2m1 of sodium pyrophosphate buffer, 0.1 ml of PMS, 
0.3m1 of NBT, 0.2m1 of the liver homogenate and water in a total volume of 2.8m1. 
The reaction was initiated by the addition of 0.2m1 of NADH. The mixture was 
incubated at 30°C for 90 seconds and arrested by the addition of 1.0ml of glacial 
acetic acid. The reaction mixture was then shaken with 4.Oml of n-butanol, allowed to 
stand for 10 minutes and centrifuged. The intensity of the chromogen in the butanol 
layer was measured at 560nm in a spectrophotometer. The result was expressed in 
Unit/mg protein. One unit of enzyme activity is defined as the amount of enzyme that 
gave 50% inhibition of NBT reduction in one minute. 
3.2.8.6 Estimation of Catalase (CAT) (EC 1.11.1.6) 
Catalase activity was assayed following the method of Luck (1974). 
Principle: 
The UV absorption of hydrogen peroxide can be measured at 240nm, whose 
absorbance decreases when degraded by the enzyme catalase. From the decrease in 
absorbance, the enzyme activity can be calculated. 
Reagents: 
1. Phosphate buffer 0.067 M (pH 7.0) 
2. Hydrogen peroxide (2mM) in phosphate buffer 
Procedure: 
H202-phosphate buffer (3.Oml) was taken in an experimental cuvette, followed by the 
rapid addition of 40µl of the liver homogenate. The mixture is mixed thoroughly. The 
time required for a decrease in absorbance by 0.05 units was recorded at 240nm in a 
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spectrophotometer. The mixture of 4Oµ1 of homogenate in H202-free phosphate buffer 
served as control. One enzyme unit was calculated as the amount of enzyme required 
to decrease the absorbance at 240nm by 0.05 units. 
3.2.8.7 Statistical analysis 
Student's t test was used to determine the significance of the differences between the 
groups. Data were expressed as mean ± SE. Differences between the control and the 
tea extract treated groups of mice were analyzed using Chi-square test, Kruskal-
Wallis tests when applicable. The P-value of X0.05 was considered to be significant. 
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3.3 In vitro Assessment of Possible Anti enotoxic Potentials of Tea 
Polvnhenols 
3.3.1 	Chemicals 
Trenbolone Acetate (Steroid) (CAS No.: 10161-33-8,Sigma-Aldrich); 
Methyltestosterone (Steroid) (CAS No. 58-18-4, Sigma-Aldrich); 
Docetaxel (Anticancer drug) (CAS No. 114977-28-5, Sigma-Aldrich); 
Tamoxifen citrate salt (TAM) (Steroidal anticancer drug) (CAS no. 54965-24-1, 99% 
purity, Sigma-Aldrich); 
(Epi) Catechin-3-gallate (CAS No.: 1257-08-5, Sigma-Aldrich); 
Epigallocatechin-3-gallate (CAS No.: 989-51-5, Sigma-Aldrich); 
RPM1 1640 (GIBCO, Invitrogen); 
Phytohaemagglutinin-M (GIBCO, Invitrogen); 
Antibiotic-antimycotic mixture (GIBCO, Invitrogen); 
Fetal serum - calf (GIBCO, Invitrogen); 
5-bromo-2-deoxyuridine (Sigma-Aldrich); 
Giemsa solution in phosphate buffer (pH 6.8; Merck, India); 
Mitomycin-C (Sigma-Aldrich); 
Cyclophosphamide (Sigma-Aldrich); 
Methyl methanesulphonate (Sigma-Aldrich); 
Sodium phenobarbitone (Sigma-Aldrich); 
Colchicine (Microlab); 
Acetone (SRL). 
Dimethyl sulphoxide (Merck, India); 
NADP (SRL). 
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Details of chemicals  
(a) Test compounds: Trenbolone (Steroid), Methyltestosterone (Steroid), 
Docetaxel (Anticancer drug), Tamoxifen citrate salt 
(TAM) (Anticancer drug). 
(b) Positive control: Methylmethane sulphonate (MMS). 
(c) Negative control: Dimethyl sulphoxide (DMSO), Water. 
(d) Natural products: Green tea extract (GTE), BIack tea extract (BTE), 
Epigallocatechin-3-gallate (EGCG) (Sigma-Aldrich), 
Catechin Galltae (CG) (Sigma- Aldrich). 
(e) Culture media: R.PMI 1640 powder (Gibco). 
Collection of cell lines : Peripheral blood lymphocyte culture of healthy individuals 
was done. 
3.3.2 Preparation of S9 mix 
Liver 59 fraction was prepared from Swiss albino healthy rats (Winstar Strain), each 
weighing about 200g. The rats were given 0.1% Phenobarbitone (1 mg/ml) in 
drinking water for 1 week for the induction of liver enzymatic activities. The S9 mix 
was freshly prepared as per standard procedures of Maron and Ames (1983). The 
animals were sacrificed and the livers were collected immediately. The liver slices 
were then carefully homogenized at 4°C in 0.15 M KC1 and centrifuged at 9000 rpm 
at 4°C for 10 min. 
3.3.3 Preparation of Green tea leaf extract (GTE) 
Camellia sinensis L. leaves were collected from the tea farms of Kangra (Himachal 
Pradesh, India) and were air dried and grounded to fine powder. It was grounded to 
fine powder. Extraction was done by soaking samples (30g of dry weight) in 300 ml 
of acetone for 8-10 h at 40-60°C in Soxhlet's apparatus. After filtration, the excess of 
solvent was removed by rotatory evaporator. 1.0 g of dried powder was obtained. The 
extracted powdered polyphenols was then dissolved in Dimethylsulphoxide (DMSO) 
and the extract concentration of 1.075X 104, 2.127 X 10-4 and 3.15 X 10-4 g/ml of 
culture medium were established. 
3.3.4 Preparation of Black tea extract (BTE) 
Back tea (Camellia sinensis) commercially sold in market (with brand name Brooke — 
Bond), was brought and grounded to fine powder. Extraction was done by soaking 
samples (30g of dry weight) in 300 ml of 50% acetone for 8-10 h at 40-50°C in 
Soxhlet's apparatus. After filtration, the excess of solvent was removed by rotatory 
evaporator. 1.0 g of dried powder was obtained. The extracted powdered polyphenols 
was then dissolved in Dimethylsulphoxide (DMSO) and the extract concentration of 
10, 20 and 30 gM and 1.075X 10, 2.127 X 10`~ and 3.15 X 10-4 g/ml of culture 
medium were established. 
3.3.5 Human lymphocyte culture 
Duplicate peripheral blood cultures were done according to Carballo et al., 1993. 
3.3.5.1 Collection of blood sample 
Peripheral blood from the healthy donors was taken fresh every time through veinal 
puncture under a septic conditions using disposable needle and disposable syringes. 
Heparin (1000 IU/ml) was used as anticoagulant. The tightly capped glass vials were 
gently mixed and stored at 4C° for half an hour to separate red blood cells (RBC) 
from plasma. 
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3.3.5.2 Setting of the cultures: 
Briefly, 0.5 ml of the heparinized blood samples was obtained from a healthy donor 
and was placed subsequently in a sterile flask containing 7 ml of RPMI 1640, 
supplemented with 1.5 ml of fetal calf serum, 1.0 ml antibiotic-antimycotic mixture 
and 0.1 ml of phytohaemagglutinin. These flasks were placed in an incubator at 37°C 
for 24 hours. Untreated culture, negative and positive controls were run 
simultaneously. For metabolic activation experiments, 0.5 ml of S9 mix was given 
with each of the tested dose for 6 h. 89 mix was prepared according to standard 
protocol of Maron and Ames (1983). Dimethylsulphoxide (5 .Uml) was used to 
dissdolve the test chemicals to get the desired concentration, it was taken as negative 
control. 
3.3.5.3 Harvesting of the cultures for analysis of Chromosomal Aberrations 
After the expiry of 72 hours, the cultures were taken out from the incubator and their 
contents after gentle shaking were transferred to a centrifuge tube, the cells were 
spun down by centrifugation (10 min, 1200 rpm) and the pellet of cells were saved by 
discarding the supernatant. The cells were collected by centrifugation and washed in 
prewarmed media to remove traces of 89 mix and tested drugs. Hypotonic treatment 
(0.075 M KC1) was carried out for 10-12 minutes at 37°C and the cells were 
recollected by centrifugation. The cell pellet was suspended in 5 ml freshly prepared 
chilled fixative (3:1; methanol:acetic acid), which was added drop by drop with a 
Pasteur pipette while continuously shaking the pellet so as to avoid formation of clots. 
In order to ensure the proper fixation, the cells were kept suspended in the fixative for 
a minimum period of one hour but preferably overnight. Two or three changes with 
fresh fixative were given before preparing the slides. After giving final washing in the 
fixative, the cells were resuspended in 0.2 ml of fresh fixative. Two to three drops of 
this cell suspension were dropped on clean, grease free, pre—chilled wet microscopic 
slides, which were then air-dried. One-day-old slides were stained in 3% Giemsa 
(sigma) for 15 minutes and rinsed in 95% alcohol and finally in absolute alcohol for 
proper differentiation after air-drying, these slides were dipped in Xylene for 5 
minutes before mounting. At least 300 metaphases were examined for the evaluation 
of different types of chromosome breakage frequencies. 
3.3.5.4 Analysis of the cells for Chromosomal Aberrations 
In order to avoid the bias in scoring of the chromosomal anomalies, before and after 
treatment of different test chemicals, all slides were coded prior to scoring. A total of 
300 well spread metaphase were analyzed for each concentration of the test chemicals 
to analyze various chromosome and chromatid type aberrations; the following method 
as described by Evans (1984) was followed. Chromosomal aberration assessment 
serves as a good indicator of the clastogenic effects of chemical agents (Gebhart, 
1970; Buckton and Evans, 1982; Hsu, 1982). The aberration can be classified into 
chromatid type aberrations, which result in the latest Go or G2 phase of cell the cycle, 
and the chromosome type aberration, which are caused by damage to the chromosome 
materials in the G1 or early S-Phase. The chromatid type aberrations include 
chromatid gaps, breaks and deletions. The chromosome type aberrations include, 
isochromatic gaps and breaks, inter-chromosomal exchanges resulting in ring 
chromosome and acentric fragments, and interstitial deletions resulting in acentric 
fragments (Hsu, 1982). Inclusion of gaps in the quantitation of chromosomal damage 
following exposure to drugs and chemicals is controversial. Many workers ignore 
gaps in their analysis (Buckton and Pike, 1964; Goetz et al, 1975). However, others 
suggest that since increase in the frequency of gaps is related to mutagen exposure, 
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they should be included in the analysis (Gebhart, 1970; Hsu, 1982 Bragger, 1982). 
Any damage altering the normal morphology of a chromosome (be it due to damage 
to DNA and chromatin or the packing proteins of chromosomes) could interfere with 
normal functioning of the chromosome causing genotoxicity. Gaps were not included 
in the present study in considering the abnormal metaphases for chromosomal 
aberrations. 
Chromatid type aberrations: 
Chromatid gap (g) The chromatid lesion appears as non-staining region on the 
chromatid with its width being less than that of a chromatid ann. 
Chromatid break (b) The aligned or non--aIigned broken ends of the chromatid with 
its size larger than the width of the chromatid. 
Chromatid deletion (d) A deleted portion at the terminal end of the chromatid. 
Chromatid fragment (f) Free displaced chromatid piece seen either in association or 
without association with the parent chromatid. 
Chromosome type aberrations: 
Chromosome gaps (ig) The gaps involving both the chromatid, isochromatid; gaped 
arms at the same location. 
Chromosome breaks (ib) The break in both the chromatid at almost the same location. 
Acentric fragments (if) Two parallel chromatids without an evident centromere. 
Ring (r) The chromosome arms joined to form circle with or without centromere. 
3.3.5.5 Harvesting of the cultures for Sister chromatid exchange (SCEs) analysis 
For SCE analysis, bromodeoxyuridine (BrdU, 10 µg/ml) was added at the beginning 
of the culture. After 24 hr of the initiation of culture, treatments were given similarly 
as described in CAs analysis. The cells were collected by centrifugation and washed 
in prewarmed media to remove traces of S9 mix and tested drugs. One hour before 
harvesting i.e. after 46 h, 0.2 ml of colchicines (0.2 µglml) was added to the culture 
flask for mitotic arrest. Cells were centrifuged at 1000 rpm for 10 min. The 
supernatant was removed and 8ml of prewarmed (37°C) 0.075 M KCl (hypotonic 
solution) was added. Cells were resuspended and incubated at 37°C for 15 min. The 
supernatant was removed by centrifugation, at 1000 rpm for 10 min,-and subsequently 
5ml chilled fixative (methanol: glacial acetic acid, 3:1) was added. In order to ensure 
the proper fixation, the cells were kept suspended in the fixative for a minimum 
period of one hour but preferably overnight. Two or three changes with fresh fixative 
were given before preparing the slides. The fixative was removed by centrifugation 
and the procedure was repeated twice The slides were processed according to Perry 
and Wolff (1974), with some modification. The slides were stained in 3% Giemsa 
solution in phosphate buffer (pH 6.8) for 15 min. Finally, 200 second cycle of 
divisions metaphases per dose were analysed. 
Around 200 second cycle of cell division metaphases with 
differentially stained chromatids were scored for each test chemicals treatment in 
absence and presence of S9 mix. Student's `t' test was applied for calculating the 
significance of difference between the treated and the controls. 
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3.3.5.6 Analysis of the cells for Cell Cycle Kinetics or Replication Index 
The cells undergoing first (M1), second (M2) and third (M3) divisions were detected 
by studying the BrdU labeled differentially stained chromosomes following the 
methodology 'of Tice et al (1976) and Crossen and Morgan, (1977). The cells with 
both the chromatids being darkly stained were scored as MI cells, those with one dark 
and one lightly stained chromatid as M2 cells and those having mixture of both the 
differentially stained and uniformly stained chromatids were scored as M3 metaphase. 
Around 100 well spread metaphase were scored for each concentration and each 
treatment durations from each donor in the absence as well as in the presence of S9 
mix. The replication index (RI) was calculated according to the formula of Tice 
(1979) as given below. The deviation from the controls was determined by using Chi-- 
square test. 
RI = [(% of cells in Mi) + 2(% of cells in M2) + 3(% of cells in M3)1 1100 
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3.3.5.7 Statistical Analysis: 
Standard deviation (SD) and standard error (SE) were calculated using the following 
formula. 
Mean X = ------------ 
11 
2-71. 52 
Variance 82 = 
SD 
SE= 
Where, X = Variable 
	
= 	Number of observations 
X2 = 	Sum of square of individual variables. 
X 	= 	Mean of variables 
S 	= 	Standard deviation. 
The statistical significance was calculated from Fisher and Yates table at (nl + n2 _2) 
degree of freedom (dl) at 0.05% level of significance. 
Regression analysis was also performed for the Tea infusion dose effect 
on the test chemicals genotoxic effect, using parmeters like Chromosomal aberrations 
(CAS), Sister chromatid exchanges (SCEs) and Replication Index (RI), using statistica 
software (Statsoft, Inc.) 
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3.4 In vitro Assessment of Possible Anticarcinogenic Potentials of 
Green Tea Polyphenols 
3.4.1 Chemicals 
MTT 3-(4,5- dimethylthiazole-2-yl)-2,5-Biphenyl tatrazolium bromide), (Sigma-
Aldrich); 
Neutral red (3-amino-m-dimethylamino-2-methylphenazine hydrochloride), (Sigma-
Aldrich); 
0.25% trypsin, (Sigma-Aldrich); 
0.02% EDTA mixture, (Sigma-Aldrich); 
DMEM (Dulbecco's modified Eagle's medium) were purchased from Himedia 
(India). Fetal bovine serum (FBS) was from Biowest (USA). 
3.4.2 Preparation of Methanolic extract of Green tea: 
Green tea Camellia sinensis L. leaves were collected from the tea farms of Kangra 
(Himachal Pradesh) and were air dried and grounded to fine powder. It was grounded 
to fine powder. Extraction was done by soaking samples (30g of dry weight) in 300 
nil of Methanol for 8-10 h at 40-60°C in Soxhlet's apparatus. After filtration, the 
excess of solvent was removed by rotavaporator. 1.0 g of dried powder was obtained. 
The extracted powdered polyphenols was then dissolved in 5 - 7% Ethanol and the 
extract concentration of 100 — 1300 gg/m1 were established. 
3.4.3 Cell line and culture conditions: 
The two cell Iines, Human Breast cancer cell line MCF-7 (cancerous) and Human 
Embryonic Kidney cell line HEK 293 (Non-cancerous) were procured from National 
Centre for Cell Sciences (NGCS), Pune, India. Cells were grown as monolayer 
cultures in Dulbecco's modified Eagle's medium containing 10% Fetal bovine serum 
and antibiotic (100 units/ml penicillin and 100mg11 streptomycin) in a humidified 
atmosphere of 5% CO2 at 37° C and cells were maintained through cyclic passage by 
sub-culture twice in a week. 
3.4.4 Cytotoxicity Assays: 
The cytotoxicity assys were performed in the cancer cells in vitro both in the presence 
and the absence of Green tea leaf extract, by performing cytotoxicity assays and the 
morphological and nuclear changes were assessed by using inverted microscopic 
technique. 
3.4.4.1 Cellular metabolic MTT Assay 
Cytotoxicity of the Methanolic extract of green tea was evaluated by the assessment 
of its In vitro impact on the Human Breast cancer cell line (MCF-7) and Human 
Embryonic Kidney cell line (HEK 293). Cell count of 2 x 104 cells/well were seeded 
in 96 well plate (200gg/well). After _ 24 hrs cells were treated with different 
concentrations of methanolic extract of Green tea for 48 hrs. After 48 his the medium 
was removed and cells were incubate with 2Ojal of MTT (5mg/ml in PBS) in fresh 
medium for 4 his at 37°C. Farmazon crystals, formed by mitochondrial reduction of 
MTT, were stabilized by adding DMSO (150plwell) and absorbance was recorded at 
570 nun after 10 min incubation using the iMark Microplate Reader(BioRad, USA). 
Percentage of cytotoxicity was calculated as a fraction of control (without any 
treatment). 
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3.4.4.2 Neutral Red uptake Assay 
Neutral red (3-amino-m-dimethylamino-2-methylphenazine hydrochloride) assay was 
based on protocol described by Borenfreund and Puerner (1984). Cytotoxicity assay 
of methanolic extract of Green tea were evaluated on the same cell lines viz MCF-7 
and HEK 293 by Neutral red assay. The assay determined the accumulation of the 
neutral red dye in the lysosomes of viable (uninjured cells). The methanolic extract of 
green tea was incubated with cells for 48 hrs in 96 well plate. Neutral red dye 
(I00ug/ml) was dissolved in serum free medium (DMEM). The pH of the neutral red 
solution was adjusted in all the experiments to 6.35 with the addition of KH2PO4 (1 
M). I0gl of neutral red was incubated with the cells for 1 hour. After that cells were 
washed with phosphate buffered saline (PBS) an 1 ml of elution medium 
(EtOH/AcCOOH, 50%:1%) was added followed by gentle shaking for 10 min so that 
complete dissolution was achieved. The absorbance was taken at 540 nm using iMark 
Microplate Reader (Bio-Rad, USA). 
3.443 Morphological Changes in the Cells 
Cardinal morphological features of apoptotic cells include shrinkage, condensation of 
chromatin and cytoplasm, detachment of the cells from the neighbouring cells, 
fragmentation of the nucleus and membrane blebbing. The morphological changes in 
the cells were followed in the presence and the absence of the Green tea extract. The 
cells were observed under inverted microscope, (Motic (AE31)) at 20X. 
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CHAPTER FOUR 
RESULTS 
4.1 Results of GC-MS analysis of Green Tea Extract 
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GC chromatograms of the Green tea extract 
Table A. Peak abundance (peak area %) of the main compounds 
Present in Green Tea Extract I g GTE 
PHENOLICS 	 PEAK AREA % 
(+)-catechin 	 5.23 
Caffeic acid 	 2.09 
Epicatechin 	 29.43 
Epigallo catechin 	 6.66 
Epigallo-catechin gauate 	 4893 
Tannic acid 	 5 
Kaempferol 	 1.33 
Quercetin 	 1.33 
RAI 	O~C:1TurLaRinss 7) FAULT.P$p'~~#ai,TEXT~.` T15a10 »w,27d6200.1 
The structure of the major component of the green tea extract as observed by the 
Spectroscope. The above structure was interpreted as Epicatechin by spectral 
analysis 
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4.2 Results of in vivo Assessment of Possible Toxicity Risks of Green 
Tea Extract in Mice 
Table 1: Daily fluid intake and percentage change in body weight of all the 
groups of mice 
Groups (Each group 
has five mice, n=4) 
Dose of GTE 
Parameters 
Fluid intake 
(ml/100g/day) 
Increase in body weight 
(%) 
Control 13.70 ± 2.93 30.56 + 17.20 
GTE 100mglkg bw 10.23 + 1.22 31.02 + 16.19 
GTE 1000mglkg bw 8.33 + 0.15 31.67 ± 16.14 
GTE 2500mgfkg bw 8.00 ±1.2 30.88 + 15.17 
GTE 5000mgfkg bw 7.50 + 1.6 30.86 ±16.14 
All values are mean are mean of 4 determinations of each group of mice ± SEM. GTE: Green tea 
extract; bw: Body weight. 
Table 2: Acute toxicity study of Green tea extract in all the groups of mice 
(For a period of 10 days) 
Doses of GTE mglkg 
body weight of the 
animal 
Number of animals in a 
group 
Number of animals dead 
0 (Control) 4 0 
100 4 0 
1000 4 0 
2500 4 0 
5000 4 0 
GTE: Green tea extract. 
The acute oral toxicity of the Green tea extract was very low in mice. No deaths and 
no other signs or symptoms of toxicity were observed up to highest test dose tested 
(5000 mg/kg of body weight). 
Except for hyperactivity and excessive urination, no other adverse effect was noted. 
There were no deaths of animals at any dose in 10 days. No negative effect was seen 
on body weight gain percentage in all the experimental groups of mice (Table 1 and 
2). 
Table 3: Effect of daily administration of the Green tea extract for 10 days on 
biochemical profiles of the control and the treated mice grous. 
Parameters Treatment groups 
Control GTE 
lOOmgIkg 
GTE 
l000mgfkg 
GTE 
2500mg1g 
GTE 
5000mg/kg  
Urea (mg/dl) 46.9 + 1.8a 44.80 ±2.3°  40.8 + 1.3a  38.23± 1.48a 36.4 + 1.3°  
Creatinine 
(mgldl) 
0.61 + 0.02 
- 
0.58 + 0.2 
- 
0.56± Ø•5b  
- 
+ 0.2 
- 
0.53 + 0.1 S 
-- 
GSH (µg1 mg 
protein) 
8.34 + 0.34° 
- 
8.52 + 0.95° 
- 
9.03 + 0.50° 
- 
9.77 + 0.34° 
- 
10.67 + 0.54° 
- 
SGOT (lUlL) 144.8 + 0.06 144.9 ±0.12 145.2 + 0.08 145.6+0.06d  145.8 + 0.35 
SOD (Unitlmg 
protein) 
15.0 +_ 0.56e 16.2 + 0.94° 
- 
17.61 +_ 0.33e 18.3 ±0.84°  18.90±0.65°  
CAT (Unit/ mg 
protein) 
84.0+ 2.11 84.5+2.30 84.8+_1.33 85.0+3.1 
- 
.85.7+_3.3 
Results are mean of 4 determinations of each group ± SEM. Values bearing different 
superscripts in the same row, are significantly different (P< 0.05). SGOT: serum glutamic 
oxaloacetic transaminase ; GSH: Reduced Glutathione ; SOD: Superoxide Dismutase ; 
CAT CataIase. 
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Biochemical parameters investigated: Table 3 is a summary of the results of the 
effects of the Green tea extract administration on the biochemical parameters of mice 
after the experimental period of 10 days. The plasma concentrations of urea, 
creatinine and SGOT were not much changed as compared to controls. The findings 
reveal that Green tea extract results in slight decrease in urea and creatinine levels but 
these changes were not significant (Fig.2 and 3). SGOT concentration was found only 
slightly increased in the groups treated with GTE, but the values too were not 
significantly different from the control (Fig.4). The levels of CASH, SOD and CAT 
were found slightly increased in the animals that received the GTE tested doses. No 
significant increase was observed in these values. (Fig. 5, 6 and 7). 
Fig. 2. Effect of Grp tea extract (ME) on blood Creatinine levels of mice 
Fig. 3. Effect of Green tea extract (GTE) on blood Urea levels of mice 
Fig.4. Effect of Green tea extract (GTE) on SGOT enzyme levels of mice 
Fig.5. Effect of Green tea extract (GTE) on GSH izyme levels of mice 
25 
.ra 20 
1W 
p„ 15 
-Z 10 .a 
5 G 
0 
0 
Ct 
Fig.6. Effect of Green tea extract (GTE) on SOD enzyme levels of mice 
Fig.7. Effect of Green tea exiact (GTE) on CAT e zvme levels of mice 
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4.3 Results of in vitro Assessment of Possible Antigenotoxic potentials 
of Tea Polyphenols 
Experiment I: Effect of Trenbolone, Methyltestosterone, Docetaxel and 
Tamoxifen on cultured Human lymphocytes 
The effect of Trenbolone, Methyltestosterone, Docetaxel and Tamoxifen was studied 
using sister chromatid exchanges (SCE's) and replication index (RI) as genotoxic end 
points. Trenbolone, Methyltestosterone, Docetaxel and Tamoxifen (dissolved in 
dimethylsulphoxide) were added 10, 20, 30 µM each after 24 hr of initiation of the 
culture, separately. Normal, Positive and the negative controls were also run 
simultaneously. For metabolic activation experiments, 0.5 ml of S9 mix was given 
with each of the tested dose. 
Bromodeoxyuridine (BrdU, 10 pg/ml) was added at the beginning of the 
culture in darkness. All the compounds were added at 10, 20, 30 µM each after 24 hr 
of initiation of the culture, separately. Two hours before the harvesting, 0.2 ml of 
colchicine (0.2 gglml) was added to the culture flask. Hypotonic treatment and 
fixation were performed in the same way as in CA analysis. Hoeschst and Giemsa 
staining was done for differential staining of chromatids. The slides were processed 
according to Perry and Wolff (1974) with some modification. Normal and negative 
controls were also run simultaneously. Exchanges were scored and SCE level was 
counted in all treatments and controls. At least 100 metaphases per culture were 
examined for each treatment. For Replication Index (RI) analysis about 100 
metaphases per culture were examined. Each metaphase was classified as being in the 
first (MI), second (M2), and third (M3) division (Schneider et al., 1981). The 
replication index (RI) was calculated using formula (Ivett and Tice, 1982) as follows: 
RI = [(% of cells in M1) + 2(% of cells in M2) + 3(% of cells in M3)] / 100. 
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We have seen the genotoxic effect of a steroid Trenbolone, 
Methyltestosterone and anticancer drugs Docetaxel and Tamoxifen, using sister 
chromatid exchanges (SCE's) and Replication Index (RI) as genotoxic end points. A 
dose dependent increase infrequencies of SCEs was observed for all above mentioned 
drugs, both in presence as well as absence of S9 mix (Table 4 and 5). A significant 
increase in the value of SCEs/cell was observed at 30 µ.M (P<0.03) of Trenbolone, in 
presence of metabolic activation. 
The cell proliferation kinetics which is the average number of cells 
that have undergone replication showed a significant differences between the cultures 
exposed to 30 µM of Treribolone, Docetaxel and Tamoxifen with the normal control 
(P<0.03). There has been an increment in M1 cells and decrease of M2 and M3 cells 
as the doses of each genotoxic drug, used here increased. 
Regression analysis was also performed to study the dose effect of 
Trenbolone, Methyltestosterone, Docetaxel and Tamoxifen treatment for sister 
chromatid exchanges per cell. An increase in the slope linear regression line was 
observed as the dose of Trenbolone, Methyltestosterone, Docetaxel and Tamoxifen 
was increased, both in presence as well as absence of S9 mix (Graphs 1-8). 
Table 4 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Trenbolone, Docetaxel, Methyltestosterone and Tamoxifen, 
in absence of 59 mix. 
Treatment 
(PM) 
Cells Scored SCEs/cell 
(mean # S.E.) 
Percentage of cells at 
Ml 	M2 M3 
RI 
Trenbolone 
10 100 4.21+ 0.31 35 58 7 1.72 
20 I00 5.04± 0.43 37 57 6 1.69 
30 100 5.83±0.46 38 55 7 1.69 
Docetaxel 
10 100 3.42±0.32 36 57 7 1.71 
20 100 3.67±1.08 38 55 7 1.69 
30 100 5.33±129 39 55 6 1.67 
Methyltestosterone 
10 100 3.12± 0.33 35 58 7 1.72 
20 100 3.42 ± 0.32 36 57 7 1.71 
30 100 4.42±032 37 57 6 1.69 
Tamoxifen 
10 100 4.06 ± 0.31 36 57 7 1.71 
20 100 5.36 ± 0.34 38 56 6 1.56 
30 100 5.63±0.42 38 55 5 I.53 
Untreated 100 2.03 ± 0.12 25 63 12 1.87 
Negative control 100 2.51±0.15 24 62 14 1.90 
(DMSO, 5.11ml) 
Positive control 100 16.62 ± 0.15* 57## 43# - 1.43 
MMS (6pM)) 
Significant at *P<0.03 Vs Normal -Wallis test ; Significant at # P<0.005 Vs Normal Chi-square test 
DMSO: Dimethylsulphoxide, MMS: Methylmethane sulphonate; SE: Standard Error. 
Ml :Metaphase first; M2:Metaphase second; M3:Metaphase third. 
Table 5 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Trenbolone, Docetaxel, Methyltestosterone and Tamoxifen, 
in presence of S9 mix 
Treatment 	Cells Scored 	SCEs/cell 	 Percentage of cells at 	 RI 
(liM) (mean ± S.E.) 	M1 	M2 	M3 
Trenbolone 
10 100 5.63+ 0.42 37 56 7 1.71 
20 100 8.21± 0.82 38 57 5 1.67 
30 100 13.67±1.12* 48# 49# 3 I.55 
Docetaxel 
10 100 3.74±0.3 39 54 7 1.68 
20 100 6.86±0.43 41 53 6 1.65 
30 100 9.56±0.49 43# 52# 5 1.62 
Methyttestosterone 
10 100 3.12 ± 0.33 37 57 6 1.69 
20 100 4.43±0.43 36 57 7 1.71 
30 100 8.22 ± 0.82 37 57 6 1.69 
Tamoxifen 
10 100 4.43 ± 0.43 38 56 6 1.68 
20 100 6.52±0.61 39 54 6 1.65 
30 100 7.07±0.67 41# 52# 3 1.54 
Untreated 100 2.03 ± 0.12 25 63 12 1.87 
Negative control 100 2.51 ± 0.15 24 62 14 1.90 
(DMSO, 5 j.tlJml) 
positive control 100 22.21 ± 0.95** 56## 42# 4 1.52 
MMS (6pM) 
Significant at *P<0.03 Vs Normal -Wallis test ; Significant at # P<0.005 Vs Normal Chi-square test 
DMSO: Dimethylsulphoxide, MMS: Methylmethane sulphonate; SE: Standard Error. 
Ml :Metaphase first; M2 :Metaphase second; M3 :Metaphase third. 
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Experiment II: Effect of Green tea extract (GTE) against Methyl Methane 
Sulphonate (MMS) induced genotoxicity in cultured Human lymphocytes. 
The green tea extract (GTE), was tested for its possible antigenotoxic effect against 
Methyl Methane Sulphonate (MMS) induced genetic damage both in presence as well 
as absence of S9 mix, using Chromosomal aberrations (CAs) and Sister chromatid 
exchanges (SCEs) as genotoxic end points. We tested the effect of 1.075X 104, 2.127 
X 10-4 and 3.15 X 104 g/ml of green tea extract (GTE) on the cells damaged by 6 µM 
of MMS. After 24 hr of the initiation of the culture, MMS and GTE were added in 
appropriate doses separately and additively and kept for 48 hr. Normal and negative 
controls were also run simultaneously. For metabolic activation experiments, 0.5m1 of 
S9 mix was given along with each treatment. Dimethylsulphoxide (5 Wml) was taken 
as negative control. 
Two hours before harvesting, 0.2 ml of colchicines (0.2 gglml) was added to 
the culture flask. Cells were centrifuged at 1000 rpm for 10 min. The supernatant was 
removed and 5 ml of prewarmed (37°C) 0.075 M KC1 (hypotonic) solution was 
added. Cells were resuspended and incubated at 37°C for 15 min. The supernanat was 
removed by centrifugation and 5 ml of fixative (methanol: glacial acetic acid; 3:1) 
was added. The fixative was removed by centrifugation and the , procedure was 
repeated twice. The slides were stained in 3% Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. At least 300 metaphases were examined for the evaluation of 
different types of chromosome breakage frequencies. 
For SCE analysis, Bromodeoxyuridine (BrdU, 10 pg/ml) was added at the 
beginning of the culture. After 24 hr of the initiation of culture, treatments were given 
similarly as described for CAs analysis. Two hours before the harvesting, 0.2 ml of 
colchicine (0.2 µg/ml) was added to the culture flask. Hypotonic treatment and 
fixation were performed in the same way as in CAs analysis. The slides were 
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processed according to Perry and Wolff (1974) with some modification. About 200 
second divisions metaphases per dose were analysed. 
In this experiment of Chromosomal aberration induction study, we found 
a similar pattern both in absence as well as presence of 89 mix. This includes the 
induction of CAs in cultured human lymphocytes by MMS and a dose dependent 
decrease when these were treated with Green tea extract (GTE) (Table 6 and 7; Fig. 8 
and 9) . Number of abnormal cells were decreased and chromatid exchanges (CTE) 
and dicentric (DIC) was completely eliminated when treated with even 1.075X 10-4 
gIml both in presence and absence of 89 mix. Abnormal metaphases get reduced from 
40% to 69%, with the addition of increasing concentrations of GTE in absence of 89 
mix and from 42% to 71% in reduction of abnormal 'metaphases in presence of S9 
In our SCE induction study, we found a significant decrease in the 
frequency of SCEs per cell, when GTE was administered at different dosage with 6 
p.M of MMS, both in presence as well as absence of S9 mix (Table 8 and 9; Fig. 10 
and 1 1),In absence of S9 mix, there is decrease in SCEs from 50% to 72% and in 
presence of S9 mix, the SCEs get reduced from 25% to 58% with the addition of 
increasing concentrations of GTE. 
Regression analysis was also performed to study the dose effect of 
Green tea extract on 6 µM of MMS for number of abnormal metaphases and sister 
chromatid exchange. For abnormal metaphases and SCE/cell, a decrease in slope of 
linear regression lines was observed as the dose of the infusion was increased in each 
treatment. (Graphs 9- 12). 
Table 6 Effect of Green tea extract (GTE) on CAs induced by MMS in human lymphocytes in the absence of S9 infix, 
Treatment Cells Scored Abnormal metaphases Total structural aberrations 
(AM) without gaps 
Gaps 	CT;O 	CSIi 	CTE 	NC 
(%±S) 
MMS 
6 300 33 (11.011.80) a 13 	13 	3 	1 	1 
GTE (glml) 
1,075x10-0 300 2(0,66±0.47) 3 	1 	I 	- 
2.127X104 300 3(1,00±0,57)  2 	1 	1 	- 	- 
3,15X10 300 3(1,00+0,57) 2 	1 	1 	- 
MMS(µM)+ GTE (glml) 
6+1.475X104 300 20(6.67± L44) gb 9 	7 	1 	1 	1 
6+2.127X10' 300 13(4.33±I17) 5 	5 	2 
6+3.15X104 300 10(3.3311.03) 4 	3 	1 	1 	- 
Untreate 1 300 2 (0.67 t 0,47) 1 	1 	- 	- 
Negative control 300 3(10±057) 2 	2 	 - 
(DMSO, 5 p1/nil) 
Significant difference: 
eP<0,01 with respect to Untreated; bP<0,05 with respect to MMS in Chi square test. MMS: Methyl Methane Sulphonate; GTE: Green tea 
extract; SE: Standard Error, CTE; Chromatid break; CSB: Chromosome break; CTE: Chromatid Exchange; DIC; Dicentric 
Table 7 Effect of Green tea extract (GTE) on CAs induced by MMS in human lymphocytes in the presence of S9 mix. 
Treatment Cells Scored Abnormal metaphases Total structural aberrations 
(MM) vithout gaps Gaps CTB 	CSB 	CTE 	DIC 
(% ± SE) 
MMS 
6 300 38 (12.671192) a 15 16 	6 	1 	1 
GTE (gfml) 
1,075X10 300 3(1,00±0.57) 2 1 	1 	 - 
2,127X10 300 4(1.33+0,66) 2 2 	1 
3.15X101  300 4(1.33±0.66) 2 2 	1 
MMS(VM)+ GTE (glml) 
6+1,075X10 300 22 (7,33 t 1,50) a 8 10 	4 	2 
6+2.127X10 300 16 (5,3311.29) a°  6 6 	2 
6+3.15X10,  300 11(3,67+ 1.08)' 5 4 	1 	1 	- 
Untreated 300 2(0.67±0.47) 1 1 	1 	- 
Negative control 300 4(133±0.66) 3 4 	1 	- 	- 
(DMSO, 5 pUml) 
Significant difference: 
eP<0.01 with respect to Untreated; 6P<0.O5 with respect to MMS in Chi square test. MMS: Methyl Methane Sulphonate; GTE: Green tea 
extract; SE, Standard Error; CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid Exchange; DIC: Dicentric 
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Table 8 Effect of Green tea extract (GTE )on SCEs induced by MMS in human lymphocytes without 59 mix, 
Treatment (pM) 	 Cells scored 	 SCEs/cell (Mean 	± SE) 
MMS 
6 	 200 	 16.62 1 0.68 
GTE (gJml) 
	
1,075X10 	 200 	 2.08±0.21 
2,127X10' 	 200 	 2,28±023 
3.15XI0l 	 200 	 2.60±025 
MMS(M)+GTE (glml) 
6+1.075X10' 	 200 	 1L16± 0.81 
6+2,127X10' 	 200 	 ,52±0,7O* 
6+3,1SX10 	 200 	 6.02±0.54 ~6 
Untreated 	 200 	 2,36 t 0.21 
Negative control 	 200 	 2,23 t 0.17 
(DMSO, 5 plln!) 
Significant difference: 
°p<0.01 with respect to Untreated; tP<0,05 with respect to MMS in Chi square test. 
GTE: Green tea extract; MMS: Methyl Methane Sulphonate; SE: Standard Error, 
Table 9 Effect of Green tea extract (GTE) on SCEs induced by MMS in human lymphocytes with 59 mix. 
Treatment (µM) 	 Cells scored 	 SCEs /cell (Mean±SE) 
MMS 
6 	 200 	 22,2110.95a 
GTE (glint) 
1,075X10 4 	 200 	 2.3210.22 
2.127X10 	 200 	 2,44±0,24 
3.15X10-0 	 200 	 270±0.28 
MMS(jM)+GTE (glml) 
6+1.07$X10-0 	 200 	 12.60±O.84 a6 
6+2.127X10' 	 200 	 10.50 f 0,78 a6 
6+3.15X104 	 200 	 8,20 1 0,69 ab 
Untreated 	 200 	 2.58 t 0.30 
Negative control 	 200 	 2.38 ± 0,27 
(DMSO, 5 µ11m1) 
Significant difference: 
P<0,01 with respect to Untreated; bP{0,05 with respect to MMS, in Chi square test, 
GTE: Green tea extract; MMS: Methyl Methane Sulphonatc; SE: Standard Error. 
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Experiment III: Effect of Green tea extract (GTE) against Trenbolone and 
Methyltestosterone induced genotoxicity in cultured Human lymphocytes 
The Green tea extract (GTE), was tested for its possible antigenotoxic effect against 
steroids Trenbolone and Methyltestosterone induced genotoxicity both in the 
presence as well as absence of S9 mix using sister chromatid exchanges (SCEs) and 
replication index (RI) as genotoxic end points . We tested the effect of 1.075X 10-4, 
2.127 X 10-4 and 3.15 X 10"4 g/ml of green tea extract (GTE) on the cells damaged by 
40 and 60 t.M of Trenbolone and Methyltestosterone, each. Bromodeoxyuridine 
(BrdU, 10 pg'ml) was added at the beginning of each culture. After 24 hr of the 
initiation of the culture, GTE, Trenbolone and Methyltestosterone, were added in 
appropriate doses separately and additively and kept for 48 hr. Normal and negative 
controls were also run simultaneously. Harvesting and processing of slides was done 
as described in earlier experiments. For metabolic activation experiments, 0.5mI of 
S9 mix was given along with each treatment. 200 metaphases were scanned for SCEs 
for each treatment and control. About 100 metaphases per culture were examined for 
RI analysis. Each metaphase was classified as being in the first (Ml), second (M2), 
and third (M3) division (Schneider et al., 1981). The replication index (RI) was 
calculated using formula (Ivett and Tice,1982 )as follows: 
RI = j(% of cells in M1) + 2(% of cells in M2) + 3(% of cells in M3)] l 100. 
We found that the genotoxicity induced by Trenbolone and 
Methyltestosterone, separately, can be countered with Green tea extract (GTE tested 
doses were 1.075X 10', 2.127 X 10' and 3.15 X 10"4 g/ml) (Table 10 and 11). The 
tested dosages of tea leaves infusion caused a significant dose dependent decrease in 
the number of SCEs/ cell, induced by 40 µM of Trenbolone (3.8% to 32% decrease 
76 
in SCEs/ cell)and 60 µM of Trenbolone (22% to 28% decrease in SCEs/ cell) and by 
40 pM of Methyltestosterone (29% to 49% decrease in SCEs! cell) and by 60 p.M of 
Methyltestosterone (17% to 41% decrease in SCEs/ cell), in the absence of S9 
mix.(Table 12). A similar pattern was observed in cultures with metabolic activation 
(Table 13; Fig. 12 - 15). The tested dosages of plant extract itself did not cause a 
significant increase in SCEs/ cell, both in presence as well as absence of S9 mix. 
In cell cycle kinetics, treatment with 40 and 60 µM of Trenbolone and 
Methyltestosterone, each resulted in decrease in RI of lymphocytes as compared to 
that of untreated (Table 10 and 11). However, treatment with all the three tested 
dosages of tea leaves infusion i.e. GTE, resulted in significant decrease in 
chromosomal segment exchanges and increase in replication indices (Table 12 and 
13; Fig. 16- 19), both in presence as well as absence of S9 mix. 
Regression analysis was also performed to study the dose effect of GTE 
treatment along with Trenbolone and Methyltestosterone, separately, for sister 
chromatid exchanges per cell. A decrease in the slope linear regression line was 
observed as the dose of GTE was increased in each case, both in presence as well as 
absence of S9 mix (Graphs 13- 20). 
Table 10 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Green Tea Extract (GTE), Trenbolone and Methyltestosterone, 
in absence of S9 mix. 
Treatment 	 Cells Scored 	 SCEs/cell 	 RI 
(PM) (mean ±S.E.) 
GTE (gfml) 
1.075X10" 200 2.08 ± 0.21 1.82 
2.127X10 200 2.28 ± 0.23 1.80 
3.15X 104  200 2.60 ± 0.25 1.78 
Trenbolone 
40 200 4.22±0.30 1.72 
60 200 5.83±0.46 b 1.69 
Methyltestosterone 
40 200 4.42±0.32 b 1.69 
60 200 5.34 ± 1.29 b 1.67 
Untreated 200 2.04±0.12 1.91 
Negative control 200 2.52 ± 0.15 1.88 
(DMSO, 5 µ1/mI) 
Positive control 200 16.62 ± 0.68 a 1.45 
MMS (61M) 
Significant at aP<0.03 Vs Normal Kruskall-Wallis test; in Chi square test LP<0.05 with 
respect to Untreated. SE: Standard Error, DMSO: Dimethylsulphoxide, MMS: 
Methylmethane sulphonate 
Table 11 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Green Tea Extract (GTE), Trenbolone and Methyltestosteone, 
in presence of 59 mix. 
Treatment 	 Cells Scored 	 SCEslcell 	 RI 
(AM) (mean±S.E.) 
GTE (g/ml) 
1.075X104  200 2.32±022 1.80 
2.127X10-4 200 2.44 ± 0.24 1.79 
3.15X104  200 2.70±028 1.76 
Trenbolone 
40 200 5.63 ± 0.42 b 1.71 
60 200 8.22± 0.82 b 1.67 
Methyltestosterone 
40 200 3.74 t 0.36 b 1.68 
60 200 9.56 ± 0.49 b 1.62 
Untreated 200 2.46 t 0.14 1.89 
Negative control 
(DMSO, 5 }d/ml) 200 3.02± 	0.17 1.87 
Positive control 200 22.22 ± 4.95 a 1.55 
MMS (6lM) 
Significant at 3P< 0.01 Vs Normal Kruskall-Wallis test.; in Chi square test bP<Z0.05 with respect 
to Untreated. DMSO: DimethylsuIphoxide, MMS: Methylmetbane suiphonate 
Table 12 Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index 
(RI) induced by Trenbolone and Methyltestosterone in human lymphocytes without S9 
mix. 
Treatment (}EM) Ce11s scored SCEsfcelt (Mean ± SE) R1 
TI (fEM)+ GTE (g/ml) 
40 + 1.075X10 200 4.06 f 042a 1.73 
40 + 2.127X104 200 3.12± 0.33 a  1.74 
40+3.15X10 200 2.84 t 0.31 ab  1.76 
T2(.tM) + GTE (gfml) 
60 + 1.075X10;  200 4.52 ± 0.48 a  1.70 
60 +2.127X104 200 4.44 ± 0.46 a 1.72 
60 + 3.15X104 200 4.14 t 0.42 a b  1.74 
Ml (PM)+ GTE (gfml) 
40+1.075X10-' 200 3.13 ± 0.30 a  1.70 
40+2.127X104 200 2.36 ± 0.21 a c 1.73 
40+3.15XI0' 200 213 ±- 0.17 a ` 1.75 
M2 (µM)+ GTE (g/ml) 
60+1.075X104 200 4.43±0.43 a 1_68 
60+2.127X104 200 4.21±0.31 a 1.70 
60t3.15X104  200 3.1O±0.31 a ° I.73 
Untreated 200 2.04 ± 0.12 1.91 
Negative control 200 2.52 ± 0.15 1.88 
(DMSO, 5 µVml) 
Significant difference: using Chi square test 
p<)•01 with respect to Untreated 
bP<0.05 with respect to TrenboIone (Values given in Table 10) 
°P<0.05 with respect to Methyltestosterone. (Values given in Table 10) 
Ti: 40 pM Trenbolone; T2: 60 µM Trenbolone.;MI: 40 pM Methyltestosterone; M2: 60 µM 
Methyltestosterone.;GTE: Green tea extract; DMSO:Dimethylsulphoxide; SE: Standard Error. 
Table 13 Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index 
(RI) induced by Trenbolone and Methyltestosterone in human lymphocytes with 59 mix. 
Treatment (g.M) Cells scored SCEs/cell (Mean ± SE) RI 
Ti (µM)+ GTE (g/ml) 
40+1.075X104  200 4.48 ± 0.45 2 1.71 
40+2.127X104  200 4.43 ± 0.43 a 1.73 
40+3.15X10 200 4.28 ± 0.35 a b 1.75 
T2 (µM)+ GTE (g/ml) 
	
60+1.075X104 	 200 	 7.32±0.642 	 1.68 
60+2.127X10-4 	 200 	 6.52±0.612 	 1.70 
60+3.15X10-0 	 200 	 6.02 ± 0.54 ab 	 1.71 
M1 (.M)+ GTE (glml) 
40+1.075X10-4 200 3.42 ± 0.32 a 1.70 
40+2.127X104  200 2.66±0.292 1.72 
40+3.15X14 200 2.28 ±0.23 2t 1.74 
M2 (µM)+ GTE (g/ml) 
60+1.075X104  200 7.32±0.642 1.63 
60+2.127X10-0 200 6.52 t 0.61 ac 1.64 
60+3.15X10-4  200 6.34±0.592c 1.66 
Untreated 200 2.45 -±- 0.14 I.89 
Negative control 200 3.02 ± 	0.17 1.87 
(DMSO, 5 µ1m1) 
Significant difference: using Chi square test 
2P<0.01 with respect to untreated 
bP<0.05 with respect to Trenbolone (Values given in Table 11) 
"P<0.05 with respect to Methyltestosterone. (Values given in Table 11) 
Ti: 40 .tM Trenbolone; T2: 60 µM Trenbolone; MI: 40 µM Methyltestosterone; M2: 60 µM 
Methyltestosterone.; GTE: Green tea extract; DMSO:Dimethylsulphoxide; SE: Standard Error. 
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Fig. 13. Effect of GTE on Sim chromatid exchanges (SCEs) induced by Trelbolone and 
Methyltosteine in human lymphocytes, without S9 mix 
Fig. 14. Sister chromatid exchanges (SCEs) in human lymphocytes created with Green 
Tea Extract (GTE), Trenbolone and Methyltestosterone; in presence of S9 mix. 
Fig. 15. Effect of GTE on Sister chromatid exchanges (SCEs) induced by Trenbolone and 
Methyltestastcnne in human lymphocytes, withS9 mix 
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Fig. 19. Effect of GTE on Replication Index (RI) induced by Treibolone and 
Methyltestosterone in human lymphocytes, with S9 mix. 
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Methyltestosterone M2 (M2= 60 µM) in human lymphocytes, with S9 mix. 
Experiment IV: Effect of Green tea extract (GTE'•againstt Docetaxel and 
Tamoxifen induced genotoxicity in cultured Human lymphocytes 
The green tea extract (GTE), was tested for its possible antigenotoxic effect against 
anticancer drugs, Docetaxel and Tamoxifen induced genetic damage both in the 
presence as well as absence of S9 mix using sister chromatid exchanges (SCEs) and 
replication index (RI) as genotoxic end points . We tested the effect of 1.075X 104, 
2.127 X 10 and 3.15 X 10-4 glml of green tea extract (GTE) on the cells damaged by 
3 and 6 gM of Docetaxel and Tamoxifen, each. After 24 hr of the initiation of the 
culture, GTE, Docetaxel and Tamoxifen, were added in appropriate doses separately 
and additively and kept for 48 hr. Normal and negative controls were also run 
simultaneously. Harvesting and processing of slides was done as described in earlier 
experiments. For metabolic activation experiments, 0.5m1 of 59 mix was given along 
with each treatment. 200 second division metaphases were scanned for SCEs for each 
treatment and control. About 100 metaphases per culture were examined for RI 
analysis. 
We found here that the genotoxicity induced by Docetaxel and 
Tamoxifen, separately, can be countered with Green tea extract (GTE tested doses 
were 1.075 X 10-4, 2,127 X 10-4 and 3.15 X 10" g/ml). The tested dosages of tea 
leaves infusion caused a significant dose dependent decrease in the number of SCEs/ 
cell, induced by 3µM of Docetaxel (a decrease from 9% to 33% in SCEs/cell in 
absence of 59 mix and from14.5% to 34% in presence of 59 mix )and 6 µM of 
Docetaxel (a decrease from 22% to 46% in SCEs/cell in absence of S9 mix and from 
26.5% to 47% in presence of S9 mix). (Table 14 and 15). In case of 3 µM Tamoxifen 
treated cultures addition of GTE resulted in decrease in the SCEs/cell from 3.7% to 
45%, in absence of 59 mix and from 26.5% to 58% in presence of 59 mix and in 
case of 6µM Tamoxifen the decrease in SCEs was from 9% to 33% in absGVsO9 
mix and from 33% to 50% decrease in SCEs in presence of S9 mix (Table 16 and 17; 
Fig. 20 - 23). 
In cell cycle kinetics, treatment with 3 and 6 µM of Docetaxel 
and Tamoxifen, each resulted in decrease in RI of lymphocytes as compared to that of 
untreated (Table 14 and 15). However, treatment with all the three tested dosages of 
tea leaves infusion resulted in significant decrease in chromosomal segment 
exchanges and increase in replication indices (Table 16 and 17; Fig.24 - 27), both in 
presence as well as absence of S9 mix. All the three tested dosages of leaves infusion 
per se did not decrease the replication indices significantly, both in presence and 
absence of S9 mix. 
Regression analysis was also performed to study the dose effect of 
GTE treatment along with Docetaxel and Tamoxifen, separately, for sister chromatid 
exchanges per cell. A decrease in the slope Iinear regression line was observed as the 
dose of GTE was increased in each case, both in presence as well as absence of S9 
mix (Graphs 21- 28). 
Table 14 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Green Tea Extract (GTE), Docetaxel and Tainoxifen., in 
absence of S9 mix. 
Treatment 	 Cells Scored 	 SCEs/cell 	 RI 
(j M) (mean) 
GTE (g/ml) 
1.075X104 	 200 	 2.08 ± 0.21 	 1.82 
2.127X10' 
3.15X104  
Docetaxel 
3(D1) 
6 (D2) 
Tamoxifen 
3 (TAM1) 
6 (TAM2) 
Untreated 
Negative control 
(DMSO, 5 ffl/m1) 
Positive control 
MMS (6 µM) 
200 2.28 ± 0.23 1.80 
200 2.60 ± 0.25 1.78 
200 3.42±0.32 b 1.69 
200 5.34 ± 0.46 b 1.67 
200 4.22± 0.31b 1.68 
200 5.84 ± 0.46 b 1.65 
200 2.04±0.12 1.91 
200 2.52±0.15 1.88 
16.62±0.68' 	1.45 
Significant at *P<0.03 Vs Normal KruskalI-Wallis test. Significant difference: 'P<0.01 with 
respect to untreated using Chi square test; GTE: Green tea extract; MMS: Methylmethane 
sulphonate; SE: Standard Error. D1: 3 p.M Docetaxei; D2: 6 pM Docetaxel ; TAMI: 3 µM 
Tamoxifen; TAM2: 6 pM Tamoxifen; DMSO:Dimethylsulphoxide; SE: Standard Error. 
Table 15 Sister chromatid exchanges (SCEs) and Replication Index (RI) in human 
lymphocytes treated with Green Tea Extract (GTE), Docetaxel and Tamoxifen, in 
presence of S9 mix. 
Treatment 	 Cells Scored 	 SCEs/cell 	 RI 
(AM) (mean) 
GTE (gtml) 
1.075X104 	 200 	 2.32±0.22 	 1.80 
2.127X104 	 200 	 2.44±0.24 	 1.79 
3.15X104  200 2.70±0.28 1.76 
Docetaxel 
3 (Dl) 200 6. 86 -i- 0.43 b 1.68 
6 (D2) 200 9. 56 ± 0.49 b 1.62 
Tanloxifen 
3 (TAMI) 200 5. 83 ± 0.45 b 1.65 
6 (TAM2) 200 8. 44 ± 0.62 b 1.63 
Untreated 200 2.46 ± 0.14 1.89 
Negative control 
(DMSO, 5 µl./ml) 200 3.02 t 0.17 1.87 
Positive control 200 22.22 ± 0.95 `  1.65 
MMS (6 µM) 
Significant at *P<0.03 Vs Normal Kruskall-Wallis test. Significant difference: aP.0.01 with 
respect to untreated using Chi square test; GTE: Green tea extract; MMS: Methyimethane 
sulphonate;SE: Standard Error. Dl: 3 tM Docetaxel; D2: 6 µM Docetaxel ; TAM1: 3 µM 
Tamoxifen; TAM2: 6 µM Tamoxifen; DMSO:Dimethylsulphoxide; SE: Standard Error. 
Table 16 Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index 
(RI) induced by Docetaxel and Tamoxifen in human lymphocytes without S9 mix. 
Treatment (PM) 
D1 (µM)+ GTE (g/ml) 
3+1.075X10 
3+2.127X10' 
3+3.15X10' 
D2 (µM)+ GTE (g/ml) 
6+1.075X104  
6+2.127X 10' 
6+3.15X104  
TAMI (.tM)+GTE (g/ml) 
3 + 1.075X10-0 
3±2.127X10  
3 + 3.15X10' 
TAM2 (µM) + GTE (g/ml) 
6 + 1.075X10-4 
6 + 2.127X104  
6 + 3.15X10' 
Untreated 
Negative control 
(DMSO, 5 .L1/m1) 
Cells scored 	SCEs/cell (Mean ± SE) 	 RI 
200 3.10 ± 0.33 a 1.70 
200 2.67 ± 0.29 b 1.73 
200 2.28 ± 0.26b 1.75 
200 4.14 ± 0.42 a 1.68 
200 4.10±0.40-  1.70 
200 2.84±0.31b 1.73 
200 4.06±0.42a 1.70 
200 3.74 ± 0.36 a 1.72 
200 2.31 ± 0.32 ` 1.74 
200 5.31 ± 0.48 a 1.68 
200 4.44 ± 0.46 a 1.69 
200 3.92 ± 0.38 ` 1.71 
200 2.04 ±0.12 1.91 
200 2.52 ±0.15 1.88 
Significant difference: using Chi square test 
aP{0.01 with respect to untreated 
bP.005 with respect to Docetaxel (Values given in Table 14) 
cP<0.05 with respect to Tamoxifen. (Values given in Table 14) 
D 1: 3 µM Docetaxel; D2: 6 pM Docetaxel ; TAM1: 3 µM Tamoxifen; 
TAM2: 6 p Tamoxifen; DMSO:Dimethylsulphoxide; SE: Standard Error. 
Table 17 Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index 
(RI) induced by Docetaxel and Tamoxifen in human lymphocytes with S9 mix. 
Treatment (pM) 	Cells scored 	SCEs/cell (Mean ± SE) 	 RI 
D1 (pM)+ GTE (g/ml) 
3+1.075X10 200 5.83 ± 0.45 a 1.71 
3+2.127X10-4 200 5.31± 0.58 1.74 
3+3.15X10' 200 4 52 ± 0.48 b 1.78 
D2 (1iM)+ GTE (glml) 
6+1.075X10 200 7.02 ± 0.48 a 1.65 
6+2.127X10-4 200 6.86 + 0.43 a b 1.68 
6+3.15X104  200 5.04±0.53 ab 1.70 
TAM1 (}iM)+ GTE (g/ml) 
3 + 1.075X10 200 4.28 ± 0.35 a 1.68 
3+2.127X10A 200 3.74 ± 0.36c 1.70 
3 + 3.15X10 200 2.46 ± 0,14c 1.74 
TAM2 (µM) + GTE (g/ml) 
6 + 1.075X10 200 5.63±. 0.42 a 1.65 
6 + 2.127X10 200 4.52 ± 0.48 ac 1.67 
6+3.15X10 200 4.14± 042 a° 1.72 
Untreated 	 200 	 2.456 ± 0.14 	 1.89 
Negative control 	 200 	 3.02 ± 0.17 	 1.87 
(DMSO, 5 .il/m1) 
Significant difference: using Chi square test 
'P<0.01 with respect to untreated 
"P<0.05 with respect to Docetaxel (Values given in Table 15) 
°P<0.05 with respect to Tamoxifen. (Values given in Table 15) 
D1: 3 p.M Docetaxel; D2: 6 pM Docetaxel ; TAM1: 3 pM Tamoxifen; 
TAM2: 6 p.M Tamoxifen; DMSO:Dimethylsulphoxide; SE: Standard Error. 
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Tamoxifen TAM1 (TAM1= 3p.M Tamoxifen) in human lymphocytes, without S9 
mix. 
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Graph 24. Effect of GTE on Sister chromatid exchanges (SCEs) induced by 
Tamoxifen TAM2 (TAM2= 6µM Tamoxifen) in human lymphocytes, without S9 
mix. 
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Graph 25. Effect of GTE on Sister chromatid exchanges (SCEs) induced by 
Docetaxcl D1 (D1= 3}~M Docetaxel) in human lymphocytes, with S9 mix. 
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Graph 26. Effect of GTE on Sister chromatid exchanges (SCEs) induced by 
Docetaxel D2 (D2= 6 µM Docetaxel) in human lymphocytes, with 59 mix. 
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Graph 27. Effect of GTE on Sister chromatid exchanges (SCEs) induced by 
TamoxifenTAM1 (TAM1= 3pM Tamoxifen) in human lymphocytes, with S9 mix. 
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Graph 28. Effect of GTE on Sister chromatid exchanges (SCEs) induced by 
TamoxifenTAM2 (TAM2= 6 µM Tamoxifen) in human lymphocytes, with 89 
mix. 
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Experiment V: Effect of Epi Catechin Gallate (CG) against Methyl Methane 
Sulphonate (MMS) induced genotoxicity in cultured Human lymphocytes 
The tea ' polyphenol Epi Catechin Gallate (CG), was tested for its possible 
antigenotoxic effect against Methyl Methane Sulphonate induced genetic damage 
both in the presence as well as absence of S9 mix using chromosomal aberrations 
(CAs) and sister chromatid exchanges (SCEs) as genotoxic end points. We tested the 
effect of 10, 20 and 30 gM of Epi Catechin Gallate (CG) on the cells damaged by 6 
E.iM of MMS. After 24 hr of the initiation of the culture, MMS and CG were added in 
appropriate doses separately and additively and kept for 48 hr. Normal and negative 
controls were also run simultaneously. For metabolic activation experiments, 0.5m1 of 
S9 mix was given along with each treatment. Harvesting and processing of slides, for 
CAs and SCEs analysis was done as described in earlier experiments. At least 300 
metaphases were examined for the evaluation of different types of chromosome 
breakage frequencies.About 200 second divisions metaphases per dose were analysed. 
In this experiment of chromosomal aberration induction study, we found 
that the induction of CAs like gaps, chromatid breaks, chromosomal breaks, 
chreomatid exchanges and dicentrics, in cultured human lymphocytes by MMS and a 
dose dependent decrease when these were treated with Epi Catcchin Gallate (CG) 
(Table 18 and 19; Fig. 28 and 29). Number of abnormal metaphases were decreased 
from 24% to 63% in absence of S9 mix and from 21% to 60% in presence of S9 mix. 
Dicentrics (DIC) were completely eliminated when treated with 20 µM of CG, both in 
presence and absence of S9 mix, and at 30 gM of CG treatment, in presence of 59 
mix. 
In our SCE induction study, we found a significant decrease in sister 
chromatid exchanges when CG was administered at different dosage with 6 ..M of 
MMS. There had been a decrease in frequency of SCEs from 36% to 54% in the 
absence of S9 mix and from 33.8% to 58.6% in the presence of 59 mix (Table 20 and 
21; Fig. 30 and 31). 
Regression analysis was also performed to study the dose effect of 
Catechin GalIate (CG) on 6 µM of MMS for the number of abnormal metaphases and 
SCEs per cell. A decrease in slope of linear regression lines was observed as the dose 
of Catechin Gallate (CG) was increased in each treatment, both in presence as well as 
absence of S9 mix (Graphs 29- 32). 
0 
Table 18 Effect of Catechin Gallate (CG) on CAs induced by MMS in human lymphocytes in the absence of S9 mix. 
Treatment Cells Scored Abnormal metaphases Total structural aberrations 
(µM) without gaps 
Gaps CTB 	CSB 	CTE 	DIC 
(% ± SE) 
MMS 
6 300 33 (110±1.80) 13 13 	3 	1 	1 
CG 
10 300 2(067±046)  1 1 	I 	- 	- 
20 300 2 (0.67 t 0.46) 2 2 	1 	 - 
30 300 3(1.0±0.57)  2 2 	1 
MMS+CG 
6+10 300 25 (833 t 1,59) a6 7 9 	2 	1 	1 
6+20 300 l8 (6,0011,37) ab 5 6 	2 	1 	- 
6+30 300 12 (4 00 + 124) ab 4 4 	1 	1 	- 
untreated 	 300 	 2(0.67 t 0,47) 	1 	1 	• 	- 	- 
Negative control 	 300 	 3 (1.010,57) 	2 	2 	 - 
(DMSO, 5 pllml) 
Significant difference: using Chi square test 
eP<0.01 with respect to untreated; bP<0,05 with respect to MMS.; CG: Catechin gallate; SE: Standard Error,; CTE: Chromatid break; 
CSB: Chromosomal break; CTE: Chromatid Exchange; DIC: Dicentric chromosome 
Table 19 Effect of Catechin Gallate (CG) on CAs induced by MMS in human lymphocytes in the presence of S9 mix, 
Treatment Cells Scored Abnormal metaphases Total structural aberrations 
(M)  vithout gaps Gaps CIE 	CSB 	CTE 	DIC 
(% t SE) 
MMS 
6 300 38 (12,67±' 1.92) a 15 16 	6 	1 	1 
CG 
10 300 3(1.00+0.57) 2 1 	1 
20 300 4(1,33±0,66) 4 4 	1 	 - 
30 300 4(I.33+0,66) 5 4 	2 	- 
MMS}CG 
6+10 300 30(1000± 1,73) ab 9 9 	3 	l 	1 
6+20 300 19 (633 t 1,41) eb 6 7 	3 	l 
6+30 300 15(5.00  + i.26) °b 4 4 	1 
Untreated 	 300 	 2 (0,67 t 0.47) 	I 	1 	1 
Negative control 	 300 	 4(133 ± 0.66) 	3 	4 	1 	- 
(DMSO, 5 µ11m1) 
Significant difference: using Chi square test 
aP<0,01 with respect to untreated; by<0,05 with respect to MMS.CG: Catechin gallate; MMS: Methyl Methane Sulphonate; SE: Standard Error, 
CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid Exchange; DIC: Dicentric 
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Fig.28. Effect of Catechin Gallate (CG) on CAs induced by MMS in human lymphocytes 
in the absence of S9 mix 
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Fig.29. Effect of Catechin Gallate (CG) on CAs induced by MMS in human 
lymphocytes in the presence of S9 mix 
Table 20 Effect of Catechin Gallate (CG) on SCEs induced by MMS in human lymphocytes without S9 mix. 
Treatment (µM) 	 Celis scored 	 SCEs/cell (Mean ± SE) 
MMS 
6 	 200 	 16.6210.68 
Co 
10 200 3,13±0,30 
20 200 3,42 ± 0.32 
30 200 3.7410.36 
MMS +CG 
6+10 200 I1.72±052 8b 
6+20 200 9.56±0.49 ab 
6+30 200 6.8610,43 ab 
Untreated 	 200 	 2.4610.14 
Negative conaol 	 200 	 3.02±0.17 
(DMSO, 5 pllml) 
Significant difference; using Chi square test 
?<0.01 with respect to untreated; bP<0,05 with respect to MMS. 
CO: Catechin gallate; MMS: Methyl Methane Sulphonate; SE: Standard Error, 
Table 21 Effect of Catechin Gallate (CG) on SCEs induced by MMS in human lymphocytes with S9 mix. 
Treatment (µM) 	 Cells scored 	 SCEs/cell (Mean 	± SE) 
MMS 
6 	 200 	 2221±O95 
CG 
10 	 200 	 2,78±0.31 
20 	 200 	 2.89±0.32 
30 	 200 	 3.04±0.35 
MMS + CG 
6+10 200 14.1110.81
ab 
6+20 200 11,23 t 0.76
8b' 
6+30 200 10.1610.74 
Untreated 200 2,38 { 0.27 
Negative control 200 2,58±030 
(DMSO, 5 µl/ml) 
Significant difference; using Chi square test 
aP<0.01 with respect to untreated; bP<0,Q5 with respect to MMS. 
CG. Catechin gallate; MMS: Methyl Methane Sulphonate ;SE: Standard Error, 
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Fig.30. Effect of Catechin Gallate (CG) on SCEs induced by MMS in human 
lymphocytes, without 59 mix 
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Fig.31. Effect of Catechin Gallate (CG) on SCEs induced by MMS in human 
lymphocytes. with 59 mix 
32 
LI, 0 
m 
C 
.= ..- = a 
24 
0. 
20 
C 
C 
0 = 
12 
8 
Cca1ion of CG 'is. A•n<nuI mt 33E;.Wi1IUt gsps  
Abrionnaf mpha witioiI ps =31 223- DO VARI 
= -.9333 
MS 
24 
	
2-2 	• 	 .• 	.. 	..- 	. 	.. 	. 
20 	• 
13 • 	 . 	• 
16 
14 	 • 	 - •- 	-.. 
ZO 
12 	• 	 . 	 I 	• '- • 	.. 
	
X- Rgr2iort 
S 	12 	18 	23 	24 	2.E 	32 	Siift± 
ccnratbn d CS {?Tioi) 
Graph 29. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by NMS in human lymphocytes, in the absence of S9 mix 
r.cnrr-rLfrafjnn of CC'S it m Ahnmm-md mphc wHhuLf gf 
Ariozmi 1T ph5 W1l1t gips 2633. - JEW O:cntration of C-13  
ConL1iorL: , = 
•• 
SS -nfi. 12 	18 	 24 	2Z 
CorrL7stt.n cf CO (MIaoM) 
Graph 30. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by PAMS in human lymphocytes, in the presence of S9 mix. 
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Graph 31. Effect of Catechin Gallate (CG) on SCEs induced by MMS in human 
lymphocytes, without S9 mix. 
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Graph 32. Effect of Catechin Gallate (CG) on SCEs induced by MMS in human 
lymphocytes, with S9 mix. 
Experiment VI: Effect of Epi Catechin Gallate (CG) against Trenbolone and 
Docetaxel induced genotoxicity in cultured Human lymphocytes 
The tea polyphenol Epi Catechin Gallate (CG), was tested for its possible 
antigenotoxic effect against Trenbolone and Docetaxel induced genetic damage both 
in the presence as well as absence of S9 mix using chromosomal aberrations (CAs) as 
genotoxic end points. After 24 hr of the initiation of the culture, CG (tested doses 
were 10, 20 and 30 µM), Trenbolone (tested doses were 40 and 60 µM) and Docetaxel 
(tested doses were 3 and 6 µM) were added, (both the chemicals were pre dissolved in 
DMSO). were added in appropriate doses separately and additively and kept for 72 h. 
For metabolic activation experiments, 0.5 ml of S9 mix was given with each of the 
tested dose for 6 h. S9 mix was prepared according to standard protocol of Maron and 
Ames, 1983. The cells were collected by centrifugation and washed in prewarmed 
media to remove traces of S9 mix and drugs. The culture bottles were kept for another 
48 h in an incubator at 37° C. Two hours before harvesting, 0.2 ml of colchicines (0.2 
pg/ml) was added to the culture flask. Cells were centrifuged at 1000 rpm for 10 min. 
The supernatant was removed and 5 ml of prewarmed (37°C) 0.075 M KCl 
(hypotonic) solution was added. Cells were resuspended and incubated at 37°C for 15 
min. The supernanat was removed by centrifugation and 5 ml of fixative (methanol: 
glacial acetic acid; 3:1) was added. The fixative was removed by centrifugation and 
the procedure was repeated twice. The slides were stained in 3% Giemsa solution in 
phosphate buffer (pH 6.8) for 15 min. At least 300 metaphases were examined for the 
evaluation of different types of chromosome abnormalities i.e. gaps, fragments, 
breaks and exchanges. 
In this experiment of chromosomal aberration induction study, we found that 
induction of CAs like gaps, chromatid breaks, chromosomal breaks, chromatid 
exchanges and dicentrics, in cultured human lymphocytes by Trenbolone and 
Docetaxel, each. A dose dependent decrease was observed when these were treated 
with Epi Catechin Gallate (CG) (Table 22 and 23; Fig.32 - 35). Number of abnormal 
cells without gaps were decreased in case of 40 pM of Trenbolone the decrease is 
from 16% to 50% in absence of S9 mix and from 4.5% to 50% in presence of S9 mix 
and in case of 60 pM of Trenbolone the decrease is from 23% to 50 % in absence of 
S9 mix and from 20% to 44% in presence of S9 mix. In case of 3 µM Docetaxel 
treated cultures addition of CG resulted in decrease in the number of abnormal 
metaphases from 21% to 50%, in absence of S9 mix and from 14% to 57% in 
presence of S9 mix and in case of 6µM Docetaxel the decrease was from 9% to 40% 
in the absence of S9 mix and from 16% to 50% decrease in the presence of S9 mix. 
Regression analysis was also performed to study the dose effect of Catechin 
Gallate (CG) against Trenbolone and Docetaxel for the number of abnormal 
metaphases. A decrease in slope of linear regression lines was observed as the dose of 
Catechin Gallate (CG) was increased in each treatment, both in presence as well as 
absence of S9 mix (Graphs 33- 40). 
Table 22 Effect of Catechin Gallate (CG) on CAs induced by Trenbolone and Docetaxel in human 
lymphocytes in the absence of S9 mix. 
Treatment 	Total Cells 	Abnormal metaphases 	 Total structural aberrations 
Scored without gaps 
(%± SE) 	Gaps 	CTB 	CSB 	CTE DIC 
CG 
10 300 2 (0.67 ± 0.46) 1 1 1 - 	- 
20 300 2(0.67±0.46)  2 2 1 - 	- 
30 300 3(1.0±0.57) 2 2 1 - 	- 
Trenbolone 
40(T1) 300 19(6.0±0.91)a 7 9 2 1 	- 
60 (T2) 300 21 (7.0 ± 0.40) a 7 6 2 1 	1 
Docetaxel 
3(D1) 300  19(6.33± 1.08) a  6 5 3 1 	- 
6 (D2) 300 22 (7.33 t 0.91) a 7 8 4 2 	1 
T1+CG 
40+10 300  15(5.0± 0.91)a 7 7 2 1 	1 
40+20 300  12(4.0± 0.91) ab 6 6 2 1 	- 
40+30 300 9(3.0±0.70) ab  5 4 1 1 	- 
T2+CG 
60+10 300 16(5.33±0.57)ab 7 5 2 1 	1 
60+20 300  13(4.33±o.64)' 6 4 1 1 	- 
60+30 300 10(3.33±0.91) ab 4 3 1 1 	- 
D1 +CG 
3+10  300 15 (5.0± 0.40) a 6 4 3 1 	- 
3+20  300  12 (4.0 } 0.57) a 6 4 2 1 	- 
3+30 300  8(2.66± 0.91) ac 4 3 1 1 	- 
D2 + CG 
6+10 300 20(6.66±0.81) a 7 6 4 2 	1 
6 + 20 300 17 (5.66 ± 0.40) a 5 3 2 I 	- 
6+30 300  13 (4.33 ± 0.64) a` 3 2 2 - 	- 
Untreated 300  2 (0.67 ± 0.47) 1 1 - - 	- 
Negative control 300 3 (1 ± 0.57) 2 2 - - 	- 
(DMSO, 5 µ1/ml) 
Significant difference: using Chi square test 
3P<0.01 with respect to untreated; bP<0.05 with respect to Trenbolone; `P<0.05 with respect to Docetaxel 
DMSO:Dimethylsulphoxide; CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid 
exchange; DIC: Dicentric: SE: Standard Error. 
Table 23 Effect of Catechin Gallate (CG) on CAs induced by Trenbolone and 
Docetaxel in human lymphocytes, in presence of S9 mix. 
Treatment 
( 
Total Cells 
Scored 
Abnormal 
metaphases 
without gaps 
(% ± SE) 
Gaps 
Total structural aberrations 
CTE 	CSB 	CTE DIC 
Treatment (}iM) 
Co 
10 300 3 (1.00±0.57) 2 1 1 - - 
20 300 4(1.33±0.66)  4 4 1 - - 
30 300 4(1.33+0.66) 5 4 2 - - 
Trenbolone 
40(T1) 300 22(7.33±0.91) a 7 6 2 1 - 
60 (1'2) 300 25(8.33±0.57) a  7 9 2 1 1 
Do cetaxel 
3(D1) 300  21(7.0±0.40) a 6 5 3 1 - 
6 (D2) 300  24 (8.0 ± 0.81) 8 7 8 4 2 1 
TI +CG 
40+10 300  21(7.0±0,40) a  7 7 2 1 1 
40 +20 300 17(66±0.57) a e  6 6 2 1 - 
40+30 300  11(3.66±1.08) a b 5 4 1 1 - 
T2 + CG 
60+10 300  25(8.33±0.57) a 7 5 2 1 1 
60+20 300  20 (6.56±0.40) ab 6 4 1 1 - 
60+30 300  14(4.66i- 0.57)ab  4 3 1 1 - 
D1+CG 
3+10 300  IS (6.00± 091) a 6 4 3 I - 
3+20 300 14(4.66± 0.40) ac 6 4 2 I - 
3+30  300  9(3.0±  0.70) a c 4 3 1 1 - 
D2 + CG 
6+10 300 20(6.66±0.81)' 7 6 4 2 1 
6+20 3Q0  15 (5.0± 0.91)a `  5 3 2 I - 
6+30  300  12(4.0±0.64) a c 3 2 2 - - 
Untreated 300 2 (0.67 ± 0.47) 1 1 - - - 
Negative control 300 4 ( 1.33 ± 0.66) 2 2 - - - 
(DMSO, 5 µ1!m1) 
Significant difference: using Chi square test 
aP<0.01 with respect to untreated; <0.05 with respect to Trenbolone; `P<0.05 with respect to Docetaxel 
DMSO:Dimethylsulphoxide; CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid 
exchange;DIC: Dicentric: SE: Standard Error. 
Fig. 32. CAs induced by Cateehin Gallate (CG), Tranboion and Docetaxel in human 
lymphocytes in the absence of S9 mix 
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Graph 33. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Trenbolone Ti (T1— 40 µM Trenbolone) in human lymphocytes, in 
the absence of 89 mix. 
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Graph 34. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Trenbolone T2 (T2= 60 µM Trenbolone) in human lymphocytes, in 
the absence of 89 mix. 2 
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Graph 35. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Docetaxel D1 (01=3 jiM Docetaxel) in human lymphocytes, in the 
absence of S9 mix. 
Ccncentr rs~ cf CGa. aorat'.ai m 2phe WWl CLtg-ps 
.= c msd 	t c tGapv= 33. E-.?P i •Ccrts4rrlrntiiafCG 
1 
R+ assbn 
$ 	12 	18 	20 	24 	28 	22 	sus ~crtl~ 
Ccnc~rstrsti ncf 	(MccLs - L-2 
Graph 36. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Docetaxel 02 (D2= 6 µM Docetaxel) in human lymphocytes, in the 
absence of S9 mix. 
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Graph 37. Effect of Catechin Gallate (CG) onChromosomal aberrations (CAs) 
induced by Trenbolone Ti (T1= 40 µM Trenbolone) in human lymphocytes, in 
the presence of S9 mix. 
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Graph 38. Effect of Catechin GaIlate (CG) on Chromosomal aberrations (CAs) 
induced by Trenbolone T2 (T2= 60 µM Trenbolone) in human lymphocytes, in 
the presence of S9 mix. 
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Graph 39. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Docetaxel D1 (D1= 3µM Docetaxel) in human lymphocytes, in the 
presence of S9 mix. 
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Graph 40. Effect of Catechin Gallate (CG) on Chromosomal aberrations (CAs) 
induced by Docetaxel D2 (P2=6 pM Docetaxel) in human lymphocytes, in the 
presence of S9 mix. 
Experiment VII: Effect of Epigallocatechin gallate (EGCG) against Methyl 
Methane Sulphonate induced genotoxicity in cultured Human lymphocytes 
The green tea polyphenol Epigallocatechin gallate (EGCG), was tested for its possible 
antigenotoxic effect against Methyl Methane Sulphonate induced genetic damage 
both in the presence as well as absence of S9 mix using chromosomal aberrations 
(CAs) as genotoxic end points. After 24 h of incubation of human lymphocyte culture, 
MMS (6 p,M) was administered, with 10, 20, and 30 µM of EGCG respectively and 
kept for 48 h at 38°C in the incubator. Normal and negative controls were also run 
simultaneously. For metabolic activation experiments, 0.5m1 of S9 mix was given 
along with each treatment. Harvesting and processing of slides, for CAs analysis was 
done as described in earlier experiments. 300 metaphases were examined for the 
occurrence of different types of abnormality i.e. gaps, breaks and exchanges. 
In this experiment we found a dose dependent decrease in abnormal 
metaphases without gaps and total structural aberrations like gaps, chromatid breaks, 
chromosomal breaks, chromatid exchanges and dicentrics, in cultured human 
lymphocytes which with treated with 6 µM of MMS, after the introduction of 10, 20 
and 30 µM of Epigallocatechin gallate (EGCG). The decrease in abnormal metaphase 
were from 25 % to 46% in the absence of S9 mix and from 29.5% to 55% in the 
presence of S9 mix (Table 24 and 25; Fig. 36 and 37). 
Regression analysis was also performed to study the dose effect of 
Epigallocatechin gallate (EGCG) 6 µM of MMS for the number of abnormal 
metaphases. A decrease in slope of linear regression lines was observed as the dose of 
Epigallocatechin gallate was increased, both in presence as well as absence of S9 mix 
(Graphs 41 and 42). 
r 
Table 24 Effect of Epigallocatechin gallate (EGCG) on CAs induced by MMS in human lymphocytes in the absence of S9 mix. 
Treatment Abnormal metaphases without Total structural aberrations 
(AM) gaps Gaps CTE 	CSB 	CTE 	DIC 
(%±SE) 
MMS 
6 28(9,33 ± 1,68) a 12 13 	4 	1 	1 
EGCG 
10 2 (0,67 1 0.47) 1 1 	1 
20 4(1.33±0.66)  3 3 	1 	- 	- 
30 4(1,33±066)  4 3 	1 	- 	- 
MMS+EGCG 
6+10 21(1,0011,47) a e 7 9 	2 	1 	1 
6+ 20 18 (6.00 1 1,37) ab  5 6 	2 	1 	- 
6+30 15(5,00±1.26) ae 4 4 	1 	1 
Untreated 2 (0.67 t 0,47) 1 1 	1 	- 
Negative control l 3(1,0±0,67) 2 2 	1 	- 	- 
(DMSO, 5 pllm1) 
Significant difference: using Chi square test 
P<0,01 with respect to untreated 
eP<U,05 with respect to MMS. 
EGCG: Epigallocatechin gallate; SE: Standard Error. 
Table 25 Effect of Epigallocatechin gallate (EGCG) on CAs induced by MMS in human lymphocytes in the presence of S9 mix. 
Treatment 	 Abnormal metaphases without 	 Total structural aberrations 
gaps 
Gaps 	CTB 	CSB 	CTE 	DIC 
(%tSE) 
MMS 
6 34(11.33±1,82) a 	14 	, 	15 	7 	2 	1 
EGCG 
10µM 2(0467±0.47) 	1 	1 	1 	- 
20µM 3(1.00±0.57) 	3 	2 	1 
30 µM 3(1.00±0.57) 	3 	3 	1 	1 
M14S+EGCG 
6+10 24 (8,00 ± 1.57) ab 	8 	9 	4 	1 	1 
6+20 19(6.33±1.41)ab 	6 	7 	3 	1 
6+ 30 15 (5,00 ± 1,26) a b 	4 	4 	1 	 - 
Untreated 2(0.67±0.47) 	1 	1 	1 
Negative cantiol 4(1.33 ± 0.66) 	3 	4 	1 	- 	- 
(DMSO, 5 Al/ml) 
Significant difference: using Chi square test 
'P<0.01 with respect to untreated 
bP<0.05 with respect to MMS. 
EGCG: Epigallocatechin gallate; SE: Standard Error. 
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Fig.36. Effect of Epigallocatechin gallate (EGCG) on CAs induced by MMS in 
human lymphocytes in the abice of S9 mix 
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Fig. 37. Effect of Epigallocatechin gallate (EGCG) on CAs induced by MMS in 
human lymphocytes in the preice of S9 mix. 
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Graph 41. Effect of Epigallocatechingallate (EGCG) on Chromosomal 
aberrations (CAs) induced by MMS in human lymphocytes, in the absence of S9 
mix. 
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Graph 42. Effect of Epigallocatechingallate (EGCG) on Chromosomal 
aberrations (CAs) induced by MMS in human lymphocytes, in the presence of 89 
mix. 
Experiment VIII: Effect of Epigallocatechin gallate (EGCG) against Trenbolone 
and Docetaxel induced genotoxicity in cultured Human lymphocytes 
Epigallocatechin gallate (EGCG) was tested for it's possible antigenotoxic effect 
against Trenbolone and Docetaxel induced genotoxicity. Sister chromatid exchange 
(SCE) was used for detection of genotoxic end point, both in the presence as well as 
absence of S9 mix. Duplicate peripheral blood cultures were done and placed in the 
incubator at 37°C for 24 hr and then BrdU (10pg/m1) was added to all cultures, as 
were, the EGCG ( tested doses were 20 and 30 µM), Trenbolone (tested doses were 
45 and 55 µM) and Docetaxel (tested doses were 3 and 6 pM). Both the tested doses 
of EGCG were treated with both of the tested doses of Trenbolone and Docetaxel, 
separately. Harvesting and processing of slides was done as described in earlier 
experiments (Perry and Wolf, 1974). 200 second division metaphases were scanned 
for each treatment and control. We found that the genotoxicity induced by 
Trenbolone and Docetaxel, separately, can be countered with 20 and 30 pM of 
Epigallo catechin gallate (EGCG), a major tea polyphenol. Frequencies of SCEs were 
reduced from 54% to 60% (in the absence of S9 mix) and from 55% to 58% (in the 
presence of S9 mix) in case of 45µM of Trenbolone. In case of 55 µM of Trenbolone, 
treated with EGCG (20 and 30 µM), result was in decrease in SCEs/cell from 38% to 
47% (in the absence of S9 mix) and from 44% to 48% (in the presence of S9 mix). In 
case of 3 pM Docetaxel, treatment with EGCG (20 and 30 pM), result was in 
decrease in SCEs/cell from 36% to 38% (in the absence of S9 mix) and from 36% to 
39% (in the presence of 59 mix). In case of 6µM Docetaxel, treatment with EGCG, 
resulted in decrease in SCEs/cell from 36% to 38.3% (in the absence of S9 mix) and 
from 39% to 41.6% (in the presence of S9 mix) (Table 26 and 27; Fig. 38 - 41). 
Table 26. Effect of Epigallocatechin gallate (EGCG) on SCEs induced by Trenbolone 
and Docetaxel in cultured human lymphocytes, without S9 mix. 
Treatment (µM) 	 Cells scored 	 SCEs/Cell (Mean ± SE) 
EGCG 
20 	 200 	 2.62 * 0.27 
30 	 200 	 2.78 ± 0.29 
Trenbolone 
45 	 200 	 6.89 t 0.66 a  
55 	 200 	 7.73±0,69 a 
Docetaxel 
3 	 200 	 6.34±0.59 a  
6 	 200 	 7.I1±0.63 a  
Trenbolone + EGCG 
45+20 200 3.12±0.33a1? 
55+ 20 200 4.47±0.45 8b  
45+30 200 2.72±0.32 ab 
55 +3 0 200 4.O6±042' 
Docetaxel + EGCG 
3+20 200 4.04±0.41 ac 
6+20  200 4.52 # 0.48 	c 
3+30 200 3.92±0.38 3c 
6+30 200 4.38±0.43 ac  
Untreated 200 2.02 ± 0.21 
Negative control (DMSO, 5 200 2.12 ± 0,23 
1/m1) 
Significant difference. using Chi square test 
aP<0.01 with respect to Untreated. 
by<0.05 with respect to Trenbolone 
°P<0.05 with respect to Docetaxel 
Table 27 Effect of Epigallocatechin gallate (EGCG) on SCEs induced by Trenbolone 
and Docetaxel in cultured human lymphocytes, with S9 mix. 
Treatment (1iM) 	 Cells scored 	 SCEs/Cell (Mean ± SE) 
EGCG 
20 200 2.75 ± 0.30 
30 200 2.83±0.31 
Trenbolone 
45 200 7.07 ± 0.67 a  
55 200 7.95 ± 0.71 a  
I]ocetaxel 
3 200 6.52±0.61 a  
6 200 7.32 ± 0.64 a  
Trenbolone + EGCG 
45+20 200 3.10±0.31 ab 
55+20 200 4.43 ± 0.43 a b 
45+30 200 2.98 ± 0.33 a b 
55+30 200 4.11 ± 0.40 a b 
Docetaxel + EGCG 
3+20 200 4.14±0.42ac 
6+20 200 4.44±O.46 ac 
3+30 200 398±0.40 ac  
6+30 200 4.27 ± 0.43 a 
Untreated 200 2.10±0.21 
Negative control (DMSO, 5pl/ml) 200 2.17 ± 0.23 
Significant difference: using Chi square test 
aP<O.OI with respect to Untreated. 
bP<0.05 with respect to Trenbolone 
`P<0.05 with respect to Docetaxel 
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Fig.39. Effect of Epigallocatechin gallate (EGCG) on SCEs induced by Trenbolone and 
Docetaxel in cultured human lymphocytes, each, without S9 mix. 
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Fig.41. Effect of Epigallocatechin gallate (EGCG) on SC1 s induced by Tienbolone and 
Docetaxel in cultured human Lymphocytes, each, with S9 mix. 
Experiment IX: Effect of Black tea extract (BTE) against Methyl Methane 
Suiphonate induced genotoxicity in cultured Human lymphocytes 
The Black tea extract (BTE), was tested for its possible antigenotoxic effect against 
Methyl Methane Sulphonate (MMS) induced genetic damage both in the presence as 
well as absence of S9 mix using chromosomal aberrations (CAs) as genotoxic end 
points. After 24 h of incubation of human lymphocyte culture, MMS (6 µM) was 
administered, with 10, 20 and 30 p.M of BTE respectively and kept for 48 h at 38°C in 
the incubator. Normal and negative controls were also run simultaneously. For 
metabolic activation experiments, 0.5m1 of S9 mix was given along with each 
treatment. Harvesting and processing of slides, for CAs analysis was done as 
described in earlier experiments. 300 metaphases were examined for the occurrence of 
different types of abnormality i.e. gaps, -breaks and exchanges. 
In this experiment we found a dose dependent decrease in abnormal 
metaphases without gaps and total structural aberrations like gaps, chromatid breaks, 
chromosomal breaks, chromatid exchanges and dicentrics, induced by 6 pM MMS, 
after the introduction of 10, 20 and 30 µM of Black tea extract (BTE). The decrease 
in abnormal metaphases were from 37% to 56% in the absence of S9 mix and from 
35% to 64% in the presence of S9 mix (Table 28 and 29; Fig. 42 and 43). 
Regression analysis was also performed to study the dose effect of Black tea 
extract (BTE) on 6 µM of MMS for the number of abnormal metaphases. A decrease 
in slope of linear regression lines was observed as the dose of Black tea extract was 
increased, both in presence as well as absence of 59 mix (Graphs 43 and 44). 
Table 28 Effect of Black Tea extract (BTE) on CAs induced by MMS in cultured human lymphocytes without 59 mix. 
Treatment 	 Abnormal metaphases without 	 Total structural aberrations 
(AM) 	 gaps 	 Gaps 	CTD 	CSB 	CIE 	DIC 
(% ± SE) 
MMS 
6 16 (5,33 t 1,29) a 	12 	12 	7 	1 	 - 
BTE 
10 3(100± 0.57) 	 1 	1 	1 	 - 
20 3 (1.00 1 0,57) 	2 	I 	1 	- 	- 
30 4(133 ± 0,66) 	4 	3 	2 	 - 	- 
MMS+BTE 
6+10  10 (3.3311.04)'b 	8 	10 	6 	2 
6+20 8 (2.67 10.93) ab 	7 	7 	4 	1 	- 
6+30 7(2.3310.87) ab 	6 	7 	3 	1 	- 
Untreated 2 (0.6710.47) 	 1 	1 	1 	 - 	- 
Negative control (DMSQ, 5 µllml) 3 (1.O± 057) 	 2 	1 	1 	 - 	- 
Significant difference: using Chi square test 
at?<0.01 with respect to untreated; bP<0.U5 with respect to MMS; DMS0,Dimethylsulphoxide; CTB- Chromatid break; CSB- Chromosome 
break; CTE- Chromatid exchange; DIC.-nicentric, $TE, Black tea extract; MMS: Methylmethane sulphonate.SE. Standard Error, 
Table 29 Effect of Black Tea extract (BTE) on CAs induced by MMS in cultured human lymphocytes with S9 mix, 
Treatment Abnormal metaphases without Total structural aberrations 
gaps  Gaps CTB 	CSB 	CTE 	DIC 
(% ±SE) 
MMS 
6 17 (5,67 ± 1.34) a 12 12 	6 	3 	- 
BTE 
10 3 (1.00 t 0,57) 1 2 	1 	- 	- 
20 3 (1.00±07) 2 2 	1 	 - 	- 
30 5(167±0.74)  3 3 	1 	 - 
MMS+BTE 
6+10 11(3,6711.09)a 10 11 	4 	2 	- 
6+20 9(3.0010.98) a6 7 8 	3 	2 	 - 
6+30 6(2,O010,81) Qa 4 5 	2 	• 	- 
Untreated 3(100 ± 05 2 1 	1 	 - 
Negative control 4 (1,33 f 0.66) 3 4 	1 	• 	- 
(DMSO, S µ1!m1) 
Significant difference: using Chi square test 
ap<0,u1 with respect to untreated; P<0.05 with respect to MMS; DMSD,Dimeth lsul hoxide; CTB: Chromatid break; CSB: Chromosome break; p 	 p 	 Yp 
CTE: Chromatid exchange; DIC: Dicentric:, BTE: Black tea extract; MMS: Methylmethane sulphonate SE: Standard Error 
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Fig.42.Effect of Black Tea extract (BIB) on CAs induced byMMS in cultured human 
lymphocytes without S9 mix. 
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Fig.43.Effect of Black Tea extract (BTE) on CAs induced by MMS in cultured human 
lymphocytes with S9 mix 
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Graph 43. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) 
induced by M1 /IS in cultured human lymphocytes, without S9 mix. 
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Graph 44. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) 
induced by N MS in cultured human lymphocytes, with S9 mix. 
Experiment X. Effect of Black tea extract (BTE) against Docetaxel and 
Tamoxifen induced genotoxicity in cultured Human lymphocytes 
The Black tea extract (BTE), was tested for its possible antigenotoxic effect against 
Docetaxel and Tamoxifen, induced genotoxicity induced genetic damage both in the 
presence as well as absence of S9 mix using chromosomal aberrations (CAs) and 
sister chromatid exchanges (SCEs) and replication index (RI) as genotoxic end points. 
We tested the effect of 1.075X 10-4, 2.127 X 10-4 and 3.15 X 10 g/ml of Black tea 
extract (BTE) on the cells damaged by 3 and 6 µM of Docataxel and Tamoxifen, 
each. After 24 hr of the initiation of the culture, BTE, Docataxel and Tamoxifen, were 
added in appropriate doses separately and additively and kept for 48 hr. Normal and 
negative controls were also run simultaneously. For metabolic activation experiments, 
0.5m1 of S9 mix was given along with each treatment. 300 metaphases were examined 
for the occurrence of different types of abnormality i.e. gaps, breaks and exchanges. 
In this experiment of chromosomal aberration induction study, we found 
induction of CAs like gaps, chromatid breaks, chromosomal breaks, chromatid 
exchanges and dicentrics, in cultured human lymphocytes by 3 and 6 gM of 
Docataxel and Tamoxifen, each, both in presence and absence of S9 mix. We found a 
distinct increase in gaps and breaks with increase in concentration of Docataxel and 
Tamoxifen, each, (Table 30 and 31; Fig. 44 - 47) both in presence and absence of S9 
mix. However, these aberrations get reduced after BTE treatment from 16% to 50% in 
absence of S9 mix and from 4% to 50% in presence of S9 mix for 3 µM of Docataxel 
and in case of 6 µ1V1 of Docataxel the decrease is from 23% to 52 % in absence of S9 
mix and upto 44% in presence of S9 mix. In case of 3 j.tM Tamoxifen treated cultures, 
addition of BTE resulted in decrease in the number of abnormal metaphases from 
35% to 45%, in absence of S9 mix and from 17% to 56% in presence of S9 mix and 
in case of 6µM Tamoxifen the decrease in abnormal metaphases was from 16% to 
48% in the absence of 59 mix and from 23% to 53% in the presence of S9 mix. (Table 
30 and 31; Fig. 44 - 47). All the tested dosages of plant infusion per se did not induce 
significant number of abnormal metaphases, both in presence and absence of S9 mix. 
200 second division metaphases were scanned for each treatment and control. 
In SCE analysis, we found that the tested dosages of BTE caused a significant dose 
dependent decrease in the number of SCEs! cell, induced by 3 ,M Docataxel upto 
19% and in case of 6 µM Docataxel upto 41% in absence of metabolic activation and 
upto 66% and 53% respectively in presence of metabolic activation (Table 32 and 33; 
Fig. 48 - 51). Similarly, a significant dose dependent decrease in the number of SCEs/ 
cell, induced by 3 }tM Tamoxifen upto 36% and in case of 6 gM Tarnoxifen upto 
29% in absence of metabolic activation and upto 22% and 24%, respectively in 
presence of metabolic activation (Table 32 and 33). The tested dosages of plant 
extract itself did not cause a significant increase in SCEs/ cell, both in presence and 
absence of S9 mix. 
In cell cycle kinetics analysis, treatment with 3 and 6 pM of Docetaxel and 
Tamoxifen, each resulted in decrease in RI of lymphocytes as compared to that of 
untreated (Table 32 and 33). However, treatment with all the three tested dosages of 
tea leaves infusion resulted in significant increase in replication indices (Table 32 and 
33; Fig.52 - 55), both in presence as well as absence of S9 mix. All the three tested 
dosages of leaves infusion per se did not decrease the replication indices significantly, 
both in presence and absence of S9 mix. 
Regression analysis was also performed to study the dose effect of Black tea 
extract (BTE), against Docetaxel and Tamoxifen, separately, for the number of 
abnormal metaphases and sister chromatid exchanges per cell. For abnormal 
metaphases and SCE/cell, a decrease in slope of linear regression lines was observed 
as the dose of BTE was increased in each treatment, both in presence and absence of 
S9 mix (Graphs 45 - 60). 
Table 30 Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) in 
human lymphocytes induced by Docetaxel and Tamoxifen, in absence of S9 mix. 
Treatment 	Total Cells 	Number of 	 Chromosomal Aberrations 
(A) Scored Abnormal cells 
(75 cells each 	without gaps 	Gaps 	C'rB 	CSB 	CTE 	DIC 
from duplicate (% ± SE) 
cultures of two 
donors) 
Treatment (pM) 
BTE (g/ml) 
I.075X104  300 3 (1.00±0.57) 1 1 1 - 	- 
2.127X104  300 3(1.00±0.57)  2 1 I - 	- 
3.15X104  300 4(1.33±0.66)  4 3 2 - 	- 
Docetaxci 
3 (DI) 300 17(5.66±137)a 10 9 8 1 	- 
6 (D2) 300 20 (6.66 ± 1.47) a 14 13 6 1 	1 
Tamoxifen 
3 (TAM1) 300  20(6.66± 1.44) a 11 11 6 2 	1 
6 (TAM2) 300 25 (8.33 ± 1.59) a is 14 8 2 	1 
Dl (WA)+ BTE (glml) 
3+1.075X104  300 16(5.33± 1.26)a 9 7 6 1 	- 
3 +2.127X10'4 300 13 (4.33± l.13)ab 8 6 5 1 	- 
3+3.15X10-4 300 9(3.00±0.98) ab  5 4 4 1 	- 
D2 (p.M)+ BTE (glml) 
6+1.075X104  300 18(6.00± 0.90)a 12 10 5 1 	1 
6+2.127X10' 300 15(5.00t0.67)ab 10 8 4 1 	- 
6+3.15X104  300  10(333±1.04)as  8 6 4 1 	- 
TAM1 (µM)+ BTE 
(g/ml) 
3+ 1.075X104  300  17 (5.66 t 1.33) a 8 10 5 I 	1 
3+2.127X104  300  13(4.33± 1.17) a` 8 9 3 1 	- 
3+ 3.15X104  340  11(3.66± 1.09) a c 6 6 4 I 	- 
TAM 2 (iM)+ BTE 
(1/mI) 
6 + 1.075XI04  300 21 (7.00±1.47) a  12 13 6 1 	1 
6+2.127X104  300  16(5.33±0.84) a 9 11 5 1 	- 
6+3.15X104 300 12(4.00±0.72)x° 6 9 2 1 	- 
Untreated 300 2 (0.67 ± 0.47) 1 1 1 - 	- 
Negative control 300 3 (1.00 ± 0.57) 2 2 1 - 	- 
(DMSO, 5 µllmI) 
Significant difference: using Chi square test 
aP<0.o1 with respect to untreated; bP<0.05 with respect to Docetaxel; 'P<0.05 with respect to Tamoxifen 
DMSO:DimethylsuIphoxide; CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid 
exchange; DIC: Dicentric:, BTE: Black tea extract; MMS: Methylmethane sulphonate SE: Standard 
Table 31 Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) in 
human lymphocytes induced by Docetaxel and Tamoxifen, in presence of S9 mix. 
Treatment Total Cells Scored Number of Chromosomal Aberrations 
(}►M) (75 cells each from Abnormal cells Gaps CTB CSB CTE 	DIC 
duplicate cultures of without gaps 
two donors) (% ± SE) 
Treatment (µM) 
BTE (glml) 
1.075X10 300 3 (1.00 ± 0.57) 1 2 1 - 	- 
2.127XI0-4 300 3 (1.00± 2 2 1 - 	- 
0.57) 
3.15X10' 300 5 (1.67 ± 0.74) 3 3 1 - 	- 
Docetaxel 
3(D1) 300 22(7.33±1.50) 8 12 11 10 1 	- 
6 (D2) 300 25(8.33±1.59) a  16 14 11 1 	1 
Tamoxifen 
3 (TAMI) 340  23(8.00±1.53)a 15 14 8 1 	_ 	- 
6 (T-AM2) 300 26(9.00±1.61)a 17 15 9 2 	1 
DI (pM)+BTE 
(€/m1) 
3 + 1.075X10-4 300  21(7.00±1.47) a 11 10 9 1 
3+2.127X104 300 17 (5.66 ± l .34) a  9 9 7 1 	- 
3 + 3.I5X104 300 13 (4.00± 1.09) a b 7 7 4 - 	- 
D2 (jiM)+- BTE 
(g/ml) 
6 + I.075X104 300 25(8.33±1.59)a 14 I3 9 1 	1 
6+2.127X104 300 21(7.00± 1.440' 11 12 8 1 	- 
6+3.15X104  300  15(5.00t1.2I)a b 9 9 4 1 	- 
TAM 1 (µM)+ BTE 
(glml) 
3 + 1-075X10 300  19 (6.00 t 1.41) a 14 11 7 1 	- 
3+2.127X104 300 16(5.33± 1.29) a  12 9 6 1 	- 
3+3.15X104 300 10(3.33± 1.04)c 10 6 4 1 	- 
TAM2 (}1M)+ BT$ 
(glml) 
6+ 1.075X10-' 300 20 (6.66 ±0.81) $ 15 11 7 1 	1 
6+2.127X10' 300 14(4.66± 0.91)' `  13 8 6 1 	- 
6±3.15X104 300 10 (3.33 ± 0.64) 1  9 7 5 - 	- 
Untreated 300 3 (1.00 ± 0.57) 2 1 1 - 	- 
Negative control 300 4 (1.33 ± 0.66) 3 4 1 - 	- 
(DMSO, 5 111/m1) 
Significant difference: using Chi square test 
ap<0.01 with respect to untreated; 1'P<0.05 with respect to Docetaxel; `P<0.05 with respect to Tamoxifen 
DMSO:Dirnethylsulphoxide; CTB: Chromatid break; CSB: Chromosome break; CTE: Chromatid 
exchange; DIC: Dicentric; BTE: Black tea extract; MMS: Methylmethane sulphonate SE: Standard 
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Fig.45. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) in human 
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Graph45. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) 
in human lymphocytes induced by Docetaxel D1 (P1=3 µM Docetaxel), in 
absence of S9 mix. 
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Graph 46. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) 
in human lymphocytes induced by Docetaxel D2 (D2= 6 µM Docetaxel), in 
absence of S9 mix. 
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Graph47. Effect of Black Tea extract (BTE) on Chromosomal aberrations (CAs) 
in human lymphocytes induced by Tamoxifen TAM1 (TAM1= 3 µM 
Tamoxifen), in absence of S9 mix. 
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Graph 48. Effect of Black Tea extract (BTE) on Chromosomal aberrations 
(CAs) in human lymphocytes induced by Tamoxifen TAM2 (TAM2= 6 gM 
Tamoxifen), in absence of S9 mix. 
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Graph 49. Effect of Black Tea extract (BTE) on Chromosomal aberrations 
(CAs) in human Iymphocytes induced by Docetaxel DI (D1= 3 µM Docetaxel), in 
presence of S9 mix. 
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Graph 50. Effect of Black Tea extract (BTE) on Chromosomal aberrations 
(CAs) in human lymphocytes induced by Docetaxel D2 (D2= 6 }tM Docetaxel), in 
presence of S9 mix. 
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Graph 51. Effect of Black Tea extract (BTE) on Chromosomal aberrations 
(CAs) in human lymphocytes induced by Tamoxifen TAMI (TAM1= 3µM 
Tamoxifen), in presence of S9 mix. 
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Graph 52. Effect of Black Tea extract (BTE) on Chromosomal aberrations 
(CAs) in human lymphocytes induced by Tamoxifen TAM2 (TAM2= 6 pM 
Tamoxifen), in presence of S9 mix. 
Table 32 Effect of Black Tea extract (BTE) on Sister chromatid exchanges (SCEs) and 
Replication Index (RI) in human lymphocytes induced by Docetaxel and Tamoxifen, in 
absence of S9 mix. 
Treatment 
(1I) 
Cells Scored SCEs/cell 
(mean ± SE) 
RI 
BTE (glml) 
1.075X10-4 200 2.31±0.48 1.82 
2.127X10-4 200 2.79±0.64 1.80 
3.15X10-4 200 3.04 ± 0.35 1.79 
Docetaxel 
3 (D1) 200 3.42 ± 0.32 a 1.69 
6 (D2) 200 5.34 ± 0.46 a 1.67 
Tamoxifen 
3 (TAM1) 200 4.22+ 0.3 la 1.68 
6 (TAM2) 200 5.84 ± 0.46 a 1.65 
Dl (}AM)+ BTE (glmi) 
3+1.075X104  200 3.12 ± 0.33 a 1.70 
3+2.127X104  200 2.84 ± 0.31 ab 1.73 
3+3.15X10-4 200 2.75 -r 0.30b 1.75 
D2 (pM)+ BTE (g/ml) 
6+1.075X10-0 200 4.44± 0.43 a 1.68 
6+2.127X 10 200 4.06+ 0.42 a 1.70 
6+3.15X10 200 3.10 ± 0.31ab 1.73 
TAM1 (.tM) + BTE (g/ml) 
6+1.075X104  200 4,11±0.40a 1.68 
6+ 2.127X 10 200 3.92 ± 0.3 8 a 1.69 
6 + 3.15X10 200 2.67 + 0.29 a ` 1.71 
TAM2 (µM)+ BTE (glml) 
3 + 1.075X10-4 200 5.34 ± 0.46 a 1.70 
3 + 2.127X] 0' 200 5.04 ± 0.53 a 1.72 
3+3.15X10 200 4.14±0.42 a` 1.74 
Untreated 200 2.02 ± 0.21 1.91 
Negative control 200 2.12 ± 0.23 1.88 
(DMSO, 5 p1/ml) 
Significant at *P<0.03 Vs Normal Kruskall-Wallis test. Significant difference: using Chi square test 
aP<0.01 with respect to untreated; bP<0.05 with respect to Docetaxel. °P<0.05 with respect to Tamoxifen.. 
BTE: Black tea extract; MMS: Methyl methane sulphonate SE: Standard 
Table 33 Effect of Black Tea extract (BTE) on Sister chromatid exchanges (SCEs) and Replication 
Index (RI) in human lymphocytes induced by Docetaxel and Tamoxifen, in presence of S9 mix. 
Treatment 	 Cells Scored 	 SCEslcell 	 RI 
(PM) (mean ± SE) 
BTE (g/ml) 
1.075X10" 200 3.17 ± 0.30 1.80 
2.127X10-0 200 3.74 ± 	0.36 1.78 
3.15X10 200 3.92 t 0.38 1.77 
Docetaxel 
3 (Dl) 200 6. 86 ± 0.43 a  1.68 
6 (D2) 200 9.56 ± 0.49 a 1.62 
Tamoxifen 
3 (TAMI) 200 5.83 ± 0.45 a 1.65 
6 (TAM2) 200 8.44 ± 0.62 a 1.63 
D1 LVW+BTE(g/m1) 
3 + 1.075X104  200 4.11 ± 0.40 ab 1.70 
3 + 2.127X10-4 200 2.98± 0.33 ab 1.72 
3 + 3.15X10-4 200 2. 27 ± 0.26 a b 1.74 
D2 (iM) + BTE (g/ml) 
6+ 1.075X10 200 7. 11 ± 0.63 a 1.63 
6 + 2.127X I 0 200 6,34± 0.59 ' 1.64 
6+3.15X10  200 4.44 ± 0.46 ab 1.66 
TAM1 (µM)+ BTE (glml) 
3+1.075X10 200 5.31 ± 0.58 a  1.67 
3+2.127X!04  200 5.04 ± 0.53 a  1.69 
3 + 3.15X10'4 200 4.52 1 0.48 ac 1.70 
TAM2 (iM)+ BTE (glml) 
6 + 1.075X10'°  200 8.23 ± 0.62 a  1.64 
6+2.127X104  200 7. 02 ± 0.48 ac 1.68 
6 + 3.15X104  200 6. 34 ± 0.59 8L  1.70 
Untreated 200 2.45 f 0.14 1.89 
Negative control 
(DMSO, 51t11rn1) 200 3.01± 	0.17 1.87 
Significant at **P< 0.01 Vs Normal Kruskall-Wallis test. Significant difference using Chi square test: 
aP.0.01 with respect to untreated; "P<0.05 with respect to Docetaxel, `P<0.05 with respect to Tamoxifen.. 
DMSO:Dimethylsulphoxide; MMS. Methylmethane sulphonate, BTE: Black tea extract, SE: Standard 
Error. 
Fig.48. Sister chromatid exchanges (SCEs) in human lymphocytes induced by Black Tea 
extract (B'IE), Docetaxel and Tamoxafei in absaice of S9 mix 
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Fig.49. Effect of Black Tea extract (B'IE) on Sister chromatid exchanges (SCEs) in 
human lymphocytes induced by Docetaxel and Tamoxifea, each, in absence of S9 mix 
Fig 50. Sister chromatid exchanges (SCEs) in human lymphocytes induced by Black Tea 
extract (BTE), Docetaxel and Tamoxdfen in presce of S9 mix 
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Fig.52. Replication Index (RI) in human lymphocytes induced by Black Tea extract 
(B'IE), Docetaxel and Tamoxifen, each, in absmce of S9 mix 
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Fig.53. Effect of Black Tea extract (BZE) on Replication Index (RI) in human 
lymphocytes induced by Docetaxel and Tamoxifai, each, in absence of S9 mix. 
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Fig.54. Replication Index (RI) in human lymphocytes induced by Black Tea pct 
(BTE), Docetaxel and Tamoxifez, each, in presence of S9 mix 
Fig.55. Effect of Black Tea extract (BTE) on Replication Index (RI) in human 
lymphocytes induced by Docetaxel and Tamoxifen, each, in preice of S9 mix 
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Graph 53. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Docetaxel D1 (DI= 3 µM Docetaxel), 
in absence of S9 mix. 
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Graph 54. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Docetaxel 02 (D2= 6 }LM Docetaxel), 
in absence of 59 mix. 
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Graph 55. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Tamoxifen TAMI (TAM1= 3 AM 
Tamoxifen), in absence of S9 mix. 
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Graph 56. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Tamoxifen TAM2 (TAM2= 6 µM 
Tamoxifen), in absence of S9 mix. 
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Graph 57. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Docetaxel Dl (D1= 3 pM Docetaxel), 
in presence of 59 mix. 
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Graph 58. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Docetaxel D2 (D2= 6 µM Docetaxel), 
in presence of 89 mix. 
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Graph 59. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Tamoxifen TAM1 (TAMI= 3 pM 
Tamoxifen), in presence of S9 mix. 
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Graph 60. Effect of Black Tea extract (BTE) on Sister chromatid exchanges 
(SCEs) in human lymphocytes induced by Tamoxifen TAM2 (TAM2= 6 .LM 
Tamoxifen), in presence of S9 mix. 
4.4 Results of in vitro Assessment of Possible Anticarcinogenic 
Potentials of Green Tea Polyphenols 
Cytotoxicity assays of the extract revealed that methanolic extract of green tea 
had a significant cytotoxic impact on MCF-7 cells at the given doses (between 100 
pg/ml to 1000 pg/ml) (Fig 56). The minimum inhibitory concentration of GTE (IC50 
mean value) in both the assays (MTT Assay as well as NR Assay) was 592.6 jig/mi. 
The morphology of cells as depicted in Plate 1, also changed with the time and the 
concentrations employed. 
The methanolic extract of green tea also demonstrate similar cytotoxic impact 
on HEK 293 cells as well but marginally at a higher concentration ( Fig 57) and the 
minimum inhibitory concentration of GTE (IC50 mean value) in both assays (MTT 
and NR Assay) was 1041.35 µg/ml. The morphology of cells as displayed in Plate 2, 
also demonstrated distinguishable change with the time and the concentrations 
employed. 
Within the few hours of treatment with Green tea extract, cells which had 
previously been almost completely confluent, had retracted and the plasma membrane 
started to ruffle and cells became rounded. With increasing GTE doses, cells had also 
begun to shrink, the cytoplasm almost disappeared and cells get detached from plates 
and typical apoptotic bodies were seen at the boundaries of detached cell. Cell 
viability analysis showed that the round cells detached from the dish wall were dead. 
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Fig 56: Cytotoxic effect of Methanolic extract of Green tea on MCF-7 cells. 
Cells were cultured in complete medium and treated with 100 µg/ml, 200 µg/ml, 300 
µg/ml, 400 pgfml , 500 µg/ml , 600µ g/ml, 700 p. g/ml, 900 p g/ml and 1000 µg/ml 
methanolic extract of Green tea for 48 hrs and monitored by MTT (Blue) as well as 
Neutral Red (Red) assay. The percentage of viable cells were calculated in comparison to 
untreated cells (100 %)( as % of untreated cells). 
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Fig 57: Cytotoxic effect of Methanolic extract of green tea on LEEK 293 cells. 
Cells were cultured in complete medium and treated with 300 µ g/n 1, 400 µ glml, 700 
µg/ml, 800 µ g/ml, 900 µ g/ml, 1000gg/ml, 1100 µg/ml, 1200 µg/ml and 1300 N.g/ml 
methanolic extract of Green tea for 48 hrs and monitored by MTT (Blue) as well as 
Neutral Red (Red) assay. The percentage of viable cells were calculated in comparison 
to untreated cells (100%). 
Plate 1: Cellular morphology of MCF-7 cells after treatment ith Green tea extract at 
various doses (B-H) and control "A". under inverted microscope at 20X. 
Plate 2: Cellular morphology of HEK 293 cells after treatment with Green tea extract at 
various doses (B-H) and control "A", under inverted microscope at 20X. 
V V 
CHAPTER FIE 
DISCUSSION 
Pharmacological and toxicological information, available during the development 
process of a drug substance, comprise a large number of data on adverse effects. 
Information on the acute and repeated-dose including the target organs, disturbance of 
fertility in the male or female (or both) gender, embryotoxicity or teratogenicity, and 
genotoxicity are typically available. Genotoxic effects of anti-cancer drugs in non-
tumor cells are of special significance due to the possibility that they may induce 
secondary tumors in cancer patients. Also, the mutagenic and carcinogenic effects of 
antineoplastic agents on the health care persons handling these drugs also need to be 
considered carefully (Aydemir et al., 2005; Siddique et al., 2008a ). Because of the 
apparent relationship between chromosome 	abnormalities, mutagenesis, and 
carcinogenesis (Sandberg, 1980), in vivo and in vitro screening for chromosome 
aberrations is an established tool in the evaluation of potential hazards to the genetic 
material due to environmental agent. A number of dietary components have been 
identified as inhibitors of mutagenesis and carcinogenesis 	induced by various 
chemical mutagens. 
5.1 GC-MS analysis of Green Tea Extract 
Various compounds were identified from the Green tea extract by Gas 
Chromatography and Mass Spectrometric analysis in the present study (Table A). 
These are listed below in decreasing order of their abundance: Epigallo-catechin 
gallate, Epicatechin, Epigallo-catechin, catechin, Tannic acid, Caffeic acid, Quercetin 
and Kaempferol. 
Ahmad and Mukhtar (1999) have earlier reported the following primary 
constituents in green tea, they are (-)epicatechin (EC), (-)epicatechin-3- gaIlate 
(ECG), (-) epigallocatechin (EGC), and (-) epigallocatechin- 3-gallate (EGCG). In 
addition, caffeine, theobromine, theophylline and phenolic acids, such as gallic acid, 
are also present as minor constituents of green tea. 
5.2 In vivo Assessment of Possible Toxicity Risks of Green Tea Extract in mice 
Phytomedicine research is gaining more attention as people are relying heavily on 
herbal medicine, which occasionally has been shown to be less toxic and cheaper, 
compared to synthetic orthodox medicine. Among such phytomedicines are the 
dietary plants with proven antioxidant properties, which plays significant role in the 
reduction of the incidence of cancer and free radical—related complications such as 
diabetes, cardiovascular and liver diseases. This however, involves the interactions of 
the dietary antioxidants with one Or more biomolecules at the cellular or molecular 
level or both, leading to the induction of certain enzymes, as well as inhibition or 
inactivation of some key enzymes. This phase of the present study thus investigates 
the possible toxicity risks of Green tea extract in mice. 
The body weight changes serve as a sensitive indication of the general 
health status of animals. However weight gains were observed in all animals 
administered with GTE upto 5000 mg/kg/day. Thus, it can be stated that even at this 
much concentration GTE, did not interfere with the normal metabolism of animals. In 
addition, the diets were well-accepted by animals treated with GTE, suggesting that it 
did not possibly cause any alterations in carbohydrate, protein or fat metabolism in 
these experimental animals (Table 1). 
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In oral acute toxicity studies, no untoward clinical signs were observed in 
the mice at all the doses of GTE studied (100, 1000, 2500 and 5000 mg/body weight). 
There were no changes in the nature of stool, urine and eye colour. No mortality was 
observed at all dose levels from the critical 24 hours post administration to the end of 
the tenth day. Orally, 5000 mg/kg of GTE was well tolerated in mice even after 10 
days. Hence the LD5o was estimated to be <5000 mg/kg (orally) (Table 2). 
Elevations of biochemical parameters such as plasma or serum urea and 
creatinine are considered reliable for investigating drug-induced nephrotoxicity in 
animals and man (Adelman et al., 1981). Elevated levels of uric acid and creatinine 
have been reported as a constant finding in lead toxicity. Urea is a waste product 
which is produced in the liver, dissolved in blood (in a concentration of 2.5-7.5 mM), 
and ' excreted by the kidneys. Urea also plays a very important role in protein 
catabolism, removal of toxic ammonia from the body, and the counter-current system 
which allows for re-absorption of water and critical ions in the nephrons. [area and 
creatinine are waste products of protein metabolism that need to be excreted by the 
kidney, therefore marked decrease in serum urea and creatinine, as noticed in this 
study, confirms an indication of no functional damage to the kidney. Urea level can 
be increased by many other factors such as dehydration, antidiuretic drugs and diet, 
whilst creatinine is more specific to the kidney, since kidney damage is the only 
significant factor that increases serum creatinine level (Nwanjo et al., 2005). 
Therefore, a decrease in urea and creatinine levels noticed in this study are a classical 
sign that the kidney was not affected by GTE administration (Table 3). 
r 
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The anti-oxidant enzymes are the marker enzymes for the liver 
malpractice and malnutrition. Liver uses transaminase enzymes SGOT and SGPT to 
metabolize amino acids and to make proteins. When liver cells get damaged SGOT 
and SGPT leak into blood stream. The SCOT level remained almost normal after 
Green tea extract treatment indicating normal level of insulin secretion (Table 3). 
SGOT and SGPT levels act as indicator of liver function, hence normal SGOT levels 
indicate normal functioning of liver. 
Glutathione (GSH) constitutes the first line of defense against free radicals and other 
oxidant species. The liver homogenate reduced glutathione (GSH) content is 
presented in Table (3) Fig. Green tea extract treatment causes a slight increase in the 
reduced glutathione content when compared with normal control group. This may be 
due to the high content of phenolic compounds in GTE that played a significant role 
on the antioxidation potential of the tea. 
Superoxide dismutase is a metalloprotein and is a first enzyme involved in the 
antioxidant defense by lowering the steady state of oxygen radical. Catalase is a 
hemeprotein, localized in the peroxisomes or the microperoxisomes, which catalyses 
the decomposition of hydrogen peroxide to water and oxygen and thus protect the cell 
from oxidative damage produced by hydrogen peroxide. Under normal physiological 
conditions, a delicate balance exists between the rate of formation of H202 via 
distnutation of O-2 by SOD activity and the rate of removal of H202 by CAT and 
glutathione peroxidase. Therefore any impairment in this pathway will affect 
activities of other enzymes in the cascade (Kono and Fridovich, 1992). The present 
study indicates that GTE treatment resulted in slightly increased SOD and CAT 
activities. Results from this study suggest that treatment with GTE may have exerted 
an oxidative effect due to its cytotoxic and hence increasing levels of SOD and CAT 
activities. 
According to El Daly 2011, ingestion of the higher dose (3% GTE) 
revealed depletion of glycogen in hepatocytes cytoplasm, in a histohemical study. It 
may possibly induced instability of metabolic enzymes related to glycogen storage. 
The mechanism by which green tea extract induces trouble in carbohydrate 
metabolism may by attributed to mitochvndrial toxicity and reactive oxygen species 
(ROS) formation by tea catechins which induced cytotoxic effects (Galati et al., 
2006). The repeated ingestion of highly concentrated up to 3% green tea extracts has 
its harmful effect on the liver tissues that are subjected to variable hazards due to 
hepatotoxicity from tea extract polyphenols. So it can be allowed to ingest GTE 
beverage in a low concentration and for one or two times a day is good for the hepatic 
tissues (El Daly, 2011). 
Conclusion: 
According to toxicity classes of Hodge and Sterner (2005), any compound with oral 
LD50 (rat) of 5000mgIkg or more should be considered as practically harmless. This 
could be attributed the fact that, the tea preparation is rich in polyphenols, which 
possess antioxidant potential. In conclusion, the results showed that the acute toxicity 
of the Green tea extract is low and no evidence was found that it poses risks to general 
health of treated animals. But still not more than four cups a day of highly 
concentrated tea (up to 3% green tea extract) must be consumed. 
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5.3 In vitro Assessment of possible Antigenotoxic Potentials of Tea Polyphenols 
The present section was aimed at clarifying the hypothesis as to how tea polyphenols 
protect against chromosomal damage induced by Methyl Methane Sulphonate, 
TrenboIone, Methyltestosterone, Docetaxel and Tamoxifen in vitro. This section will 
discuss the results with tea polyphenols, which have been found to exhibit certain 
beneficial or protective effects in suppressing Chromosomal Abberations and Sister 
Chromatid Exchanges and in enhancing Replication Index in human lymphocyte 
culture, separately as well as when given together with the test chemicals. Methyl 
Methane Sulphonate, a known DNA alkylating agent, is used as a positive control. 
Different types of aberrations such as chromosome break or gap and chromatid break 
or gaps were recorded. Higher percentage of chromosome aberration and significant 
increase in sister chromatid exchanges were noted in drug treated culture groups, 
when compared with that of control. Decreasing Replicative index were also observed 
in drug treated cultures. Another interesting finding we noted was fuzzy morphology 
of 5.0-10.0% metaphase chromosome in Docetaxel and Tamoxifen treated cultures. It 
was suggested that in Docetaxel and Tamoxifen might have interacted with DNA 
associated Scaffold protein like acidic nonhistone chromosomal protein (Elgin et al., 
1975) from their binding sites and induced potential DNA lesion or fuzzy metaphase 
(Gorla et al., 1999). Results indicate a warning signal to injudicious and 
indiscriminate use of these drugs and protective role of tea polyphenols against the 
genotoxic damage of human lymphocytes. It has been demonstrated, clearly that in 
addition to the mutagen itself, the source of hepatic S9 mix used in in vitro assays 
could play a role in the mutagenic response or inhibitory capacity of the individual 
drug or isoflavonoid used (Alldrick et al 1986). 
Mechanisms of Action of the Anabolic Steroids: 
Anabolic steroids, as Trenbolone, show genotoxicity as they cause increased protein 
synthesis within cells, which results in the buildup of cellular tissue (anabolism), 
especially in muscles. The main approach in which steroid hormones interact with 
cells is by binding to proteins called steroid receptors. When steroids bind to these 
receptors, the proteins move into the cell nucleus and either alter the expression of 
genes (Lavery and Mc Evan, 2005; Gupta et al., 2009a) or activate processes that send 
signals to other parts of the cell (Cheskis et al., 2004; Gupta et al.,2009b). Anabolic 
steroids are a class of steroid hormones related to the hormone testosterone. Anabolic 
steroids have been used by physicians for many purposes as for hypoplastic anemias 
due to leukemia or kidney failure, especially aplastic anemia, (Basaria et al., 2001), 
growth stimulation, to increase lean body mass and prevent bone loss in elderly men 
etc. (Baum and Crespi, 2007; Francis, 2001) In the case of anabolic steroids, the 
receptors involved are called the androgen receptors. The mechanisms of action differ 
depending on the specific anabolic steroid. Different types of anabolic steroids bind to 
the androgen receptor with different affinities, depending on their chemical structure 
(Hartgens and Kuipers, 2004). 
Mechanisms of Action of the Carcinogenic 1 Mutagenic Agents: 
A high proportion of human cancers are attributed to environmental agents, brought 
about by xenobiotics. Epidemiological evidences strongly suggest that there could be 
strong environmental factors behind the causes of cancer. Most chemical carcinogens 
are alkylating or acylating agents (electrophilic reagents) and may produce such 
compounds following metabolism in the body. This means that they have electron 
deficient centre and will combine with electron rich centre within the cell. Alkylating 
agents are able to react at many sites in DNA, in particular at the nitrogen ring and the 
exocyclic oxygen atoms of the phosphate inter nucleotide linkages (Margison and 
O'Connor, 1979; Singer and Kusmierek, 1982). Substitution at the N-7 position of 
guanine in DNA is usually the major reaction product with alkylating carcinogens. 
Miller and Miller (1977) concluded that most carcinogens and mutagens are 
electrophilic reagents or they, in majority of cases, can give rise to electrophilic 
reagents through metabolism (bioactivation) or through various chemical changes. 
The human peripheral blood lymphocyte culture system is a single 
system that provides us with a larger number of dividing cells. These can be easily 
cultured to yield large number of mitotic figures for chromosome analysis. However, 
the great limitations of this morphological approach is that only gross genetic damage 
is visible and negative findings do not exclude other types of genetic damage such as 
those resulting in point mutations. Thus SCEs and chromosome aberrations are two 
different end points depicting cytogenetic damage due to mutagenic action and their 
amelioration when treated with antimutagenic test chemicals. The mechanism of these 
end points is probably different. One system cannot replace the other. Therefore both 
the endpoint should be scored to assess the genetic damage cause by drugs and 
chemicals and their amelioration by test compounds. 
An increase in the frequency of chromosomal aberrations in 
peripheral blood lymphocytes is associated with an increased overall risk of cancer 
(Hagmar et al.,1994,1998). Most of the chromosomal aberrations observed in the 
cells are lethal, but there are many other aberrations that are viable and cause genetic 
effects, either somatic or inherited (Swierenga et aI., 1991).The readily quantifiable 
nature of sister chromatid exchanges with high sensitivity for revealing toxicant-DNA 
interaction and the demonstrated ability of genotoxic chemicals to induce significant 
increase in sister chromatid exchanges in cultured cells has resulted in this endpoint 
being used as indicator of DNA damage in blood lymphocytes of individuals exposed 
to genotoxic carcinogens (Albertini et al., 2000). The above genotoxic endpoints are 
well known markers of genotoxicity and any reduction in the frequency of these 
genotoxic endpoints gives us indication of the antigenotoxicity of a particular 
compound (Albertini et al., 2000). Many products protect against xenobiotics either 
by inducing detoxifying enzymes or by inhibiting oxidative enzymes (Morse and 
Stoner, 1993). Plants are the essential source of medicines. Through the advances in 
pharmacology and synthetic organic chemistry, the dependence on natural products, 
remain unchanged (Roopashree et al., 2008). In India, the majority of populations use 
traditional natural prepartion derived from the plant material for the treatment of 
various diseases (Siddique et aI., 2006). The earlier studies have shown that various 
plant extacts and natural plant products possess protective role against the genotoxic 
effects of certain estrogens, synthetic progestins and anticancerous drugs in cultured 
human lymphocytes (Siddique and Afzal, 2004; Siddique and Afzal, 2005 a, b; Beg et 
al., 2007 a, b; Siddique et al., 2006 ; Siddique et al., 2007 a, b; Siddique et al., 2008 
b,c, d). The antigeotoxic potential of the plant extracts have been attributed to their 
total phenolic content (Maurich et aL, 2004). 
Epigallocatechin-3-gallate (EGCG) is widely accepted as an 
antioxidant. EGCG scavenges superoxide anion radicals (02 ), hydrogen peroxide 
(H202), hydroxy radicals (HO), peroxyl radicals, singlet oxygen, and peroxynitrite 
(Bors and Saran, 1987; Guo et al., 1999; Haenen et al., 1997; Nakagawa and 
Yokozawa, 2002; Nanjo et al., 1993; Paquay et al., 2000). The main characteristic of 
an antioxidant is its ability to trap free radicals. Highly reactive free radicals and 
oxygen species are present in biological systems from a wide variety of sources. 
These free radicals may oxidize nucleic acids, proteins, lipids or DNA and can initiate 
degenerative disease. Antioxidant compounds like polyphenols and flavonoids 
scavenge free radicals such as peroxide, hydroperoxide or lipid peroxyl and thus 
inhibit the oxidative mechanisms that lead to degenerative diseases. In addition, 
phenolic foods have added advantage over the other antioxidants since they are water-
soluble and are therefore excreted by the body unlike fat-based vitamin E that is 
absorbed and retained even at potentially harmful levels (Aqil et al., 
2006).Antioxidant compounds may be water-soluble lipid-soluble, insoluble, or 
bound to cell walls. Hence, extraction efficiency is an important factor in 
quantification of antioxidant activity of foods. Keeping this in mind Acetone is used 
in this study for extracting polyphenolic fractions from the dried tea leaves. 
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Antimutagenic action of green and black tea extracts and its polyphenols 
against several food xenobiotics such as aflatoxin B 1 has been reported. The property 
of antimutagenesis has been related to different components of tea extracts like 
isolated theaflavins (Shiraki et al., 1994) and other polyphenolic flavonoids (Rice-
Evans et al., 1995). Tea polyphenols inhibit the activation of mutagens and 
carcinogens by interacting with microsomal protein and impairing electron transfer 
(Hernaez et al., 1998). The epicatechin derivatives inhibit cytochrome P-450 
dependent monooxygenase, NADPH cytochrome reductase that reduces the 
transformation of promutagen to mutagen (Wang et al., 1988; Hernaez et al., 1998). 
The gallic acid moiety of theaflavins is known to inhibit DNA single strand breaks 
and scavenge electrophilic free radicals to produce antioxidative and antimutagenic 
effects (Shiraki et al., 1994). Antimutagenic effects of aqueous black tea extract 
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(ATE) and black tea polyphenols (BTP) were evaluated in the Ames test using 
Salmonella typhimurium tester strains TA-98 and TA-100. The antimutagenic 
activity of BTP was found to be higher than that of ATE, which may be attributable to 
the higher amount of polyphenolic ingredients (Taneja et al 2003, Shukla et al, 2003). 
Hence bioavailability of tea polyphenols following tea consumption by the human 
population i.e. absorption, distribution, and metabolism of green and black tea 
polyphenols in humans are of utmost importance. Hence it can be concluded that tea 
is a widely consumed polyphenolic beverage that may play a significant role as a 
naturally occurring antioxidant substitute and hence contribute to human health. 
Conclusion: 
Treatment of the genotoxic drugs used in our study, with Green tea extract, black tea 
extract and green tea polyphenols like Catechin Gallate and Epigallocatechin-3- 
gallate results in the significamt reduction of the genotoxic damage induced by them. 
This clearly indicates the protective role of tea polyphenolics against the genotoxicity 
in the mammalian cells. In the present work, variations in effects between the 
presence and absence of metabolic activation system were noticed. The results 
indicate that tea polyphenols are not mutagenic itself up to the tested range i.e. 300 µg 
/ ml for the cultured lymphocytes. Moreover at this concentration it acted as an 
antigenotoxic agent protecting the cells against mutagenic effects of the test 
chemicals. Hence it has been determined that Tea polyphenols, (both Green and Black 
tea), possess an antimutagenic potential. 
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5.4 In vitro Assessment of Possible Anticarcinogenic Potentials of Green Tea 
Polyphenols 
Galloway (2000) characterized different categories of compounds in 
differentiating between DNA damaging compounds generally inducing aberrations 
without severe concomitant cytotoxicity from cytotoxicity-associated clastogens. He 
pointed out that a limit on cytotoxicity, and an accurate way of estimating it, would be 
important" for reducing the frequency of non-relevant positive results in genotoxicity 
(especially clastogenicity) tests and thus for the increase of the accuracy of such 
assays. 
In the present study, induction of genotoxicity, determined through 
Chromosomal Aberrations, Sister Chromatid exchanges and Replication Index 
analysis, has been assessed along with cytotoxicity of tea polyphenols on cancer cell 
lines (in vitro). The results indicate that tea polyphenols are not cytotoxic up to the 
tested range i.e. 300 µg/ml for the cultured lymphocytes. At this concentration it acted 
as an antigenotoxic agent protecting the cells against mutagenic effects of test 
chemicals, but above 500 pg / ml or so it is found to be cytotoxic for the MCF 7 
and HEK. 293 cell lines. 
Morphologically, the cancerous cells are characterized by a large nucleus, 
having an irregular size and shape, the nucleoli are prominent cytoplasm is hrunken 
with no phagocytic & pinocytic activity, with decreased cytoplasmic- nuclear ratio, 
with more pseudopodial processes, deficient in endoplasmic reticulum, golgi 
complex, with smaller mitochondria. In vitro cancer cells grow as monolayers of 
closely apposed polygonal cells with epithelial morphology, most cells were 
mononuclear. Within the few hours of treatment with Green tea extract, cells which 
had previously been almost completely confluent, had retracted and the plasma 
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membrane started to ruffle and cells became rounded. Cells had also begun to shrink, 
the cytoplasm almost disappeared and cells get detached from plates and typical 
apoptotie bodies were seen at the boundaries of detached cell. Cell viability analysis 
showed that the round cells detached from the dish wall were dead. 
Besides being used by healthy people as a. means to support continued 
health, this "miracle herb" extract is also consumed by many cancer patients who 
follow popular trends and self-medicate with complementary and alternative medicine 
(CAM) in hopes to support their conventional therapy or to lessen the burden of side 
effects—sometimes without the knowledge of their health care providers. GTE or 
EGCG may also hold cancer therapeutic potential when combined with established - 
cancer treatments (Zhang et al., 2008). But the consumption of Green tea or Black tea 
extract must be done in consultation with the health care providers as GTE/ BTE, may 
block the efficacy of the anticancer drugs being given to the patients. As indicated in a 
study (Golden et al., 2009) that GTE as well as some of its individual components 
blocked the anticancer efficacy of bortezomib (BZM), a proteasome inhibitor that is 
in clinical use for the treatment of multiple myeloma and is under consideration for 
the treatment of other cancers as well. In the presence of polyphenolic green tea 
components, BZM was unable to exert proteasome inhibitory function and, as a 
consequence, there was no trigger for proapoptotic ER stress and subsequent cell 
death. Hence the researchers have suggested that patients undergoing BZM therapy to 
abstain from consuming green tea products, in particular those widely available, 
highly concentrated GTEs that are sold in liquid or capsule form. 
It has been reported that EGCG or a mixture of green tea polyphenols 
induced differential impacts in normal versus tumor cells by activating different 
pathways (Hsu et al., 2002; Hsu et al., 2003 ) and creating opposite oxidative 
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environments (Yamamoto et al., 2003; Yamamoto et al., 2004). Another study has 
demonstrated that EGCG and EGC possess growth inhibitory activities against human 
lung tumor cell lines H661 and H1299. ECG has Iower inhibitory activity and EC was 
much less effective. Lung cancer cell line H441 and colon cancer cell line HT-29 
appear to be less susceptible to inhibition by these polyphenols. The reasons for the 
observed differences in inhibition potency in terms of chemical structure and cell lines 
are not known (Yang et al., 1998). 
Babich et al., 2011 have suggested three distinct cellular responses as a result 
of exposure to polyphenols, with each response dependent upon the concentration and 
pro-oxidant nature of the polyphenols. 
(a) A mild exposure causes mild oxidative stress and thereby ignites cellular 
antioxidant defense systems. 
(b) An intermediate to high exposure gradually overwhelms the antioxidant defense 
systems and induces apoptotic cell death. 
(c) A very high exposure quickly overwhelms the cellular antioxidant defenses and 
causes oxidative damage leading to cell death by necrosis. 
The concentration of tea polyphenols in the blood is critically important to 
know their physiological role in living animals. So far, it has been reported that the 
concentration of EGCG rises to about 10 pM in the blood when a high dose EGCG is 
administered orally, 10 pM (24 h treatment) is the lowest cytotoxic EGCG 
concentration (Ullmann et al., 2003). Li et al. (2010) cited their study as "the first 
demonstration that EGCG induces ROS formation and consequently causes DNA 
oxidative damage in tumor cells in animals." 
The anticarcinogenic potential of tea polyphenols have been correlated their 
cytotoxic effects, by many researchers, with the induction of apoptosis, activation of 
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caspases, inhibition of protein kinase, modulation of cell cycle regulation and 
inhibition of cell proliferation, making it a protective beverage. Catechins are 
involved in thiol-dependent activation of mitogenic- activated protein kinases (Opare 
Kennedy et al., 2001). Specifically, EGCG regulates expression of VEGF, matrix 
metalloproteinases, uPA, IGF-1, EGFR, cell cycle regulatory proteins and inhibits 
NFk B, PI3-K/Akt, RasIRaf1MAPK and AP-1 signaling pathways, thereby causing 
strong cancer chemopreventive effects (Shankar et al., 2007). A number of recent 
researches have been presented the data of black tea polyphenol induced cellular 
signal transduction pathway associated with AP-1, NFk B and MAP kinase. Black tea 
polyphenols are more effective than EGCG, green tea polyphenol, in inhibiting AP-1 
binding activity (Clien et al., 1999). 
The galloyl structure on the B ring and the gallate moiety both in green and 
black tea polyphenols are important for the inhibition (Yang et al., 2000) and 
antioxidative activities (Shiraki et al., 1994). Most of the relevant mechanisms of 
cancer prevention by tea polyphenols are not related to their redox properties, but are 
due to the direct binding of the polyphenol to target molecules, including the 
inhibition of selected protein kinases, matrix metalloproteinases, and DNA 
methyltransferases (Gupta et al., 2008). Activation of Forkhead box 0 transcription 
factor (FOXO3a) by the green tea polyphenol epigallocatechin-3-gallate induces 
estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells 
(Belguise et al., 2007). Lin and Lin (1997) assessed the effects of EGCG on nitric 
oxide production by murine peritoneal macrophages. Their results suggest that EGCG 
blocked early events of nitric oxide synthase induction by inhibiting the binding of 
transcription factor nuclear factor kappa B to the inducible nitric oxide synthase 
(iNOS) promoter, thereby inhibiting the induction of iNOS transcription. The ortho- 
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trihydroxyl group in the B ring and the galloyl moiety at 3 position of flavan-3-ol 
skeleton are the most important structural features for displaying an excellent 
scavenging ability. It has been shown that, through several mechanisms, tea 
polyphenols present antioxidant and anticarcinogenic activities, thus affording several 
health benefits (Gonzalez de Mejia E, 2003; Gupta et al, 2009c). The structure of 
flavanols provides strong nucleophillic centers at position 6 and 8. This property 
enables flavanols to react with electrophilic carcinogens. An initial step of 
carcinogenesis is the metabolic activation of chemical carcinogens by the P-450-
dependent biotransformation reaction (Shukla Y, 2007). Animal and in-vitro studies 
have provided evidence that the polyphenols found in tea may inhibit tumorigenesis in 
many animal models, including those for cancer of the skin, lung, oral cavity, 
oesophagus, stomach, small intestine, colon, liver, pancreas, bladder, and prostate. 
The suggested mechanism of action includes the following (Gupta et al., 2008): 
— Antioxidant activity and scavenging free radicals. 
— Modulating enzymes implicated in the carcinogenic process. 
— Modifying the pathways of signal transduction, thereby positively altering the 
expression of genes involved in cell proliferation, angiogenesis, and apoptosis, 
all important stages of cancer progression. 
— Antimicrobial actions (association between Helicobacter pylori and gastric 
cancer). 
Although a great deal of information has been accumulated on the effect of tea 
on cancer, a clear understanding of the mechanism by which tea components may 
affect the genesis, growth, and progression of specific cancers is essential. A phase I 
clinical trial has suggested that green tea is well tolerated and can be safely 
administered without any side effects over a period of 6 months (Pisters et al., 2001). 
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Another phase II clinical trial, however, concluded that green tea carries only a 
limited antineoplastic activity in patients with androgen dependent prostate cancer 
(Jatoi et al., 2003). Thus the ideal chemopreventive study should be conducted in a 
population with high risk of prostate cancer development. 
Conclusion: 
Cytotoxicity assays of the Green tea extract revealed that the methanolic extract of 
Green tea had a significant cytotoxic impact on MCF-7 cells and HEK 293 cells with 
the minimum inhibitory concentration (ICSD mean value) of 592.6 i.g/m1 and 1041.35 
µg/m1, respectively. Hence proving the anticarcinogenic potentials of the Green tea 
polyphenols. 
it 
BIBLIOGRAPHY 
Abe M, Takaoka N, Idemoto Y,Takagi C, Imai T, Nakasaki K. (2008). Characteristic 
fungi observed in the fermentation process for Pure tea. International Journal ofFood 
Microbiology 124 (2), 199-203. 
Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, 
Weinstein IB. (2007). The - inhibitory effect of (-)-epigallocatechin gallate on 
activation of the epidermal growth factor receptor is associated with altered lipid 
order in HT29 colon cancer cells. Cancer Research 67(13):6493-501. 
Adelman RD, Spangler WL, Beason F, Ishizaki G, Conzelman GM. (1981). 
Frusemide enhancement of netilmicin nephrotoxicity in dogs. Journal of 
Antimicrobials and Chemotherapy 7, 431-435. 
Association of the British Pharmaceutical Industry. ABPI Data Sheet Compendium 
(1993). Datapharm Publications, London. 
Afzal M, Siddique YH, Beg T. (2008).Mutagen induced genotoxicity and action of tea 
polyphenolics in mammalian test system: in vitro and in vivo models and 
methodological considerations. In: Recent Trends in Toxicology. Ed. Siddique YH. 
Transworld Research Network, 37/661 (2), fort P.O., Trivandrum, Kerala, India. 
Afzal M. (2010). Project Report of the UGC Project Reference No. 32-482/2006 (SR) 
entitled 	"Antimutagenic and anticarcinogenic potentials of tea polyphenolics in 
mammalian systems". (2007-2010). 
Ahmad N and Mukhtar H. (1999) Green tea polyphenols and cancer: biologic 
mechanisms and practical implications. Nutrition Reviews 57, 78— 83. 
Ahmad I, Farrnkh A, Amad F, Owais M. (2006). Herbal Medicines: Prospects and 
Constraints, In Ahmad I., F. Aqil and M. Owais, Modem Phytomedicine: Turning 
Medicinal Plants into Drugs. Wiley-VCH Verlag GinbH & Co., Germany, 59-78. 
Alberts B, Bray D, Lewis J, Roberts K, Watson J. (1994). Molecular Biology of the 
Cell. Garland Publishing, New York. 
AIbertini RJ, Anderson D, Douglas GR, Hagmar L, Heminiki K, Merelo F, 
Natrajan AT, Norppa H, Shuker DEG, Tice R, Walters MD, Aitio A. (2000). 
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in 
humans. Mutation Research 463, 111-172. 
Alldrick AJ, Flynn J and Rowland IR. (1986). Effect of plant — derived flavonoids and 
polyphenolic acids on the activity of mutagens from cooked food. Mutation 
Research 163, 225 — 232. 
Aqil F, Ahmad I, Mehmood Z (2006). Antioxidant and Free Radical Scavenging 
Properties of Twelve Traditionally used Iranian Medicinal Plants. Turkish Journal of 
Biology 30, 177-183. 
109 
Arts MJTJ, Haenen GRMM, Wilms LC, Beetstra SAJN, Heijnen CGM, Voss HP, 
Bast A. (2002). Interaction between flavonoids and proteins: Effect on the total 
antioxidant capacity. Journal oftlgricultural and Food Chemistry 50, 1184-1187. 
Aydemir N, Celikler S, Bilalouglr R.(2005). In vitro genotoxic effects of the anti-
cancer drug gemcitabine in human lymphoctes. Mutation Research. 582: 35-41. 
Babich H, Schuck AG, Weisburg JH and Zuckerbraun HL.(201 1). Research Strategies 
in the Study of the Pro-Oxidant Nature of Polyphenol Nutraceuticals. Journal of 
Toxicology 2011, 1-12. 
Balentine DA, Harbowy ME, Graham HN.(1998). Tea: the Plant and its 
Manufacture; Chemistry and Consumption of the Beverage in Caffeine. ed. GA 
Spiller, CRC Press, Los Altos, California, USA, 35-72. 
Basaria S, Wahlstrom JT, Dobs AS. (2001). Clinical review 138: Anabolic-
androgenic steroid therapy in the treatment of chronic diseases. The Journal of 
Clinical Endocrinology and Metabolism 86, 11, 5108-17. 
Bastianetto S, Yao ZX, Papadopoulos V, Quirion R.(2006). Neuroprotective effects of 
green and black teas and their catechin gallate esters against beta-amyloid-induced 
toxicity. European Journal ofNeurosciences 23(1), 55-64. 
Baum NH, Crespi CA. (2007). Testosterone replacement in elderly men. 
Geriatrics 62, 9: 14-8. 
Beg T, Siddique YH and Afzal M. (2007a). Antigenotoxic potential of gingerol in 
cultured mammalian cells. The lcfai Journal of Life Sciences 1, 39-44. 
Beg T, Siddique YH, Ara G, Afzal M. (2007b). Antimutagenic evaluation of Genistin, 
a polyphenol in cultured human peripheral blood lymphocytes. Biomedical Research 
18, 141- 145. 
Belguise K, Guo S and Sonenshein GE. (2007). Activation of FOXO3 a by the green 
tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression 
reversing invasive phenotype of breast cancer cells. Cancer Research 67, 12, 5763-
5770. 
Beranek DT. (1990). Distribution of methyl and ethyl adducts following alkylation 
with monofunctional alkylating agents. Mutation Research 231(1),11-30. 
Berridge MV, Tan AS. (1993). Characterisation of the cellular reduction of 3-(4,5-
dimethylthiazol-2y1)-2,5-diphenyltetrazolium bromide (MTT): Subcellular 
localization, substrate dependence, and involvement of mitochondrial electron 
transport in MTT reduction. Archives of Biochemistry and Biophysics 303, 474-482. 
Berridge MV, Herst PM , and Tan AS. (2005)Tetrazolium dyes as tools in cell 
biology: new insights into their cellular reduction. Biotechnology Annual Review, 
11,127-152. 
BIG 1-98 Collaborative Group. Letrozole therapy alone or in sequence with 
tamoxifen in women with breast cancer. New England Journal of Medicine 361,766-
776, 2009 (Trial 18-98). 
110 
Bitensky,L. (1963) The reversible activation of lysosomes in normal cells and the 
effects of pathological conditions. In Ciba Foundation Symposium on Lysosomes. De 
Reuck,A.V.S. and Cameron M.P. (eds). Ciba, London: 362-375. 
Blumberg UH, Caretner MG, Wurz GT, DeGregorio MW. (1998) Intrinsic reactivity 
of Tamoxifen and Toremifene metabolites with DNA. Breast Cancer Research and 
Treatment 50, 135- 141. 
Boerrigter ME, Muflaart E, Vijg J. (1991). Induction and disappearance of DNA 
strand breaks in human peripheral blood lymphocytes and fibroblasts treated with 
methyl methanesulfonate. Experimental Cell Research 192(1), 61-6. 
Bors W and Saran M. (1987). Radical scavenging by flavonoid antioxidants. 
Free Radical Reseach Communications 2, 289- 294. 
Borenfreund E and Puerner JA. (1984). A simple quantitative procedure using 
monolayer culture for toxicity assays. Journal of Tissue Culture Methods 9, 7-9. 
Borenfreund E and Puerner JA. (1985) Toxicity determined in vitro by 
morphological alterations and neutral red absorption. Toxicology Letters 24, 119-
124. 
Brad J, Sirota JH (1948). The renal clearance of endogenous "creatinine" in man. 
Journal of Clinical Investigation 27(5),645-654. 
Brogger A. (1982). The chromatid gaps — a useful parameter in genotoxicity. 
Cytogenetics and Cell Genetics 33, 14 —19. 
Brown PJ, Wright WB. (1963). An investigation of the interactions between milk 
proteins and tea polyphenols. Journal of Chromatography 11, 504-514. 
Buckton KA and Evans HJ. (1982) Human peripheral lymphocyte cultures, An invitro 
assay for cytogenetic effects of environmental mutagens. In: Hsu, TC (eds) 
Cyctogenetic assay of environmental mutagens. Allanheld Osmun Totowa. 183-201. 
Buckton KA and Pike MC (1964) Time in culture; An important variable in studying 
in vivo radiation induced chromosome damage in man. International Journal of 
Radiation Biology 8, 439 — 452. 
Buschman JL. (1998). Green tea and cancer in humans: a review of the literaturee. 
Nutrition and Cancer 31, 51-57. 
Bulychev A, Trouet A and Tulkens P. (1978) Uptake and intracellular distribution of 
neutral red in cultured fibroblasts. Experimental Cell Research 115, 343-355. 
Cabrera C, Artacho R and Gimenez R. (2006). Beneficial effects of green tea: A 
review. Journal ofAmerican College ofNutrition, 25, 79-99. 
Carballo MA, Aluarez S, Boveris A. (1993). Cellular stress by light and rose Bengal. 
Mutation Research, 288, 215-222. 
Carrano AV, Thompson LH, Lindi PA and Minkler JL (1978). Sister chromatid 
exchange as an indicator of mutagenesis. Nature 271, 551 — 553. 
111 
Clifford MN, Copeland EL, Bloxsidge JP, Mitchell LA. (2000). Hippuric acid as a 
major excretion product associated with black tea consumption. Xenobiotica 30, 317-. 
326. 
Crossen PE and Morgan VHF. (1977). Analysis of human lymphocyte cell cycle time 
in culture measured by sister chromatid differential staining. Experimental Cell 
Research 104, 453 — 457. 
Chan PT, Fong WP, Cheung YL, Huang, Ho WKK, Chen ZY. (1999). Jasmine green 
tea epicatechins are hypolipidemic in hamsters fed a high-fat diet. Journal of 
Nutrition 129:1094-1101. 
Chandra M, Subapriya R, Hara Y, Nagini S. (2006). Enhancement of erythrocyte 
antioxidants by green and black tea polyphenols during 7,12-
dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Journal of 
Medicinal Food 9(3), 373-7. 
Chen YC, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. (1999). Inhibition of TPA-
induced protein kinase c and transcription activator protein-1 binding activities by 
theaflavin-3,3'-digallate from black tea in nih3t3 cells. Journal of Agricultural and 
Food Chemistry 47, 1416-1421. 
Cheskis B. Regulation of cell signalling cascades by steroid hormones. (2004). 
Journal of Cell Biochemistry 93 (1), 20-7. 
Cho YS, Schiller NL, Kahng HY, Oh KH. (2007). Cellular responses and proteomic 
analysis of escherichia coli exposed to green tea Polyphenols. Current Microbiology 
55, 501-506. 
Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara 
Y. (2001). Phase I Pharmacokinetic Study of Tea Polyphenols following Single-dose 
Administration of Epigallocatechin Gallate and Polyphenon E. Cancer Epidemiology 
Biomarkers and Prevention 10(1), 53-58. 
Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Don RT, Hara Y, 
Alberts DS.(2003). Pharmacokinetics and Safety of Green Tea Polyphenols after 
Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in 
Healthy Individuals. Cinical C'ancer Research 9, 3312-9. 
Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, 
Dimayuga P, Cercek B, Shah PK. (2004). Differential effects of green tea-
derived catechin on developing versus established atherosclerosis in 
apolipoprotein E-null mice. Circulation 109, 2448-53. 
Cooper R, Morré DJ and Morre DM. (2005). Medicinal benefits of green tea: Review 
of noncancer health benefits. Journal of Alternative and Complementary Medicine 
11(3), 521-8. 
De SaFerrira ICF, Ferrago Vargas VM. (1999). Mutagenicity of medicinal plant 
extracts in Salmonellalmicrosome assay. Phytotherapy Research 13: 397-400. 
Dewhurst J, Gordon RR. (1984). Fertility following change of sex: a follow-up. 
Lancet 2, 1461-1462. 
112 
Dhawan A, Anderson D, de Pascual-Teresa S, Santos-Buelga C, Clifford MN, 
Ioannides C. (2002). Evaluation of the antigenotoxic potential of monomeric and 
dimeric flavanols, and black tea polyphenols against heterocyclic amine-induced 
DNA damage in human lymphocytes using the Comet assay. Mutation Research 
515(1-2), 39.56. 
Dong Z, Ma W, Huang C and Yang CS. (1997). Inhibition of tumor promoter-induced 
activator protein 1 activation and cell transformation by tea polyphenols, - 
epigallocatechin gallate, and theaflavins. Cancer Research. 57, 4414- 4419. 
El Daly AA. (2011). Effect of Green Tea Extract on the Rat Liver; Histoarchitectural, 
Histochemical and Ultrastructural Studies. Journal ofAmerican Science 7(5), 65-73. 
Elgin SCR, Weintraub H. Chromosomal protein and chromatid structure. (1975). 
Annual Review of Biochemistry 44, 725-9. 
Evans HJ. (1984). Human peripheral blood lymphocytes for the analysis of 
chromosome aberrations in mutagen tests. In : Kiley BJ, Legator, M. Nichols W 
and Ramel C (eds). Handbook of Mutagenecity Test Procedures. Elsevier, 
Amsterdam.40 — 427. 
Falk H, Thomas LB, Popper-H, Ishak KG. (1979). Hepatic angiosacroma associated 
with androgenic-anabolic steroids. Lancet 2, 1120-1123. 
Filman DJ, Brawn RJ and Dandliker WB. (1975) Intracellular supravital stain 
delocalization as an assay for antibody-dependent complement-mediated cell damage. 
Journa 1 of Immunoogical Methods 6, 189-207. 
Fisher and Yates. (1963). Statistical Tables for Biological, Agricultural and Medical 
Research. 6th Ed.Hafaer Pub Co., New York. 
Food and Drug Administration. Saftey assessment. In vitro mutagenic tests. 
Fournier C, Taucher-Scholz G. (2004). Radiation induced cell cycle arrest: an 
overview of specific effects following high-let exposure. Radiotherapy and Oncology 
73 (2), 119-122. 
Francis RM. (2001). Androgen replacement in aging men. Calcified Tissue 
International 69 (4), 235-8. 
Frei B and Higdon JV. (2003). Antioxidant activity of tea polyphenols in vivo: 
evidence from animal studies. Journal ofNutrition 33(10), 3275S-84S. 
Fujiki H, Suganuma M, Imai K, Nakachi K. (2002). Green tea: cancer preventive 
beverage andlor drug. Cancer Letters 188(1-2), 9-13. 
Fujiki H. (2005).Green tea: Health benefits as cancer preventive for humans. 
Chemical Record 5(3), 119-32. 
Fung AD, Ou J, Bueler S, Brown GW. (2002). A conserved domain of 
Schizosaccharomyces pombe dfpl(+) is uniquely required for chromosome stability 
following alkylation damage during S phase. Molecular Cell Biology 13, 4477-90. 
113 
Galati G, Lin A, Sultan AM, O'Brien PJ. (2006). Cellular and in vivo hepatotoxicity 
caused by green tea phenolic acids and catechins. Free Radical Biology and Medicine 
40, 570-580. 
Galloway SM. (2000) Cytotoxicity and chromosome aberrations in vitro: experience 
in industry and the case for an upper limit on toxicity in the aberration assay. 
Environmental Molecular Mutagenesis 35, 191-201. 
Gebhart E. (1970).The treatment of human chromosomes in vitro; Results. In: Vogel, 
F; Rohbom, G (eds). ChemicalMutagenesis in Mammals and Man. Springer Verlag 
Berlin, Heidelberg, New York. 367-382  
Gebhart E. (1982).The epide miological approach; Chromosome aberrations in 
persons exposed to chemical mutagens.In : Hsu, TC (ed). Cytogenetic assays of 
environmental mutagens, Allanheld Osmun Totowa, 385 — 408. 
Gibbons S, Moser E, Kaatz GW. (2004). Catechin gallates inhibit multidrug 
resistance (MDR) in Staphylococcus aureus. Planta Medica 70(12), 1240-2. 
Goetz P. Sram RJ and Dohnalova . J. (1975) Relationship between experimental result 
in mammals and man. Cytogenetic analysis of bone marrow injury induced by a 
single dose of cyclophosphamide. Mutation Research 31, 247 — 254. 
Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, 
Chen TC and Schonthal AH . (2009).Green tea polyphenols block the anticancer 
effects of bortezomib and other boronic acid -based proteasome inhibitors. Blood, 
113, 5927-5937 
Gonzalez de Mejia E.(2003). The chemo-protector effects of tea and its components. 
Archives of Latino American Nutrition 53(2), 111-8. 
Gorla N, Ovando HG, Larripa I. (1999). Chromosomal aberrations in human 
lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin. Toxicologyl Letters 
104,43-8. 
Gradisar H, Pristovsek P. Plaper A, Jerala R. (2007). Green tea catechins inhibit 
bacterial DNA gyrase by interaction with its ATP binding site. Journal of Medicinal 
Chemistry 50(2), 264-71. 
Graf U, Moraga AA, Castro R, Carillo ED. (1994) Genotoxicity testing of different 
types of beverages in the Drosophila wing somatic mutation and recombination test. 
Food and Chemical Toxicology 3 2(5), 423-430. 
Gupta J, Siddique YH, Beg T, Ara G and Afzal M. (2008). A Review on the 
beneficial effects of tea polyphenols on human health. International Journal of 
Pharmacology 4(5), 314-338. 
Gupta J, Siddique YH, Ara G, Beg T and Afzal M. (2009a). Protective role of tea 
polyphenol, EGCG, against genotoxic damage induced by anticancer drug and 
steroid compound in cultured human lymphocytes. The Internet Journal of 
Nutrition and Wellness. Volume 7. 
114 
Gupta J, Siddique YH, Ara G, Beg T and Afzal M. (2009b). Protective role of green 
tea extract against genotoxic damage induced by anabolic steroids in cultured human 
lymphocytes. Biology and Medicine. Volume 1 (2), 87- 99. 
Gupta J, Siddique YH, Ara G, Beg T and Afzal M. (2009c). Protective role of gree 
tea extract, against genotoxic damage induced by anticancer drug and steroid 
compound in cultured human lymphocytes. Pharmacologyonline 3, 156-174. 
Guo Q, Zhao B, Shen S,Hou J, Hu J and Xin W. (1999). ESR study on the structure-
antioxidant activity relationship of tea catechins and their epimers. Biochirnica et 
Biophysica Acta 1427, 13--23. 
Haenen GR, Paquay JB, Korthouwer RE and Bast A. (1997). Peroxynitrite 
scavenging by flavonoids. Biochemical and Biophysical Research 
Communications 236, 591-593. 
Hagmar L, Brogger A, Hansteen IL, Heims S, Hoggstedt B, Knudsen L, 
Lambert B, Linnaimaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, 
Kerfving S, Sorsa M. (1994). Cancer risk in humans predicted by increased level of 
chromosomal aberrations in human lymphocytes: Nordic study group on the health 
risk of chromosome damage. Cancer Research 54, 2919-2922. 
Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudson JE, Norppa H, 
Reuterwall C. (1998). Chromosomal aberration in human lymphocytes predict 
human cancer: A report from the European Study Group on Cytogenetic Biomarkers 
and Health (ESCH). Cancer Research 58, 4117-4121. 
Hahn H, Eder E, Deininger C. (1991). Genotoxicity of 1,3-dichloro-2-propanol in the 
SOS chromotest and in the Ames test. elucidation of the genotoxic mechanism. 
Chemico BiologicalInteraction 80(1), 73-88. 
Halder J and Bhaduri AN. (1998). Protective role of black tea against oxidative 
damage of human red blood cells. Biochemical and Biophysical Research 
Communications 244, 903-907. 
Hara Y, Matsuzaki T, Suzuki T. (1987). Angiotensin I converting enzyme inhibiting 
activity of tea components. Journal of Agricultural and Chemical Society Japan 61, 
803-808. 
Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H.(2003). Role 
of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP 
cells. Oncogene 22(31), 4851-9. 
Henry JP and Stephens-Larson P. (1984). Reduction of chronic psychosocial 
hypertension in mice by decaffeinated tea. Hypertension 6, 437-444. 
Hernaez J, Xu M, Dashwood R (1998). Antimutagenic activityof tea towards 2-
hydroxyamino-3-methylimidazo (4,5)quinoline: effect of tea concentration and brew 
time onelectrophillic scavenging. Mutation Research 402, 299-306. 
Hartgens F, Kuipers H. (2004). Effects of androgenic-anabolic steroids in athletes. 
Sports Medicine 34(8), 513-54. 
115 
Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL, HeberD. 
(2005). Bioavailability and antioxidant effect of epigallocatechin gallate administered 
in purified form versus as green tea extract in healthy individuals. Journal of 
Nutritional Biochemistry 16(10), 610-6. 
Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL, Heber D. 
(2006). Tea Polyphenols and Theaflavins Are Present in Prostate Tissue of Humans 
and Mice after Green and Black Tea Consumption. Journal ofNutrition 136(7), 1839-
1843. 
Hirasawa M, Takada K, Otake S. (2006). Inhibition of acid production in dental 
plaque bacteria by green tea catechins. Caries Research 40(3) 265-70. 
Hodge A and. Sterner B. (2005) .Toxicity classes. In: Canadian center for 
occupational Health and safety. 
Hotchkiss AK, Furr J, Makynen EA, Ankley GT, Gray LE Jr. (2007). In utero 
exposure to the environmental androgen trenbolone masculinizes female Sprague-
Dawley rats. Toxicology Letters 174, 31-41. 
Hotta Y, Huang L, Muto T, Yajima M, Miyazeki K, Ishikawa N, Fukuzawa Y, 
Wakida Y, Tushima H, Nonogaki T. (2006). Positive inotropic effect of purified green 
tea catechin derivative e in guinea pig hearts: the measurements of cellular Cat} and 
nitric oxide release. European Journal ofPharmacology 552(1-3), 123-30. 
Hruskova J, Danes L, Kliment V. (1961) Venezuelan equine encephalomyelitis virus: 
determination  of inhalation LD50 for guinea pigs and mice. Acta Virologica 13, 203-
208 
Hsu S, Yu FS, Lewis J, Singh B, Borke J, Osaki T, Athar M and Schuster G. (2002). 
Induction of p57 is required for cell survival when exposed to green tea polyphenols. 
Anticancer Research 22, 4115- 4120. 
Hsu S, Bollag WB, Lewis J, Huang Q, Singh B, Sharawy M, Yamamoto T and 
Schuster G. (2003). Green tea polyphenols induce differentiation and proliferation in 
epidermal keratinocytes. The Journal of Pharmacology and Experimental 
Therapeutics 306: 29-34. 
Hsu S. (2005).Green tea and the skin. Journal ofAmerican Academy of Dermatology 
52(6), 1049-59. 
Hsu SD, Dickinson DP, Qin H, Borke J, Ogbureke KU, Winger JN, Camba AM, 
Bollag WB, Stoppler HJ, Sharawy M, Schuster GS. (2007). Green tea polyphenols 
reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and 
protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. 
Autoimmunity 40(2), 138-47. 
Hsu TC. (1982). Introduction In: Hsu TC (ed) Cyctogenetic Assays of Environmental 
Mi:tagens. Allanheld Osmum Totowa, 1 — 9. 
Hsuuw YD and Chan WH. (2007). Epigallocatechin gallate dose-dependently induces 
apoptosis or necrosis in human MCF-7 cells. Annals of the New York Academy of 
Science 1095, 428-40. 
116 
Huang Q, Wang X and Ho CT. (2007): Investigation of Adsorption Behavior of (-
Epigallocatechin Gallate on Bovine Serum Albumin Surface Using Quartz Crystal 
Microbalance with Dissipation Monitoring. Journal of Agricultural and Food 
Chemistry 55 (25), 10110-10116. 
Huang CC, Wu WB, Fang, JY, Chiang HS, Chen SK, Chen BH, Chen YT, Hung CF. 
(2007). (-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against 
UVB-induced damage in HaCaT keratinocytes. Molecules 12(8), 1845-5S. 
Huie RE and Padmaja S. (1993). The reaction of NO with superoxide. Free Radical 
Research Communications 18(4), 95-9. 
IARC (International Agency for Research on Cancer) Monographs on the evaluation 
of carcinogenic risks to human. 1996. Tamoxifen. In IARC monographs on the 
evaluation of carcinogenic risks to humans, no.66, Some Pharm. Drugs. IARC, 
Lyon, 253- 365. 
ICH S2B (1997). Genotoxicity: A Standard Battery for Genotoxicity Testing of 
Pharmaceuticals S2B. ICHHarmonised Tripartite Guidline. 
IPSC, 1985. Informational Programme on Chemical Saftey. Environmantal 
Health Criteria 48. Guidelines for the study of genetic effects in human 
population. WHO Geneva p 25- 54. 
Ikeda M, Suzuki C, Umegaki K, Saito K, Tabuchi M, Tomita T. (2007). Preventive 
effects of green tea catechins on spontaneous stroke in rats. Medical Science Monitor 
13(2), 40-45. 
Ikeda I, Tsuda K, Suzuki Y, Kobayashi M, Unno T, Tomoyori H, Goto H, Kawata Y, 
Imaizumi K, Nozawa A, Kakuda T. (2005). Tea catechins with a galloyl moiety 
suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of 
dietary fat in rats. Journal of Nutrition 135(2), 155-9. 
Imai K and Nakachi K. (1985). Cross sectional study of effects of drinking green tea 
on cardiovascular and liver disease. Biochemistry Medical Journal 310, 693-696. 
Imanishi H, Sasaki YF, Ohta T, Watanabe M, Kato T, Shirasu Y. (1991) Tea tannin 
components modify the induction of sister chromatid exchanges and chromosome 
aberrations in mutagen-treated cultured mammalian cells and mice. Mutation 
Research 259, 79-81. 
Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M. (2000). Tea 
catechins and related polyphenols as anti-cancer agents. Biofactors 13(1-4), 81-5. 
Ivett JL, Tice P.R. (1982). Average generation of time: a new method of analysis and 
quantitation of cellular proliferation kinetics. Environ. Mutagen 4, 358. 
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, 
Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. (1997). Cancer 
Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. 
Science 275, 218-238. 
117 
Jatoi A, Ellison N, Burch AP, et al (2003). A phase II trail of green tea in the 
treatment of patients with androgen independent metastatic prostate carcinoma. 
Cancer 97, 1441-6. 
Jensen RIB, Bigbee WL, Langlois RG. (1990). Multiple endpoints for somatic 
mutations in humans provide complementary views for biodosimetry, genotoxicity 
and health risks. Progress in Clinical and Biological Research 340C, 81-92. 
Jordan MA and Wilson L. (1998). Microtubules and actin filaments: dynamic targets 
for cancer chemotherapy. Current Opinion in Cell Biology 10, 123-130. 
Jobstl E, Howse JR, Fairclough JP, Williamson MP. (2006). Noncovalent cross-
linking of casein by epigallocatechin gallate characterized by singlemolecule force 
microscopy. Journal ofAgricultural and Food Chemistry 54, 4077-4081. 
Ju J, Lu G, Lambert JD, Yang CS. (2007). Inhibition of carcinogenesis by tea 
constituents. Seminars in Cancer Biology 17(5), 395-402. 
Kakkar P, Das B and Viswanathan PN. (1984). A modified spectrophotometric assay 
of superoxide dismutase. Indian Journal of Biochemistry and Biophysics 21: 130-132. 
Katiyar S, Elmets CA, Katiyar SK. (2006). Green tea and skin cancer: 
photoimmunology, angiogenesis and DNA repair. Journal ofNuutritional Bdochenustly 
18(5), 287-96. 
Katiyar SK, Bergamo BM, Vyalil PK, Elmets CA. (2001). Green tea polyphenols: 
DNA photo damage and photoimmunology. Journal of Photochemistry and 
Photobiology B 65(2-3), 109-14. 
Katiyar SK, Perez A, Mukhtar H. (2000a). Green tea polyphenol treatment to human 
skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. 
Clin Cancer Res., 6(10), 3864-9. 
Katiyar SK, Ahmad N, Mukhtar H. (2000b). Green tea and skin. Archives of 
Dermatology 136(8), 989-94. 
Kawai K, Matsuno K, Kasai H. (2006). Detection of 4-oxo-2-hexenal, a novel 
mutagenic product of lipid peroxidation, in human diet and cooking vapor. Mutation 
Research 28;603(2), 186-92. 
Kim JH, Kang BH and Jeong JM. (2003). Antioxidant antimutagenic and 
chemopreventive activities of a phyto-extract mixture derived from various 
vegetables, fruits and oriental herbs. Food Science and Biotechnology 12, 631-638. 
Kirkland D. (2011),Improvements in the reliability of in vitro genotoxicity testing. 
Expert Opininion on Drug Metabolosm and Toxicolology 7(12), 1513-20. 
Khan SA, Priyamvada S, Farooq N, Khan S, Khan MW, Yusufi ANK. (2009) 
Protective effect of green tea extract on gentamicin-induced nephrotoxicity and 
oxidative damage in rat kidney. Pharmacological Research 59, 254 —262. 
Klaunig J, Xu Y, Han C, Kamendulis L, Chen J, Heiser C, Gordon M and Mohler E. 
(1999). The effect of tea consumption on oxidative stress in smokers and non- 
118 
smokers. Proceedings of the Society for Experimental Biology and Medicine 220, 
249-254. 
Kohn T, Suzuki M, Nanjo F. (2003): Identification of metabolites of (-)- epicatechin 
gallate and their metabolic fate in the rat. Journal ofAgricultural and Food Chemistry 
51, 5561-66. 
Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. (1992). Green tea consumption and 
serum lipid profile: a cross-sectional study in Northern Kyush. Japanese effort of 
Preventive Medicine 21, 526-531. 
Kono Y, Fridovich 1. (1992). Superoxide inhibits catalase. Journal of Biological 
Chemistry 257, 5751-54. 
Koo SI and Noh SK. (2007). Green tea as inhibitor of the intestinal absorption of 
lipids: potential mechanism for its lipid-lowering effect. Journal of Nutritional 
Biochemistry 18(3), 179-83. 
Kundu JK and Surh YJ. (2007). Epigallocatechin gallate inhibits phorbol ester-
induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. 
Annals of New York Academy of Sciences 1095, 504-12. 
Latt SA. (1973). Microflurometric detection of deoxyribonucleic acid replication in 
human metaphase chromosome. Proceeding of the National Academy of Sciences 
U.S.A. 70, 3395-3399. 
Latt SA. (1974). Sister chromatid exchange,indices of human chromosome damage 
and repair: detection by fluorescence and induction by mitomycin C. Proceeding of 
the National Academy of Sciences U.S.A. 71, 3162-3166. 
Latt SA, Allen J, Bloom SE, Carrono AV, Falke E, Kram D, Schneider E, Shredk R, 
Tice R, Whitefield B and Wolff S. (1981). Sister chromatid exchange; a report of the 
genetox program. Mutation Research 87, 17-62. 
Langley-Evans SC. (2000): Antioxidant potential of green and black tea determined 
using the ferric reducing power (FRAP) assay. International Journal of Food Science 
and Nutition Si, 181-188 
Lavery DN, McEwan IJ. (2005). Structure and function of steroid receptor AF1 
transactivation domains: induction of active conformations. The Biochemical Journal, 
391 (3): 449-64. 
Lawley PD. (1989). Mutagens as carcinogens: development of current concepts. 
Mutation Research 213(1), 3-25. 
Lee HC, Jenner AM, Low CS, Lee YK. (2006). Effect of tea phenolics and their 
aromatic fecal bacterial metabolites on intestinal microbiota. Research in 
Microbiology 157, 876-884. 
Lee SJ and Lee KW. (2007). Protective effect of (-)-epigallocatechin gallate against 
advanced glycation endproducts-induced injury in neuronal cells. Biological and 
Pharmaceutical Bulletin 30(8):1369-73. 
119 
Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY. (2001): Theaflavins in black 
tea and catechins in green tea are equally effective antioxidants. Journal of Nutrition 
131, 2248-2251. 
Li GX, Chen YK, Hou Z, et al. (2010). Pro-oxidative activities and dose-response 
relationship of (—)-epigallocatechin-3-gallate in the inhibition of lung cancer cell 
growth: a comparative study in vivo and in vitro. Carcinogenesis 31, 5, 902--910. 
Lin CL, Huang HC, Lin JK. (2007). Theaflavins attenuate hepatic lipid accumulation 
through activating AMPK in human HepG2 cells. Journal of Lipid Research 48(11), 
2334-43. 
Lin YL, Lin JK. (1997). (-)-Epigallocatechin-3-gallate blocks the induction of nitric 
oxide synthase by down-regulating lipopolysaccharide-induced activity of 
transcription factor nuclear factor-kappaB. Molecular Biochemistry 52, 465-72. 
Lin YL, Tsai SH, Lin-Shiau SY, Ho CT, Lin JK (1999). Theaflaviii-3,3'-gallate from 
black tea blocks the nitric oxide synthase by down-regulating the activation NF-kB in 
macrophages. European Journal ofPharmcology 367, 379-388. 
Lin JK and Lin-Shiau SY. (2006). Mechanisms of hypolipidemic and anti-obesity 
effects of tea and tea polyphenols. Molecular Nutrition and Food Research 50(2), 
211-7. 
Luck H. (1974) In: Methods in Enzymatic Analysis 2 (Ed Bergmeyer) Academic 
Press New York p 885. 
Luck G, Liao H, Murray NJ, Grimmer HR, Williamson MP, Lilley TH and Haslam E. 
(1994). - Polyphenols astringency and praline-rich proteins. Phytochemistry. 37, 357-
371. 
Lyseng-Williamson, K.A., Fenton, C. (2005). Docetaxel: a review of its use in 
metastatic breast cancer. Drugs. 65(17), 2513-31. 
Mace ML Jr, Daskal Y, Wray W.(1978). Scanning-electron microscopy of 
chromosome aberrations. Mutation Research 52(2), 199-206. 
Maciocia G. (2005). The Foundations of Chinese Medicine. Andrea Pieroni, Lisa 
Leimar Price, Lisa Price., 2nd Edition. 
Mandel S. Weinreb 0, Reznichenko L, Kalfon L, Amit T. (2006). Green tea catechins 
as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. Journal 
of Neural Transmission Supplementa (71), 249-57. 
Manna S, Banerjee S, Mukherjee S, Das S, Panda CK. (2006). Epigallocatechin 
gallate induced apoptosis in Sarcomal 80 cells in vivo: mediated by p53 pathway and 
inhibition in U1 B, U4-U6 UsnRNAs expression. Apoptosis 11(12), 2267-76. 
Margison GP and O'Connor PJ (1979). In: Grover, PL (ed). Chemical 
Carcinogenesis and DNA. CRC. Press, Boca Roton, F.L. 111 — 159. 
Marsh DJ, Frasier C, Decter J (1965). Measurement of urea concentrations in 
nanoliter specimens of renal tubular fluid and capillary blood. Anals of Biochemistry 
11, 73-80, 1965 
120 
Marshall TC, Dorough HW, Swim HE. (1976). Screening of pesticides for mutagenic 
potential using Salmonella typhimurium mutants. Journal of Agricultural Food and 
Chemistry 24(3), 560-3. 
Marzin D. (1991). Trenbolone: application of the Ames test. Recent data. Annals 
of Veterinary Research 22, 257-62. 
Maurich T, Pistelli L and Turchi G. (2004). Anti-clastogenic activity of two 
structurally related pterocarpans purified from Bituminaria bituminosa in cultured 
human lymphocytes. Mutation Research 561, 75-81. 
McKay DL and Blumberg TB. (2002). The role of tea in human health: An update. 
Journal ofAmerican College ofNutrition 21, 1-13. 
Meintieres S, Biola A, Pallardy M and Marzin D. (2001) Apoptosis can be a 
confusing factor in in vitro clastogenic assays. Mutagenesis 16, 243-250. 
Meintieres S and Marzin D. (2004) Apoptosis may contribute to false-positive results 
in the in vitro micronucleus test performed in extreme osmolality, ionic strength and 
pH conditions. Mutation Research 560, 101-118. 
Mellarango MI and Smith AC (1984). Sister chromatid exchange in human 
lymphocytes. Revista Brasileira de Medicina. VII, 2, 229 — 331. 
Meng XF, Sang SM, Zhu NQ, Lu H, Sheng SQ, Lee MJ, Ho CT, Yang CS. (2002). 
Identification and characterization of methylated and ring-fission metabolites of tea 
catechins formed in humans, mice, and rats. Chemical Research in Toxicology 15, 
1042-1050. 
Miller JA and Miller EC (1977). Ultimate chemical carcinogens as Reactive 
MutagenicbElectrophiles. In: Origins of Human Cancer. Cold Spring Harbor, 
NewYork, 605. 
Minocha R, Dani HM, Siddiqi MA. (1986) Evaluation of carcinogenicity of infusions 
from green tea leaves by microsomal degranulation technique. Indian Journal of 
Experimental Biology 24, 224-228. 
Mishra HP, Fridovich I (1972). The role of superoxide anion in the autoxidation of 
epinephrine and a simple assay for superoxide dismutase. Journal of Biological 
Chemistry 247, 3170-3175. 
Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK (2004). EGCG down-
regulates telomerase in human breast carcinoma MCF-7 cells, leading to 
suppression of cell viability and induction of apoptosis. International Journal of 
Oncology 24, 703-10. 
Moron MS, Depierre JW, Mannervik B (1979). Levels of glutathione, glutathione 
reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et 
Biophysica Acta 582(1), 67-78. 
Morse MA and Stoner GD. (1993). Cancer chemoprevention: principles and 
prospects. Carcinogenesis, 14, 1737-1746. 
121 
Mukherjee P, Sarkar (Datta) D, Sharma A. (1997) Effects of dietary consumption of 
black tea infusion alone and in combination with known clastogens on mouse bone 
marrow chromosomes in vivo. Food and Chemical Toxicology 35, 657-661. 
Muller L, Kikuchi Y, Probst G, Schechtrnan L, Shimada H, Sofuni T and Tweats D. 
(1999) ICH harmonised guidances on genotoxicity testing of pharmaceuticals: 
evolution, reasoning and impact. Mutation Research 436, 195-225 
Mulder TP, Van Platerink CJ, Wijnand Schuyl PJ, Van Amelsvoort JM. (2001). 
Analysis of theaflavins in biological fluids using liquid chromatography electrospray 
mass spectromentry. Journal of Chromatography B. Biomedical Sciences and 
Applications 760(2), 271-279. 
Nagabhushan M, Sarode AV, Nair J, Amonkar AJ, D'Souza AV, Bhide S V. (1991) 
Mutagenicity and carcinogenicity of tea, Camellia sinensis. Indian Journal of 
Experimental Biology 29, 401-406. 
Nakagawa H, Hasumi K, Woo JY, Nagai K, Wachi M. (2000). Generation of 
hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent 
apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis., 25(9), 1567-
74. 
Nakagawa T and Yokozawa T. (2002). Direct scavenging of nitric oxide and 
superoxide by green tea. Food and Chemical Toxicology 40, 1745-1750. 
Nanjo F,Honda M, Okushio K, Matsumoto N, Ishigaki F, Ishigami T and Hara 
Y.(1993). Effects of dietary tea catechins on alpha-tocopherol levels, lipid 
peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil 
diets. Biology and Pharmaceutical Bulletin 16, 1156-1159. 
National Centre for complementary and alternative medicine, Aug 1, 2008.< 
http//nccam.nih.gov/healthlindex.htm> 
Newman DJ, Cragg GM, Snader KM. (2003). Natural Products as Sources of New 
Drugs over the Period 1981-2002. Journal ofNatural Products 66, 1022-1037 
Nicholls DG and Budd SL. (2000) Mitochondria and neuronal survival. 
Physiological Reviews 80, 315-360. 
Nisbett SB, Parker JA, Habal F. (1985). Methyl testosterone-induced night blindness. 
Canadian Journal of Ophthalmology.20, 254-6. 
Nwanjo HU, Okafor MC, Oze GO. (2005). Changes in biochemical parameters of 
kidney function in rats co-administered with chloroquine and aspirin. Journal of 
Clinical Scences, vol. 23, 10-12. 
Ohshi na H, Yoshie Y, Auriol S, Gilbert I. (1998) Antioxidant and pro-oxidant 
actions of flavonoids: Effects on DNA damage induced by nitric oxide, peroxynitrite, 
and nitroxyl anion. Free Radical Biology and Medicine 25(9), 1057-1065. 
Opare Kennedy D, Kojima A, Hasuma T, Yano Y, Otani, Matsui-Yuasa L(2001) 
Growth inhibitory effect of green tea extract and (-)-epigalIocatechin in Ehrlich 
ascites tumor cells involves a cellular thiol-dependent activation of mitogenic-
activated protein kinases. Chemico BiologicalInteractions 134(2), 113-33. 
122 
Osanai K, Landis-Piwowar KR, Dou QP, Chan TH. (2007). A para-amino substituent 
on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel 
proteasome inhibitor and cancer cell apoptosis inducer. Bioorganic and Medicinal 
Chemistry 15(15), 5076-82. 
Overly WL, Dankoff JA, Wang BK, Singh LTD. (1984). Androgens and hepatocellular 
carcinoma in an athlete. Annuals ofInternal Medicine 100, 158-159. 
Pan MH, Lin-Shiau SY, Ho CT, Lin JH and Lin JK. (2000). Suppression of 
lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate 
from black tea and other polyphenols through downregulation of IkappaB kinase 
activity in macrophages. Biochemical Pharmacology 59, 357-367. 
Pan T, Jankovic J, Le W. (2003). Potential therapeutic properties of green tea 
polyphenols in Parkinson's disease. Drugs Aging 20(10), 711-21. 
Pan MH, Lin CC, Lin JK, Chen WJ. (2007). Tea polyphenol (-)-epigallocatechin 3-
gallate suppresses heregulin-betal-induced fatty acid synthase expression in human 
breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-
activated protein kinase cascade signaling. Journal of Agricultural Food and 
Chemistry 55(13), 5030-7. 
Pannala AS, Rice-Evans CA, Halliwell B, Singh S. (1997). Inhibition of 
peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochemical and 
Biophysical Research Communications 232(1), 164-168. 
Paquay JB, Haenen GR, Stender G, Wiseman SA, Tijburg LB and Bast A.(2000). 
Protection against nitric oxide toxicity by tea. Journal of Agricultural and Food 
Chemistry 48, 5768-5772. 
Paveto C, Giiida MC, Esteva MI, Martino V, Coussio J, Flawia MM, Torres TIN. 
(2004). Anti-Trypanosorna cruzi activity of green tea (Camellia sinensis) catechins. 
Antimicrobial Agents and Chemotherapy 48(1), 69-74. 
Pegg AE. (1984). Methylation of the 06 position of guanine in DNA is the most 
likely initiating event in carcinogenesis by methylating agents. Cancer Investigation 
2(3), 223-31. 
Perry P and Evans HJ. (1975). Cytological detection of mutagen/carcinogen exposure 
by sister chromatid exchange. Nature 258, 121 — 125. 
Perry P and Wolff S. (1974). New Giemsa method for the differential staining of 
sister chromatids. Nature 251 , 156 -- 158. 
Philips DH. (2001).Understandingthe genotoxicity of Tamoxifen. Carcinogenesis 
22(6), 839- 849. 
Pianetti S,Guo S, Kavanagh KT, Sonenshein GE. (2002). Green tea polyphenol 
epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed 
phenotype of breast cancer cells. Cancer Research 62(3), 652-5. 
Pisters KM, Newman RA, Coldman B. (2001) Phase I trialof oral green tea extract in 
adult patients with solid tumors. Journal of Clinical Oncology 19, 1830-8. 
123 
Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, 
Kim JA, Quon MJ, Montagnani M. (2007). EGCG, a green tea polyphenol, improves 
endothelial function and insulin sensitivity, reduces blood pressure, and protects 
against myocardial UR injury in SHR. American Journal of Physiology 
Endocrinology and Metabolism 292(5):E1378-87. 
Quinn MJ Jr, Lavoie ET, Ottinger MA. (2007a). Reproductive toxicity of 
trenbolone acetate in embryonically exposed Japanese quail. Chemosphere 66, 
1191-6. 
Quinn MJ Jr,. McKernan M, Lavoie ET, Ottinger MA. (2007b). 
Immunotoxicity of trenbolone acetate in Japanese quail. Journal of 
Toxicology and Environmental Health. Part A. 70, 88-93. 
Ran ZH, Xu Q, Tong JL, Xiao SD. (2007). Apoptotic effect of Epigallocatechin-3-
gallate on the human gastric cancer cell line MKN45 via activation of the 
mitochondrial pathway. World Journal of Gastroenterology 13(31), 4255-9. 
Rang HP, Dale MM, Ritter JM, Moore PK. (2003) Pharmacology. 5th ed. London: 
Churchill Livingstone; p. 694-8. 
Rice-Evans CA, Miller NJ, Boswell PG, et al (1995). The relative antioxidant 
activities of plant derived polyphenolic flavonoids. Free Radical Research 22, 375-
88. 
Rice-Evans C. (1999). Implications of the mechanisms of action of tea polyphenols 
as antioxidants in vitro for chemoprevention in humans. Proceedings of the Society 
for Experimental Biology and Medicine 220(4), 262-6. 
Richold M. (1988). The genotoxicity of trenbolone, a synthetic steroid. Archives of 
Toxicology 61, 249-25S. 
Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, 
Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC. (2007). The green tea 
compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses 
migration of bladder carcinoma cells. Journal of Cellular Biochemistry 102(2):377- 
88. 
Rietveld A, Wiseman S. (2003): Antioxidant effects of tea: evidence from human 
clinical trials. American Society ofNutrition and Science 133, 3285s-3292s. 
Roberts JT, Essenhigh DM (1986). Adenocarcinoma of prostate in a 40-year-old 
body-builder. Lancet 2, 742 
Romero- Jimnez M, Sanchez JC, AnalIa M, Serrano MC, Moraga AA. (2005). 
Genotoxicity and antigenotoxicity of sme traditional medicinal herbs. Mutation 
Research 585,147-155. 
Roncada T, Vicentimi VEP, Mantovani MS. (2004). Possible modulating actions of 
plant extracts on chromosome breaking activity of MMC and Ara C in human 
lymphocyte in vitro. Toxicology in vitro 18, 617-622. 
Roopashree TS, Raman D, Das K and Bhaskaran S. (2008). Recent advances in 
herbal drugs with special reference to Cassia fora. I : Phytopharrnacology and 
124 
Therapeutic values. Vol.19 (Eds) V.K. Singh, J.N. Govil. Rajeev Kr. Sharma. LLC, 
Studium Press, USA. 
Rowinsky EK. (1997) The development and clinical utility of the taxane class of 
antimicrotubule chemotherapy agents. Annual Review of Medicines 48, 353-374. 
Sadava D, Whitlock E, Kane SE. (2007). The green tea polyphenol, epigallocatechin-
3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. 
Biochemical and Biophysical Research Communications 360(1), 233-7. 
Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. (1995). 
Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking 
antioxidants. Archives ofBiochemistry and Biophysics 322(2), 339-46. 
Sancar A, Lindsey-Boltz L, Unsal-Kacmaz K, Linn S. (2004). Molecular mechanisms 
of mammalian dna repair and the dna damage checkpoints. Annual Review of 
Biochemistry 73, 39-85. 
Sandberg AA. (1980). The Chromosomes in Human Cancer and Leukemia. Elsevier, 
New York. 
Sannella AR, Messori L, Casini A, Francesco Vincieri F, Bilia AR, Majori G, 
Severini C. (2007). Antimalarial properties of green tea. Biochemical and Biophysical 
Research Communications 353(1), 177-81. 
Savage JR (1977). Application of chromosome banding techniques to the study of 
primary chromosome structural changes. Journal of Medical Genetics 14 (5), 362-
370. 
Schiffmann D, Metzler M, Neudecker T, Henschler D. (1985). Morphological 
transformation of Syrian hamster embryo fibroblasts by the anabolic agent trenbolone. 
Archives of Toxicology 58, 59-63, 
Schneider EL, Nakanishi Y, Lewis J, Sternberg H. (1981) .Simultaneous examination 
of examination of sister chromatid exchanges and cell replication kinetics in tumor 
and animal cells in vivo. Cancer Research, 41, 4973-4975. 
Schwartz JL. (1989). Monofunctional alkylating agent-induced S-phase-dependent 
DNA damage. Mutation Research 216(2), 111-8. 
Scott D, Galloway SM, Marshall RR, Ishidate M Jr., Brusick D, Ashby J and Myhr 
BC. (1991) International Commission for Protection Against Environmental 
Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report 
from ICPEMC Task Group 9. Mutation Research 257, 147-205. 
Shankar S, Suthakar G, Srivastava RK.(2007). Epigallocatechin-3-gallate inhibits cell 
cycle and induces apoptosis in pancreatic cancer. Frontiers in Bioscience 12, 5039-51. 
Sheng R, Gu ZL, Xie ML, Zhou WX,a Guo GY. (2007). EGCG inhibits 
cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and 
protects cardiomyocytes from oxidative stress in rats. Acta Pharmacologica Sinica 
28(2), 191-201. 
Shiraki M, Hara Y, Osawa T, Kumon H, Nakayama T and Kawakishi S. (1994). 
125 
Antioxidative and antimutagenic effects of theaflavins from black tea. Mutation 
Research Letters 323 (1-2), 9-34. 
Shixian Q, VanCrey B, Shi J, Kakuda Y, Jiang Y. (2006). Green tea extract 
thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-
0-methyltransferase. Journal ofMedicinal Food 9(4), 451-8. 
Shoeb M. (2006). Anticancer agents from medicinal plants, Bangladesh Journal of 
Pharmacology 1, 35-41. 
Shukla Y, Arora A, Taneja P (2003). Antigenotoxic potential of certain dietary 
constituents. Teratgenesis Carcinogenesis and Mutagenesis 1, 323-35. 
Shukla Y. (2007).Tea and Cancer Chemoprevention: A Comprehensive Review, 
Asian Pacific Journal of Cancer Prevention 8, 155-166. 
Siddique YH and Afzal M. (2004). Antigenotoxic effects of allicin against SCEs 
induced by methyl methane sulphonate in cultured mammalian cells. Indian Journal 
ofExperimental Biology 42,437-438. 
Siddique YH and Afzal M. (2005a). Antigenotoxic effect of allicin against methyl 
methanesulphonate induced genotoxic damage. Journal of Environmental Biology 26, 
547-550. 
Siddique YH and Afzal M. (2005b). Protective role of allicin and L-ascorbic acid 
against the genotoxic damage induced by chlormadinone acetate in cultured human 
lymphocytes Indian Journal of Experimental Biology 43, 769-772. 
Siddique YH, Ara G, Beg T, Shahi MH and Afzal M. (2006). Protective role of 
Ocimum sanctum L. infusion against norethynodrel induced genotoxic damage in 
cultured human peripheral blood lymphocytes. Journal of Indian Society of 
Toxicology 2, 10-14. 
Siddique YH, Ara G, Beg T and Afzal M. (2007a). Anti-genotoxic effect of Ocimum 
sanctum L. extract against cyproterone induced genotoxic damage in cultured 
mammalian cells. Acta Biologica Hungarica 58 (4), 397-409. 
Siddique YH, Ma G, Beg T and Afzal M. (2007b). Protective role of 
nordihydroguaiaretic acid (NDGA) against the genotoxic damage induced by 
ethynodiol diacetate in human lymphocytes in vitro. Journal of Environmental 
Biology 28, 279-282. 
Siddique YH, Beg T, Afzal M.(2008a) Antigenotoxic effect of apigenin against anti-
cancerous drugs. Toxicology In Vitro 22, 625-631. 
Siddique YH, Ara G, Beg T, Faisal M, Ahmad M and Afzal M. (2008b). 
Antigenotoxic role of Centella asiatica L. extract against cyrpoterone acetate induced 
genotoxic damage in cultured human lymphocytes. Toxicology In Vitro 22, 10-17. 
Siddique YH, Ara G, Beg T and Afzal M. (2008c). Anti-genotoxic effect of 
nordihydroguaiaretic acid (NDGA) against chlormadinone acetate induced genotoxic 
damage in mice bone marrow cells. Journal ofNatural Medicines 62, 52-56. 
126 
Siddiqui IA, Saleem M, Adhami YM, Asim M, Mukhtar H. (2007). Tea beverage in 
chemoprevention and chemotherapy of prostate cancer. Acta Pharinacologica Sinica 
28(9), 1392-408. 
Siddiqui IA, Adhami VM, Saleem M, Mukhtar H. (2006). Beneficial effects of tea 
and its polyphenols against prostate cancer. Molecular Nutrition and Food Research 
50(2), 130-43. 
Siddiqui IA, Afaq F, Adhami VM, Ahmad N, Mukhtar H. (2004). Antioxidants of the 
beverage tea in promotion of human health. Antioxidants and Redox Signaling 6(3), 
571-82. 
Singer B and Kusmierck JT (1982). Chemical mutagenesis. Annual Review of 
Biochemistry 52, 655 — 693. 
Sinha AK, Linscombe VA, Gollapudi BB and Flake RE. (1984). Evaluation of 
culture media for effects on cell cycle kinetics and incidence of chromosomal 
aberrations in human blood cells. Canadian Journal of Genetics and Cytology 26, 7 --
12. 
Smith DM and Dou QP. (2000). Green tea polyphenol epigallocatechin inhibits DNA 
replication and consequently induces leukemia cell apoptosis. International Journal of 
Molecular Medicine 7(6), 645-52. 
Snyder RD. (2007) Assessment of atypical DNA intercalating agents in biological and 
in silico systems. Mutatation Research 488, 151-169. 
Soe KL, Soe M, Glutt C. (1992). Liver pathology associated with the use of anabolic 
androgenic steroids. Liver 12, 73-9. 
Song JM, Lee KH, Seong BL. (2005). Antiviral effect of catechins in green tea on 
influenza virus. Antiviral Research 68(2), 66-74. 
Stapleton PD, Shah S, Ehlert K, Hara Y, Taylor PW. (2007). The beta-lactam-
resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of 
Staphylococcus aureus. Microbiology 153(Pt 7), 2093-103. 
Stapleton PD, Gettert J, Taylor PW. (2006). Epicatechin gallate, a component of 
green tea, reduces halotolerance in Staphylococcus aureus. International Journal of 
Food Microbiology 111(3), 276-9. 
Stapleton PD, Shah 5, Anderson JC, Hara Y, Hamilton-Miller JM and P.W. Taylor, 
2004. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins 
and gallates. International Journal ofAntimicrobial Agents 23(5):462-7. 
Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, 
Fujiki H. (2001). A new function of green tea: prevention of lifestyle-related diseases. 
Annals of New York Academy of Sciences 928, 274-80. 
Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. (1999). Synergistic 
effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on 
cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Research 
59(1), 44-7. 
127 
Suganuma M, Okabe S, Sueoka N, Sueoka E, Matsuyama S, Imai K, Nakachi K, 
Fujiki H. (1999). Green tea and cancer chemoprevention. Mutation Research 428(1-
2), 339-44. 
Swierenga SHH, Heddle JA, Sigal EA. (1991). Recommended protocols on a survey 
of current practice in genotoxicity testing laboratories, IV. Chromosomal aberrations 
and sister chromatid exchanges in Chineses Hamster Ovary V79, Chinese Hamster 
Lung and human lymphocytes cultures. Mutation Research 246, 301- 322. 
Taneja P, Arora A, Shukla Y (2003). Antimutagenic effects of black tea in the 
Salmonella typhimurium reverse mutation assay. Asian Pacific Journal of Cancer 
Prevention 4, 193- 8. 
Taylor JH. (1958). Sister chromatid exchange in tritium labeled chromosomes. 
Genetics 43, 515 — 529. 
Tercero JA, Diffley JF. (2001). Regulation of DNA replication fork progression 
through damaged DNA by the Mecl/Rad53 checkpoint, Nature 412(6846), 553-7. 
Tewes FJ, Koo LC, Mesgen TJ, Rylander R. (1990) Lung cancer risk and 
mutagenicity of tea. Environmental Research 52(1), 23-33. 
Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 
(2007). Green tea polyphenols and its constituent epigallocatechin gallate inhibits 
proliferation of human breast cancer cells in vitro and in vivo. Cancer Letters 245(1-
2), 232-41. 
Tice R, Schneider EL and Rary JM. (1976). The utilization of BrdU incorporation 
into DNA for the analysis of cellular kinetics. Experimental Cell Research 102, 232 -
236. 
Tinwell H and Ashby J. (1994) Genetic toxicity and potential carcinogenicity of taxol. 
Carcinogenesis, 15, 1499-1501. 
Ullmann U, Haller J, Decourt JP, et al.(2003). A single ascending dose study of 
epigallocatechin gallate in healthy volunteers. Journal of International Medical 
Research 31, 88-101. 
Tipoe GL, Leung TM, Hung MW, Fung ML. (2007). Green tea polyphenols as an 
anti-oxidant and anti-inflammatory agent for cardiovascular protection. 
Cardiovascular and Hematological Disorders- Drug Targets 7(2), 135-44. 
Van Dorsten FA, Daykin CA, Mulder TPJ, Van Duynhoven JPM. (2006): 
Metabonomica approch to determine metabolic differences between green tea and 
black tea consumption. Journal of Agricultural and Food Chemistry 54, 6929-6938. 
120 
Von Hoff DD. (1997) The taxoids: same roots, different drugs. Seminars in 
Oncology 2, S13-3—S13-10. 
Wang ZY, Das M, Bickers DR. (1988). Interaction of epicatechins derived from green 
tea with rat hepatic cytochrome P-450. Drug Metabolism and Disposition 16, 98-103. 
128 
Wang LQ, Meselhy MR, Li Y, Nakamura N, Min BS, Qin GW, Hattori M. (2001): 
The heterocyclic ring fission and dehydroxylation of catechins and related compounds 
by Eubacterium sp strain SDG-2, a human intestinal bacterium. Chemical and 
Pharmaceutical Bulletin 49, 1640-1643. 
Werkhoven J. (1978). Tea Processing. FAO, Rome (Italy). 
Weisburger JH. (1996) Tea antioxidants and health. In: Cadenas, E. & Packer, L., 
eds., Handbook of Antioxidants, New York, Marcel Dekker, pp 469-486. 
Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney 
Jr JF, Vita JA. (2007).Acute EGCG supplementation reverses endothelial dysfunction 
in patients with coronary artery disease. Journal of American College of Nutrition 
26(2), 95-102. 
Williamson MP, McCormick TG, Nance CL, Shearer WT. (2006). Epigallocatechin 
gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential 
for HP/-1 therapy. Journal ofAllergy and clinical Immunology 118(6), 1369-74. 
Xiao H, Hao X, Simi B, Ju J, Jiang H, Reddy BS, Yang CS. (2008). Green tea 
polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent 
oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. 
Carcinogenesis 29(1), 113-9. 
Yamamoto Y and Gaynor RB. (2006). Therapeutic potential of inhibition of the NF-
kappaB pathway in the treatment of inflammation and cancer. Journal of Clinical 
Investigation 107(2), 135-42. 
Yamamoto T, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Ueta E, Osaki 
T, Athar M, Schuster G and Hsu S. (2004). Roles of catalase and hydrogen peroxide 
in green tea polyphenolinduced chemopreventive effects. The Journal of 
Pharmacology and Experimental Therapeutics 308, 317-323. 
Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, 
Lockwood P, Ueta E, Osaki T and Schuster G. (2003).Green tea polyphenol causes 
differential oxidative environments in tumor versus normal epithelial cells. The 
Journal ofPharmacology and Experimental Therapeutics 307: 230-236. 
Yamane T, Nakatani H, Kikuoka N, Matsumoto H, Iwata Y, Kitao Y, Oya K, 
Takahashi T. (1996) Inhibitory effects and toxicity of green tea polyphenols for 
gastrointestinal carcinogenesis. Cancer, 77(8 Suppl), 1662-1667 
Yang CS. (1997). Inhibition of carcinogenesis by tea. Nature 389, 34-5. 
Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz, SP.(1998). Blood and 
urine levels of tea catechins after ingestion of different amounts of green tea by 
human volunteers. Cancer Epidemiology, Biomarkers and Prevention 7(4),351-4. 
Yang G, Liao J, Kim K, Yurkow EJ and Yang CS.(1998). Inhibition of growth and 
induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 
19,4,611-616. 
Yang CS, Chung JY, Yang GY, Li C, Meng X and Lee MJ.(2000). Mechanisms of 
inhibition of carcinogenesis by tea. Biofactors 13(1-4), 73-9. 
129 
Yuan JH, Li YQ, Yang XY. (2007). Inhibition of epigallocatechin gallate on 
orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude 
mice. Pharmacology 80(4), 269-78. 
Yun JH, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. (2007). (-)-Epigallocatechin 
gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from 
RAW 264.7 cells. Journal ofPeriodontal Research 42(3):212-8. 
Zhang A, Zhu QY, Luk YS, He KY, Fung KP, Chen ZY. (1997). Inhibitory effects of 
jasmine green tea epicatechin isomers on free radical-induced lysis of red blood cells. 
Life Sciences 61, 383-394. 
Zhang X, Zhang H, Tighiouart M, et al. (2008).Synergistic inhibition of head and 
neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine 
kinase inhibitor. Int J Cancer 123, 1005-1014. 
Zhu M, Chen Y, Li RC. (2000). Oral absorption and bioavailability of tea catechins. 
Planta Med. 66(5), 444-7. 
Zuo Y, Chen H and Deng Y. (2002). Simultaneous determination of catechins, 
caffeine and gallic acids in green, Oolong, black and py-erh teas using HPLC with a 
photodiode array detector. Talanta 57, 307-316. 
Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH. 
(2007). (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing 
VEGF production and angiogenesis. World Journal of Gastroenterology 13(8), 1162-
9. 
Zykova TA, Zhang Y, Zhu F, Bode AM, Dong Z. (2005). The signal transduction 
networks required for phosphorylation of STATI at Ser727 in mouse epidermal JB6 
cells in the UVB response and inhibitory mechanisms of tea polyphenols. 
Carcinogenesis 26(2), 331-42. 
PUBLICATIONS 
ARTICLES RELATED TO THE THESIS 
Gupta J., Rizvi M.M.A., Zafaryab M., Siddique Y.H. and Afzal M. (2013). 
Antigenotoxicity and Anticarcinogenicity studies of green tea polyphenols in 
mammalian systems. Food and Chemical Biology. (Communicated) 
Gupta J., Siddique Y.H. and Afzal M. (2013). Modulation of Genotoxic Effects of 
Docetaxel and Tamoxifen by Black Tea Extract in Human Lymphocyte 
Chromosomes in vitro. Journal of Pharmacy Research. (Communicated) 
Gupta J., Siddique Y.H. and Afzal M. (2013). Protective role of green tea extract 
against genotoxic damage induced by anticancer drugs in cultured human 
lymphocytes. Food biology. (Accepted) In press. 
Gupta J., Siddique Y.H., Ara G., Beg T. and Afzal M. (2009). Protective role of 
green tea extract, against genotoxic damage induced by anticancer drug and steroid 
compound in cultured human lymphocytes. Pharmacologyonline 3, 156-174. 
Gupta J., Siddique Y.H., Ara G., Beg T. and Afzal M. (2009). Protective role of 
green tea extract against genotoxic damage induced by anabolic steroids in cultured 
human lymphocytes. Biology and Medicine. Volume 1 (2), 87- 99. 
Gupta J., Siddique Y.H., Ara G., Beg T. and Afzal M. (2009). Protective role of tea 
polyphenol, EGCG, against genotoxic damage induced by anticancer drug and steroid 
compound in cultured human lymphocytes. The Internet Journal of Nutrition and 
Wellness. Volume 7 Number 1. 
Gupta, J., Siddique, Y.H., Ara, G., Beg, T. and Afzal, M. (2008). A Review'on the 
Beneficial Effects of Tea Polyphenols on Human Health. International J4'urnal of 
Pharmacology 4(5): 34-338. 
Beg T., Siddique Y.H., Ara. G., Gupta J., and Afzal M. (2009) Protective action of 
EGCG against anticancer drugs MMS and CP. Internet Journal of Pharmacology. 
Beg T., Siddique Y.H., Ara G., Gupta J., and Afzal M. (2008). Antioxidant effect of 
ECG on Testosterone propionate induced chromosome damage. International Journal 
of Pharmacology. 4: 258 — 263. 
Beg T, Siddique YH, Ara G, Gupta J, and Afzal, M. (2008). Antigenotoxic effect of 
genistein and gingerol on genotoxicity induced by norethandrolone and oxandrolone 
in cultured human lymphocytes. International Journal of Pharmacology. 4: 177 -
183. 
Beg T, Siddique YH, Ara G, Gupta J, and Afzal, M. (2008). Antigenotoxic effect of 
EGCG against androgenic steroids Stanozolol and Trenbolone. Natural Products: An 
Indian Journal. 4:210-215. 
PUBLISHED ABSTRACTS RELATED TO THE THESIS 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2010).Black tea extract 
ameliorates Docataxel induced DNA damage in cultured human lymphocytes. 
MAASCON-1, I Annual National Symposium of the Muslim Association for the 
Advancement of Sciences on "Frontiers in Life Sciences: Basic and Applied". 
October 23- 24, 2010. Department of Zoology, Aligarh Muslim University, Aligarh. 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2010). Modulation of 
Genotoxic effects of Tamoxifen by Black tea extract in human lymphocytes 
chromosomes in vitro. National Conference on Advances in Biological Sciences. 
March 29-30, 2010 at Department of Zoology, Panjab University, Chandigarh. 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2010). Green tea extract 
reduces Docataxel-induced DNA damage in cultured human lymphocytes. XXYVth 
Annual Conference of EMS! and International Symposium on Mutagens and Genetic 
Diversity for Health and Agriculture. March 12- 14, 2010 at Panjab University, 
Chandigarh. 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2009). Protective role of 
green tea extract against genotoxic damage induced by anabolic steroids in cultured 
human lymphocytes. TOXOCON 5, 5t'' ANNUAL National Conference of Indian Society of 
Toxicology on" Intravenous Drug Abuse & AIDS; Substance abuse. Chandigarh. (Oral 
presentation). 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2009). Protective role of 
green tea extract against genotoxie damage induced by anticancer drug and steroid 
compound, separately, in cultured human lymphocytes. ISHG 2009 International 
symposium on 'Ethics?  Culture and Population Genornics' & 34"' Annual Conference of the 
Indian Society ofHuman Genetics. New Delhi. (Poster presentation: Poster No. 142). 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M.., (2009). Protective role of 
green tea extract against genotoxic damage induced by anabolic steroids in cultured 
human lymphocytes. Toxeminar-1 "Human Toxicology and Environmental Health: 
New Frontiers and Future Challenges", Department of Zoology, Aligarh Muslim 
University, Aligarh. February 22, 2009. 
Gupta J., Siddique Y.H., Beg T., Ara G. and Afzal M., (2009). The main catechin of 
green tea ,(-)- epigallocatechin-3-gallate (EGCG), reduced Docetaxel- induced DNA 
damage in cultured human lymphocytes. Toxeminar-1 "Human Toxicology and 
Environmental Health: New Frontiers and Future Challenges", Department of 
Zoology, Aligarh Muslim University, Aligarh. February 22, 2009. 
Gupta, J., Siddique 'Y.H., Beg, T., Ara, G., Afzal, M (2008). A review on tea 
polyphenols. International symposium on the Predictive, Preventive and Mechanistic 
Mutagenesis & XXXIII EMSI Annual Meeting. Aligarh Muslim University, Aligarh, 
Aligarh, Jan 1-3, p.113. 
Afzal, M., Siddique 'Y.H., Beg, T., Ara, G., Shahi, M.II., Gupta, J (2008). Steroid 
induced genotoxicity and natural products in human lymphocyte chromosomes in 
vitro. International symposium on the Predictive, Preventive and Mechanistic 
Mutagenesis & XXXIII EMSI Annual Meeting. AMU, Aligarh, Jan 1-3, p.5. 
(Abstract) 
Food Biology, Jun 2013. 	 16602- 45658.1- SM 
Protective role of green tea extract against genotoxic damage 
induced by anticancer drugs in cultured human lymphocytes. 
Jyoti Gupta, Yasir Hasan Siddiqueb, Mohammad Afzalc 
a Ph.D. Scholar, Human Genetics and Toxicology Laboratory, Department of Zoology, Aligarh Muslim University, 
Aligarh-202002-India. 
b Lecturer, Human Genetics and Toxicology Laboratory, Department of Zoology, Aligarh Muslim University, 
Aligarh-202002-India. 
r Professor, Human Genetics and Toxicology Laboratory, Department of Zoology, Aligarh Muslim University, 
Aligarh-202002-India. 
* Corresponding Author. Tel.: 0571-2700920-3442, 08411008200 
E mail address: jyotiguptaO@gmail.com 
Abstract 
Tea (Camellia sinensis) is a rich source of polyphenols called flavonoids, effective antioxidants found 
throughout the plant kingdom. A group of flavonoids in green tea are known as catechins, which are 
quickly absorbed into the body and are thought to contribute to some of the potential health benefits of 
tea. The fresh tea leaves contain four major catechins as colourless water soluble compounds. 
epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC) and epigallocatechin gallate 
(EGCG). The aim of present n work is to study antigenotoxic effect of Green tea extract (GTE), against 
genotoxic damage induced by anticancer drugs Docetaxel and Tamoxifen in cultured human 
lymphocytes, both in absence and presence of metabolic activation, using duplicate peripheral blood 
cultures. Metaphase plates so obtained were used for Sister chromatid exchange (SCEs) analysis and 
calculation of Replication index. We found that the genotoxicity induced by Tamoxifen and Docetaxel, 
separately can be countered with Green tea extract (GTE) doses. 
Keywords: Green tea extract (GTE), Tea potyphenols, Tamoxifen, Docetaxel, Antigenotoxicity, 
Genotoxicity. 
INTRODUCTION 
Tea is the second-most consumed beverage in the world (water is the first) and has been used medicinally for 
centuries in India and China. The tea shrub (genus Camellia, family Theaceae) tchromosome number (2n-30)1 is 
a perennial evergreen with its natural habitat in the tropical and sub tropical forests of the world. Cultivated 
varieties are grown widely in its home countries of South and South East Asia, as well as in parts of Africa and the 
Middle East (1). Green tea is prepared by picking, lightly steaming and allowing the leaves to dry (2). Catechins 
are highly potent flavonoids present in tea and serve perhaps as the best dietary source of natural antioxidants. 
Flavonoids are group of phenolic compounds occurring abundantly in vegetables, fruits, and green plants that had 
attracted special attention as they showed high antioxidant property (3).Several catechins are present in significant 
quantities; epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG) and epigallocatechin gallate 
(EGCG) (4) [Figure 1i]. 
Fig r 1. Mathi catechinl components of green tea polypihenols. 
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Tamoxifen (TAM) is an anti-oestrogen used to treat patients with early-stage breast cancer, as well as those with 
metastatic breast cancer. As adjuvant therapy, tamoxifen helps prevent the original breast cancer from returning 
and also helps prevent the development of new cancers in the other breast (5). It has been proposed that this 
non-steroid and its reactive intermediates increase the risk of endometrial and uterine cancer in breast cancer 
patients receiving TAM therapy (6). Human TAM metabolites has carcinogenic potential. 4- hydroxyl-N-
desmethyltamoxifen (metabolites Bx) reacts with DNA in vitro in absence of any other activating factors.During 
long term treatment with TAM, even rare DNA modifications could accumulate to levels which may affect genome 
stability (7). 
Tamoxifen* 
C32H37NO8 Molecular Weight 563.6 
(Z)-2-[4-(1,2-Diphenyibut-t -eny1)phenoxy]-N,N-
dimethylethylamine citrate 
Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of 
breast, ovarian, and non-small cell lung cancer (8). Docetaxel has an approved claim for treatment of patients who 
have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline- 
based chemotherapy and failed to stop cancer progression or relapsed. Docetaxet is marketed worldwide under 
the name Taxotere by Sanofi-Aventis. 
Docetaxel* 
C43H53N014 Molecular weight :807.879 g/mol 
(2R,3S)-N-carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5,20-epoxy-I, 2, 4, 7, 10, 13- 
hexahydroxytax-11-en-9-one 4-acetate 2-benzoate, trihydrate 
Xo 
HK 0 
a 
bH 
Figures Courtesy: National Centre for Complementary and Alternative Medicine, May 2009. 
<htip:llnccam.nih.govlhealthfindex.htm> 
MATERIALS AND METHODS 
Chemicals: Tamoxifen citrate salt (TAM) (CAS no. 54965-24-1, 99% purity, Sigma-Aldrich); Docetaxel (CAS No. 
114977-28-5, Sigma-Aldrich),Sodium phenobarbitone (Sigma-Aldrich); Colchicine (Microlab); Dimethyl suiphoxide 
(Merck); RPMI 1640 (GIBCO, invitrogen); Phytohaemagglutinin-M (GIBCO, invitrogen); Antibiotic-antimycotic 
mixture (GIBCO, Invitrogen); Fetal serum - calf (GIBCO, Invitrogen); 5-bromo-2-deoxyuridine (Sigma-Aldrich); 
Hoechst 33258 stain (Sigma-Aldrich); Giemsa stain (Merck). 
Preparation of leaf extract: Camellia slnensis L. leaves were collected from the nursery of Forest Research 
Institute (FRI), Dehradun (Uttrakhand, India) and were air dried and grounded to fine powder. Extraction was done 
by soaking samples (30g of dry weight) in 300 ml of acetone for 8-10 h at 40-60°C in Soxhlet's apparatus. After 
filtration, the excess of solvent was removed by rotatory evaporator. The extract is labeled as Green tea extract 
(GTE). The extract concentration of 1.075X 10-4, 2.127 X 10-4 and 3.15 X 10-4 glml of culture medium were 
established. 
Human lymphocyte culture: Duplicate peripheral blood cultures were conducted according to Carballo et at (9). 
Briefly, 0.5 ml of the heparinized blood samples was obtained from a healthy donor and was placed subsequently 
in a sterile flask containing 7 ml of RPMI 1640, supplemented with 1.5 ml of fetal calf serum, 1.0 ml antibiotic-
antimycotic mixture and 0.1 ml of phytohaemagglutinin. These flasks were placed in an incubator at 37°C for 24 
hours. Untreated culture, negative and positive controls were run simultaneously. Duplicate peripheral blood 
cultures were done and placed in the incubator at 37°C for 24 hr and then Green tea extract (GTE) (tested doses 
were 1.075X 10-4, 2.127 X 10-0 and 3.15 X 10-4 glml), Tamoxifen and Docataxel ( tested doses 3 and 6 pM each) 
were added, separately, (Both the chemicals were dissolved in DMSO). Then, all the tested doses of Green tea 
extract (GTE) were treated with both of the tested doses of Tamoxifen and Docetaxel, separately. For metabolic 
activation experiments, 0.5 ml of S9 mix was given with each of the tested dose for 6 h. S9 mix was prepared 
according to standard protocol of Maron and Ames (10). 
Sister chromatid exchange (SCEs) analysis: For SCE analysis, bromodeoxyuridine (BrdU, 10 pglml) was 
added at the beginning of the culture. After 24 hr of the initiation of culture, treatments were given similarly as 
described above. The cells were collected by centrifugation and washed in pre-warmed media to remove traces of 
S9 mix and drugs. One hours before harvesting i.e. after 46 h, 0.2 ml of colchicines (0.2 uglmt) was added to the 
culture flask for mitotic arrest. Cells were centrifuged at 1000 rpm for 10 min. The supematant was removed and 
Bmt of pre-warmed (37°C) 4.075 M KCI (hypotonic solution) was added. Cells were re-suspended and incubated 
at 3700 for 15 min. The supernatant was removed by centrifugation, at 1000 rpm for 10 min, and subsequently 
5mi chilled fixative (methanol: glacial acetic acid, 3:1) was added. The fixative was removed by centrifugation and 
the procedure was repeated twice The slides were processed according to Perry and Wolff (11), with some 
modification. The slides were stained in 3% Giemsa solution in phosphate buffer (pH 6.8) for 15 min. 200 second 
divisions metaphases per dose were analysed. 
Replication Index (RI): 100 metaphases per culture were examined. Each metaphase was classified as being in 
the first (Ml), second (M2), or third (M3) division (12). The replication index (RI) was calculated by formula (13) as 
follows: 
RI = [(% of cells in Mw) + 2(% of cells in M2) + 3(% of cells in M3)] 1100 
STATISTICAL ANALYSIS 
Student's two tailed "t" test was used to calculate the statistical significance in SCEs for antigenotoxicity 
experiment of Green tea extract (GTE). Kruskall Wallis test was used for the analysis of the means of frequencies 
of SCEs induced by Trenbolone and Docetaxel and cell cycle kinetics was analysed by chi-square test. Student's 
't' test were also performed. The level of significance was tested from standard statistical table of Fisher and Yates 
(14). 
RESULTS 
The results of this study are tabulated below. A dose dependent increase in frequencies of SCEs and cell cycle 
kinetics is observed for both the above mentioned drugs, both in presence as well as absence of 89 mix. The cell 
proliferation kinetics which is the average number of cells that have undergone replication showed a significant 
differences between the cultures exposed to 6 iM of Trenbolone and Docetaxel both in presence of S9 mix 
(Table I and 2). We found that the genotoxicity induced by Trenbolone and Docetaxel separately,can be 
countered with 1.075X 10-4, 2.127 X 10-4 and 3.15 X 10-4 gfm] each of Green tea extract (GTE), which contains 
major tea polyphenols. Frequencies of SCEs were reduced when cultures exposed to Trenbolone and Docetaxel 
were treated with GTE, both in the presence as well as absence of 59 mix (Table 3 and 4). 
DISCUSSIONS 
The earlier studies have shown that various plant extacts and natural plant products possess protective role 
against the genotoxic effects of certain estrogens, synthetic progestins and anticancerous drugs in cultured human 
lymphocytes (15,16,17,18,19,20,21,22,23,24,25) Siddique et a(., 2005a, 2005b, 2005c, 2006a, 2007a, 2007b, 2007c, 
2008a, 2008b; Beg et al., 2007a, 2007b) and mice bone marrow cells (17,26,27)Siddique et al., 2005c, 2006b, 
2008c). The readily quantifiable nature of sister chromatid exchanges with high sensitivity for revealing toxicant-DNA 
interaction and the demonstrated ability of genotoxic chemicals to induce significant increase in sister chromatid 
exchanges in cultured cells has resulted in this endpoint being used as indicator of DNA damage, in blood 
lymphocytes of individuals exposed to genotoxic carcinogens (28). It has been shown through several mechanisms 
that tea polyphenols present antioxidant and anticarcinogenic activities, thus affording several health benefits (29). 
The antigenotoxic potential of green tea catechins have correlated their cyotoxic effects with the Induction of 
apoptosis, activation of caspases, inhibition of protein kinase, modulation of cell cycle regulation and inhibition of cell 
proliferation (30). To better understand the mechanism of antigenotoxicity of green tea, attention needs to be 
directed to antiproliferative effects of all its individual catechin components. Various studies have reported the 
relative cytotoxicity of the tea polyphenols. 
In our studies we have shown how the genotoxic effect a genotoxic steroid Trenbolone and an anticancer drug 
Docetaxe! can be countered by Green tea extracts. Green tea extracts contain a unique set of catechins that 
possess biologic activity in antioxidant, antiangiogenesis, and antiproliferative assays that are potentially relevant to 
the prevention and treatment of various forms of cancer (31). Most chemical carcinogens are alkylating or acylating 
agents (electrophilic reagents) and produce such compounds following metabolism in the body. This means that 
they have electron deficient centre and will combine with electron rich centre within the cell. Green tea and (-)-
epigallocatechin gallate (EGCG) are now acknowledged cancer preventives in Japan and has made it possible for us 
to establish the concept of a cancer preventive beverage (32). Green tea polyphenols inhibit angiogenesis and 
metastasis, (33,34) and induce growth arrest and apoptosis through regulation of multiple signaling pathways. 
Catechins are involve in thiol-dependent activation of mitogenic- activated protein kinases (35). The suggested 
mechanism of action includes the following (36): 
— 	Antioxidant activity and scavenging free radicals. 
— 	Modulating enzymes implicated in the carcinogenic process. 
— 	Modifying the pathways of signal transduction, thereby positively altering the expression of genes 
involved in cell proliferation, angiogenesis, and apoptosis, all important stages of cancer progression.  
— Antimicrobial actions (association between Helrcobacterpylori and gastric cancer). 
It has been shown that, through several mechanisms, tea polyphenols present antioxidant activities, thus affording 
several health benefits (3,37,38,39,40,). 
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Table 1. Sister chromatid exchanges (SCEs) and Replication Index (RI) in cultured 
human lymphocytes treated with Tamoxifen and Docetaxel, each, in absence of 59 mix. 
Treatment Cells Scored SCEs/cell Percentage of cells at Ill 
(KM) (mean ± S.E.) M 1 M2 M3 
Docetaxel 
3 100 3.42±0.32 36 57 7 1.71- 
6 100 5.33±129 39 55 6 1.67 
Tamoxifen 
3 100 4.06 ± 0.31 36 57 7 1.71 
6 100 5.63±0.42 38 55 5 1.53 
Untreated 100 2.03 ± 0.12 25 63 12 1.87 
Negative control 100 2.51±0,15 24 62 14 1.90 
(DMSO, 5 µI/ml) 
Positive control 100 37.56 ± 1.81** 56## 42# 4 1.52 
Cyclophosphamide 
(16 Fillnil ) 
Table 2. Sister chromatid exchanges (SCEs) and Replication Index (RI) in cultured 
human lymphocytes treated with Tamoxifen and Docetaxel, each, in presence of 59 mix. 
Treatment 	Cells Scored 	SCEs/cell 	 Percentage of cells at 	 RI 
(pM) (meant S.E.) 	M1 	M2 	M3 
Docetaxel 
3 100 3.74±0,36 39 54 7 I.68 
6 100 9.56±0.49 43# 52# 5 1.62 
Tamoxifen 
3 100 4.43 ± 0.43 38 56 6 1.68 
6 100 7.07±0.67 41# 52# 3 1.54 
Untreated 100 2.03 ± 0.12 25 63 12 1.87 
Negative control [00 2.51 ± 0.15 24 62 14 1.90 
(DMSO, 5 p1/m1) 
Positive control 100 39.56 ± 1.88** 57## 43# - 1.43 
Cyclophosphamide 
(16p11m1) 
Significant at *P<0.03 Vs Normal -Wallis test ; Significant at # P<0.005 Vs Normal Chi-square test 
DMSO: Dimethylsulphoxide, SE: Standard Error.M1:Metaphase first; M2:Metaphase second; 
M3:Metaphase third 
Table 3. Effect of Green Tea extract (GTE) on Sister chromatid exchanges (SCEs) and 
Replication Index (Ri) in cultured human lymphocytes induced by Tamoxifen and 
Docetaxel, each, in absence of S9 mix. 
SCEs/cell 
(mean ± SE) 
2,78 ± 0.31 
2.88 ± 0.32 
3.04 ± 0.35 
4.22+ 0.31a 
5.84 ± 0.46 a 
3.42±0.32a 
5.34 ± 0.46 a 
200 4.06 ± 0.42 a 1.73 
200 3.12 ± 0.33 a 1.74 
200 2.84 ± 0.31 ab 1.76 
200 4.52 ± 0.48 a 1.70 
200 4.44± 0.46 a 1.72 
200 4.14± 0.42 ab 1.74 
200 3.12± 0.33 a 1.70 
200 2.84± 0.31 ac 1.73 
200 2.75± 0.30e 1.75 
200 4.44± 0.43 a 1.68 
200 4.06+ 0.42 a ° 1.70 
200 3.10 ± 0.31 a ° 1.73 
200 2.04± 0.12 1.91 
Treatment 
(uM) 
GTE (glml) 
1.075X10' 
2.127X10A 
3.15X10-`  
Tamoxifen 
3 (Ti) 
6(T2) 
Docetaxel 
3(D1) 
6 (D2) 
TI (µM)+ GTE (giml) 
3 + 1.075XI04 
3 + 2.127X10 
3+3.15X10 -4 
T2 (µ1v1) + GTE (glmI) 
6+ 1.075X10 
6 + 2.127X10-4 
6 + 3.15X10' 
DI (µM)+ GTE (gfml) 
3+1.075X104 
3+2.127X104 
3+3.15X1O' 
D2 (plvl)+ GTE (gltnl) 
6+1.075X 10'~ 
6+2.127X10-4 
6+3.15X10-`  
Untreated 
Cells Scored 
200 
200 
200 
200 
200 
200 
200 
RI 
1.82 
1.80 
1.78 
1.72 
1.69 
1.69 
1.67 
Negative control 	 200 	 2.58 ± 0.30 	 1.88 
(DMSO, 5 pl/ml) 
Positive control 	 200 	 16.62 ± 0.68 	 1.65 
Cyclopbosphamide (16 
ullml ' 
Significant at *P<0.03 Vs Normal Kruskall-Wallis test. Significant difference: aP<0.01 with respect to untreated; 
"P<0.05 with respect to Tamoxifen. `P<0.05 with respect to Docetaxel. GTE: Green tea extract; Ti: 3 µM 
Tamoxifen ; T2: 6 uM Tamoxifen. 
Dl: 3 µM Docetaxel; D2: 6 I.M Docetaxel. DMSO:Dimethy]sulphoxide; SE: Standard Error. 
Table 4. Effect of Green Tea extract (GTE) on Sister chromatid exchanges (SCEs) and 
Replication Index (RI) in cultured human lymphocytes tinduced by Tamoxoifen and 
Docetaxel, each, in presence of S9 mix. 
Treatment 	 Cells Scored 	 SCEs/cell 	 RI 
(MM) (mean ± SE) 
GTE (girth) 
1.075X10'4 200 3.13 	0.30 1.80 
2.127X10-4 200 3.42± 0.32 1.79 
3.15X104 200 3.74 ± 0.36 1.76 
Tamoxifen 
3 (TI) 200 5, 63 ± 0.42 a 1.71 
6(T2) 200 8.21 ± 0.828 1.67 
Docetaxel 
3 (Di) 200 6. 86 ± 0.43 & 1.68 
6 (D2) 200 9.56 ± 0.49 ' 1.62 
Ti (j. M)+ GTE (ghnl) 
3+1.075X104  200 4.47 ± 0.45 ab 1.71 
3 + 2.127X10 200 4.43 ± 0.43 "' 1.73 
3 + 3,15X104  200 4. 27 ± 0.35 ab 1.75 
T2 (l.iM)+ GTE (g/ml) 
6 + I.075X10' 200 7. 32 t 0.64 a  1.68 
6+2.i27XI04  200 6.52± 0.61 ab  1.70 
6+3.15X104  200 6.02±0.54 ab 1.71 
Dl (pM) + GTE (g/ml) 
3+ 1.075X 10'4 200 4.113: 0.40 g ` 1.70 
3+2.127X104  200 2.98± 0.33 1.72 
3 + 3.15X10F' 200 2.27± 0.26 a`  1.74 
D2 (µM) + GTE (g/mt) 
6 + 1.075X10 200 7. 11 ± 0.63 a ` 1.63 
6 + 2.127X10-4 200 6. 34 ± 0.59 a`  1.64 
6+3.15X104  200 4.44± 0.46 a ` 1.66 
Untreated 200 2. 45 f 0.14 1.89 
Negative control 
(DMS0, 5 j./ml) 200 3. 01 ± 	0.17 1.87 
Positive control 200 22. 21 ± 	0.95** 1.45 
Cyclophosphamide (16 
ui/ml) 
Significant at **Pc 4.01 Vs Normal Kruskali-Wallis test. Significant difference: 8P<0.01 with respect to 
untreated; LP<0.05 with respect to Trenbolone. `P<0.05 with respect to Docetaxel. GTE: Green tea extract; Ti: 3 
µM Tamoxifen ; T2: 6 µM Tamoxifen DI: 3 pM Docetaxci; D2: 6 pM Docetaxel. DMSO:Dimethylsulphoxide; 
SE: Standard Error. 
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PROTECTIVE ROLE OF GREEN TEA EXTRACT AGAINST GENOTOXIC 
DAMAGE INDUCED BY ANTICANCER DRUG AND STEROID COMPOUND, 
SEPARATELY, IN CULTURED HUMAN LYMPHOCYTES. 
Gupta J., Siddique Y.H., Beg T., Ara G. and dal M.* 
Human Genetics and Toxicology Laboratory, Department of Zoology, 
Aligarh Muslim University, 
Aligarh (U.P.)- 202002, India. 
Summary 
Tea (Camellia sinensis) is a rich source of polyphenols called flavonoids, effective 
antioxidants found throughout the plant kingdom. A group of flavonoids in green tea are 
known as catechins. The fresh tea leaves contain four major catechins as colourless water 
soluble compounds. epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC) 
and epigallocatechin gallate (EGCG). The aim of present work is to study antigenotoxic 
effect of Green tea extract (GTE), against genotoxic damage induced by a steroid 
Trenbolone and an anticancer drug Docetaxel in cultured human lymphocytes, both in 
absence and presence of metabolic activation, using duplicate peripheral blood cultures. 
Metaphase plates so obtained were used for Chromosomal aberration (CAs) analysis, 
Sister chromatid exchange (SCEs) analysis and calculation of Replication index. 40 and 
60 µM of Trenbolone, 3 pM and 6 µM Docetaxel ( with and without metabolic 
activation) was used. 1.075X 10-4, 2.127 X 10-4 and 3.15 X 10-4 g/ml Green tea extract 
(GTE), was used to study its antigenotoxic role against above mentioned drugs. A dose 
dependent increase in frequencies of SCEs, abnormal metaphase were observed for by 
Trenbolone and Docetaxel treatment, both in presence as well as absence of 59 mix, 
which was mitigated to a great extent by treatment with Green tea extract (GTE). It is 
concluded that the genotoxicity induced by Trenbolone and Docetaxel, can be countered 
with Green tea extract (GTE) doses. 
Keywords: Green tea extract (GTE), Tea polyphenols, Trenbolone, Docetaxel, 
Antigenotoxicity, Genotoxicity. 
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Introduction 
Tea is the second-most consumed beverage in the world (water is the first) and has been 
used medicinally for centuries in India and China. The tea shrub (genus Camellia, family 
Theaceae) [chromosome number (2n,30)] is a perennial evergreen with its natural habitat 
in the tropical and sub tropical forests of the world. Cultivated varieties are grown widely 
in its home countries of South and South East Asia, as well as in parts of Africa and the 
Middle East (1). Green tea is prepared by picking, lightly steaming and allowing the 
leaves to dry .A group of flavonoids in green tea are known as catechins, which are 
quickly absorbed into the body and are thought to contribute to some of the potential 
health benefits of tea. Flavonoids are group of phenolic compounds occurring abundantly 
in vegetables, fruits, and green plants that had attracted special attention as they showed 
high antioxidant property (2). The fresh tea leaves contain four major catechins as 
compounds: epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC) and 
epigallocatechin gallate (EGCG) (3) [Figure 1]. EGCG makes up about 10-50% of the 
total catechin content and appears to be the most powerful of the catechins.(2). In India, 
the majority of populations use traditional natural prepartion derived from the plant 
material for the treatment of various diseases (4) and for that reason it has become 
necessary to assess their antimutagenic potential or mutagenic potential for modulating 
the action of plant extract when associated with other substances. 
Figure 1. Main catediin components of green tea polyphenols. 
H 	 9H 
are 
	
'ffpH 	 rTOH 
OH 	 OH 
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Trenbolone is a synthetic steroid used frequently by veterinarians on livestock as a 
promoter of growth in animal husbandry (5). Trenbolone is not used in an unrefined 
form, but is rather administered as Trenbolone acetate. Trenbolone compounds have not 
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yet been approved by the Food and Drug Administration, USA for use by humans due to 
their considerable negative side effects, although bodybuilders use the drug illegally to 
increase body mass and strength (6). Trenbolone compounds increase nitrogen uptake by 
muscles after metabolization, leading to increased rate of protein synthesis. Trenbolone is 
a very potent androgen with strong anabolic activity. Trenbolone compounds have a 
binding affinity for the androgen receptor three times as high as that of testosterone (7). 
Trenbolone 
C18H2202 Molecular weight: 270.366 
17J3 Hydroxyestra-4,9,11-trien-3-one 
Docetaxel is a clinically well established anti-mitotic chemotherapy medication used 
mainly for the treatment of breast, ovarian, and non-small cell lung cancer (8). Docetaxel 
has an approved claim for treatment of patients who have locally advanced, or metastatic 
breast or non small-cell lung cancer who have undergone anthracycline-based 
chemotherapy and failed to stop cancer progression or relapsed. Docetaxel is marketed 
worldwide under the name Taxotere by Sanofi-Aventis. Docetaxel is a chemotherapeutic 
agent and is a cytotoxic compound and so is effectively a biologically damaging drug (9, 
6). 
Docetaxel 
C4ZH53NO14 Molecular weight :807.879 91mol 
(2R,3S)-N-carboxy-3-phenylisoserine. N-tert-butyl ester, 13-ester with 5, 20-epoxy-1, 2, 4, 7, 10, 13- 
hexahydroxytax-11-en-9-one 4-acetate 2-benzoate, trihydrate 
3'f 	 Ho o H r  
a r-H 0 w 	— 
 
-k....- , 
wr ~ 	QH 
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Materials and Methods 
Chemicals: Docataxel (CAS No. 114977-28-5, Sigma-Aldrich); Trenbolone (CAS No.: 
10161-33-8, Sigma-Aldrich); Sodium phenobarbitone (Sigma-Aldrich); Colchicine 
(Microlab); Dimethyl sulphoxide (Merck); RPM[ 1640 (GIBCO, Invitrogen); 
Phytohaemagglutinin-M (GIBCO, Invitrogen); Antibiotic-antimycotic mixture (GIBCO, 
Invitrogen); Fetal serum - calf (GIBCO, Invitrogen); 5-bromo-2-deoxyuridine (Sigma-
Aldrich); Hoechst 33258 stain (Sigma-Aldrich); Giemsa stain (Merck). 
Preparation of leaf extract: Ca»tellia sinensis L. leaves were collected from the nursery 
of Forest Research Institute (FRI), Dehradun (U.A.) and were air dried and grounded to 
fine powder. Extraction was done by soaking samples (30g of dry weight) in 300 ml of 
acetone for 8-10 h at 40-60°C in Soxhlet's apparatus. After filtration, the excess of solvent 
was removed by rotatory evaporator. The extract is labeled as Green tea extract (GTE). The 
extract concentration of 1.075X 10-4, 2.127 X 10 and 3.15 X 10-0 g/ml of culture medium 
were established. 
Human lymphocyte culture: Duplicate peripheral blood cultures were conducted (10). 
Briefly, 0.5 ml of the heparinized blood samples were obtained from two healthy donors 
and were placed subsequently in a sterile flask containing 7 ml of RPMI 1640, 
supplemented with 1.5 ml of fetal calf serum, 1.0 ml antibiotic-antimycotic mixture and 0.1 
ml of phytohaemagglutinin. These flasks were placed in an incubator at 37°C for 24 hours. 
Preparation of S9 mix: Liver 39 fraction was prepared from Swiss albino healthy rats 
(Wistar Strain), each weighing about 200g. The rats were given 0.1% Phenobarbitone (1 
mg/ml) in drinking water for 1 week for the induction of liver enzymatic activities. The S9 
mix was freshly prepared as per standard procedures of Maron and Ames (11). The animals 
were sacrificed and the livers were collected immediately. The liver slices were then 
carefully homogenized at 4°C in 0.15 M KCl and centrifuged at 9000 rpm at 4°C for 10 
min. 	 - 
Chromosomal aberration analysis: Untreated culture, negative and positive controls 
were run simultaneously. Duplicate peripheral blood cultures were done, from blood 
collected from two different donors. The cultures were placed in the incubator at 37°C for 
24 hr and then Trenbolone (tested doses were 40 and 60 µM) and Docetaxel (tested doses 
were 3 and 6 µM) were added, separately, (Both the chemicals were dissolved in DMSO). 
Then, all the tested doses of Green tea extract (GTE) (tested doses were 1.075X 10-4, 2.127 
X 10-4 and 3.15 X 10-4 g/mI), were treated with both of the tested doses of Trenbolone and 
Docetaxel, separately. For metabolic. activation experiments, 0.5 ml of S9 mix was given 
with each of the tested dose for 6 h. 39 mix was prepared according to standard protocol of 
Maron and Ames (11). The cells were collected by centrifugation and washed in 
prewarmed media to remove traces of 39 mix and drugs. The culture bottles were kept for 
another 48 h in an incubator at 37° C. At 47th hr, 0.2 ml of colchicine (0.2 µg/ ml) was 
added to the culture bottle. Cells were centrifuged at 1000 rpm for 10 min. The supernatant 
was removed and 8ml of prewarmed (37°C) 0.075 M KC1 (hypotonic solution) was added. 
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Cells were resuspended and incubated at 37°C for 15 min. The supernatant was removed 
by centrifugation, at 1000 rpm for 10 min, and subsequently 5m1 chilled fixative (methanol: 
glacial acetic acid, 3:1) was added. The fixative was removed by centrifugation and the 
procedure was repeated twice. The slides were stained in 3% Giemsa solution in phosphate 
buffer (,pH 6.8) for 15 min. About 75 cells from each duplicate culture were observed and a 
total of 300 metaphases were examined for the occurrence of different types of 
abnormalities. Criteria to classify different types of aberrations were in accordance with 
the recommendations of Environmental Health 48 for Environmental Monitoring of Human 
Population (12) IPCS, 1985) 
Sister chromatid exchange (SCEs) analysis: For SCE analysis, bromodeoxyuridine 
(BrdU, 10 gg/ml) was added at the beginning of the culture. After 24 hr of the initiation of 
culture, treatments were given similarly as described above. The cells were collected by 
centrifugation and washed in prewarmed media to remove traces of S9 mix and drugs. One 
hours before harvesting i.e. after 46 h, 0.2 ml of colchicines (0.2 µg/ml) was added to the 
culture flask for mitotic arrest. Cells were centrifuged at 1000 rpm for 10 min. The 
supernatant was removed and 8m1 of prewarmed (37°C) 0.075 M KC1 (hypotonic solution) 
was added. Cells were resuspended and incubated at 37°C for 15 min. The supernatant 
was removed by centrifugation, at 1000 rpm for 10 min, and subsequently 5m1 chilled 
fixative (methanol: glacial acetic acid, 3:1) was added. The fixative was removed by 
centrifugation and the procedure was repeated twice The slides were processed according 
to Perry and Wolff (13), with some modification. The slides were stained in 3% Giemsa 
solution in phosphate buffer (pH 6.8) for 15 min. 200 second divisions metaphases per dose 
were analysed. 
Replication Index (RI): 100 metaphases per culture were examined. Each metaphase was 
classified as being in the first (Ml), second (M2), or third (M3) division (14). The 
replication index (RI) was calculated by formula (15)Ivett and Tice,1982) as follows: 
RI = [(% of cells in M1) + 2(% of cells in M2) + 3(% of cells in M3)] / 100 
Statistical analysis: Student's two tailed "t" test was used to calculate the statistical 
significance in CAs and SCEs for antigenotoxicity experiment of Green tea extract (GTE). 
Kruskall Wallis test was used for the analysis of the means of frequencies of SCEs induced 
by Trenbolone and Docetaxel and cell cycle kinetics was analysed by chi-square test. 
Student's `t' test were also performed. The level of significance was tested from standard 
statistical table of Fisher and Yates (16). Standard error (SE) for Chromosomal Aberrations 
is calculated using software STATISTICA. 
Results 
Genotoxic effect of a genotoxic steroid Trenbolone and an anticancer drug Docetaxel was 
studied using Chromosomal aberration analysis, sister chromatid exchanges (SCE's) and 
Replication Index as genotoxic end points. A dose dependent increase in frequencies of 
CAs, SCEs and cell cycle kinetics is observed for both Trenbolone and Docetaxel, both in 
presence as well as absence of S9 mix (Table 1- 4; Fig 2- 7). A significant increase in the 
value of SCEs/cell was observed at 6 µM (P<0.05) of Docetaxel, in presence of 
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metabolic activation. The cell proliferation kinetics which is the average number of cells 
that have undergone replication showed a significant decrease between the cultures 
exposed to Docetaxel and Trenbolone and the normal control. There has been an 
increment in M1 ceIls and decrease of M2 and M3 cells as the doses of Trenbolone and 
Docetaxel increase. 
We found that the genotoxicity induced by Trenbolone and Docetaxel, separately can be 
countered with Green tea extract (GTE) (tested doses were 1.075X 10', 2.127 X 10 4 and 
3.15 X 10-4 g/ml). Frequencies of CAs and SCEs were reduced when cultures expose to 
40 and 60 J.LM of Trenbolone and 3 and 6 iM of Docetaxel were treated with Green tea 
extract (GTE (tested doses)) both in presence as well as absence of S9 mix.(Table 1-4; 
Fig 2-4) Similar results were obtained for cell cycle kinetics when after treatment with 
GTE, cultures exposed to Trenbolone and Docetaxtil, showed an increase in number of 
M2 and M3 cells, both in presence as well as absence of 89 mix. (Table 3, 4; Fig 6, 7). 
161 
Pliarhnaeo1ogyonIine 3: 156-174 (2009) 	 Gupta et aL 
Table 1 Effect of Green Tea extract (GTE) on chromosomal aberrations (CAs) in human 
lymphocytes induced by Trenbolone and Docetaxel, each, in absence of S9 mix. 
Treatment Total Cells Scored Abnormal cells Chromosomal Aberrations 
(jiM) (75 cells each from (Mean ± SE) Gaps CTB CSB CTE DIC 
duplicate cultures of 
two donors) 
Treatment (pM) 
GTE (glml) 
1.075X104  300 2 ± 0.40 2 1 1 - - 
2.127X10-4 300 3±057  2 2 1 - - 
3.15X10-4 300 3 ± 0,57 2 2 1 - - 
Trenbolone 
40(T1) 300 18±0.91a  7 9 2 1 - 
60 (12) 300 21 ± 0.40' 7 6 2 1 1 
Docetaxel 
3 (D1) 300 19 ± 1.08 a  6 5 3 1 - 
6 (D2) 300 22 ± 0.91 a  7 8 4 2 1 
Ti (p.M)+ GTE (glml) 
40+1.075X104 300 15± 0.91' 7 7 2 1 1 
40+2.127X10-4 300 12± 0•91b 6 6 2 1 - 
40+3.15X104 300 9±0.70ab 5 4 1 1 - 
T2 (uM)+ GTE (g/ml) 
60+1.075X104 300 16±0.57u1 7 5 2 1 1 
60+2.127X10 300 13 ±0.64 ab 6 4 1 1 - 
60+3.15X10-' 300 10±0.91 ab 4 3 1 1 - 
Dl (WM)+ GTE (glml) 
3+1.075X10-0 300 15 ± 0.40 a  6 4 3 I - 
3+2.127X10-0 300 12 ± 0.57 8 c 6 4 2 I - 
3+3.15X10-0 300 8± 0.91 a` 4 3 1 1 - 
D2 (pM)+ GTE (glml) 
6+1.075X10-0 300 20 ± 0.81 a 7 6 4 2 1 
6+2.127XI04 300 17 ± 0.40 a 5 3 2 1 - 
6+3.15X10-4 300 13±0.64 a` 3 2 2 - - 
Untreated 300 2±0.40  1 1 - - - 
Negative control 300 3 * 0.40 2 2 - - - 
(DMSO, 5 gllml) 
Significant difference: 
'p<001 with respect to untreated; by<0.05 with respect to Trenbolone; P<0.05 with respect to Docetaxel 
DMSO:Dimethyisulphoxide; CTB; Chromatid break; CSB: Chromosome break; CTE: Chromatid exchange; DIC: 
Dicentric: SE: Standard Error. 
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Table 2 Effect of Green Tea extract (GTE) on chromosomal aberrations (CAs) in human 
lymphocytes induced by Trenbolone and Docetaxel, each, in presence of S9 mix. 
Treatment 	 Total Cells Scored 	Abnormal cells 	 Chromosomal Aberrations 
(UM) 	 (75 cells each from 	 (Vu ± SE) Gaps 	CTB 	CSB 	CTE 	DIC 
duplicate cultures of two 
donors) 
Treatment (l.M) 
GTE (glml) 
1.075X10 300 3 t 0.57 2 1 1 - - 
2.127X10-4 300 4± 0.40 a 2 2 1 - - 
3.15X10-4 300 4± 0.64 a 2 2 1 - - 
Trenbolone 
40 (Tl) 300 22±0.91 a 7 6 2 1 - 
60 (T2) 300 25±0.57 a  7 9 2 1 1 
Docetaxel 
3 (D1) 300  21 ± 0.40 ° 6 5 3 1 - 
6 (D2) 300  24±0.81 a 7 8 4 2 1 
TI (iM)+ GTE (g/ml) 
40+1.075X14-0 300 21 ± 0.40 a 7 7 2 1 I 
40+2.127X10-4 300 17±0.57 ae 6 6 2 1 - 
40+3.15X10-4 300 11 ±1.08 ab 5 4 1 1 - 
T2 (µM)+ GTE (g/ml) 
60+1075X10-0 300 25±0.57 8 7 5 2 1 1 
60+2.127X10-4 300 20 ± 0.40 ab 6 4 I 1 - 
60+3.15X10-4 300 14±o.57 a 6 4 3 1 1 - 
D1 (µM)+ GTE (glml) 
3+1.075X10-4 300 18± 0.91 a  6 4 3 1 - 
3+2.127X10-0 300 14 ± 0.40 a c-  6 4 2 I - 
3+3.15X10-0 300 9± 0.70 1` 4 3 1 1 - 
D2 (j►M)+ GTE (glml) 
6+1.075X10' 300 20t 0.81) a  7 6 4 2 1 
6+2.127X10.4 300 15± 0.91 a v 5 3 2 1 - 
6+3.15X10'4 300 12±o.&) a ° 3 2 2 - - 
Untreated 300 2± 0.40 1 1 - - - 
ative control 300 3 * 0.57 2 2 - - - 
ISO, 5 µlfmi) 
significant difference: 
P<0.01 with respect to untreated; bP<0.05 with respect to Trenbolone; °P<0.05 with respect to Docetaxel 
)MSC:Dimethylsulphoxide; CTB; Chromatid break; CSB: Chromosome break; CTE: Chromatid exchange; DIC: 
)icentric: SE. Standard Error. 
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Table 3 Effect of Green Tea extract (GTE) on Sister chromatid exchanges (SCEs) and Replication Index 
(RI) in human lymphocytes induced by Trenbolone and Docetaxel, each, in absence of 59 mix. 
Treatment 	 Cells Scored 	 SCEslcetl 	 RI 
(µM) (mean ± SE) 
GTE (g/ml) 
	
1.075X10-0 	 200 	 2.78 ± 0.31 	 1.82 
2.127X10-0 200 2.88 ± 0.32 1.80 
3.15X10 	 200 	 3.04 ± 0.35 	 1.78 
Trenbolone 
40 (T1) 200 4.22+0.31a 1.72 
60 (T2) 200 5.84±0,468 1.69 
Docetaxel 
3 (D1) 200 3.42 ± 0.32 a 1.69 
6 (D2) 200 5.34 * 0.46 a 1.67 
T 1 (izM)+ GTE (g/ml) 
40 + 1.075X10' 200 4.06 ± 0.428 1.73 
40+2.127X10 200 3.12 ± 0,333 1.74 
40 + 3.15X104  200 2.84 ± 0.31 a b 1.76 
T2 (gM) + GTE (glml) 
60 + 1.075X10-0 200 4.52 ± 0.48 8 1.70 
60 + 2.127X104  200 4.44 ± 0.46 " 1.72 
60+3.15X104  200 4.14± 0.42 ab  1.74 
Dl (PM)+ GTE (g/ml) 
3+1.075X104  200 3.12± 0.33 a 1.70 
3+2.127X10' 200 2.84± 0.31 8C 1.73 
3+3.15X10-4 200 2.75± 0.30` 1.75 
D2 (µM)+ GTE (glmI) 
6+1.075X104  200 4.44 ± 0.43 3 1.68 
6+2.127X10" 200 4.06+ 0.42 a ° 1.70 
6+3.15X104  200 3.10±0.31 a `  1.73 
Untreated 200 2.04± 0.12 1.91 
Negative control 200 2.58 ± 0.30 1.88 
(DMSO, 5 jVmI) 
Positive control 200 16.62 ± 0.68* 1.65 
MMS (6 uM) 
Significant at *P<0.03 Vs Normal KruskaLl-Wallis test. Significant difference: 3P<0.01 with respect to untreated; "P<0.05 with 
respect to Trenbolone. <0.05 with respect to Docetaxel. GTE: Green tea extract; Ti: 40 NM Trenbolone; T2: 60 pM Trenbolone. 
Dl: 3 pM Docetaxel; 02: 6 pM Docetaxel. DMSO:Dimethylsulphoxide; MMS: Methylmethane sulphonate SE: Standard Error. 
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Table 4. Effect of Green Tea extract (GTE) on Sister chromatid exchanges (SCEs) and 
Replication Index (RI) in human lymphocytes tinduced by Trenbolone and Docetaxel, each, 
in presence of S9 mix. 
Treatment 	 Cells Scored 	 SCEs/cell 	 RI 
(FM) (mean±SE) 
GTE (glml) 
1.075X10A 	 200 	 3. 13 ± 0.30 	 1.80 
2.127X10 200 3.42± 0.32 1.79 
3,15X104 	 200 	 3.74 0.36 	 1.76 
Trenbolone 
40 (Tl) 	 200 	 5.63± 0.42 a 	 1.71 
60 (T2) 200 8. 21 ± 0.82 a 1.67 
Docetaxel 
3 (Dl) 200 6. 86 ± 0.43 8 1.68 
6 (D2) 200 9.56 ± 0.49 a 1.62 
Ti (µM)+ GTE (glml) 
40 *1075X10 200 4.47± 0.45 's 1.71 
40 + 2.127X104  200 4.43 ± 0.43 ab 1.73 
40+3.15X104  200 4.27± 0.35 ab 1.75 
T2 (pM)+ GTE (gJml) 
60 + 1.075XI0' 200 7.32 ± 0.64 a  1.68 
60+2.127X104  200 6.52± 0.61 ab 1.70 
60+3.15X10 200 6.02± 0.54 ab 1.71 
D1 (}1M) + GTE (glml) 
3 + 1.075X104  200 4.11 ± 0.40 CC 1.70 
3 + 2.127X104  200 2. 98 ± 0.33 a c 1.72 
3+3.15X10-4 200 2.27± 0.26 a0 1.74 
D2 (µM) + GTE (pf ml) 
6+ 1.075X104  200 7. ii ± 0.63 a ° 1.63 
6+2.127X10' 200 6.341 0.59 ac 1.64 
6 t 3.15X10-4 200 4.44 ± 0.46 a ° 1.66 
Untreated 200 2.45 t 0.14 1.89 
Negative control 
(DMSO, 5 µ11m1) 200 3. 01 t 	0.17 1.87 
Positive control 200 22.21 f 	0.95** 1.45 
MMS (6 uM) 
Significant at **P< 0.01 Vs Normal Kruskall-Wallis test. Significant difference: 'P<0.01 with respect to untreated; eP<0.05 
with respect to Trenbolone. `IP<0.05 with respect to Docetaxel. GTE: Green tea extract; Ti: 40 µM Trenbolone; T2: 60 .M 
Trenbolone. DI: 3 µM Docetaxel; D2: 6 4M Docetaxel. DMSO:Diinethy]sulphoxide; MMS: Methylmethane sulphonate SE: 
Standard Error. 
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Fig. 2 Effect of Green tea extract on abnormal metaphases induced by Trenbolone 
and Docetaxel in absence of S9 mix 
Ti = Trenbolone 40 ji.M; T2 = Trenbolone 60 µM; DI= Docetaxel 3 µM; D2= DocetaxeI 6 µM; GTE1= 
Green tea extract 1.075X I0-4 g/m1; GTE2 = Green tea extract 2.127 X 10' g/m1; GTE3 = Green tea extract 
3.15 X 1 glml; U = Untreated; NC = Negative Control (DMSO 5111)m1) 
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Fig. 3 Effect of Green tea extract on abnormal metaphases induced by Trenbolone 
and Docetaxel in presence of S9 mix 
T1 = Trenbolone 40 µM; T2 = Trenbolone 60 jM; D1Y Docetaxci 3 j.M; D2= Docetaxel 6 tM; GTE1= 
Green tea extract 1.075X 10'4 glml; GTE2 = Green tea extract 2.127 X 10-4 g/ml; GTE3 = Green tea extract 
3.15 X I0-4 g/ml; U = Untreated; NC = Negative Control (DMSO 5 illml ) 
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Fig. 4 Effect of Green tea extract on Sister chromatid exchanges induced by Trenbolone and 
Docetaxel in absence of S9 mix 
TI = Trenbolone 40 tiM; T2 = Trenbolone 60 tM; D1= Docetaxel 3 riM; D2= Docetaxel 6 JIM; GTE1 
Green tea extract 1.075X 104 g/ml; GTE2 = Green tea extract 2.127 X 10-4 g/rnl; GTE3 = Green tea extract 
3.15 X 104 g/ml; U = Untreated; NC = Negative Control (DMSO 5 j.tI/ml) 
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Fig. 5 Effect of Green tea extract on Sister chromatid exchanges induced by Trenbolone and 
Docetaxel in presence of 59 mix 
Ti = Trenbolone 40 tM; T2 = Trenbolone 60 .tM; D1= Docetaxel 3 pM; D2= Docetaxel 6 pM; GTE1= 
Green tea extract 1.075X I0-4 g/nil; GTE2 = Green tea extract 2.127 X 10-4 g/ml; GTE3 -- Green tea extract 
3.15 X 10-4 g/ml; U = Untreated; NC = Negative Control (DMSO 5 µUm[ ) 
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Fig. 6 Effect of Green tea extract on Replication Index (RI) induced by Trenbolone 
and Docetaxel in absence of S9 mix 
Ti = Trenbolone 40 µM; T2 = Trenbolone 60 µM; D1= Docetaxel 3 pM; D2= Docetaxel 6µM; GTEI= 
Green tea extract 1.075X 10"4 gfrnl; GTE2 = Green tea extract 2.127 X 104 g/ml; GTE3 = Green tea extract 
3.15 X 104 g/ml; U = Untreated; NC = Negative Control (DMSO 5 t1/ml) 
r 
Fig. 7 Effect of Green tea extract on Replication Index (RI) induced by Trenbolone 
and Docetaxel in presence of S9 mix 
Ti = TrenboIone 40 JIM; T2 = Trenbolone 60 pM; D1= Docetaxel 3 µM; D2= Docetaxel 6 µM; GTE1= 
Green tea extract 1.075X 10'4 g/ml; GTE2 = Green tea extract 2.127 X 104 g/ml; GTE3 = Green tea extract 
3.15 X 104 g/ml; U = Untreated; NC = Negative Control (DMSO 5 µL/ml) 
T'4 
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Discussion 
The earlier studies have shown that various plant extacts and natural plant products 
possess protective role against the genotoxic effects of certain estrogens, synthetic 
progestins and anticancerous drugs in cultured human lymphocytes 
(17,18,19,20,21,4,22,24,25,26,27) and mice bone marrow cells (28,29,30).Our study 
clearly demonstrates the antigenotoxic potencial of Green tea extract (GTE) both in 
absence as well as presence of metabolic activation systems. 
Genotoxic effects of anti-cancer drugs in non- tumor cells are of special significance due 
to the possibility that they may induce secondary tumors in cancer patients. Also, the 
mutagenic and carcinogenic effects of antineoplastic agents on the health care persons 
handling these drugs also need to be considered carefully (31, 26). Anabolic steroids, as 
Trenbolone, also show genotoxicity as they cause increase protein synthesis within cells, 
which results in the buildup of cellular tissue (anabolism), especially in muscles. The 
main way in which steroid hormones interact with cells is by binding to proteins called 
steroid receptors. When steroids bind to these receptors, the proteins move into the cell 
nucleus and either alter the expression of genes (32,6) or activate processes that send 
signals to other parts of the cell (33, 34). 
An increase in the frequency of chromosomal aberrations in peripheral blood 
lymphocytes is associated with an increased overall risk of cancer (35, 36). Most of the 
chromosomal aberrations observed in the cells are lethal, but there are many other 
aberrations that are viable and cause genetic effects, either somatic or inherited (37).The 
readily quantifiable nature of sister chromatid exchanges with high sensitivity for 
revealing toxicant-DNA interaction and the demonstrated ability of genotoxic chemicals 
to induce significant increase in sister chromatid exchanges in cultured cells has resulted 
in this endpoint being used as indicator of DNA damage in blood lymphocytes of 
individuals exposed to genotoxic carcinogens (38). The above genotoxic endpoints are 
well known markers of genotoxicity and any reduction in the frequency of these 
genotoxic endpoints gives us indication of the antigenotoxicity of a particular compound 
(38). The antigenotoxic potential of the plant extracts have been attributed to their total 
phenolic content (39). It has been shown that, through several mechanisms, tea 
polyphenols present antioxidant and anticarciuiogenic activities, thus affording several 
health benefits (40,41). . Catechins are involve in thiol-dependent activation of 
mitogenic- activated protein kinases (42). Specifically, EGCG regulates expression of 
VEGF, matrix metalloproteinases, uPA, IGF-1, EGFR, cell cycle regulatory proteins and 
inhibits NFk B, P13-KIAkt, RasIRaf1MAPK and AP-1 signaling pathways, thereby 
causing strong cancer chemopreventive effects (43). The galloyl structure on the B ring 
and the gallate moiety are important for the inhibition (44). Most of the relevant 
mechanisms of cancer prevention by tea polyphenols are not related to their redox 
properties, but are due to the direct binding of the polyphenol to target molecules, 
including the inhibition of selected protein kinases, matrix metalloproteinases, and DNA 
etethyltransferases (2). Activation of Forkhead box 0 transcription factor (FOXO3a) by 
the green tea polyphenol epigallocatechin-3-gaIlate induces estrogen receptor alpha 
expression reversing invasive phenotype of breast cancer cells (45). 
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Tea polyphenols act as antioxidants in vitro by scavenging reactive oxygen and nitrogen 
species and chelating redox-active transition metal ions. (46). They may also function 
indirectly as antioxidants through, inhibition of the redox-sensitive transcription factors, 
nuclear factor-kappaB and activator protein-1; inhibition of "pro-oxidant" enzymes, such 
as inducible nitric oxide synthase, lipoxygenases, cyclooxygenases and xanthine oxidase; 
and induction of phase II and antioxidant enzymes, such as glutathione S-transferases 
and superoxide dismutases. (47)). Green tea polyphenols can act as a biological 
antioxidant in a cell culture experimental model and protect cells in culture (48) and 
mammalian veins (49) from oxidative stress-induced toxicity. In scavenging assays using 
a xanthine-xanthine oxidase (enzymatic system), epicatechin gallate (ECG) shows the 
highest scavenging potential (50). Tea catechins prevent the molecular degradation in 
oxidative stress conditions by directly altering the subcellular ROS production, 
glutathione metabolism and cytochrome P450 2E1 activity (51). For cancer prevention, 
evidence is so overwhelming that the Chemoprevention Branch of the National Cancer 
Institute has initiated a plan for developing tea compounds as cancer-chemopreventive 
agents in human trials (17). 
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Abstract 
Tea (Camellia slnensis) is one of the most popular beverages consumed worldwide as an infusion of leaves and is 
valued for its medicinal properties. Tea is a rich source of polyphenols called flavonoids, effective antioxidants found 
throughout the plant kingdom. The slight astringent, bitter taste of green tea is attributed to polyphenols. A group of 
flavonoids in green tea are known as catechins, which are quickly absorbed into the body and are thought to 
contribute to some of the potential health benefits of tea. The fresh tea leaves-contain four major catechins as 
colourless water soluble compounds. epicatechin (EC), epicatechin gallate (ECG). epigallocatechin (EGC) and 
epigallocatechin gallate (EGCG). Epidemiologic observations and laboratory studies have indicated that tea 
polyphenols act as antioxidants in vitro by scavenging reactive oxygen and nitrogen species and chelating redox 
active transition metal ions and hence tea may reduce the risk of a variety of illnesses, including cancer and coronary 
heart disease. In this study we seen the antigenotoxic effect of green tea extract against genotoxic damage induced 
by two anabolic steroids Trenbolone and Methyltestosterone in cultured human lymphocytes, both in absence and 
presence of metabolic activation. The results prove the antigenotoxic potential of green tea extract_ Because the 
epidemiologic studies and research findings in laboratory animals have shown the antigenotoxic potential of tea 
polyphenots, the usefulness of tea polyphenols for various human diseases like cancer and coronary heart disease 
etc should be evaluated in clinical trials. 
Keywords: Green tea extract (GTE); Tea polyphenols; Trenbolone; Methyltestosterone; Antigenotoxidty; 
Genotoxicity; Chromosomal aberrations; Sister chromatid exchanges. 
Introduction 
Tea is the second-most consumed beverage in 
the world (water is the first) and has been used 
medicinally for centuries in India and China. The 
tea shrub (genus Camellia, family Theaceae) 
[chromosome number (2n=30)1 is a perennial 
evergreen with its natural habitat in the tropical 
and sub tropical forests of the world. Cultivated 
varieties are grown widely in its home countries 
of South and South East Asia, as well as in parts 
of Africa and the Middle East (Yamamoto et al., 
1997). Green tea is prepared by picking, lightly 
steaming and allowing the leaves to dry 
(Werkhoven, 1978). Catechins are highly potent 
flavonolds present in tea and serve perhaps as 
the best dietary source of natural antioxidants. 
flavonoids are group of phenolic compounds 
occurring abundantly in vegetables, fruits, and 
green plants that had attracted special attention 
as they showed high antioxidant property (Gupta 
et al., 2008).Several catechins are present in 
significant quantities; epicatechin (EC), 
epigallocate chin (EGC), epicatechin gallate 
(ECG) and epigallocatechin gallate (EGCG) 
(Zhu of al., 2000) [Figure 1]. EGCG makes up 
about 10-50% of the total catechin content and 
appears to be the most powerful of the catechins 
— with antioxidant activity about 25-100 times 
more potent than vitamins C and E. Tea 
catechins and polyphenols are effective 
scavengers of reactive oxygen species in vitro 
and may also function indirectly as antioxidants 
through their effects on transcription factors and 
enzyme activities (Higdon and Frei, 2003). 
Trenbolone is a synthetic steroid used 
frequently by veterinarians on livestock as a 
promoter of growth in animal husbandry 
(Richold, 1988). Trenbolone is not used in an 
unrefined form, but is rather administered as 
Trenbolone acetate. Trenbolone acetate is often 
referred to as "Fina" by users, because injectible 
trenbolone acetate is often prepared from 
Finaplix H pellets, an ear-implant used by cattle 
ranchers to maintain the weight of cattle during 
shipping to slaughter. Trenbolone compounds 
have not yet been approved by the Food and 
Drug Administration, USA for use by humans 
due to their considerable negative side effects, 
although bodybuilders use the drug illegally to 
increase body mass and strength. Trenbolone 
compounds increase nitrogen uptake by 
muscles after metabolization, leading to 
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increased rate of protein synthesis. Trenbolone 
is a very potent androgen with strong anabolic 
activity, It is well suited for the rapid buildup of 
strength and muscle mass, usually providing the 
user exceptional results in a relatively short time 
period. Trenbolone compounds have a binding 
affinity for the androgen receptor three times as 
high as that of testosterone (Beg at al., 2007). 
Cases of prostate and hepatic cancers have 
been associated with long term anabolic steroid 
abuse (Roberts and Essenhigh ,1986; Overly et 
al., 	 1984). 
Figure 1. Main catechin components of gr een tea polyphenols. 
{-)-Epicalechin (-)-Epigarotateehin 
(4. E pi cats c h i n-3-g of i ate 	(-)-Epiga[Iocatecttin 3-gal late 
Trenbolone 
C I-f O2 Molecular weight 270.366 
1 7f -Hydroxyestra-4, 9,11-trien-3-one 
OH 
Methyltestosterone is a 17-alpha-alkylated 	testosterone deficiency. It is also used in women 
anabolic steroid used to treat men with a to treat breast cancer, breast pain, swelling due 
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to pregnancy. Methyltestosterone capsules USP 
10 mg are red capsules imprinted "ICN 0901" on 
both sections. People who abuse 
Methyltestosterone could suffer from acute 
poisoning and may also be at risk of death from 
premature heart disease or cancer. A case of 
night blindness was reported after continuous 
use of Methyltestosterone (Nisbett at al., 1985). 
For women, long term effects include voice 
changes and in children, fusion of the epiphyses 
in children. Androgen ingestion by a pregnant 
mother can cause virilization of a female fetus 
(Dewhurst and Gordon, 1984). Orally active (17-
alpha substituted) anabolic steroids can cause 
abnormalities of hepatic function, manifest as 
abnormally elevated hepatic enzyme activity in 
biochemical tests of liver function, and 
sometimes as overt jaundice. The histological 
abnormality of peliosis hepatis has been 
associated with anabolic steroid use (See et al., 
1992). Angiosarcoma (Falk et al, 1979) and a 
case of hepatocellular carcinoma in an anabolic 
steroid user has been reported (Overly et al., 
1984). 
Methyliestosterone 
CzoH3002, Molecular Weight. 302.46 
17-(3-hydroxy-17-methylandrost-4-en-3-on e 
Materials and Methods 
Chemicals 
Methyltestosteone (CAS No. 58-18-4, Sigma-
Aldrich); Trenbolone (CAS No.: 10161-33-
8,Sigma-Aldrich); Sodium Phenobarbitone 
(Sigma-Aldrich); Colchicine (Microlab); Dimethyl 
suiphoxide 	(Merck); 	Methyl 	methane 
sulphonate(Sigrna-Aldrich); RPMI 1640 (GIBCO, 
Invitrogen); Phytohaemagglutinin-M (GIBCO, 
Invitrogen); 	Antibiotic-antimycotic 	mixture 
(GIBCO, Invitrogen); Fetal serum - calf (GIBCO, 
Invitrogen); 5-bromo-2-deoxyuridine (Sigma-
Aldrich); Hoechst 33258 stain (Sigma-Aldrich); 
Giemsa stain (Merck). 
Preparation of leaf extract 
Camellia sinensis L. leaves were collected from 
the nursery of Forest Research Institute (FRI), 
Dehradun (U.A.) and were air dried and 
grounded to fine powder. Extraction was done 
by soaking samples (30g of dry weight) in 300 
ml of acetone for 8-10 h at 40-60°C in Soxhlet's 
apparatus. After filtration, the excess of solvent 
was removed by rotatory evaporator. The extract 
is labeled as Green tea extract (GTE). The 
extract concentrations of 1.075X 10-4, 2.127 X 
10-4 and 3.15 X 10-4 g/ml of culture medium 
were established. 
Human lymphocyte culture 
Duplicate peripheral blood cultures were 
conducted according to Carballo at al., 1993. 
Briefly, 0.5 ml of the heparinized blood samples 
was obtained from a healthy donor and was 
placed subsequently in a sterile flask containing 
7 ml of RPMI 1640, supplemented with 1.5 ml of 
fetal calf serum, 1.0 ml antibiotic-antimycotic 
mixture and 0.1 mJ of phytohaemagglutinin. 
These flasks were placed in an incubator at 
37°C for 24 hours. Untreated culture, negative 
and positive controls were run simultaneously. 
Duplicate peripheral blood cultures were done 
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and placed in the incubator at 37°C for 24 hr and 
then Green tea extract (GTE) (tested doses 
were 1.075X 104, 2.127 X 10-0 and 3.15 X 10~ 
g/ml), Trenbolone (tested doses were 40 and 60 
NM) and Methyltestosterone (tested doses were 
40 and 60 pM) were added, separately (Both the 
steroids were dissolved in DMSO). Then, all the 
tested doses of Green tea extract (GTE) were 
treated with both of the tested doses of 
Trenbolone and Methyltestosterone, separately. 
For metabolic activation experiments, 0.5 ml of 
S9 mix was given with each of the tested dose 
for 6 h. S9 mix was prepared according to 
standard protocol of Maron and Ames (1983). 
Sister chromatid exchange (SCE) analysis 
For SCE analysis, bromodeoxyuridine (BrdU, 10 
pg/ml) was added at the beginning of the 
culture. After 24 hr of the initiation of culture, 
treatments were given similarly as described 
above. The cells were collected by centrifugation 
and washed in prewarmed media to remove 
traces of 59 mix and drugs. One hour before 
harvesting i.e. after 46 h, 0.2 ml of colchicines 
(0.2 pgiml) was added to the culture flask for 
mitotic arrest. Cells were centrifuged at 1000 
rpm for 10 min. The supernatant was removed 
and 8m1 of prewarmed (37°C) 0.075 M KCI 
(hypotonic solution) was added. Cells were 
resuspended and incubated at 37°C for 15 min. 
The supernatant was removed by centrifugation, 
at 1000 rpm for 10 min, and subsequently 5m1 
chilled fixative (methanol: glacial acetic acid, 
3:1) was added. The fixative was removed by 
centrifugation and the procedure was repeated 
twice. The slides were processed according to 
Perry and Wolff (1974), with some modification. 
The slides were stained in 3% Giemsa solution 
in phosphate buffer (pH 6.8) for 15 min. 200 
second divisions metaphases per dose were 
analysed. 
Replication Index (RI) 
100 metaphases per culture were examined. 
Each metaphase was classified as being in the 
first (Ml), second (M2), or third (M3) division 
(Schneider et al., 1981). The replication index 
(RI) was calculated by formula (Ivett and Tice, 
1982) as follows: 
RI [(% of cells in M1) + 2(% of cells in M2) + 
3(% of cells in M3)] / 100 
Statistical analysis 
Student's two tailed "t° test was used to 
calculate the statistical significance in CAs and 
SCEs for antigenotoxicity experiment of tea 
polyphenol EGCG. Kruskall Wallis test was used 
for the analysis of the means of frequencies of 
SCEs induced by Trenbolone and Docetaxel 
and cell cycle kinetics was analysed by chi-
square test. Student's't' test were also 
performed. The level of significance was tested 
from standard statistical table of Fisher and 
Yates (1963). 
Results 
Genotoxic effect of a genotoxic steroid 
Trenbolone and Methyltestosteone was studied 
using sister chromatid exchanges (SCEs) and 
Replication Index as genotoxic end points. A 
dose dependent increase in frequencies of 
SCEs and decrease in cell cycle kinetics is 
observed for both Trenbolone and 
Methyltestosteone both in presence as well as 
absence of S9 mix (Table 1 & 2). There has 
been an increment in M1 cells and decrease of 
M2 and M3 cells as the doses of Trenbolone 
and Docetaxel increase. 
We found that the genotoxicity induced 
by Trenbolone and Methyltestosteone, 
separately can be countered with 1.075X 10, 
2.127 X 10-4 and 3.15 X 10-4 g/ml of Green tea 
extract (GTE). Frequencies of SCEs were 
reduced when cultures expose to 40 and 60 uM 
of Trenbolone, were treated with Green tea 
extract (GTE), both in presence as well as 
absence of S9 mix (Table 3 & 4; Fig 1 & 2). 
Replication Index showed an increase when 
cultures expose to 40 and 60 i M of Trenbolone, 
were treated with Green tea extract (GTE), both 
in presence as well as absence of 59 mix (Table 
3 & 4; Fig 3 & 4). Similar results were obtained 
when cultures expose to 40 and 60 pM of 
Methyltestosteone, were treated with Green tea 
extract (GTE), both in presence as well as 
absence of S9 mix (Table 5 & 6; Fig 1, 2, 3, 4). 
Discussion 
Anabolic steroids are a class of steroid 
hormones related to the hormone testosterone. 
Anabolic steroids have been used by physicians 
for many purposes as for hypoplastic anemias 
due to leukemia or kidney failure, especially 
aplastic anemia,(Basaris et al., 2001) Growth 
stimulation, to increase lean body mass and 
prevent bane loss in elderly men etc. (Kenny at 
al., 2001; Baum and Crespi, 2007; Francis, 
2007) They increase protein synthesis within 
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cells, which results in the buildup of cellular 
tissue (anabolism), especially in muscles. The 
main way in which steroid hormones interact 
with cells is by binding to proteins called steroid 
receptors. When steroids bind to these 
receptors, the proteins move into the cell 
nucleus and either alter the expression of genes 
(Lavery 	and McEwan, 2005) or activate 
processes that send signals to other parts of the 
cell (Cheskis, 2004). In the case of anabolic 
steroids, the receptors involved are called the 
androgen receptors. The mechanisms of action 
differ depending on the specific anabolic steroid. 
Different types of anabolic steroids bind to the 
androgen receptor with different affinities, 
depending on their chemical structure (Hartgens 
and Kuipers, 2004). The earlier studies have 
shown that various plant extracts and natural 
plant products possess protective role against 
the genotoxic effects of certain estrogens, 
synthetic pragestins and anticancerous drugs in 
cultured human lymphocytes (Siddique and 
Afzal, 2004; Siddique and Afzal, 2005 a,b; Beg 
at al., 2007a,b; Siddique at al., 2006 a,b; 
Siddique et al., 2007 a-c; Siddique at al.,2008 a-
c) and mice bone marrow cells (Siddique at 
al.,2005; Siddique at al., 2006b; Siddique at al., 
2008a).Green tea extract (GTE) was studied for 
its antimutagenic effect on the SCEs and Ri 
induced by Trenbolone and Methyltestosterone, 
both in the presence and absence of metabolic 
activation system in human lymphocytes in vitro. 
The readily quantifiable nature of sister 
chromatid exchanges with high sensitivity for 
revealing toxicant-DNA interaction and the 
demonstrated ability of genotoxic chemicals to 
induce significant increase in sister chromatid 
exchanges in cultured cells has resulted in this 
endpoint being used as indicator of DNA 
damage in blood lymphocytes of individuals 
exposed to genotoxic carcinogens (Albertini at 
al., 2000). The above genotoxic endpoints are 
well known markers of genotoxicity and any 
reduction in the frequency of these genotoxic 
endpoints gives us indication of the 
antigenotoxicity of a particular compound (Many 
products protect against xenobiotics either by 
inducing detoxifying enzymes or by inhibiting 
oxidative enzymes (Morse and Stoner, 1993). 
The antigenotoxic potential of the plant extracts 
have been attributed to their total phenolic 
content (Maurich et al., 2004). it has been 
shown that, through several mechanisms, tea 
polyphenols present antioxidant and 
anticarcinogenic activities, thus affording several 
health benefits (Gonzalez de Melia, 2003; Afzal 
et al., 2008).The health benefits of catechins 
have been studied extensively in humans and in 
animal models. The anticarcinogenic potential of 
green tea catechins have correlated their 
cytotoxic effects with the induction of apoptosis, 
activation of caspases, inhibition of protein 
kinase, modulation of cell cycle regulation and 
inhibition of cell proliferation (Yang, 1999). For 
cancer prevention, evidence is so overwhelming 
that the Chemoprevention Branch of the 
National Cancer Institute has initiated a plan for 
developing tea compounds as cancer-
chernopreventive agents in human trials 
(Siddiqui at al., 2004; Gupta at al., 2008). 
Table 1. Sister chromatid exchanges (SCEs) and Replication Index (RI) in human lymphocytes treated with 
Trenbolone and Methyltestosterone, each, in absence of 59 mix 
Treatment 
(}t M) 
Cells Scored SCEs/cell 
(mean) 
RI 
Trenbolose 
40 200 4.22± 0.31 h 1.72 
60 200 584±046b 1.69 
Methylteslosterone 
40 200 4.42 ± 0.32 b 1.69 
60 200 5.34;t 1.29 ° 1.67 
Untreated 	 200 	 2.0410.12 	 1.91 
Negative control 200 2.52 ±0.15 1.38 
(DMSO, 5 Ni/ml) 
Positive control. 	 200 	 l6.62±0.6' 	 l .65 
MMS (6 u] 
Significant at'P-c0.03 Vs Normal Kruskall-Wallis test 
ep<0.05 With respect to Untreated. 
SE: Standard Error, DMSD: aimethylsulphoxide, MMS: Methylmethane suiphonate 
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Table 2. Sister chromatid exchanges (SCEs) and Replication Index (RI) in human lymphocytes treated with 
Trenbolone and Mettlyltestosterone, each, in presence of S9 mix. 
Treatment Cells Scored SCEs/cell RI 
(pM) (mean) 
Trenbolone 
40 200 5.64+_ 0.426 1.71 
60 200 8.22± 0.82b 1.67 
Methyltestosterone 
40 200 4.74 ± 0.366 1.68 
60 200 9.56 ± 0.49b 1.62 
Untreated 200 2.46 ± 0.14 1.89 
Negative control 
(DMSO, 5 µ11m1) 200 3.02± 0.17 1.87 
Positive contra] 200 22.22± 0.95 1.45 
MMS (6 NM) 
Significant at 'P< 0.01 Vs Normal Kruskall-Wallis test. 
bP<0.05 with respect to Untreated. 
DMSO: Dimethylsulphoxide, MMS: Methylmethane sulphonate 
Table 3: Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index (RI) induced by Trenbolone in 
human lymphocytes without S9 mix. 
Treatment (IsM) 	 Cells scored 	 SCEs/cell (Mean ± SE) 	 RI 
GTE (g/mi) 
	
1.075X10-4 	 200 	 2.08 ± 0.21 	 1.82 
2.127X10-4 	 200 	 2.28 ± 023 	 1.80 
3.15X10'4 	 200 	 2.60 d: 0.25 	 1.78 
Ti ({tM)+ GTE (gfml) 
40+1.075X10'4 200 4.06 ± 0.42ab 1.73 
40+2.127X10' 200 3.12± 0.33`'  1.74 
40+3.15X104  200 2.84 ± 0.31'b 1.76 
T2(pM) + GTE (g/ml) 
60+1.075XItY 200 4.52 ± 0.48 a°  1.70 
60+2.127Xt04  200 4.44±0.46 ab 1.72 
60+3.15X104 200 4.14t0.42ae 1.74 
Untreated 200 2.04±0.12 1.91 
Negative control 200 2.52 ± 0.15 1.88 
(DMSO, 5 p1/ml) 
Significant difference: 
P<0.01 with respect to untreated 
bp<0.05 with respect to Trenbolone (Values given in Tabtel ) 
TI: 40 pM Trenbolone; T2: 60 pM Trenbolone. 
GTE: Green tea extract; DMSO:Dimethylsulphoxide; SE: Standard Error. 
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Table 4: Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index (RI) induced by Trenbolone in 
human lymphocytes with 59 mix. 
Treatment (tM) 	 Cells scored 	 SCEslcell (Mean ± SE) 	 RI 
GTE (glml) 
1.075X10 200 2.32±0.22 1.80 
2.127X104 200 2.44±0.24 1.79 
3.1574104 200 2.70±0.28 1.76 
Ti (l)+ GTE (glen]) 
40+1.075X104 200 4.48± 0.45' e 1.71 
40+2.127X10 200 4.44 ± 0.43 ` h  1.73 
40+3.15X104  200 4.28± 0.35'" 1.75 
T2 (1)+ GTE (Pmt) 
60+1.075X10 ° 200 7.32 t 0.64' ° 1.68 
60+2. t27X1(V 200 6.52 ± 0.61 b 1.70 
60+3.15X10 4 200 6.02±0.54'e 1.71 
Untreated 200 2.46 ± 0.14 1.89 
Negative control 200 3.02± 0.17 1.87 
(DMSO, 5 u I/ml) 
Significant difference: 
0P<0.01 with respect to untreated, "P<0.05 with respect to Trenbolone ( Values given in Table2). Ti: 40 pM Trenbolcne; T2; 60 
}iM Trenbolone. GTE: Green tea extract; DMSQ:flimethyfsulphoxide; SE; Standard Error. 
Table 5: Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index (RI) induced by 
Methyltestosterone in human lymphocytes without S9 mix. 
Treatment (µM) Cells scored SCEslcell (Meant SE) RI 
GTE (glml) 
1.075X10' 200 2.08±0.21 1.82 
2.127Xt04 200 218±023 1.80 
3.15X10' 200 2.60±0.25 1.78 
Ml (µM1)+ GTE (glml) 
40+1.075X104  200 3,14±0.30" 1.70 
40+2.127X10" 200 2,36±0.21'6 1.73 
40+3.15X10J 200 2.24 ± 0.17 a ' 1.75 
M2 (jM)+ GTE (g/ nil) 
60+1.075Xt0-  200 4.44±0.43 h 1.68 
60+2.127X104 200 4.22±0.3I 1  1.70 
60+3.15X10' 200 3.10±0.31'6 1.73 
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Untreated 	 200 	 2.04* 0.12 	 1.91 
Negative control 	 200 	 2.52 t 0.15 	 1.88 
(DMSO, 5 ullml) 
Significant difference: 
HP<0.01 with respect to untreated 
'P<0.05 with respect to Methyltestosterone (Values given in Table'{). 
Ml: 40µM Methyttestosterone; M2: 60 jiM Methyltestasterone. 
GTE: Green tea extract: DMSO:Dimethylsulphoxide; SE: Standard Error. 
Table 6. Effect of GTE on Sister chromatid exchanges (SCEs) and Replication Index (RI) induced by 
Methyltestosterone in human lymphocytes with 59 mix. 
Treatment (jM) 	Cells scored 	SCEs/cell (Meant SE) 	 IZl 
GTE (glml) 
1075X10 ; 200 2.32±0.22 1.80 
2.127X104  200 2.44±0.24 1.79 
3.15X10-4 200 2.70 ± 0.28 1.76 
Ml (pM)+ GTE (gfml) 
40+1.075X 104  200 4.06±0.42'' 1.70 
40+2.127X104  200 2.67 ± 0.29 1.72 
40+3.15X 10 200 2.28 ±0.23'b 1.74 
M2 (tM)+ GTE (glml) 
60+1.075X10' 200 7.32 ±0.64 1.63 
60+2.127X104  200 6.52±0.61' 1.64 
60+3.15X 104 200 6.34±0.59b 1.66 
Untreated 200 2.45 f 0.14 1.89 
Negative control 200 3.01 t 	0.17 1.87 
(DMSO, 5 jUml) 
Significant difference: 
'P<o.0l with respect to untreated  
bP<0.05 with respect to Methyltestosterone (Values given in Table 2). 
M1-401iM Methyltestosterone: M2: 60 pM Methyltestosterone. 
GTE: Green tea extract DMSO:Dimethylsulphoxide; SE: Standard Error. 
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FIG.1 Sister chromatid exchange (SCEstcell)(mean) in human lymphocytes 
treated with Trenbolone, Methyltestosterone and Green tea extract, in absence of S9 mix. 
Ti = Trenbolone 40 µM; 12 = Trenbolone 60 NM; M1 = Methyltestosterone 40 pM; M2 = Methyltestosterone 60 pM; 
GTE1 Green tea extract 1.075X 104 glml; GTE2 = Green tea extract 2.127 X 10-0 gfml; GTE3 = Green tea extract 
3.15 X 10 g/ml; U = Untreated; NC = Negative Control (DMSO 5 pllml) 
FIG.2 Sister chromatid exchange (SCEslcell)(mean) in human lymphocytes 
treated with Trenbolone, Methyltestosterone and Green tea extract, in presence of S9 mix. 
TI = Trenbolone 40 pM; T2 = Trenbolone 60 µM; MI = Methyltestosterone 40 µM; M2 = Methyltestosterone 60 µM; 
GTE1= Green tea extract 1.075X 10"' glml; GTE2 = Green tea extract 2.127 X 10 4` gfml; GTE3 = Green tea extract 
3.15 X 10'4 g/mI; U = Untreated; NC = Negative Control (DMSO 5 p1/ml) 
~_ 
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FIG.3 Replication Index (RI) in human lymphocytes treated with Trenbolone, Methyltestosterone and 
Green tea extract, in absence of S9 mix. 
Ti = Trenbolone 40 iM; T2 = Trenbolone 60 NM; M1 = Methyltestosterone 40 NM; M2 = Methyltestosterone 60 .M; 
GTEI= Green tea extract 1.075X 104 glml; GTE2 = Green tea extract 2.127 X 10-4 glml; GTE3 = Green tea extract 
3.15 X 10"' gfml; U = Untreated; NC = Negative Control (DMSO 5 i I1mI) 
FIG.4 Replication Index (RI) in human lymphocytes treated with Trenbolone, Methyltestosterone and 
Green tea extract, in presence of S9 mix. 
TI = Trenbolone 40 µM; T2 = Trenbolone 60 IM; M1 = Methyltestosterone 40 uM; M2 = Methyltestosterone 60 tM; 
GTEI= Green tea extract 1.075X 104 gfml; GTE2 = Green tea extract 2.127 X 10'4 glml; GTE3 = Green tea extract 
3.15 X 104 g/ml; U = Untreated; NC = Negative Control (DM30 5 pUmi) 
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Abstract 
Tea (Camellia sinensis) is a rich source of polyphenols called flavonoids, effective antioxidants 
found throughout the plant kingdom. The slight astringent, bitter taste of green tea is attributed to 
polyphenols. A group of flavonoids in green tea are known as catechins, which are quickly 
absorbed into the body and are thought to contribute to some of the potential health benefits of 
tea. The fresh tea leaves contain four major catechins as colourless water soluble compounds. 
epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC) and epigallocatechin gallate 
(EGCG). In this study we seen the antigenotoxic effect of tea polyphenol Epigallocatechin gallate 
(EGCG), against genotoxic damage induced by a steroid Trenbolone and an anticancer drug 
Docetaxel in cultured human lymphocytes, both in absence and presence of metabolic activation. 
Introduction 
EGCG makes up about 10-50010 of the total catechin content and appears to be the most powerful 
of the catechins. In green tea catechin levels ranged from 51.5 - 84.3 mg/g, with epigallocatechin 
gallate (EGCG) being the main catechin in Chinese and Indian green teas. (EGCG) 
epigallocatechin gallate, a major catechin of Found in green tea, has possible role in 
chemoprevention and chemotherapy of various types of cancers mainly prostate cancer (1, 2) 
and colon cancer (3, 4). EGCG is found to be the major and most photoprotective polyphenolic 
component of green tea (5). EGCG also induces growth arrest and apoptosis through multiple 
mechanisms, and can be used for cancer prevention, mainly pancreatic (6). Tea catechins and 
polyphenols are effective scavengers of reactive oxygen species in vitro and may also function 
indirectly as antioxidants through their effects on transcription factors and enzyme activities (7). 
Trenbolone is a synthetic steroid used frequently by veterinarians on livestock as a promoter of 
growth in animal husbandry (8). Trenbolone compounds have not yet been approved by the Food 
and Drug Administration, USA for use by humans due to their considerable negative side effects, 
although bodybuilders use the drug illegally to increase body mass and strength. Cases of 
prostate and hepatic cancers have been associated with long term anabolic steroid abuse (9,10). 
Trenbolone compounds increase nitrogen uptake by muscles after metabolization, leading to 
increased rate of protein synthesis. 
Docetexel is a clinically well established anti-mitotic chemotherapy medication used mainly for the 
treatment of breast, ovarian, and non-small cell lung cancer (11) Docetaxel has an approved 
claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell 
lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer 
progression or relapsed. Docetaxel is marketed worldwide under the name Taxotere by Sanofi-
Aventis. Evaluation of docetaxel pharmacokinetics in phase II and III clinical studies were with 
100 mg/m2 dosages given over one-hour infusions every three weeks Docetaxel is a 
chemotherapeutic agent and is a cytotoxic compound and so is effectively a biologically damaging 
drug (12). Because docetaxel is a cell cycle specific agent, it is cytotoxic to all dividing cells in the 
body. 
EGCG was studied for its antimutagenic effect on the CAs and SCEs induced by Trenbolone and 
Docetaxel, both in the presence and absence of metabolic activation system in human 
lymphocytes in vitro. The readily quantifiable nature of sister chromatid exchanges with high 
sensitivity for revealing toxicant-DNA interaction and the demonstrated ability of genotoxic 
chemicals to induce significant increase In sister chromatid exchanges in cultured cells has 
resulted in this endpoint being used as indicator of DNA damage in blood lymphocytes of 
individuals exposed to genotoxic carcinogens (13). The above genotoxic endpoints are well known 
markers of genotoxicity and any reduction in the frequency of these genotoxic endpoints gives us 
indication of the antigenotoxicity of a particular compound (14). Many products protect against 
xenobiotics either by inducing detoxifying enzymes or by inhibiting oxidative enzymes (15). 
Materials and Methods 
Chemicals 
Docataxel (CAS No. 114977-28-5,Sigma-Aldrich); Trenbolone (CAS No.: 10161-33-8,Sigma-
Aldrich); Sodium phenobarbitone (Sigma-Aldrich); Colchicine (Microlab);- Dimethyi sulphoxide 
(Merck); Epigallocatechin-3-galiate (CAS No.: 989-51-5, Sigma-Aldrich); RPMI 1640 (GIBCO, 
Invitrogen); Phytohaemaggiutinin-M (GIBCO, Invitrogen); Antibiotic-antimycotic mixture (GIBCO, 
Invitrogen); Fetal Serum - calf (GIBCO, Invitrogen); 5-bromo-2-deoxyuridine (Sigma-Aldrich); 
Hoechst 33258 stain (Sigma-Aldrich); Giemsa stain (Merck). 
Human lymphocyte culture 
Duplicate peripheral blood cultures were conducted according to Carballo et al.,1993 (16). Briefly, 
0.5 ml of the heparinized blood samples was obtained from a healthy female donor and was 
placed subsequently in a sterile flask containing 7 ml of RPMI 1640, supplemented with 1.5 ml of 
fetal calf serum and 0.1 ml of phytohaemagglutinin. These flasks were placed in an Incubator at 
37oC for 24 hours. Untreated culture, negative and positive controls were run simultaneously. 
Sister chromatid exchange (SCEs) analysis 
For SCE analysis, bromodeoxyuridine (BrdU, 10 pg/ml) was added at the beginning of the culture. 
After 24 hr of the initiation of culture, treatments were given similarly as described for CAs 
analysis. Two hours before harvesting, 0.2 ml of colchicines (0.2 pg/ml) was added to the culture 
flask. Hypotonic treatment and fixation were performed in the same way as in CAs analysis. The 
slides were processed according to Perry and Wolff (1974) (17) with some modification. 200 
second divisions metaphases per dose were analysed. 
Replication Index (RI) 
100 metaphases per culture were examined. Each metaphase was classified as being In the first 
(M1), second (M2), or third (M3) division (18). The replication index (RI) was calculated by 
formula (19) as follows: 
RI = [(% of cells in 111) + 2(% of cells in M2) + 3(% of cells in M3)] / 100 
The effect of a genotoxic steroid Trenbolone and an anticancer drug Docetaxel was studied using 
sister chromatid exchanges (SCE's) and Replication Index as genotoxic end points. Trenbolone 
and Docetaxel were added at 10, 20, 30 pM each after 24 hr of initiation of the culture, 
separately. Normal, Positive and the negative control were also run simultaneously. For metabolic 
activation experiments, 0.5 ml of 59 mix was given with each of the tested dose. Epigallocatechin 
gallate (EGCG) has been tested for it's possible antigenotoxic effect against Trenbolone and 
Docetaxel induced genotoxicity. Sister chromatid exchange (SCE) was used as a parameter. 
Duplicate peripheral blood cultures were done and placed in the incubator at 3700 for 24 hr and 
then l3rdU (10pg/ml) was added to all cultures, as were, EGCG ( tested doses were 20 and 30 
NM), Trenbolone (tested doses were 45 and 55 pM) and then with Docetaxel ( tested doses were 3 
and 6 pM). Both the tested doses of EGCG weretreated with both of the tested doses of 
Trenbolone and Docetaxel, separately. 
Statistical analysis 
Student's two tailed "t" test was used to calculate the statistical significance in CAs and SCEs for 
antigenotoxicity experiment of tea polyphenol EGCG. Kruskall Wallis test was used for the 
analysis of the means of frequencies of SCEsinduced by Trenbolone and Docetaxel and cell cycle 
kinetics was analysed by chi-square test. Student's 't' test were also performed. The level or  
significance was tested from standard statistical table of Fisher and Yates (1963) (20). 
Results 
Genotoxic effect of a genotoxic steroid Trenbolone and an anticancer drug Docetaxel was studied 
using sister chromatid exchanges (SCE's) and Replication Index as genotoxic end points.A dose 
dependent increase infrequencies of SCEs and cell cycle kinetics is observed for both Trenbolone 
and Docetaxel, both in presence as well as absence of 59 mix (Table 1 &- 2; Fig 1 & 2). A 
significant increase in the value of SCEs/cell was observed at 30 pM (P<0.03) of Trenbolone, in 
presence of metabolic activation. The cell proliferation kinetics which is the average number of 
cells that have undergone replication showed a significant differences between the cultures 
exposed to 30 pM of Docetaxel and the normal control (P<0.03). There has been an increment in 
M1 cells and decrease of M2 and M3 cells as the doses of Trenbolone and Docetaxel increase. 
We found that the genotoxiclty induced by Trenbolone and Docetaxel, separately can be 
countered with 20 and 30 pM of Epigallo catechin gallate (EGCG), a major tea polyphenol. 
Frequencies of SCEs were reduced when cultures expose to 45 and 55 pM of Trenbolone, were 
treated with EGCG (20 and 30 pM ), both in presence as well as absence of S9 mix (Table 3 & 4; 
Fig 3 & 4). Similar results were obtained when cultures expose to 3 and 6 pM of Docetaxel, were 
treated with EGCG (20 and 30 NM ), both in presence as well as absence of 59 mix (Table 5 & 6; 
Fig 5 & 6). 
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Table 1: Sister chromatid exchanges (SCEs) and Replication Index (RI) in human lymphocytes 
treated with Trenbolone and Docetaxel, each, in absence of 59 mix. 
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Table 2: Sister chromatid exchanges (SCEs) and Replication Index (RI) in human lymphocytes 
treated with Trenbolone and bocetaxei, each, in presence of 59 mix. 
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Table 3: Antimutagenic effect of EGCG on SCEs induced by Trenbolone in cultured human 
lymphocytes without S9 mix. 
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Table 4: Antimutagenic effect of EGCG on SCEs induced by Trenbolone in cultured human 
lymphocytes with S9 mix. 
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Table 5: Antimutagenic effect of EGCG on SCEs induced by Docetaxel in cultured human 
lymphocytes without 59 mix. 
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Table 6: Antimutagenic effect of EGCG on SCEs induced by Docetaxel in cultured human 
lymphocytes with S9 mix. 
Figure 1: Sister chromatid exchange (SCEs/cell)(mean) in human lymphocytes treated with 
Trenbolone and Docetaxel, each, in absence of S9 mix. 
N- Normal; NC- Negative control; PC- Positive control MMS (6 IM) 
Ti- Trenbolone 10 PM; T2- Trenbolone 20 IPM; T3- Trenbolone 30 pM; 
D1- Docetaxel 10 pM; D2- Docetaxel 10 pM; D3- Docetaxel 30 pM 
Figure 2: Sister Chromatid exchange (SC Es/cel)(mean) in human lymphocytes treated with 
Trenbolone and Docetaxel, each, in presence of S9 mix. 
N- Normal; NC- Negative control; PC- Positive control MMS (6 pM) 
Ti- Trenbolone 10 pM; T2- Trenbolone 20 pM; T3- Trenbolone 30 pM; 
D1- Docetaxel 10 pM; D2- Docetaxel 10 pM; 03- Docetaxel 30 pM. 
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Figure 3: Effect of EGCG on SCEs induced by Trenbolone in cultured human lymphocytes Without 
S9 mix. 
N- Normal; INC-Negative control; Ti- Trenbolone 45 pM; 
T2- Trenbolone 55 pM; EGCG1- Epigallocatechin gallate 20 jM; 
EGCG2- Epigaliocatechin gallate 30 pM. 
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Figure 4: Effect of EGCG on SCEs induced by Trenbolone in cultured human lymphocytes with S9 
mix. 
N- Normal; NC-Negative control; Ti- Trenbolone 45 pM; 
T2- Trenbolone 55 pM; EGCG1- Epigallocatechin gallate 20 pM; 
EGCG2- Epigallocatechin gallate 30 pM. 
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Figure 5: Effect of EGCG on SCEs induced by Docetaxel in cultured human lymphocytes without 
S9 mix. 
N- Normal; NC-Negative control; D1- Docetaxel 3 pM; 
D2- Docetaxel 6 NM; EGCG1- Epigallocatechin gallate 20 pM ; 
EGCG2- Epigallocatechin gallate 30 pM. 
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Figure 6: Effect of EGCG an SCEs induced by Docetaxel in cultured human lymphocytes with S9 
mix. 
N- Normal; NC-Negative control; D1- Docetaxel 3 pM; 
D2- Docetaxel 6 PM; EGCG1- Epigallocatechin gallate 20 pM 
EGCG2- Epigallocatechin gallate 30 pM. 
Discussions 
Plants are the essential source of medicines. Through the advances in pharmacology and 
synthetic organic chemistry, the dependence on natural products, remain unchanged (21). In 
India, the majority of populations use traditional natural prepartion derived from the plant 
material for the treatment of various diseases (23). The earlier studies have shown that various 
plant extacts and natural plant products possess protective role against the genotoxic effects of 
certain estrogens, synthetic progestins and anticancerous drugs in cultured human lymphocytes 
(19, 20, 21, 22, 24, 25, 26, 27, 28). The antigenotoxic potential of the plant extracts have been 
attributed to their total phenolic content (29). It has been shown that, through several 
mechanisms, tea poiyphenols present antioxidant and anticarcinogenic activities, thus affording 
several health benefits (30, 31).The health benefits of catechins have been studied extensively in 
humans and in animal models. The anticarcinogenic potential of green tea catechins have 
correlated their cyotoxic effects with the induction of apoptosis, activation of caspases, inhibition 
of protein ki - ase, modulation of cell cycle regulation and inhibition of cell proliferation (32). For 
cancer prevention, evidence is so overwhelming that the Chemoprevention Branch of the National 
Cancer Institute has initiated a plan for developing tea compounds as cancer-chemopreventive 
agents in human trials (33). In this study we have found that a major tea polyphenol, EGCG,.can 
modulte the genotoxic effects of Trebolone and Docetaxei, indicating its protective role. EGCG is 
widely accepted as an antioxidant. EGCG scavenges superoxide anion radicals (02•—), hydrogen 
peroxide (H202), hydroxy radicals (HO.), peroxyl radicals, singlet oxygen, and peroxynitrite (34, 
35 36, 37, 38, 39). The reactive species liberated by genotoxic steroids and anticancer drugs, 
before or after metabolic activation, may be responsible for their genotoxic action. Formation of 
endogenous adducts and certain neoplastic change have also been reported earlier (40, 41). The 
suggested mechanism of action of tea polyphenols includes the following (42): 
. Antioxidant activity and scavenging free radicals. 
• Modulating enzymes implicated In the carcinogenic process. 
• Modifying the pathways of signal transduction, thereby positively altering the expression of 
genes involved in cell proliferation, angiogenesis, and apoptosis, all important stages of 
cancer progression. 
Antimicrobial actions (association between Helicobacter pylori and gastric cancer). 
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A Review on the Beneficial Effects of Tea Polyphenols on Human Health 
J. Gupta, Y.H. Siddique, T. Beg, .G. Ara and M. Afzal 
Laboratory of Human Genetics and Toxicology, Section of Genetics, Department of Zoology, 
Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, India 
Abstract: The aim of this review is to focus some light on the beneficial effects of the tea polyphenols on 
human health, based on various laboratory, epidemiological and clinical studies carried out on tea and tea 
polyphenols in the last few years. Tea is second only to water as the most consumed beverage in the world. 
Tea has been consumed worldwide since ancient times to maintain and improve health. The health benefits 
associated with tea consumption have resulted in the wide inclusion of green tea extracts in botanical dietary 
supplements, which are widely consumed as adjuvants for complementary and alternative medicines. 
Depending upon the level of fermentation, tea can be categorized into three types: green (unfermented), oolong 
(partially fermented) and black (highly to fully fermented). Black tea represents approximately 78% of total 
consumed tea in the world, whereas green tea accounts for approximately 20% of tea consumed. Tea is 
particularly rich in polyphenols, including catechins, theaflavins and thearubigins, which are thought to 
contribute to the health benefits of tea. Tea polyphenols comprise about one-third of the weight of the dried 
leaf and they exhibit biochemical and pharmacological activities including antioxidant activities, inhibition of 
cell proliferation, induction of apoptosis, cell cycle arrest and modulation of carcinogen metabolism. Several 
studies demonstrate that most tea polyphenols exert their effects by scavenging Reactive Oxygen Species 
(ROS) since excessive production of ROS has been implicated in the development of a variety of ailments 
including cancer of the prostate gland (CaP). Tea catechins include (-)-epicatechin (EC),(-)-epigallocatechin 
(EGC), (-)-epicatechin gallate (ECG) and (-)-epigallocatethin gallate (EGCG). These catechins have been shown 
to be epimerized to (-)-catechin (C), (-)-gallocatechin (GC), (-)-catechin gallate (CG) and (-)-gallocatechin gallate 
(GCG), respectively, during heat treatment. Tea polyphenols act as antioxidants in vitro by scavenging reactive 
oxygen and nitrogen species and chelating redox-active transition metal ions. Among the health-promoting 
effects of tea and tea polyphenols, the cancer-chemopreventive effects in various animal modal systems have 
been intensively investigated; meanwhile, the hypolipidernic and aritiobesity effects in animals and humans 
have also become a hot issue for molecular nutrition and food research In vitro and animal studies provide 
strong evidence that tea polyphenols may possess the bioactivity to affect the pathogenesis of several chronic 
diseases, especially cardiovascular disease and cancer. Research conducted in recent years reveals that both 
black and green tea have very similar beneficial attributes in lowering the risk of many human diseases, 
including several types of cancer and heart diseases. 
Key words: Polyphenols, catechins, epiga]locatechingallate, biological effects 
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Plants are the essential source of medicines. Through 
the advances in pharmacology and synthetic organic 
chemistry, the dependence on natural products, remain 
unchanged (Roopashree at al., 2008). In India, the 
majority of populations use traditional natural preparation 
derived from the plant material for the treatment of various 
diseases (Siddique et al., 2006a) and for that reason it has 
become necessary to assess their antimutagenic potential 
or mutagenie potential for modulating the action of plant  
extract when associated with other substances. The 
genotoxicity testing provides human a risk assessment. 
The earlier studies have shown that various plant 
extracts and natural plant products possess protective 
role against the genotoxic effects of certain estrogens, 
synthetic progestins 	and anticancerous drugs in 
cultured human lymphocytes (Siddique and Afzal, 
2004; Siddique and Afzal, 2005a, b; Beg at al., 2007a, b; 
Siddique andAfzal, 2005, 2006a-c, 2007a-c, 2008a,b) and 
mice bone marrow cells (Siddique at al., 2006d, 2008c). 
Since the plant extracts have compounds that may either 
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Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, India 
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enhance or reduce the genotoxic effect of a particular 
compound, the knowledge of particular plant extract 
will contribute for us to form the basis of herbal 
medicine (Roncada et al., 2004). The antigeotoxic potential 
of the plant extracts have been attributed to their total 
phenolic content (Maurich et al., 2004). Medicinal herbs 
contain complex mixtures of thousands of compounds 
that can exert their antioxidant and free radical scavenging 
effect either separately or in synergistic ways (Romero-
Jimenez et al., 2005). 
Plant favanoids and anhi:nutagenicity: One or the other 
kind of chemical is being used for almost every activity in 
our daily life. A large number of substances such as 
drugs, cosmetics, pesticides and petroleum products 
have been established as mutagens (Marshall et al., 1976; 
Hahn at al., 1991) Ames Test confirmed  that several 
components of the human diet contains a great variety of 
natural mutagens or 'nature's pesticides'(Kawai at al., 
2006). The main danger of such wide spread and 
inadvertant exposure lies in the danger of their potential 
of enhancing genetic load The environmental mutagons 
are attributed to several human ills like cancer, 
atheroscerlosis and ageing (Jensen et al., 1990). Thus, the 
increasing %vide use of these mutagens in almost every 
sphere of human life, requires an urgent need for studies 
on the possibility of intervention through antimutagenic 
action. A large number of natural substances are capable 
of inactivating environmental mutagens. The 
characterization of these substances is also important for 
the possibility of intervention using them as 
chemotherapeutic or prophylactic agents against human 
ill healths attributable to mutations. These substances are 
termed as antimutagens (Yamamoto and Gaynor, 2006). 
They are found in various food items in variable 
quantities. The chemicals present in plants like 
Flavanoids, Vitamins A, C, E, Beta- carotenes etc. are 
some of the important antimutagens. Ames Test has been 
used generally to identify and characterise antimutagenic 
potentials of natural plant extracts (Azizan and Blevins, 
1995). Flavonoids are widely distributed in plants fulfilling 
many functions including producing yellow or red/blue 
pigmentation in flowers and protection against attack by 
microbes and insects. These flavanoids have been found 
to possess antitumor properties in animal models 
(Kandaswami et al., 2005). The term Flavonoids according 
to IUPAC Compendium of Chemical Terminology refers to 
a class of plant secondary metabolites. They can be 
classified into: 
• Flavonoids, derived from 2-phenylcbromen-4-one 
(2-phenyl-l,4-benzopyrone) structure 
• Isoflavonoids, derived from 3-phenylchromen-4-one 
(3-phenyl-I,4-benzopyronc) structure 
• Neoflavonoids, derived from 4-phenylcoumarine 
(4-phenyl-l,2-benzopyrone) structure 
Plant polyphenols like quercetin, rutin, catechins, 
chlorogenic acid, pyrocatechol etc. exhibit 
antimuagenicity against N- Methyl N Nitrosoguanidine, 
Benzo (a) pyrene and LTV- induced mutations in Ames 
Test. Dietary research on the impact of foods and 
beverages on human health has been globally dominant 
in the last decade. Flavonoids, a group of phenolic 
compounds occurring abundantly in vegetables, fruits 
and green plants, attracted special attention as they 
showed high antioxidant property. The antioxidants are 
known to prevent cellular damage caused by reactive 
oxygen species. Catechins are highly potent flavonoids 
present in tea and serve perhaps as the best dietary 
source of natural antioxidants. The tea shrub (genus 
Camellia, family Theaceae) [chromosome number 
(2n = 30)] is a perennial evergreen with its natural habitat 
in the tropical and sub tropical forests of the world. 
Cultivated varieties are grown widely in its home 
countries of South and South East Asia, as well as in 
parts of Africa and the Middle East Based on differences 
in morphology between Camellia sinensis var. assamica 
and Camellia sinensis var. sinensis, botanists have long 
asserted a dual botanical origin for tea (Yamamoto et al., 
1994). Camellia sinensis var. assamica is native to the 
area from Yunnan province, China to the northern region 
of Myanmar and the state of Assam in India. Camellia 
sinensis var. sinensis is native to eastern and 
southeastern China (Yamamoto at al., 1994). Historical 
references to tea date back to 5,000 years. Tea was 
consumed even earlier by the indigenous peoples of 
China. Tea recorded as having medicinal value in a 
Chinese medical book (Maciocia, 2005). In Chinese and 
Indian traditional medicine, tea has been used for. 
treatment of insomnia, calming effects, mental and visual 
clarity, thirst quenching, detoxification of poisons, 
improving digestion, prevention of indigestion, breaking 
down oils, fats, body temperature regulation improving 
urination, speeding bowel evacuation, treatment of 
dysentery, loosening of phlegm, strengthening of teeth, 
treatment of epigastric pain, treatment of skin ftmgus, 
reducing hunger and longevity. 
Tea processing: Leaves of Camellia sinensis soon begin 
to wilt and oxidize if not dried quickly after picking. The 
leaves turn progressively darker because chlorophyll 
breaks down and tannins are released. This process, 
enzymatic oxidation, is called fermentation. Tannins, a 
group of simple and complex phenol, polyphenols and 
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flavonoid compounds produced by plants, are relatively 
resistant to digestion or fermentation (Abe et al., 2008). 
The next step in processing is to stop the oxidation 
process at a predetermined stage by heating, which 
deactivates the enzymes responsible. Processing involves 
following steps (Werkhoven, 1978): 
• Withering (the process of letting leaves lose 
moisture content after plucking; often the first step in 
the processing of tea) 
• Rolling (ruptures cell walls allowing the polyphenols 
to become oxidized).s 
• Fermenting (the process of the polyphenols 
becoming oxidized) 
• Firing (Halls the fermentation process and begins 
desiccation) 
• Drying (reduces moisture content to make the final 
product more stable) 
The various types of tea are made by different 
combinations of these processes. 
The young shoots or flushes are plucked and 
processed into green (unfermented), black (fermented), 
oolong, (red, partially fermented) or yellow . (partially 
fermented) teas. In fermented teas, the action of leaf 
oxidizing enzymes, convert the tannins and catechins in 
tea leaves into brown/red colored products. 
Tea is a rich source of polyphenols called flavonoids, 
the effective antioxidants found throughout the plant 
kingdom. The slight astringent, bitter taste of green tea is 
attributed to polyphenols. A group of flavonoids in green  
tea are known as catechins, which are quickly absorbed 
into the body and are thought to contribute to some of 
the potential health benefits of tea. The fresh tea leaves 
contain four major catechins as colourless water soluble 
compounds: epicatechin (EC), epicatechin gallate (ECG), 
epigallocatechin (EGC) , and epigallocateohin gallate 
(EGCG) (Zhu et al., 2000) (Fig. 1). EGCG makes up about 
1 X50% of the total catechin content and appears to be the 
most powerful of the catechins. In a fresh tea leaf, 
catechins can be up to 30% of the dry weight Catechins 
are highest in concentration in white and green teas, while 
black tea has substantially less content due to its 
oxidative preparation. Catechin levels reported for black 
teas ranged from 5.6-47.5 mg g. In green teas cateebin 
levels ranged from 51.5-84.3 mg g`', with epigallocatechin 
gallate (EGCG) being the main catechin in Chinese and 
Indian green teas. Tea contains theanine and the 
stimulant caffeine at about 3% of its dry weight, 
translating to between 30 and 90 mg per 0.25 L cup 
depending on type and brand and brewing method. Tea 
also contains small amounts of theobromine and 
theophylline. Tea also contains fluoride, with certain 
types of brick tea made from old leaves and stems 
having the highest levels. The health benefits of tea 
ranging from a lower risk of certain cancers to weight 
loss and protection against Alzheimer's, have been 
linked to the polyphenol content of the tea. Green tea 
contains between 30 and 4091 of water-extractable 
polyphenols, while black tea (green tea that has been 
oxidized by fermentation) contains between 3 and 
10%. Oolong tea is semi-fermented tea and is 
somewhere between green and black tea. Dried green tea 
(Epch 	 )-EPg.Il echin 
(-}E 	in-3-  
Fig. 1: Main catechin components of green tea polyhenols 
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1. Theafavin-1 R,=R,= H 
2. T1~eafiavin-3gil1atc A R,— gellayl R,- H 
3. Teafwvin.'-galleto-B R,-11 R,- gallcyi 
a. Theafiav9n-3, 3'-digallate-B R, =R,— galloyl 
Fig. 2; Main polyphenols found in black and oolong tea 
leaves contain about 30-40% Catechins, 3-6% Caffeine, 
- 310 mg polyphenols per 6 ounces, while black tea 
(Crushed tea leaves - Polyphenol oxidase —► Oxidation? 
Polymerization) contains 3-10% Catechins, 2-6% 
Theaflavins, >20% Thearubigins, 3-6% Caffeine, -340 mg 
polyphenols per 6 ounces. (According to Nutritional 
Science Research Group, Division of Cancer Prevention). 
Both catechins and theaflavins have recently received 
much attention as protective agents against 
cardiovascular disease and cancer. (Imai and Nakachi, 
1985; Buschman, 1998; Yang, 1999). They are also 
believed to have a wide range of other pharmaceutical 
benefits, including antihypertensive (Henry and 
Srepens-Larson, 1984; Hara at al., 1987), antioxidative 
(Zhang at al., 1997; Halder and Bhaduri, 1998) 
hypolipidemic (Chan at al., 1999; Kona at al., 1992) 
activities. 
Most of the green tea catechins, during the 
manufacture of black tea, are oxidized and converted into 
orange or brown products known as theaflavins (TF) and 
thearubigins (TR). These compounds retain the basic 
C6-C3-C6 structure and are thus still classified as 
flavonoids. Theaflavins consist of two catechin molecules 
joined together and account for about 10% of the 
converted catechins, whereas the thearubigins are more 
complex flavonoid molecules, whose structural chemistry 
are still unknown and may account for up to 70% of 
flavonoids in black tea. The major TF in black and oolong 
tea are theaflavin (TF,), theaflavin-3-gallate (TF), 
theaflavin-3'-gallate (TFB) and theaflavin 3,3'-digallate 
(TF) (Zhu at al., 2000) (Fig. 2). Theaflavins and 
Thearubigins are responsible for the characteristic color 
and flavor of black tea. Hence it is rightly quoted by 
Bernard-Paul Heroux, a Basque Philosopher that There is 
no trouble so great or grave that cannot be much 
diminished by a nice cup of tea. 
The health benefits of tea ranging from a lower risk of 
certain cancers to weight loss and protection against 
Alzheimer's, have been linked to the polyphenol content 
of the tea (Table 1-4). It is generally believed that possible 
beneficial health effects of tea polyphenols are due to 
their anti-oxidant activity, wrote lead author Hui Cheng 
Lee from the National University of Singapore. 
Studies on tea polyphenols were done through 
computerized literature searches using the following 
databases: Medline, Abstract (Pubmed), Embase, Amed, 
Google Advanced Search, Only studies indicating the 
type of tea polyphenols and biological effects of tea and 
tea polyphenols were included. No language restrictions 
were imposed. Various studies on tea polyphenols have 
been summarized in tabular form as follows. 
RESULTS AND DISCUSSION 
Thus we have seen that all of the above findings 
clearly report the important biological effects of tea 
polyphenols. Green tea, being a rich source of 
polyphenols, contributes to various beneficial health 
effects (Cabrera et al., 2006). 
Tea and cancer: As interpreted from the above data, it 
follows that (EGCG) epigallocatechin gallate, a major 
catechin of found in green tea, has possible role in 
chemoprevention and chemotherapy of various types 
of cancers mainly prostate cancer (Siddiqui et al., 
2006a, 2007e; Lyn-Cook at at, 1999) and colon cancer 
(Xiao at al., 2008; Yuan at at, 2007) (Table 1, 2). EGCG 
inhibits the growth of gastric cancer by reducing VEGF 
production and angiogenesis and is a promising 
candidate for anti-angiogenic treatment of gastric cancer 
(Zhu at al., 2007). Green tea extracts contain a unique set 
of catechins that possess biologic activity in antioxidant, 
antiangiogenesis and antiproliferative assays that are 
potentially relevant to the prevention and treatment of 
various forms of cancer (Cooper etal., 2005a,b). Green tea 
and (-)-epigallocatechin galIate (EGCG) are now 
acknowledged cancer preventives in Japan and has made 
it possible for us to establish the concept of a cancer 
preventive beverage (Fujiki at al., 2002). Green tea 
polyphenols 	inhibit angiogenesis and metastasis 
(Isemura et al., 2000; Ju at at, 2007) and induce growth 
arrest and apoptosis through regulation of multiple 
signaling pathways. Catechins are involved in cellular 
thud-dependent activation of mitogenic-activated protein 
kinases (Opare Kennedy at al., 2001). Specifically, EGCG 
regulates expression of VEGF, matrix metalloproteinases, 
4 
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Cable 1: Studies carried out on catechins, green tea polyphenols  
i.No. Properties     Model used References 
1 Inhibit 17 a-Hydroxylase/C(17,20)- Lyase (CYP17) Rat testis    Kimura etal. (2007) 
2 Digestive recovery of Catechins modulated Liver a rects Great e1 al (2007) 
(in vtbo digestion profiling 
using HFCL) 
3 Increase cellular lipid antioxidant activity of Human intestinal CaCO2 cells Infra and Kuo (2007) 
Vitamin C and E 
4 Act against Octratoxin A-induced cell damage Pig kidney cal] line LLC-PK-1 Costa et aL (2007) 
5 Protects reactive oxygen species induced degradation Isolated cell Erection from Raze and John (2007) 
of lipids, proteins and 2-deoxyn'bose Rat liver. 
6 Upreg1ates Superoxide disnu Lase (SOD), Reversing DronophUa melanogaster Li and John (2007) 
fat-induced mortality. 
7 Prevents development ofspontaneous stroke. Male Malignant stroke prone Ikeda el al. (2007) 
spcntaneottsly hypersensitive rats 
S lob ibits bacteria] DNA gyrase by interacting with its Bacteria Gradisar et al. (2007) 
ATP binding site 
9 Reduces blood glucose level by Rat Matsui e1 al. (2007) 
a-glucosidase inhibition 
10 Supplements in reducingbody fat, as well as other Epide tiological observations in Basu artdlucas (2007) 
biomaskers of cardiovascular disease risks. humans of Southeast Asian countries 
11 Green tea has potentials for the prevention as well as Prostate cancer (PCa) cell lines. Siddiqui et al. (2007e) 
treatment of Pca. 
12 Has medicinal properties with special reference to Animal models of careinogenesis Khan and Mukhtar 
cancer and cardiovascular diseases. (2007) 
13 Regulates egression of VEGF, matrix Human epidemiological studies Shankar et al. (2007a) 
metalloprotemases, u?A,1GF-1, EGFI~ 
cell cycle regulatory proteins and inhibits 
Nlk D, PI3-KIAkt, RasIitnfiMAPK and AP-1 
signaling pathways, thereby causing strong cancer 
chcmoprevcntive.efects. 
14 Interfere with the emulsification, digestion and Human epidemiological studies Koo and Noh (2007) 
micellar solubilizaliat of lipids, critical steps 
involved in the intestinal absorption of dietary fat, 
cholesterol and other lipids. 
15 Strongly inhibit P1am+odwnfalcipannn growth Fk me firm fnlc[pansm (in vitro) Saanella et d (2007) 
in s frv. Thus green tea has antimalarial properties. 
16 Decrease the total number ofACF and the total Amxyrnethanc (AOM)-induced rat Xi no et aL (2008) 
number of aberrant crypt per rat. colon cancer used as model and 
aberrant crypt fpci (ACF) as an 
endpoint. 
17 Act as brain permeable iron chelator, hence has in vitro and hi vivo animal stud ice Mandel e1 al. (2006) 
potential for treatment of neurodegenerative diseases 
18 A email reduction in cytocluurneP450 (CYP3A4) Epidemiological studies ofhuman Chowel al. (2006) 
activity beings. 
19 Have positive inotropic effect and protective role in Guinea pig heart Hotta etal. (2006) 
myocardial ischemia-reperfusicn induced injury (NO electrode and Iluorometry) 
20 Have antioxidant activities. Trolecc equivalent antioxidant Secram et al. (2006) 
capacity {TFAC) and Oxygen 
radical antioxidant capacity assay 
(ORAC f. 
21 Cytotaxicity and cytoprotective mechanism evaluated. Isolated rat hep atocytes Galati et al (2006) 
(Mitoehondrial membrane potential 
collapse and ROS formation) 
22 Exhibit antioxidant activities, inhibition of cell Cell culture and animal model Siddiqui eat 
proliferation, induction ofapoptosis, eelI cycle arrest systems of cancer including cancer (2006a) 
and modulation of carcinogen metabolism. of the prostate gland (CaP). 
23 Chemoprevention of lung cancer by tea. Epidemiological studies on hwnan Clark and You (2006) 
cancer. 
24 	COrem tea consumption is associated with reduced A pcpulatien-based, prospective 	 Kvriyama eta! (2006) 
mortality due to all causes and due to cardiovascular cohort study in Japanese adults, 
disease but not with reduced mortality due to cancer, with over 11 years of follow-up. 
25. 	Growth of certain pathogenic bacteria was Differed strains of intestinal 	 Leeet d (2005) 
significantly repressed by tea phenolics and their bacteria 
derivatives, 
26 	Production of IL-S after stimulation by Nasal mucosal fibroblasts and A549 	 Kim et al. (2006) 
proinflanonatory cytokines in both nasal fibroblasts bronchial epithelial cells were 
and bronchial epithelia] cells was significantly analyzed for the production of rL-a 
blocked by pretreatment with Been tea polyphenols. 
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S. No. Properties Model used References 
27 Have hypolipidemic and anti-obesity effects. Various animal model systems. Lin andLin-Shiau (2004) 
28 Peroxldation of LDDL is markedly prevented by LDL of human blood serum ostrowska and 
green tea extract Skrzydlewska (2006) 
29 Decrease the extent of lipid perevddation and enhance 7,12-dimethylbenz[a]antla•acene Chandra 
the levels of GSH, GSHJGSSG ratio and activities (DMBA)-induced hamster buccal Mohan et al (2006) 
ofGSH-dependent enzymes. pouch (HBP) caxcinogenesis 
30 Potent inhibitor of inlhlenza virus replication and Influenza virus subtypes AIHINI, Song etal. (2005) 
also suppressed viral RNA synthesis AI113N2 And B virus 
31 Protect erythrocytes against Ier-butyl hypremdde Erythrocytes from type 2 Diabetics Rizvi et a4 (2005) 
induced oxidative shess., thus protect against mammal 
development of ]eng-term complications of diabetes 
32 Suppnesspostprandialhypeririacylglycerolemiaby Murine model Ikedaeto1.(2005) 
slowing down trig]ycerol absoiptian through the 
inhibition of pancreatic lipase, 
33 Possess biologic activity in antioxidant, In vitro and in vivo animal studies. Cooper et aL (2005) 
antiangiogenesis and antiproliferativeassays. 
34 There is inhibitory effect oftheaflavins and UVB lndnced phosphorylation of Zykova et aL (2005) 
EGO.) onUVB-induced STATI (Ser727), ERKs, STAT1 (Scr727) in mouse 
JNKs, PDKI and p90RSK2phosphorylation. epidermal JB6 C141 cells was 
observed. 
35 Act as chemopreventive, natural healing and Epidemiological studies on human. Hsu ei at (2005) 
anti-aging agents for human skin. 
36 Tea represents an important source of dietary Healthy and obesepeople tested for Zielirtska-Przyjemska 
antioxidants. reactive oxygen species (ROS) and Dobrowolska 
production. Inflammatory marker: -Zachwieja (2005) 
CRP. estimated. in vitro studies 
of human neutrophils also made 
37 Heteroactivation of cytochrome P450 1A1 occurs by 7-ethoxyresorufin deethy lase as an Anger el aL (2005) 
teas and tea polyphenols. A crude extract of black tea index of cytochrorne P4501A1 
polyphenols inhibited 7-ethoxyresorufm dectzylase, (CYPOA1) activity in liver 
microsornes from rats pretreated 
with 3-methylcholanthrene. 
38 Tea extracts, particularly Darjeeling tea extract, Chinese hamsterv79 cells Sinha et aL (2005) 
are effective in counteracting the clastogenicity 
(chromatid breaks, in particular) of the most 
potent form ofAs, sodium aisenite. 
39 Inhibit multidnig resistance(MDR) S7aplrylocactusf ca ceus Gibbons et at 
in . apJrylococcaLr to cnar (2004) 
40 Inhibit of P-glycoprotein (P-gp) in KB-C2 cells Kitagawa et al 
multidrug-resistant P-gp overcxpressing cells. (2004) 
41 Have t3ypanocidal action against trypomastigote Blood of infected BALB/c mice Paveto etal. (2004) 
and amastigote forms and inhibit arginine [parasite is 7lypan osoma cruzL] 
kinase enzyme activity. 
42 Have antiproliferative activity and prevents Hepatoma cells and Crespy and Williamson 
hepatotoxicity. Long-term intake of Catechins hepatoma-treated rats, (2004) 
is beneficial against lipid and glucose metabolism 
disorders 
43 Green tea has protective effect on adenomatous Epidemiological studies of green Borrelli or al (2004) 
polyps and chronic atrophic gastritis formations, tea consumption in relation to 
gastrointestinal cancer. 
44 Lower risk of simple infections, like bacteria] and Epidemiological studies, Siddiquietal 
viral, to elir nic debilitating diseases, including in vitro as well as in vivo, (2004) 
cancer, coronary heart disease, stroke and osteoporosis. on human. 
4$ Has irlucitory effects on the production xf a Porpsryromwuu eancmva! S akanaka and Okada 
virulence factor of the periodontal-disease-causing (2004) 
anaerobic baetesivmPorphyromonasgugivabr 
46 Act as reactive oxygen species scavengers Human and animal models Higdon and Feri 
(antioxidant activity) and art as protective agent (2003) 
against oxidative DNA damage in animal models 
47 Act as inhibitor of BACE1 activity in BACE1 { beta-secretase} Jean el aL (2003) 
not -competitive manner with a substrate in activity assay 
Dixon plots. 
48 Cytotoxic to breast cancer cells, thus have Human and rodents breast cancer Rosengren (2003) 
potential in the treatment of breast cancer, cells bi vitro 
49 Help in inhibition of cancer cell proliferation and of a Cultured HeLa cells (NADH oxidase Morrd et al. (2003) 
cancer specific oxidase(EC O NOX). {ECrO-NOX) activity assay) 
50 Inhibit carcinogen-induced increases in the oxidized Animal models of skin, lung. colon, Frei and Higdon (2003) 
DNA base, 8-hydroxy-2'-deoxyguanosine hi vivo. liver, pancreatic cancer and 
atherosclerosis 
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51 Promotes health and reduce disease occurrence and Cell cultures and animal models Pan el al. (2003) 
possibly protect against Padcineon's disease and 
olherneurodegenerative diseases. 
52 Demonstrate cancer preventive activity. Cell cultures and animal models Lambert and Yang 
(2003) 
53 Inhibit the development of prostate and breast Epidemiological studies an human Gonzalez de Mejta. 
cancer, exhibiting antioxidant and anticarcinogenic and animal studies. (2003) 
activities. 
54 Protect the cells from arsenic induced cytotooticity. Chinese hamster Sinha at a].. (2003) 
V-74 se]la in cultam 
55 Act as a biological antioxidant in a cell culture Cultured rat calvarial osteoblasts. Park et al. (2003) 
experimental model and protect cells from Oxidative stress was induced in 
oxidative stress-induced toxicity. cultured osteoblasts, either by 
adding HzO% or by the action 
xanthine oxidase (XO) in the 
presence ofxanlhine. 
56 Act as a biological antioxidant and protect veins Human saphenous veins. Oxidative Han at al (2003) 
from oxidative stress-induced toxicity, stress was induced exogcnously in 
the vein segments, either by adding 
or by using of xanthine 
oxidase in the presence of xanthine. 
57 Have anti-diabetic activity and have role in reducing Murinemodel Sabu of a1, (2002) 
oxidative stress in experimental diabetes. 
58 Have antioxidant activity. Mu nine model Ioannides and 
Yoxall (2003) 
59 Tea polyphenols could play a role in the pathogenesis Epidemiological and clinical McKay and 
ofcancer and heart disease, studies of human. Blumberg (2002) 
60. The polyphenols ofgreen tea cause the Rainbow trout gelatinase activities Saito of ul (2002v) 
strong inhibition of some gelatinase activities 
61 Green tea eolract, show direct scavenging activity A nitric oxide (NO) and superoxide Nakagawa and 
against NO and Q(2)(-) and green tea tannin (D=-)) generating system In vi -o Yokozawa (2002) 
mixture, at the same concentration, showed high 
scavenging activity. 
62 Black, green and oolong teas were all shown to Mammalian epididymai fat cell Anderson and Pallansky 
increase insulin activity. Thus, tea contains assay in vitro (2002) 	- 
in vita insulin-enhancing activity and the 
predominant active ingredient is 
epigallocatechin gall ate, 
63 The greater inhibitory potency of tea in the Satmwnstla assay, using rat liver Santana-Rios e1 of 
Salmonella assay mightbe related to the relative in the presence of 59. (2001) 
1 evels of the nine major constituents, perhaps 
acting synergistically with other (minor) 
constituents, to inhibit mutegen activation 
as well as scavenging the reactive intcmiediate(s). 
64 Green tea has preventive effects on both chronic TNF alpha-de$cient mice and Sueoka et of (2001) 
infla mnatcay diseases and lifestyle-related diseases 1NF-alpha transgenic mice, which 
(including cardiovascular disease and cancer), overexpress TNF-alpha only in the 
resulting in prolongation of life span. lungs. 
65 Inhibits breast cancer and endothelial cell Breast cancer growth and endothelial Sartippour et al. 
proliferation. cells in in vth'a assays and in animal (2001) 
models. 
66 Inhibit cell proliferation and induce apoplosis. NNK induced lung tumorigenesis .Yanger a1. (2000) 
mice model. 
67 Treatment of human skin with varying doses Mouse models of Katiyar et al. 
afGTP (1-4 mgl2.5 cm2 of skin area) before a photocarcinogenesis (20003) 
single dose of UVB exposure decreased dose 
dependently thefmnation ofUVB-induced 
CPDs in both epidermis and dermis, 
68 Posses anti-inflammatory and anticarcinogenic Chemical carcinogenesis and Katiyarel al. 
potential, which can be exploited against avariety photocarcinogenesis in murine skin. (2000b) 
of skin disorders. 
69 Possess antimutageniclantioxidantactivity Modified Ames tests, superoxide Pillai etal. (1999) 
scavenging assays and assays for 
protection against DNA scission 
used 
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Table 2: Studies carried out on 	i 	llocatechin-3- allate (-)EGCG 
S.No. Properties Modelused References 
1 Act as an anti-oxidant and anti-inllarnmatoly agentSor Animal and human epidemiological TlTipae et aL (2007) 
cardiovascular protection. studies 
2 Inhibits cell cycle and induces apoptosis in pancreatic Human pancreatic cancer cells. Shankar et al. (2007b) 
cancer 
3 Reduces autoimmune symptoms in a marine model for The NOD mouse, a model for human Hsu e1 al. (2007a) 
human SjogeWs , yndmine, through activation of Sjogren's syndrome (SS). 
MAPK elements and protect human salivary acinar 
cells fromTNFalpha-induced cytotoxicity. 
4 Inhibits SMC-ECM interaction and the action Rat vascular smooth muscle cell Lo et al. (2007) 
mechanisms are through interference with SMC's (SMCs) adhesion and migration 
integrin betal receptor and binding to extraceltular experiment, on collagen and 
matrix (ECM) proteiru.. larninm. 	. 
5 Combined inhibitory effects of (-)-EGCG andNS-398, Human prostate cancer cells Adhami et a1. 
a selective cycloaxygenase-2 inhibitors, occurs on the LNCaP, PC-3 and CWR22Rnu1 (2007) 
growth of hnrnart prostate cancer cells both and in vivo, sihymic nude mice 
in vitro and in vis v. implanted with androgen-sensitive 
CWR22Rnul cells. 
6 Protective effect when applied topically before OVA 12-week-old Wistar albino rats. Sevin et al. (2007) 
exposure. No benefit was detected when EGCG was 
applied after UJV exposure. 
7 Catechin and (-)-EGCG treated collagen exhibited Assay of collagenolytic activity Madhan clot. (2007) 
56 and 95%orcsistance, respectively, against by collagmase. 
collagenolytic hydrolysis by collagenasc . 
S (-)-EGCG in green tea polyphenols ((IT?) is the Epidemiological and laboratory Kumar etal. 
most potent chemapreventive agent that can induce studies. (2007) 
apoptosis, suppress [befontnation and growth of 
human cancers including colorectal cancers (CRC). 
9 Functions as proeeddants to activate Saccf~ontmes cer•evlsiae Macta ei aL (2007) 
oxidative-stress-responsive transcription ScldamwcFwrom}+ces porn be 
factors in yeasts- under weak alkaline conditions. 
10 Prevents UVB-induced skin tumor development UVB-induced skin tumor in mice. Katiyar el al. (2007) 
in mice. 
11 Induces easpase 14 in epidermal keratinocytes via Normal human epidermal Hsu clot. (2007b) 
MAPK pathways and reduces psoriasiform lesions keratinoeytes (NHEK) and 
in the flaky skin mouse model, flaky skin mouse model. 
12 ()-EGCG, when was included in the incubation Human intestinal CaCD2 cells Intro and Kuo (2007) 
with vitamin E or C, more antioxidant activities 
were consistently observed than when vitamins 
were added alone. 
13 Improves endothelial function and insulin Spontaneously hypertensive rats Potenza et al- (2007) 
sensitivity, reduces blood pressure and protects (SHR; model of metabolic syndrome 
against myocardial IIR injury in SHR with hypertension, insulin resistance 
and overweight). 
14 Inhibits proliferatiorn of human breast cancer cells In vitro cell culture models and Thangapaaham et aL 
in vitro and in vivo and also found to induce in vivo allrymic nude mice models (2007) 
apoptosis and inhibit the proliferation when the of breast cancer. 
tumor tissue sections were examined by 
iminuno hi stochemi s t y. 
15 The antibacterial activity of ()-EGCG was Meihicillin-resistant Staphylococcus Hatano et at. 
enhanced in the presence ofascorbic acid and ascorbic aureus (MItSA). (2007) 
acid was the most effective for retaining the 
concentration of stable EGCG. 
16 (-)-EGCG treatmeatr'educes expression of two Human mast cell line HMC-1. Melgarejo el al. 
integrins (alphas and beta3) and a chernokine (2007) 
(MCPI), resulting in a lower adhesion of mast 
cells associated with a decreased potential to 
produce signals eliciting monocyterecruitment. 
17 (-)-EGCG treatment inhibited the hyphal Murine model of disseminated Han (2007) 
formation from the yeast Loran of C. albicans, candidiasis caused by 
causing growth-inhibition of the candidal cells Gm&da albicant 
and there occurs synergic anticandidal effect of 
EGCG combined with amphotericin B. 
1. (-)-EGCG inhibited early but not late stage PCa. Male. TRAMP (Transgenic Hanger etaL (2007) 
Adenocarcinoma Mouse Prostate) 
19 (-)-EGCG can induce apoptosis ofMKN45 cells Human gastric cancer cell line Ran et al. (2007) 
in time- and dose-dependent manner. The apoptotic MKN4S. 
pathway triggered by EGCG in MKN45 is 
mitochondrial-dependent 
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20 	(-)-EGCG treatment causes mice survival rates 	 7)3pa x coma cna cpimastigote 	 Gaida ct aL (2007) 
increased from 11%to 60°/%while parasitemia form and murine model of acute 
diminished to 503 & The treatment also produced 	 Chagas' disease. 
oligosomal fragmentation of epimastigotes DNA, 
suggesting a prograrnntcd cell death 
(PCD)-like process. 
21 Inhibition oftrunorigenesis in ApcNfinl+mice Apc (Mite/+) mice Bose el aL (2007) 
occurs by a combination of(-)-EGCG and fish oil. 
22 (-)-EGCG treatment protects against Neuron cc lie Lee and Lee (2007) 
glyceraldehyde-derived advanced glycation 
endproducts (AGE)-induced neurotmcicity. 
23 (-)-EGCG presynaptically facilitates Nerve terminals purified from rat Chou of aL (2007) 
Ca24-dcpndn5 gli tarnate release via activation cerebral toricx. 
of protein kinase C in rat cerebral cortex 
24 (-)-EGCG has a preventive effect on the growth Colon tumor implanted Yuan et aL (2007) 
and liver and pulmonary metastases of orthotopie orthotopically in the cecum of nude 
colon cancer in nude mice and this anticancer mice. 
effect could be partly caused by activating the 
25 Nr12-IIGfIA signal pathway. Human SH-SYSY neuroblastoma Weinreb et aL 
Exhibition ofantioxidative-iron chelating activities cells. (2007) 
of(-)-EcJCG underlying its neuroprotectivel 
neurorescue mechanism of action, further suggesting 
a potential neurodegenesative-modifying effect 
for EGCG. 
26 (-)-EGCG inhibits the binding of cpidamal gros+th HT29 colon cancer cells. Adachi et aI. (2007) 
factor EGF to the EGFR and the subsequent 
dimerization and activation of the EGFR by 
altering mzsnbrane organization. 
27 (-)- EGCG suppresses expression of receptor activator Osteoblast-like NRG cells Ishida aid. (2007) 
ofNF-kappaB Jigand (RANKL), which indicated an infected with 
inflammation suppression effect of EGCG in Staplrylvcaccw ass eus 
osteomyelitis treatment. 
22 The O-aryl derivatives of (-)-EGCG have the potential 7,12-dimethylbenz[a]anthracene Vyas e1 aL (2007) 
to be developed as cancer chemopreventive agents. (D3IBA)/12-0-tetradecanoylphorhol 
13-acetate (CAA)— induced cancer in 
Swiss albino mice. 
29 Cells Treated with a combination of bicalutamide and NRP-152 and NRP-154 prostate Morrissey et al, 
(-)- EGCG also demonstrate a dose-dependent decrease epithelial cells. (2007) 
in cell number, growth arrest and apoptosis in prostate 
ep ilhelia[ cells, that was significantly greater than 
bicatutamide alone 
30 (-)- EGCG inhlbits telomerase and induces apoptosis Human Small-cell lung carcinoma Sadava et a. (2007) 
in ding-resistant lung cancer cells. (SCLC) cells. 
Activation ofFOX03a by 
31 (-)- epigallocatcchin-3-gallate induces estrogen Her-2lneu-driven mammary Belguise et aL 
receptor alpha expressi1 reversing invasive tumor cells. (2007) 
phenotype ofbmast cancer cells. 
32 (-)-EGCG ftutctions as an antioaddant, preventing A comprehensive search of the Carlson et a! (2007) 
oxidative damage in healthy cells, but also as an PubMed database and other 
antianglogenic agent, preventing tamees from se condaiy data sources, regarding 
developing a blood supply needed to grow larger. the chemopreventive potential of 
EGCG 
33 (-)-EGCG improves systemic hemodynamics and Rodent model of p olymicrobial Wheeler el at. 
survival in rodent models oEpolymioebtaf sepsis. sepsis. (2007) 
34 (-)-EGCG ameliorated histological changes and Rat pancreatic fibrosis issduced Meng et al. (2007) 
significantly suppressed collagen deposition in a by diethyldithiocarbantate (DDC). 
dose-dependent manner. It also inhibits 
overexpression ofTGF-betal and alpha-smooth 
muscle actin (a symbol of activation of pancreatic 
stellate cells). 
35 	(-)-EGCO suppresses heregu[in betat-induced fatty 	 MCF-7 breast cancer cell line. 	 Panel al. (2407) 
acid sysithase expression in human breast cancer 
cells by inhibiting phosphatidylinositol 
3-kaiase/Akl and mitogen-activated protein kmase 
cascade signal 
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36 	(-)-EOCG acutely improves endothelial function in 	 Patients with euralary artery 	 Widlansky etal. (2007) 
humans with coronary artery disease, 	 disease examined for endothelial 
functias and brachial artery 
flow-mediated dilation, 
37 ()-EGCG caused a Ca(2+) influx into smooth Cultured rat aortic smooth Campos- 
muscle cells via VOCC (probably L-type) and other muscle cells. Toimil and Orallo 
SKF-96365- and Cd(2+)-sensitive Ca(2f)-permeable (2007) 
channels. 
38 Administration of (-)-EGCG. selenium and ES-2 ovarian cell line. Wilson- 
thyrmoquinone, selenium suppress metabolic activity, Simpson of a1. 
alter behavioral responses and causemolecular damage (2007) 
in aggressive behavioral activity of ovarian 
carcinogenesis. 
39 0-acetylated ()-EGCG analogs possessing a p-NH(2) Molecule designed. Osanai etal. (2007) 
or p-NHBoc (Boc; tert-butoxycarbonyl) D-ring 
(5 and 7) act as novel tumor cellular pmteasome 
inhibitors and apoptosisinducers with potency 
similar to natural (-)-EGCG and similar to (-)-EGCG 
peracetate. 
40 Peracctatc-protcctcd (-)-EGCG [Pro-EGCG] enhances Cultured human breast cancer Landis 
levels ofproteasctne inhiibition, growth suppression MDA-ME-231 cells and -Piwowarerel. 
and apoptosis induction, compared with cells treated MDA-MB-231 tumors induced (2007) 
with natural (-)-J GCG. in nude mice. 
41 (-)- EGCG significantly arrests progression Rai model of hepatic Pibrogenesis Zhen etal. (2007) 
ofhcpatic fibrosis and caused significant amelioration and cultured hepatic stellate cells 
of liver injury (reduced activities ofsenun alanine (HSCs). 
ammotransferase and aspartate aminotransierase). 
42 (-)-EGCG significantly inhibits, in a dose-dependent Osteoclasts differentiated from Yun el a[. (2007) 
manner, the survival of esteoclersts differentiated RAW 264.7 cells. 
from RAW 264.1 cells and induced the apoptosis, 
via caspase activation of osteoclasis. 
43 Intraperitoneal injection ofBGCG inhibits the Heterotopic tumors were induced Zhu et al. (20007) 
growth of gastric cancer by 60.4%by reducing VEGF in nude mica by subcutaneously 
production and angiogenesis. injection of SGC-7901 cells. 
44 (-)-EGCG !rNbits TPA-inducedDNA binding of Mouse skin In viva. Kundu and Surh 
NF-ksppaB and CREB by blocking activation of (2007) 
p38 MAPK, which may provide a molecular basis of 
COX-2 inhibition by EGCG in mouse skin in silo. 
45 (-)- EGCG can induce apoptotic changes, including Human MCF-7 cells. Hsuuw and Chan 
mitochondrial membranepotential changes and (2007) 
activation of c4unN-terminal kinase QNK), 
caspase-9 and ca;pase-3. 
46 (-)- EGCG inhibits monocyle chemotectic protein-1 MCP-1 inhuman endothelial Hong el aL (2007) 
expression in endothelial cells via blocking ECV304 sells. 
NF-kappaB signaling. 
47 (-)-EGCO has a stronger reactive oxygen species Chemiluminesccnceanalysis. Tian et of (2007) 
(ROS) scavenging activity than ascorbic acid. 
48 (-)-EGCG inhibits extracellutar signal-related kinases Epidemiological, edip ocyte cell Moon at al, (2007) 
(ERK), activates AMP-activated protein kinase lines culture, animal and clinical 
(AMPK), modulates adipocyte marker proteins studies. 
and down-regulates lipogenic enzymes as well 
as other potential targets. 
49 (-).EGCG inhibited bladder carcinoma cell growth Human bladder carcinoma cells Riegec-Christ of aL 
and suppressed the in vitro migration capacity of and mice bladder carcinoma (2007) 
cells via downregulation of N-cadherin and xenografts bi tiivo. 
inactivation of AIt signaling. 
50 (-)-EGCG inhibits prostaglandin D(2)-stimulated Oeteoblast-like MC3T3-E1 cells. Yemauchi at al. 
H5p27 induction via suppression of the p44/p42 (2007) 
MAP kinase pathway in osteoblasts. 
51 Single GUV method reveals interaction of tea Single giantunilamellar vesicles Tamba et at 
eatechin (}EGCG with lipid membranes. (Guys) of lipid membranes of egg (2007) 
Phosphatidylcholine. 
52 	(-)-EGCG along with ethanol (EtOft) significantly 	 Human Chang liver cells. 	 Kaviarasanel al. 
prevents EtOH-dependent cell loss and lactate (2007) 
dehydrogcnaseleakage. 
323 
Int. J. Pharmacol., 4 (5): 314-338, 2008 
Table 2: Continued 
S. No, Properties  Model used References 
53 (-)-EGCG inhibits cardiac myocyte apoptosis Cardiac hypertrophy was Sheng el al. (2007) 
and oxidative stress in pressure overload induced established in rats. 
cardiac hypeirophy. Also, EGCG prevented 
catdiamyaryte apoptasisfrcm oxidative 
stress in vi. 
54 ()-EGCG enhances CD8+T cell-mediated antltumar MurinemodeL Kang et erg. (2007) 
imnuuiity induced by DNA vaccination. 
55 (.) EGCG pr xttotee the rapid protein kiaase Human neuroblastoma cell line Kalfon et al. (2007) 
C- and proteascane-mediated degradation ofBad SH-SY5Y. 
revealing a novel pathway in the neurcprotective 
mechanism of the action of EGCG. 
56 (-).EGCG prcraotedhag growth in hair fadictea Human dermal papilla cells Kwon el at_ (2007) 
ex silo culture and theproliferation of cultured DPCs. (DPCe) in vivo and in vf&o and 
hair growth in vitro. 
57 EGCG and epicatechin gallate inhibited lactate MAttcnu streptocQccl Hirasawa etal. 
dehydrogenase suggesting that EGCG is effective in (2006) 
reducing and production in dental plaque and 
mutans FtreptococcL 
53 (-)-EGCG has cancer chernoprevention, Epidemiological, cell culture, animal Zaveri (2006) 
hypercholestcrolcmia, arthorosclerosis, Parkinson's and clinical studies. 
disease, Alzheiinces disease and other aging-related 
disorders. 
59 Patients met criteria for partial response (PR) by Four patients with low grade Shanafelt etal. 
standard response criteria after self-initiating oral B-cell malignancies (2005) 
ingestion of(-)-EGCG containing products. 
60 InhIbition of catechol-O-mcthyltransferase (the enzyme Epidemiological, cell culture, animal Shixian et al. (2006) 
that degrades norepinephrine) is a possible explanation and clinical studies. 
for why the men tea exvact is effective in stimulating 
thermogenesis by ()-epigallocatechin gallate. 
61 (-)-EGCG, the main polyphenol in green tea, binds Human CD4+ T cells. Williamson et al 
to the T-cell receptor, CD4. Suggesting potential (2006) 
use of EGCG as adjunctive therapy in HIV-1 infection. 
62 (-)-E(3CG is a powerful antioxidant and vviien injected I» nitro studies on brain membranes Zhangand Osborne(2006) 
into the eye with SNP (sodium nitroprusside) (retina) and Blectroretinogram 
attenuates the detrimental influence of SNP to (ERG). 
retinal photoreceptors. 
63 (-)-EGCG mitigates neurcitoxicity mediated by Primary neurons in mice. Giunta elaL (2006) 
HIV-1 proteins gpI20 and Tat in thepresence of 
IFN gamma, thus EGCG may represent a novel 
natural compound for the prevention and treatment. 
of IRV-associated dementia (HAD)- 
64 (-)-EGCG induced apoptosis in Sarcornal80 cells Swiss albinomice having Manna etal. (2006) 
in vim: mediated by p53 pathway and inhibition inoculation of SarcomalSO 
in U1B. U4-U6 UsnRNAe rispression. (S 180) cells 
65 The mechanisms of(-)- EL3CG action, particularly the Epidemiological studies of human. Fujiki (2005) 
reduction of TNF-alpha are discussed and it is 
shown that the uae of 3H EGCG reveals a wide 
range of target organs for cancer prevention. 
66 Mechanisms of cancer prevention by (-).EGCG Epidemiological, cell culture and Sang etal. (2005) 
are not related to their redox properties, but are animal studies. 
due to the direct binding of the polyphenol to target 
molecules, including the inhibition of selected 
proteinkinases, rnatrixmetalloproteinasec and 
DNA mehy ltransfcases. 
61 (-)-EGCG causes significant induction of cell cycle Human melanoma cell lines (A-375 Nihal etal. (2005) 
arrest and apoptosis of melanoma cells that is amelanotic malignant melanoma and 
mediated via modulations in the ckhoyclin-edk ETs-294T metastatic melanoma) and 
network and Bc12 (amity proteins. normal human epidermal 
melanocytes (1VHE11l1). 
68 (-)-EGCG selectively inhibits COX-2 without Androgen-sensitive LNCaP and Hussain et al. 
affecting COX-1 expression in human prostate androgen-insensitivePC-3 human (2005) 
carcinoma cells. prostate carcinoma cells, 
69 The inhibition of S. maltaphilia dihydrofolate 18 isolates of,SXehofinp!aomof= Navarro- 
reduclase by (-)-EGCG is related to its antifolate makap1dGa Martinez et al. 
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Table 2: Continued 
S. No. Properties Model used References 
70 Inhibition of dihydrofolate reductase (DHFR) occurs Chicken, bovine liver dihydrofolate Navarro-Penin et a1. 
by EGCG and this explains why tea extracts have reduclase (DBFR). (2005) 
been traditionally used in alternative medicine as 
antiearcinogenic/antibiotie agents or in the treatment 
of conditions such as psoriasis. 
71 (-)-Epigallocatechin gallate attenuates theneurmmal Ganglionic neurons of the nodose Wei et at (2004) 
NADPH-d(nNOS expression in the nodose ganglion ganglion (NG) in acute hypoxic rats. 
of acute hypoxic rats suggesting that it may attenuate 
the oxidative stress following acute hypoxcia. 
72 (-)-EGCG suppressed ncutrophil infiltration by a direct Rat neutrophils in vitro and in vivo. Takano et al. (2004) 
action on neutrophila 
73 Generation of hydrogenpe -oxide primarily contributes Human T-cell acute lymphoblastic Nakagawa etaL 
to the induction of Fe(13)-dependent apoptosis in Jurkat leukemia Jurkat cells. (2004) 
cells by {)-EGCG. 
74 Epigallocatechin-3 gallate inhibits fler-2Jneu signaling. Her-2/neu-overexpressing breast Pianetti el at. 
proliferation and transforms phenotype of breast cancer cells (2002) 
cancer cells. 
Table 3: Studies carried Out on Enicatechin oi- Epieatechin Rallate IECG 
S. No. Properties Model used  References  
1 ECG attenuates UVB-induced keratinocyte death HaCaT keratinocytes. Huang et Id. (2007) 
dose-dependently. ECG markedly inhibits 
LIVB-viduced cell membrane lipid peroxidation and 
H202 generation in keratinocytee. suggesting that ECG 
can act as a free radical scavenger when keratinocytes 
are photodamaged. 
2 Sensitizes meticillin-resistant Staphylococcus aureus Methicillin-resistant Stapleton el of (2007) 
(MRSA) to beta-lactaor antibiotics. promotes Slaplry1acaccu.r ataezes (MRSA). 
staphylococcal Thus, Epicatechin gallate -mediated 
alterations to the physical nature of the bilayer will 
elicit ativct ral changes to wall teichoic acid that 
result in modulation of the cell-surfate properties 
necessary to maintain the beta-lactam-resistant 
phenotype. 
3 Green tea catechin ()-epicatecbin gallate induces HiCT- L16 cells. Chu et al. (2007) 
tumour suppressor protein ATF3 via EGR-I 
activation. Thus, EGR-1, a tumour suppressor 
protein, could substantiate ECG s role of ATF3 
expression in human colorectal cancer cells. 
4 in vitro cytotoxicity exhibited by ()-catechin galbate, Cells derived from tissues of the Babich e1 al. (2007) 
similar to its epimer, Epicatechin gallate and both human oral cavity. 
exhibited antiproliferative effect a. CG-induced apoptosis 
was detected 
5 Epicatechin gallate reduces haIotolerarice in Seiphylococcus rurrenr grown in the Stapleton et al. (2006) 
St.aphylxcxecur OWC um. Thus, this molecule can be presence of high-salt coneentrlions. 
used to aid the preservation of salt-containing foods. 
6 Tea flavan-3-ol gallate esters (i c. ECG, EGCG) and Primary cultures of rat Bastianetto et el (2006) 
gallic acid inhibits apoptotic events induced by hippocampal cells, 
Abeta-derived peptides, exhibiting neuroprotective 
effects of catechin gallate esters against 
beta-amytoid-induced toxicity. 
7 Epieatethin gallate end catechin gallate have capacity Methicillin-resistant Stapleton et al. 
to reverse oxacillin resistance in the homogeneous ,SYaplrylococcus aureus (MRSA). (2004) 
PBP2a producer B!3568 and in EMRSA-16. 
S. Catechin gallates inhibit multidrug resistance A wild-type and three Gibbons et ai. 
(MDR) in. aphylecoceus wireur. multidrug-resistant (MDR) (2004) 
strains of. c hylococcur aureur. 
Table 4: Studies carried out on Theatlavins and than ubicins (black tea nolvohenols 
S. No. 	Properties Model used References_ 
1 	Theallavins attenuate hepatic lipid accumulation Human HepG2 cells culture and Lin et of (2007) 
through activating AMPK in human Hey 02 cells, animal experimental model 
suggesting that theaflavins may be active in the 
prevention offattg liver and obesity. 
2 	Black tea polyphenols mimic insulinfinsulin-like Mammalian cell culture. Cameron ei of 
growth factor-1 signalling to the longevity factor (2007) 
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fable 4: Continued 
S. No. Properties Model used References 
3 A significant decrease in both chromosomal 11urnan lymphocytes in vitro. Halder et at (2W 
aberrations (CA) and micronuclei facmation 0&0 Mutagetslcarcinogcns wed are 
were observed in the human lymphocyte cultures benzo[ajpyeme (131a3P) and aflatoxin 
treated with either theaflavins and thearubigins_ B1(AFB1) with 59 activation. 
4 The theaflavin fraction (Tfs) produced a Marineskeletomotor apparatus. Basu el al. (2005) 
eoncantratian- dependent effect oTrticte ,ottArctit 
mechanism of skeletal muscle and that calcium 
and nitric oxide may modulate this action ofTfs. 
5 Antimtidative properties of black tea are manifested Bpidemiologica1 studies, In vitro Luczaj and 
by its ability to inhibit free radical generation, as well as in vino. Skrzydlewska 
scavenge free radicals and chelate transition metal (2005) 
ions. Black tea, as well as individual theaflavins, 
can influence activation of transcription factors such 
as NF7cappsB or AP-1. Theaflavins have also been 
proved to inhibit the activity of prowddative enzymes 
such as xanthine oAdase or nitric oxide synthase. 
6 Both the activepolyphen is theaflavins and SalmonellastrainaTA47a, TA98, Gupta at at (20(1a) 
thearubigins extracted from the black tea TA100 and TA102 in preincub alion 
(World blend) also showed significant anfimutagenic tests, both with std without 
effects against knoua positive compounds in these 59 activation. 
strains. 
7 Black tea active polyphenols theaflavins (M) wise albino mice measuring Gupta aid. (2002b) 
and thearubigins (!R) have significant anticlasto chic chromosome ab esrations (CA) and 
effects in bone marrow cells of mice sister chromatid exchanges (SC1;j. 
8 Theaflavin-3,3'-diga[laic from black tea blocks the Lipopolysarcharide-activated murine Lin at at (1999) 
nitric oxide synthuse by down-regulating the macrophages. RAW 364.7 cells 
activation ofNF-kappaB in macrophages. 
Gallic acid moiety of theafavin-3.3'-digallate 
is essential for their potent artti-inElaouoatiunT 
uPA, IGF-1, EGFR, cell cycle regulatory proteins and 
inhibits NFk B, P13-K/Akt, Ras/RaDMAPK and AP-1 
signaling pathways, thereby causing strong cancer 
chemopreventive effects (Shankar at al., 2007a). () -EGCG 
revealed a wide range of target organs for cancer 
prevention (Fujiki, 2005). Both (-)-epigallocatechin-3-
gallate and theaflavin-3,3'-digallate (major green and black 
tea polyphenols, respectively) inhibit the phosphorylation 
of c-jun and p44/42 (l RK 112). The galloyl structure on the 
B' ring and the gallate moiety are important for the 
inhibition (Yang et al., 2000). Most of the relevant 
mechanisms of cancer prevention by tea polyphenols are 
not related to their redox properties, but are due to the 
direct binding of the polyphenol to target molecules, 
including the inhibition of selected protein kinases, matrix 
metalloproteinases and DNA methyltransferases. It has 
been shown that, through severaj mechanisms, tea 
polyphenols present antioxidant and anticarcinogenc 
activities, thus affording several health benefits (Gonzalez 
de Mejia, 2003). Animal studies offer a unique opportunity 
to assess the contribution of the antioxidant properties of 
tea and tea polyphenols to the physiological effects of 
tea administration in different models of oxidative stress. 
Most promising are the consistent findings in animal 
models of skin, lung, colon, liver and pancreatic cancer 
that tea and tea polyphenol administration inhibit 
carcinogen-induced increases in the oxidized DNA base 
(Frei and Higdon, 2003). Green tea polyphenols and 
EGCG treatment were also found to induce apoptosis and 
inhibit the proliferation when the tumor tissue 
sections were examined by immunohistochemistry 
(Thangapazham at al., 2007). It has been confirmed by 
various techniques that EGCG inhibits telomerase and 
induces apoptosis in drug-resistant lung cancer cells 
(Sadava et al., 2007). EGCG may be useful in the 
chemoprevention of breast carcinoma in which fatty acid 
s'nthase (FAS) overexpression results from human 
epidermal growth factor receptor (HER2 orland HERS 
signaling) (Pan et aL, 2007). EGCG inhibits the growth of 
gastric cancer by reducing VEGF production and 
angiogenesis and is a promising candidate for anti-
angiogenic treatment of gastric cancer (Zhu et al., 2007). 
EGCG inhibited the to vih-o growth of invasive bladder 
carcinoma cells and decreases the migratory potential of 
bladder carcinoma cells (Rieger-Christ at at, 2007). Black 
tea polyphenols, theaflavins may have a major impact on 
the chemoprevention of oral cancer, than the green tea 
polyphenols (Chandra and Mohan, 2006). EGCG has a 
preventive effect on the growth of liver and pulmonary 
metastases of orthotopic colon cancer in nude mice and 
this anticancer effect could be partly caused by activating 
theNr12-tJGT1A signal pathway (Yuan at at, 2007). The 
inhibitory effect of(-)-EGCG on activation of the epidermal 
growth factor receptor is associated with altered lipid 
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order in HT29 colon cancer cells (Adachi et al., 2007). 
Activation of Forkhead box 0 transcription factor 
(FOXO3a) by the green tea polyphenol epigallocatechin-
3-gallate induces estrogen receptor alpha expression 
reversing invasive phenotype of breast cancer cells 
(Belguise et al., 2007). (-)-EGCG inhibits Her-21neu 
signaling, proliferation and transformed phenotype of 
breast cancer cells (Pianetti et al., 2002). 
Skin and tea polyphenols: The outcome of the several 
experimental studies suggests that green tea possess anti-
inflammatory and anticarcinogenic potential, which can 
very well be exploited against a variety of skin disorders 
(Katiyar el at., 2000b, 2001). Green tea polyphenols act as 
chemopreventive, naturally healing and anti-aging agents 
for human skin (Hsu, 2005). (-)- EGCG- is the major and 
most photoprotective polyphenolic component of green 
tea (Katiyar et al., 2007). The inhibition of LN light-
induced DNA damage in the form of cyclobutane 
pyrimidine dimers (CPDs) in the skin by green tea 
polyphenols treatment may, at least in part, be responsible 
for the inhibition of photocarcinogenesis (Katiyar et al., 
2000a) (Table 1). Green tea polyphenol induces caspase 14 
in epidermal keratinocytes via MAPK pathways and 
reduces psoriasiform lesions in the flaky skin mouse 
model (Hsu et al., 2007b). Signal transducers and 
activators of transcription (STATs) play a critical role in 
signal transduction pathways. Phosphorylation of STAT1 
(Ser727) occurs through PI-3K; ERKs, p38 kinase, JNKs, 
PDKI and p9ORSK2 in the cellular response to UVB. The 
aflavins and EGCG show an inhibitory effect on LNB-
induced STATI (Ser727), ERKs, JNKs, PDKI and 
p9QRSK2 phosphorylation (Zykova et al., 2005). EGCG 
inhibits 12-O-tetradecanoylphorbol-l3-acetate (TPA) 
induced DNA binding of NF-kappaB and CREB by 
blocking activation of p38 MAPK, which may provide a 
molecular basis of COX-2 inhibition by EGCG in mouse 
skin in vivo (Kundu and Surh, 2007). ECG dose-
dependently attenuates UVB-induced keratinocyte death. 
Moreover, ECG markedly inhibited i7VB-induced cell 
membrane lipid peroxidation and H202 generation in 
keratinocytes, suggesting that ECG can act as a free 
radical scavenger when keratinocytes were 
photodamaged (Huang et al., 2007). EGCG prevents UVB-
induced skin tumor development in mice and this 
prevention is mediated through (a) the induction of 
immunoregulatory cytokine interleukin (IL) 12; (h) IL-12-
dependent DNA repair following nucleotide excision 
repair mechanism; (c) the inhibition of UV-induced 
immunosuppression through IL-12-dependent DNA 
repair; (d) the inhibition of angiogenic factors and (c) the 
stimulation of cytotoxic T cells in a tumor 
microenvironment (Katiyar et al., 2000). 
Antioxidant effects of tea: (-)-Epigallocatechin-gallate ((-)-
EGCG) and (-)-epicatechin-gallate ((-)-ECG) exhibit 
antioxidant behaviour (Ryan and Hynes, 2007). 
Epicatechins in green tea and theaflav ins in black tea were 
found to be able to reduce the concentration of Reactive 
alpha-dicarbonyl compounds in physiological phosphate 
buffer conditions (Lo et al., 2006). Tea polyphenols act as 
antioxidants in vitro by scavenging reactive oxygen and 
nitrogen species and chelating redox-active transition 
metal ions (Lo et al., 2006). They may also function 
indirectly as antioxidants through 1) inhibition of the 
redox-sensitive transcription factors, nuclear factor-
kappaB and activator protein-1; 2) inhibition of pro-
oxidant enzymes, such as inducible nitric oxide synthase, 
lipoxygenases, cyclooxygenases and xanthine oxidase 
and 3) induction of phase Ii and antioxidant enzymes, 
such as glutathione S-transferases and superoxide 
dismutases (Frei and Higdon, 2003). White tea, having 
high levels of epigallocatechin-3-gallate (EGCG) and 
several other polyphenols than green tea has greater 
antimutagenic activity in comparison with green tea, 
perhaps due to synergistic action of major constituents or 
polyphenols with other (minor) constituents, to inhibit 
mutagen activation as well as scavenging the reactive 
intermediate(s) (Santana-Rios et al., 2001) (Table 1). 
Antioxidative properties of black tea are manifested by its 
ability to inhibit free radical generation, scavenge free 
radicals and chelate transition metal ions. Black tea, as 
well as individual theaflavins, can influence activation of 
transcription factors such as NFkappaB or AP-1. 
Theaflavins have been also proved to inhibit the activity 
of prooxidative enzymes such as xanthine oxidase or nitric 
oxide synthase (Luczaj and Skrzydlewska, 2005)(Table 4). 
Green tea polYphenols can act as a biological antioxidant 
in a cell culture experimental model and protect cells in 
culture (Park et al., 2003) and mammalian veins (Han et al., 
2003) from oxidative stress-induced toxicity. Tea 
polyphenols also possess antimutagenic activity 
(loannides and Yoxall, 2003). This protective effect of 
black tea infusions may be due to the outcome of 
antioxidative influence of tea components 
(Sengupta et al., 2003). Measurement of protection 
against DNA scissions produce results that again show 
that EGCG produces the strongest protective effects. In 
scavenging assays using a xanthine-xanthine oxidase 
(enzymatic system), epicatechin gallate (ECG) shows the 
highest scavenging potential (Pillai et a1., I999). 
Compounds isolated from green tea tannin mixture show 
that (-)-epigallocatechin 3-0-gallate (EGCg), ' (-)-
gallocatechin 3-0-gallate (GCg) and (-)-epicatechin 3-0-
gallate (ECg) had higher scavenging activities than (-)-. 
epigallocatechin (EGC), (+)-gallocatechin (GC), (-)-
epicatechin (EC) and (+)-catecliin (C), thus showing the 
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importance of the structure of flavan 3-oI linked to gallic 
acid for this activity (Nakagawa and Yokozawa, 2002). Tea 
catechins prevent the molecular degradation in oxidative 
stress conditions by directly altering the subcellular ROS 
production, glutathione metabolism and cytochrome P450 
2EI activity (Razes and John, 2007). Tea catechins and 
polyphenols are effective scavengers of reactive oxygen 
species in vitro and may also function indirectly as 
antioxidants through their effects on transcription factors 
and enzyme activities (Higdon, 2003). EGCG scavenged 
superoxide radical and 11,02 in a dose dependent manner. 
EGCG had protective effect on DNA at low concentrations 
(2-30 mM), but it enhanced the DNA oxidative damage at 
higher concentrations (>60 mM), exhibiting a prooxidant 
effect on DNA (Tian et aL, 2007). EGCG may attenuate the 
oxidative stress following acute hypoxia (Wei at al., 2004). 
Various age related diseases owing to free radical injury 
in the human body like arthritis etc. have been shown to 
be prevented by tea polyphenols in vivo (Haqqi et ol,, 
1999). 
Tea and cardiovascular health: Green tea is proposed to 
be a dietary supplement in the prevention of 
cardiovascular diseases in which oxidative stress and 
proinflammation are the principal causes (Tipoe at al., 
2007). Clinical trials employing putative intermediary 
indicators of the disease, particularly biomarkere of 
oxidative stress status, suggest tea polyphenols could 
play a very important role in the pathogenesis of cancer 
andheatt disease (McKay and Blumberg, 2002). Green tea 
and its catechins may reduce the risk of Coronary Heart 
Disease (CHD) by lowering the plasma levels of 
cholesterol and triglyceride. Studies indicate that green 
tea catechins, particularly (-)-epigallocatechin gallate, 
interfere with the emulsification, digestion and micellar 
solubilization of lipids, the critical steps involved in the 
intestinal absorption of dietary fat, cholesterol and other 
lipids (Koo and Nob, 2007) (Table 2). Continuous 
ingestion of green tea catechins from an early age 
prevents the development of spontaneous stroke in 
malignant stroke-prone spontaneously hypertensive rats 
(M-SHRSP), probably by inhibiting the further 
development of high blood pressure at later ages 
(Ikeda at al., 2007). EGCG, improves endothelial function 
and insulin sensitivity, reduces blood pressure and 
protects against myocardial isehernia-reperfusion (IIR) 
injury in spontaneously hypertensive rats (Potenza at al., 
2007). Catechin (GCg orEGCg), like the nitric oxide (NO) 
donor, may have a therapeutic use as an NO-mediated 
vasorelaxant and may have an additional protective 
action in myocardial ischemia-reperfusion induced 
injury (Hotta at al., 2006) (Table 3). Tea catechins 
with a galloyl moiety suppress postprandial 
hypertriacylglyccrolemia by delaying lymphatic transport 
of dietary fat in rats and also because postprandial 
hypettriacylglycerolemia is a risk factor for coronary heart 
disease, it is suggested suggest that catechins with a 
galloyi moiety may prevent this disease (Ikeda at al., 
2005). Acute EGCG supplementation reverses endothelial 
dysfunction in patients with the coronary artery disease 
(Widlansky at al., 2007). 
Tea and apoptosis: (-)-EGCG induces growth arrest and 
apoptosis through multiple mechanisms and can be used 
for cancer prevention, mainly pancreatic (Sharikar at al., 
2007b). EGCG could induce apoptosis in vivo in Sarcoma 
180 cells through alteration in G2/M phase of the cell 
cycle by up-regulation of p53, bax and down-regulation of 
c-myc, bcl-2 and U1B, U4-U6 UsnRNAs (Manna at al., 
2006) (Table 2). EGC inhibits DNA replication and 
consequently induces leukemia cell apoptosis (Smith and 
Doti, 2001). EGCG can induce apoptosis of the human 
gastric cancer cell line MKRT45 and the effect is in a time-
and dose-dependent manner. The apoptotic pathway 
triggered by EGCG in MKN45 is mitochondrial-dependent 
(Ran et aL, 2007). The O-acetylated (-)-EGCG analogs 
possessing a p-NH(2) or p-NHBoc (Boc; tert-
butoxycarborryl) D-ring (5 and 7) act as novel tumor 
cellular proteasome inhibitors and apoptosis inducers 
with potency similar to natural (-)-EGCG and similar to 
(-)-EGCG peracetate (Osanai et al., 2007). (-)-EGCG might 
prevent alveolar bone resorption by inhibiting 
osteoclast survival through the caspase-mediated 
apoptosis (Yun at al., 2007). EGCG treatment has a dose-
dependent effect onROS generation and intracellular ATP 
levels in MCF-7 cells, leading to either apoptosis or 
necrosis and that the apoptotic cascade involves INK 
activation,' Bax expression, mitochondrial membrane 
potential changes and activation of caspase-9 and 
caspase-3 (Hsuuw and Chan, 2007). Interesting results 
has been obtained in a study that EGCG inhibits cardiac 
myocyte apoptosis and oxidative stress in the pressure 
overload induced cardiac hypertrophy. Also, EGCG 
prevents cardiomyocyte apoptosis from oxidative stress 
in vitro. The mechanism may be related to the inhibitory 
effects of EGCG on p53 induction and bcl-2 decrease 
(Sheng at al,, 2007), EGCG induces apoptosis in human 
prostate carcinoma cells by shifting the balance between 
pro- and antiapoptotic proteins in favor of apoptosis 
(Hastak et al., 2003). Tea catechins have ability to 
produce H2O, and that the resulting increase in H202 
levels triggers Fe(H)-dependent formation of highly toxic 
hydroxyl radical, which in turn induces apoptotic cell 
death (Nakagawa at al., 2000). 
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Anti-microbial effectsoftea: GreenteacatechinsECG, CG 
and EGCG increase the sensitivity of methicillin-resistant 
Staphylococcus aureus (EMRSA-15) to oxacillin 
(Table 1-3). The gallate moiety was essential for the 
oxacillin-modulating activity of (-)- ECG (Stapleton et al., 
2004). (-)-ECG alters the architecture of the cell wall of 
Staphylococcus aureus causing beta-lactam-resistance 
modification (Stapleton et al., 2007). Catechin gallates 
inhibit multidrtug resistance (MDR) in Staphylococcus 
aureus (Gibbons of al., 2004) (-)-ECG also reduces 
halotolerance in Staphylococcus aureus suggesting that 
this molecule can be used to aid the preservation of salt-
containing foods (Stapleton etal., 2006) (Table 3). Crude 
extract of green tea as well as two of its main constituents, 
EGCG and ECG, strongly inhibit Plasmodiumfalciparum 
growth in vitro (Saiunella etal., 2007). Green tea catechins 
inhibit bacterial DNA gyrase by interaction with its ATP 
binding site (Gradisar et al., 2007). EGCG is effective in 
reducing acid production in dental plaque and mutans 
Streptococci. EGCG and epicatechin gallate inhibits 
lactate dehydrogenase activity much more efficiently than 
epigallocatechin, epicatechin, catechin or gallocatechin, 
(Hirasawa et al., 2006). The 3-galloyl group of catechin 
skeleton plays an important role on the observed antiviral 
activity against influenza virus (Song et al., 2005). Green 
tea catechins have been found to exhibit anti-
Trypanosoma cruzi activity, suggesting that these 
compounds could be used to sterilize blood and, 
eventually, as therapeutic agents for Chagas disease 
(Paveto et al., 2004). EGCG has anticandidal activity 
causing blockage of the hyphal formation and has the 
synergism combined with Amp B against disseminated 
candidiasis (Han, 2007). EGCG has potential use as 
adjunctive therapy in HIV-1 infection owing to its 
binding to the T-cell receptor, CD4 (Williamson et al., 
2006).Tea catechins possess antifolate activity also 
(Navarro-Peran et al., 2005). EGCG exhibit antifolate 
activity against Stenotrophomonas maltophilia (Navarro-
Martinez etal., 2005). 
Tea consumption and weight loss: Molecular mechanisms 
of fatty acid synthase gene suppression by tea 
polyphenols (EGCG, theaflavins) may bring down-
regulation of EGFRIPI3K/Akt/Sp-1 signal transduction 
pathways, suggesting hypolipidemic and anti-obesity 
effects of tea and tea polyphenols (Lin and Lin-Shiau, 
2006) (Table 1). Green tea extract intake is associated with 
increased weight loss due to diet-induced thermogenesis, 
which is generally attributed to the catechin 
epigaIlocatechin gallate (Shixian et al., 2006). 
Neuroprotective effect of tea: Green tea polyphenols have 
demonstrated neuroprotectant activity in cell cultures and 
animal models, such as the prevention of neurotoxin- 
induced cell injury (Pan et al., 2003). Recent findings from 
in vivo and in vitro studies concerning the transitional 
metal (iron and copper) chelating property of green tea 
and its major polyphenol, (-)-epigallocatechin-3-gallate, 
suggests its potential role in the treatment of 
neurodegenerative 	diseases (Mandel et al., 2006) 
(Table 2). EGCG may exhibit protective effects against 
advanced glycation endproducts (AGES) induced injury 
in neuronal cells, through its antioxidative properties, as 
well as by interfering with AGEs-AGE receptor (RAGE) 
interaction mediated pathways, suggesting a beneficial 
role for this tea catechin against neurodegenerative 
diseases (Lee and Lee, 2007). Catechin gallates (through 
the galloyl moiety) contribute to the neuroprotective 
effects of both green and black teas.Not only green but 
also black teas may reduce age-related neurodegenerative 
diseases, such as Alzheimer's disease (Bastianetto et al., 
2006). 
CONCLUSION 
Animal and in vitro studies have provided evidence 
that the polyphenols found in tea may inhibit 
tumorigenesis in many animal models, including those for 
cancer of the skin, lung, oral cavity, oesophagus, 
stomach, small intestine, colon, liver, pancreas, bladder 
and prostate. The suggested mechanism of action 
includes the following; 
• Antioxidant activity and scavenging free radicals 
• Modulating enzymes implicated in the carcinogenic 
process 
• Modifying the pathways of signal transduction, 
thereby positively altering the expression of genes 
involved in cell proliferation, angiogenesis and 
apoptosis, all important stages of cancer 
progression. 
• Antimicrobial actions (association between 
Helreobaeter pylori and gastric cancer) 
Many studies on health benefits of tea have been 
linked to the catechin content Epicatechin can reduce the 
risk of four of the major health problems: stroke, heart 
failure, cancer and diabetes. For cancer prevention, 
evidence is so overwhelming that the Chemoprevention 
Branch of the National Cancer Institute has initiated a 
plan for developing tea compounds as cancer-
chemopreventive agents in human trials (Siddiqui et al., 
2004). Thus, epicatechin should be considered essential 
to the diet. While the exact mechanisms of action are still 
F 
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unknown, these studies provide possible explanations. 
The possible beneficial health effects of tea consumption 
have been suggested and supported by some studies, but 
others have found no beneficial effects. The studies show 
contrast with other claims, including antinutritional effects 
such as preventing absorption of iron and protein, usually 
attributed to tannin. It is reasonable to conclude that 
drinking both the green and black tea is compatible with 
healthy dietary advice in helping to reduce the risk of 
cancer development, helping to maintain overall health 
and well-being. 
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